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Abstract 
A Dialogue of the Deaf: The rise and stall of harm reduction policy 
in Australia from 1980 to 2000. 
In the 1980s, a new policy approach to illicit drug use was established. This 
philosophy of 'harm reduction' was in stark contrast to traditional abstinence—
oriented drug policy and was developed primarily by medical professionals working 
with affected communities. Since its implementation, harm reduction has attracted 
criticism, with the suggestion that such services that reduce the risk of illicit drug 
use, in contrast with policy that encourages abstinence toward illicit drugs, result in 
socially pathological results for society. Debates between supporters of harm 
reduction and abstinence-oriented approaches often result in a deadlock, given such 
fundamental disagreement over 'deep core' values. 
This research applies the Advocacy Coalition Framework (ACF), developed by Paul 
Sabatier and Hank Jenkins-Smith, to explain the pattern of implementation of harm 
reduction policies in Australia in the period from 1980 to 2000. The ACF is 
principally focused on explaining how major policy change occurs, with emphasis on 
the role of technical information in learning between coalitions. The ACF has 
largely been applied to examination of environmental policy development, and this 
research evaluated the utility of the ACF to comprehending change in social policy 
systems. 
The ACF was generally an adequate theory to comprehend illicit drug policy 
developments between 1980 and 2000. The theory adequately described policy 
oriented learning between coalitions, the notion of advocacy coalitions and 
explaining major policy change. This research found that discord between coalitions 
regarding the validity of information in subsystems occurred at a deeper level than 
expected. Moreover, the nature of the problem area was subject to more change than 
allowed for in the ACF's emphasis on stable system parameters. The thesis 
concludes by offering some direction for future developments with regard to the 
ACF when applied to analysing change in social policy arenas. 
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Introduction 
There is little doubt that the dominant response to the proliferation of injecting drug 
use in most Western states is one underwritten by a moral philosophy that regards 
such use as both indulgent and highly dangerous to both the individual and society. 
Similarly, there is little doubt that this perspective will continue to remain the 
dominant approach taken by Australian governments, at least in the medium term. 
This is because prohibition of drugs is a highly entrenched policy position that enjoys 
a considerable degree of support from the electorate. The policy of prohibiting drugs 
such as heroin and amphetamines, as an approach to reduce their supply into society, 
has largely been unchallenged since its inception in the early twentieth century. 
Indeed, there seems to be widespread and ongoing consensus from both the public 
and policy-makers that prohibition is a highly necessary policy instrument. 
An alternative policy approach does, however exist, and poses (at least in the early 
stages of its development) a challenge to prohibition. This harm reduction approach, 
(whereby services are provided that have an overall aim to reduce the risks of illicit 
drug use without requiring a reduction in use), entered the drug policy arena in the 
early 1980s in several Western states amid a public health crisis and reports of 
increasing health and social problems associated with drug use. While the harm 
reduction approach has a relatively secure place in illicit drug policy, it ,often faces 
challenges from a section of stakeholders that suggest the very foundations of the 
approach generate socially pathological effects. The controversy surrounding the 
philosophy of harm reduction programs often compromises so-called rational debate 
and scholarly exchange of research and information. The issue of illicit drug use is 
often underwritten by highly emotive opinions and ideas borne from linkages of the 
issue to religious and cultural systems. Indeed, the illicit drug policy arena is a 
dynamic system in which rational information (such as that borne from scientific 
research) competes with faith and morality-based notions, with the latter carrying 
more political weight than in most other policy arenas. 
Currently in Australia, illicit drug policy is at am impasse, and has arguably been so 
for close to a decade. While harm reduction programs instigated in the 1980s in 
response to HIV/AIDS continue to operate, more recent efforts to implement further 
programs have been unsuccessful. In contrast to transmission rates of human 
immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), 
the prevalence of the hepatitis C virus (HCV) has skyrocketed among injecting drug 
users. It seems that there are limits to the capacity of harm reduction policy (enacted 
in the Australian context) to not only contain transmission of HCV but also to 
expand to implement initiatives beyond that initiated in the 1980s. The advocacy 
coalition framework (ACF), developed by Paul Sabatier and Hank Jenkins-Smith' 
will be employed to examine the development, implementation and advocacy of 
harm reduction policy in Australia in the period 1980 to 2000. Of particular interest 
are instances of successful and unsuccessful bids by proponents of harm reduction 
programs at achieving policy change, with the overall aim of examining the 
strategies employed by supporters of harm reduction in order to convert beliefs into 
policy. 
1 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', Journal 
of European Public Policy, 5:1, March, p99. 
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Aims of the research 
This thesis has three key aims. First, the research seeks to understand the nature of 
policy change in the illicit drug policy subsystem in Australia between 1980 and 
2000. More specifically, it provides an examination of how harm reduction 
approaches became incorporated into Australian federal and state public policy. A 
key focus of the research is an identification of the strategies used by advocates to 
realise policy objectives. This research is principally concerned with the way in 
which key ideas of harm reduction have been accepted or rejected and the factors 
affecting policy change. Policy change will be analysed through the lens of the ACF 
that facilitates an identification of the stakeholders, their ideas and strategies used to 
realise policy. Such an endeavour contributes further to the literature on both illicit 
drug policy making, as well as the development of (illicit drug) public policy in the 
Australian context. 
In a second aim, this thesis seeks to provide direction on possible further 
development of the ACF with regard to its application to social systems. The vast 
majority of applications of the ACF have been with regard to natural systems such as 
water or forestry policy. Thus, this research will provide an evaluation of the ACF 
when applied to social policy settings (for example: arenas such as health, 
unemployment, welfare or drug policy) which are characterised by discussions of 
human nature and in which the underlying causes of policy problems are highly 
contested. Moreover, such social phenomena are not always conducive to 
measurement (due to the illegality of some behaviours), and further, consensus on 
the appropriate epistemological tools to evaluate policy is often the topic of disputes. 
Such social policies can be contrasted to policy directed at natural systems whereby 
3 
the scientific approach is accepted as the mechanism to understand the nature of the 
policy problem. 
The third aim of this thesis is to provide insight into the theory and practice of harm 
reduction ideas, identifying and evaluating the triumphs and defeats of those that 
advocate for such an approach. Through this endeavour, the 'political limits' of such 
a controversial policy approach will be discussed. Moreover, the evolution of the 
concept when integrated into mainstream drug policy will also show how such ideas 
'fit' when acting as a reluctant bedfellow with prohibition ideas. As such, the 
application of the ACF in this policy context is novel, and will extend existing work 
in this area. 
Why Illicit Drug Policy? Why the Advocacy Coalition Framework? 
Injecting drug use is a contentious and ongoing issue in Australia as the severity of 
drug related problems has not decreased (and in some cases increased substantially) 
since the mid-1980s, with little progress predicted on the horizon. While there have 
been minor changes to policy in the previous decades, the overarching outlook of 
policy has not evolved much since the mid-1980s despite changes to illicit drug 
markets, the identification of new diseases and harms associated with drug use and 
the production of much research and scientific endeavour devoted to this subject 
area. Indeed, since the 1970s, drug-related problems have been evaluated in many 
Royal Commissions, reviews, Inquiries and have periodically been subject to a high 
level of interest from the media and various state and federal Governments in 
Australia. In the 1980s, major policy change occurred in the illicit drug policy 
subsystem whereby implementation of a national framework enshrined the 'harm 
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minimisation' approach. In this context the harm minimisation approach consisted 
of a combination of supply (law enforcement), demand (anti-drug education) and 
harm reduction (services for those that continue to use drugs). 
The combination of the seemingly antagonistic policy mix of prohibition (an 
approach that seeks to reduce the instance of drug use) and harm reduction (an 
approach that provide services for existing drug users) combined to produce a policy 
that at times seems both incoherent and a shrewd political device that represents the 
majority of diverse stakeholders. Arguably, harm reduction's place in the overall 
policy schema is at odds with the dominant disposition of drug policy that is geared 
to reducing the supply of drugs and prevalence of use. This thesis seeks to explore 
this uneasy relationship with a focus on the politics of harm reduction. Such an 
exploration will provide insight into why harm reduction policy has stagnated in 
Australia and the barriers to further policy change. Such research is worthy of the 
attention of scholars in this field in order to better understand the nature of this policy 
deadlock. 
Another reason for conducting this research is to fill a substantial research gap - 
namely the analysis of Australian illicit drug policy through the lens of public policy 
theory. While much writing on Australian illicit drug policy has occurred, the 
majority has been descriptive, with a relative dearth of critical analyses using public 
policy theory. Trevor King has examined types of public policy tools when applied 
to drug police and indeed wrote a thesis on comparing methadone policy 
2 King, T., 1998, 'The Search for Rationality in Illicit Drug Policy', in M., Hamilton, A., Kellehear & 
G., Rumbold (Eds), Drug Use in Australia: a harm minimisation approach, Oxford University Press, 
Melbourne, p145-158. 
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development in several countries. 3 Apart from these examples, theories of public 
policy have not been applied to analyse policy change in the Australian illicit drug 
policy arena. The ACF has never been applied to analyse any policy system in 
Australia, and has only been employed to analyse drug policy in a single country, 
namely Switzerland in the work of Kubler. 4 Moreover, to date, the ACF has been 
largely utilised to examine natural systems such as particular aspects of 
environmental policy (water and forest policy to name two). 5 The ACF is relevant to 
this highly contentious subject area because of its particular focus on the interplay 
between beliefs, ideas and the role of technical information in terms of policy 
change. 
Traditionally, drug policy is typically underwritten by morality based information 
with rational/scientific information increasingly playing a role in recent decades, 
however, the influence of scientific/rational information is still somewhat limited, 
especially when contrasted to that in natural systems. Ergo, this research should 
challenge the model of the ACF when examining the debate regarding differing 
epistemological stances in drug policy, especially as the ACF makes key 
assumptions on the role of quantitative/technical information in policy change. 
Moreover, this research should contribute to an exploration of how the ACF 
performs in arenas whereby quantitative information and scientific endeavour are 
relatively less compelling in comparison to other systems. Sabatier has contended 
that the ACF should perform well when applied to social systems. 6 This thesis 
3 King, T., 1994, A Comparative Analysis of Methadone Policy Development in the US, the UK, the 
Netherlands and Victoria, Australia, MA Thesis, La Trobe University, Melbourne. 
4 Kubler, D., 2001, 'Understanding policy change with the Advocacy Coalition Framework, Journal 
of European Public Policy, Volume 8, No. 4, pp623-641. 
5 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', Journal 
of European Public Policy, 5:1, March, p100-101. 
6 Sabatier, P., & Jenkins Smith, H., 1999, 'The Advocacy Coalition Framework: An Assessment, 
Theories of the Policy Process, P., Sabatier (Ed), Westview Press, Boulder. 
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examines that assertion in depth by both evaluating a number of the core principles 
of the ACF and its utility to explain changes to illicit drug policy. 
Indeed, the subjects discussed in this thesis often go beyond that of illicit drug policy 
to examine wider concepts such as the types of groups in society that are deserving 
or undeserving of public funds and the nature of morality based arguments when 
contrasted with rational/scientific ones. In sum, this research examines the limits of 
political acceptability of harm reduction ideas and the seemingly inability of 
Governments to curb and contain HCV and other drug related problems through the 
lens of the ACF. Thus, the identification of the limits of harm reduction and the role 
of scientific/rational information in drug policy debates will provide insight into the 
deadlock in illicit drug policy that often characterises debates regarding solutions to 
ongoing drug-related problems. 
Research Design 
This research employs the advocacy coalition framework as a theoretical lens to 
examine illicit drug policy in Australia from 1980 to 2000. This theory seeks to 
engender a coherent understanding of all the major steps (problem definition, policy 
formulation, implementation and revision) that feature in the policy process. The 
ACF is principally geared to allow examination of policy change in discrete policy 
subsystems and provides a framework for determining the conditions in which 
change occurs. 
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Implicit within the ACF is the importance of the examination of information that is 
used to support various policy alternatives in key texts. Such texts use such 
information to both describe the rationale of, and approach to, a given problem. 
Theories of the policy process need to address the role that 
technical information concerning the magnitude and facets 
of the problem, its causes, and the probable impacts... of 
various solutions play in this process. This is what the vast 
majority of discussion among policy elites is about and, 
assuming a modicum of rationality on their part, it must be 
important.' 
Key documents used in this thesis include: primary accounts from bureaucrats, key 
actors and stakeholders (some expressed in secondary sources) as well as secondary 
sources such as: the numerous Royal Commissions into drugs; National Drug 
Strategies; Evaluations of National Drug Strategies (1989 and 1997); National 
HIV/AIDS Strategies (1989 and 1996); National Methadone Policy; National 
Hepatitis C Strategy; reviews of HCV policy; state and territory government reports 
on drug policy and position papers; Australian Bureau of Criminal Intelligence 
reports; reports from Parliamentary committees; reports from international groups 
such as the World Health Organisation; conference papers; Hansard records; 
transcripts of discussions that occurred in peak meetings (for example the 1999 
NSW Drug Summit); media articles; electronic sources such as websites from lobby 
groups; reports from local councils in Australia; research and commentary in journal 
articles and books written on the subject. Such position papers are subject to textual 
analysis to understand the way in which policy problems were defined and the 
prescription of solutions. 
7 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', Journal 
of European Public Policy, 5:1, March, p99. 
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The subject of this research is illicit drug policy in Australia and more specifically, 
policy concerned with injecting drug use in particular, therefore, cannabis policy is 
not included. While many injecting drug users are often cannabis users, this 
association does not hold in the reverse. Indeed the Australian Health and Welfare 
Institute in the 2004 National Drug Strategy Household Survey estimated that 33.6% 
of Australians have used cannabis in their lifetimes in comparison to an estimate of 
2.3% of Australians that have tried heroin at least once in their lifetimes. 8 Moreover, 
harms resulting from cannabis use generate, to a degree, a different risk profile to 
intravenous drug use- for example, the transmission of blood borne viruses (BBVs) is 
not associated with cannabis use. The predominant illicit drugs of interest in this 
research are hence of the injectable variety, such as heroin and other opiates (for 
example morphine), amphetamines, and to a lesser extent, benzodiazepines. This 
thesis is not concerned with an analysis of each particular drug type listed above and 
the associated drug related harms and policy responses, rather it subsumes all 
injectable drugs under one category unless stated otherwise. The issue of injecting 
drug use was chosen to test the merits of the ACF when applied to the analysis of 
social problems because this activity attracts a high level of emotive and morally-
driven exchanges between policymakers and stakeholders, concerning highly 
marginalised people. Indeed, this thesis is focused on examining the most 
confronting aspect of illicit drug use, being the practice of intravenous 
administration, and the policy responses from Government agencies toward this 
activity. As such, this thesis examines the politics of advocating for services to make 
injecting drug use less risky, which for some is considered unacceptable as it is 
considered a first step of normalising such an activity. A definition of the illicit drug 
policy subsystem under examination is offered in chapter two. 
8 Australian Institute of Health and Welfare, 2004, National Drug Strategy Household Survey, Drug 
Statistics Series, No. 16, Canberra. 
9 
The research also takes a focus on a particular drug policy instrument, being the 
harm reduction approach. The research does not seek to explain in depth all facets of 
drug policy such as law enforcement, treatment modalities, or demand reduction 
interventions such as school drug education. Specifically, this research is concerned 
with an examination of the emergence and evolution of harm reduction theory and 
practice. While such an approach has origins (explored in chapter three) in medical-
scientific fields, it is a distinct approach to, for example, the medical model of 
addiction whereby dependencies are regarded as a type of illness. It is clear however 
that proponents of harm reduction support the notion that drug use is a health issue 
rather than a criminal issue, and moreover, seek to ameliorate public health issues 
that may arise from illicit drug use. Ultimately this research is focussed on harm 
reduction rather than generic 'medical' approaches to drug use. 
Similarly, in this thesis, there are numerous references to law enforcement, 
prohibition and the idea of a coalition of actors that support 'moral abstinence' 
oriented approaches to drug policy. While all three terms are linked, it is not 
assumed that all law enforcement personnel support all abstinence-oriented drug 
policy (whether this refers to abstinence-oriented treatment, drug laws or anti-drug 
education). It is recognised, however, that the overall aim of prohibition as a policy 
instrument is to reduce (with the absolute aim of eliminating) the supply of illicit 
drugs into society. Thus prohibition and law enforcement are the operational 
manifestation of 'moral abstinence' ideas in drug policy that seek to eliminate the 
instance of injecting drug use. Within the moral abstinence approach to drug policy 
there are, of course, many degrees of intensity in theory and practice. Indeed, it is 
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the section of supporters of this approach that directly opposes harm reduction ideas 
that is the main focus of interest. 
A synthesis of the analysis of both federal and state policy occurs in chapters three to 
five. While states have the authority to make policy such as whether to instigate 
initiatives such as supervised injecting centres (SICs), needle and syringe programs 
(NSPs) or to change drug laws, the Australian Goveniment 9 does provide a national 
framework in which health and law enforcement sectors collaborate to make policy 
and/or set policy directions. At times, in this thesis however, particular Australian 
states are granted more attention as the debate or issue being discussed is located 
within their jurisdiction. 
What is harm reduction? 
The notion of harm reduction is often used interchangeably with the term 'harm 
minimisation', however, in Australia the terms have distinct meanings in illicit drug 
policy. In the context of federal policy, 'harm minimisation' refers to an overarching 
philosophy or principle that is used to describe the mixture of policy tools deployed 
in Australian illicit drug policy. As mentioned above, harm minimisation describes 
the mixture of supply, demand and harm reduction tools. Therefore, law 
enforcement and drug education in schools as well as NSPs are all subsumed as part 
of the overarching philosophy of harm minimisation. Indeed, the very mix of these 
tools is considered to constitute Australia's 'harm minimisation approach' to drug 
policy. In contrast, harm reduction refers to a specific set of ideas manifested in 
policies and programs such as NSPs, safer drug using education, SICs and 
9 'Australian Government' refers to the national level of Government, formerly known as the 
'Commonwealth Government'. 
11 
methadone maintenance treatment (MMT). Such a term does not encompass law 
enforcement or drug education in which the overall aim is reductions in the 
prevalence of drug use. Rather, the key principle of harm reduction is reducing the 
risks for current drug users and this is conducted through measures such as the 
provision of: sterile injecting equipment to discourage the instance of needle sharing 
and consequently the transmission of BBVs such as the human immunodeficiency 
virus and acquired immune deficiency syndrome (HIV/AIDS) and Hepatitis C virus 
(HCV); safe places to inject in order to to reduce overdoses and the hazards of public 
injection; and, education about how to limit the risks when injecting. 
While there are many different perceptions of what the term harm reduction means, 
five core principles of harm reduction can be identified. First, at the core of harm 
reduction is a focus on addressing the consequences of drug use as a greater goal 
than reducing the prevalence of the activity: 
...the essential feature of harm reduction is the attempt to 
ameliorate the adverse health, social, or economic 
consequences associated with the use of mood-altering 
substances without necessarily requiring a reduction in the 
consumption of these substances.' 
In contrast to traditional approaches to drug use, staff in harm reduction programs do 
not attempt to dissuade injecting drug users from their illicit drug use, rather the 
focus is on reducing the negative consequences of illicit drug use. Second, harm 
reduction theory and practice espouses a value-neutral position on drug use, whereby 
the use of illicit drugs (including the practice of injecting drug use) and the drugs 
themselves are not endowed with negative or positive connotations. Again, such a 
position contrasts with law enforcement interventions that seek to reduce the supply 
to  Inciardi, J., & Harrison, L., 2000, 'Introduction: The Concept of Harm Reduction', in Inciardi & 
Harrison (eds), Harm Reduction: National and International Perspectives, Sage, California, pviii. 
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of illicit drugs into the community on the basis that such drugs are inherently 
destructive. Related to this value-neutral position of harm reduction regarding drug 
use is an underlying morality in which the drug user is treated with respect. Again, 
this is in contrast with other approaches that have the effect of marginalising and 
penalising drug users through incarceration or other sanctions in an effort to affect 
behavioural change in drug users towards abstinence. 
Third, harm reduction interventions are informed by evidence-based information. 
Evaluations of the efficacy of programs and scientific approaches to understanding 
drug use and associated harms are the cornerstone of harm reduction practice. 
Indeed, alongside the development of harm reduction theory and practice has been 
the production of a suite of rigorous peer-reviewed research to better understand the 
complex issue of drug use. This is in contrast with other morality-based approaches 
(such as law enforcement and anti-drug education) whereby scientific information is 
less persuasive or at least occupies a submissive role to morality-based information. 
Fifth, harm reduction also has a different view towards the phenomena of drug use in 
society. To an extent, supporters of harm reduction believe that some level of drug 
use is inevitable and normal in society. Moreover it is also recognised by some harm 
reduction writers that drugs provide not only costs to the user but also clear 
benefits.' 1 This last contention, about the nature of drug use, is a somewhat 
controversial point and is a major point of difference between those interested in 
drug policy. Moreover, harm reduction advocates (at least in the academic realm) 
note the ongoing occurrence of drug use through time and reflect on the human's 
attraction to mind-altering substances as a relatively normal activity. 
II Riley, D., O'Hare, P., 2000, 'Harm Reduction: History, Definition and Practice', in Inciardi & 
Harrison (eds), I-farm Reduction: National and International Perspectives, Sage, California, p6. 
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Indeed, the extent to which harm reduction is a political movement with an 
underlying agenda to affect widespread change in the populace regarding attitudes to 
drugs (rather than simply a term to describe certain policies and programs) is a key 
ongoing question for advocates. When thinking about the concept of harm reduction, 
some writers suggest that harm reduction is a political movement that seeks to 
change mainstream thinking about illicit drugs in its own right: 
...harm reduction accepts the reality of both the desire for 
drugs by millions of people and the related fact that many 
of these individuals may be harmed by their use of drugs... 
people should be allowed to make choices — to use drugs in 
either relatively harmless ways or in very destructive ways, 
or to use no drugs at all. Regardless of their choice, they 
must not be treated as enemies of the state if they encounter 
trouble as a result of their drug use, help should be 
available to them. 12 
Others regard harm reduction as complementary to traditional approaches to illicit 
drug use and perceive: 
...harm reduction as an alternative to both drug prohibition 
and drug legalization. Harm reduction.. .seeks to preserve 
prohibition while softening some of its harsh 
consequences... as such harm reduction is a compromise 
position with the aim of reducing aspects of drug related 
harm. 13 
In this view, harm reduction is limited to ameliorating the consequences of drug 
related problems without any longer term political agenda. Others regard harm 
reduction as a goal rather than as a policy or program: 
12 Trebach, A., & Inciardi, J., 1993, Legalize it? Debating American drug policy, American University 
Press, Washington DC, p77. 
13 Inciardi, J., & Harrison, L., 2000, 'Introduction: The Concept of Harm Reduction', in Inciardi & 
Harrison (eds), Harm Reduction: National and International Perspectives, Sage, California, pviii. 
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Harm reduction is a goal for policies and programs; it is a 
willingness to trade potential increases in drug use for 
potential decreases in drug related harm. 14 
In this example, harm reduction is seen as a measurable outcome for policies and 
programs. The second part of the quote points to a potential (longer term and very 
controversial) outcome whereby harm reduction (in theory) may result in an increase 
in the number of drug users while concurrently reducing aggregate risk of the activity 
for all users. Harm reduction can also be a theoretical framework whereby the harms 
from both licit and illicit drug use can be calculated: 
The harm reduction approach attempts to identify, measure 
and minimize the adverse consequences of drug use at a 
number of levels, not just that of society as a whole. In a 
harm reduction framework, the term risk is used to describe 
the probability of drug-taking behaviour resulting in any of 
a number of consequences. The terms harm and benefit are 
used to describe whether a particular consequence is 
viewed as positive or negative. In most cases drug taking 
behaviours result in several kinds of effects: beneficial, 
neutral and harmful. The consequences of drug use can be 
conceptualized as being three main types: health (physical 
and psychological), social and economic. The 
consequences can be said to occur at three levels: 
individual; community (family, friends, colleagues etc.) 
and societal (the structures and functions of society). They 
can also be broken down with respect to the time of their 
occurrence, into short-term and long-term effects.. .the 
harm reduction framework can be used as a means of better 
objectifying the evaluation process with respect to both 
drug programs and policies by allowing the identification 
of harms.. 15 
Therefore, the meaning of harm reduction is often contested, subjective and 
contingent on the context in which it is deployed. Descriptions of harm reduction 
programs and services follow • in order to illustrate the manner in which harm 
reduction ideas are applied in policy. 
14 ibid. 
15 Riley, D., O'Hare, P., 2000, 'Harm Reduction: History, Definition and Practice', in Inciardi & 
Harrison (eds) Harm Reduction: National and International Perspectives, Sage, California, p2. 
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So what is harm reduction in practice? 
Needle and syringe programs (NSPs), methadone maintenance treatment (MMT) and 
supervised injecting centres (SICs) are examples of harm reduction programs and 
services directed toward current injecting drug users. All these services aim to make 
injecting drug use less risky for both the individual and society. The quintessential 
harm reduction service is the NSP. First established in Europe in the mid 1980s," 
such programs provide sterile injecting equipment to injecting drug users with the aim 
of reducing transmission rates of BBVs. Moreover, NSPs also provide other services 
such as safer using education (for example: how to inject properly to avoid BBV 
transmission and vein damage), referrals to mainstream services and general outreach 
services!' The provision of sterile injecting equipment and safer using education is 
regarded as an effective way to reduce transmission rates of HIV/AIDS and HCV, 
moreover, such reductions should mean savings in public health budgets in the longer 
term. 
Many studies have reinforced the link between increased syringe availability and a 
decrease in risk (for example, less sharing of injecting equipment) as well as decreases 
in harm (for example, a lower incidence of HIV/AIDS infection, or increased access by 
marginalised people to medical practitioners)." Safer using education material (both 
16 The first NSP was enacted to respond to rising rates of Hepatitis (not Hepatitis C) in the 
Netherlands. Riley, D., O'Hare, P., 2000, 'Harm Reduction: History, Definition and Practice', in 
Inciardi & Harrison (eds), Harm Reduction: National and International Perspectives, Sage, 
California, p10. 
17 ibid. 
18 Hart, G., Carvell, A., Woodward, N., et. al., 1989, 'Evaluation of needle exchanges in central 
London: Behaviour change and anti-HR/ status over 1 year', AIDS, 3, pp261-265; Jurgens, R., 1996, 
'HIV/AIDS in prisons: Final report', Canadian HIV/AIDS Legal Network and Canadians AIDS 
Society, Montreal; Lurie, P., & Reingold, A., (eds), 1993, The public health impact of needle 
exchange programs in the United States and abroad, University of California Press, Berkley; Rana, 
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written and verbal) are core strategies used by staff at NSPs to instruct the user about 
how to reduce the risks associated with injecting drug use such as: where to inject (for 
example: difference between veins and arteries) and how to keep healthy (for example: 
filtering drugs to avoid vein damage, using a sterile syringe every time to avoid 
transmission of HIV/AIDS or HCV). Such an approach is based upon: 
...a knowledge and means approach to behavioural change: 
People are provided with information about the changes 
that are needed and also with the means to bring about this 
change (sterile needles, syringes...and condoms). 19 
MMT is another harm reduction strategy, the aim of which is stabilisation of the 
lifestyle and drug use of opiate dependent people and eventual reintegration back into 
the mainstream. The chaotic lifestyles of opiate dependent people often means that the 
process of procuring the drug is associated with harms such as: committing crime to 
pay for the drug; associating with criminal networks; and that the illegality of the 
activity leads to injecting quickly in public places to avoid detection, sharing needles 
and so on. Many studies have shown that MMT is effective at reducing morbidity, 
mortality, HIV/AIDS transmission and users' involvement in crime. 20 
S., 1996, 'Harm reduction in Asia', AHRN Newsletter, 1, pp4-6; Robertson, J., 1990, 'The Edinburgh 
epidemic: A case study', in J. Strang & G. Stimson (eds), AIDS and drug misuse, Routledge, London, 
pp95-107; Stimson, G., 1989, Syringe exchange programs for injecting drug users, AIDS, 3, pp253- 
260; Stimson, G., 1997, Harm Reduction in practice: How the UK avoided an epidemic of HIV 
infection in drug injectors, paper presented at the Eighth International Conference on the Reduction of 
Drug Related Harm, Paris; Stimson, G., Alldritt, L & Dolan, K et. al., 1988, Injecting equipment 
exchange schemes, Final Report, Monitoring Research Group, Goldsmiths' College, London; van den 
Hoek, J., van Haastrecht, H., Coutinho, R., 1989, 'Risk reduction among intravenous drug users in 
Amsterdam under the influence of AIDS', American Journal of Public Health, 79, pp1355-1357; 
Wodak, A., 1990, 'AIDS and injecting drug use in Australia: A case control study in policy 
development and implementation', in J. Strang & G. Stimson (eds) AIDS and drug misuse, Routledge, 
London, pp132-141; Wodak, A., 1996, Harm Reduction works, Paper presented at the Harm 
Reduction Satellite to the XIth International Conference on AIDS, Vancouver. 
19 ibid., p10. 
20 Ball, J., & Ross, A., 1991, 'The effectiveness of methadone maintenance treatment', Springer-
Verlag, New York; Dole, A., 1989, 'Methadone treatment and the AIDS epidemic', Journal of the 
American Medical Association, 262, pp1681-1682; Fazey, C., 1992, 'Heroin Addiction, crime and 
treatment', in P O'Hare, R Newcombe, A. Matthews, E Buning & E Drucker (eds), The reduction of 
drug related harm, Routledge, New York, pp154-161; Gossop, M., 1978, 'Review of the evidence for 
methadone maintenance as a treatment for narcotic addiction', Lancet, 1, pp812-815; Newman, R., 
1987, 'Methadone maintenance: it ain't what it used to be', British Journal of Addiction, 71, pp183- 
17 
In all countries one of the key factors underlying the success 
of methadone as a harm reduction measure is that it brings the 
user back into the community rather than treating him or her 
like an outsider or a criminal. This not only allows for 
rehabilitation of the user but it also means that the drugs and 
crime cycle can be broken. 21 
Following the same rationale, in the United Kingdom doctors have prescribed such 
drugs as oral methadone and, to a lesser extent, injectable methadone, injectable heroin 
or amphetamines, cocaine and other drugs. 22 
SICs are another example of harm reduction ideas in practice. Such facilities have 
been operational in Europe since the 1980s 23 and provide a place to inject illicit drugs 
under medical supervision. Increasing rates of fatal overdoses and public order issues 
associated with public heroin injection are two reasons why SICs were initiated. 24 
These facilities dispense sterile injecting equipment and are staffed by qualified 
professionals (usually with medical backgrounds) who provide information and 
referrals for drug users to mainstream services if requested. 25 In the European context 
186; Newman, R., 1987, Methadone treatment, New England Journal of Medicine, 317, pp447-450; 
Rana, S., 1996, Harm Reduction in Asia, AHRN Newsletter, 1, pp4-6; Wodak, A., 1990, 'AIDS and 
injecting drug use in Australia: A case control study in policy development and implementation', in J. 
Strang & G. Stimson (eds) AIDS and drug misuse, Routledge, London„ pp132-141; Wodak, A., 1996, 
Harm Reduction works, paper presented at the Harm Reduction Satellite to the XIth International 
Conference on AIDS, Vancouver; World Health Organisation, 1989, The uses of methadone in 
treatment and management of opioid dependence, World Health Organisation, Geneva; World Health 
Organisation, 1990, The content and structure of methadone treatment programs: A study in six 
countries, World Health Organisation, Geneva. 
21 Dole, A., 1989, 'Methadone treatment and the AIDS epidemic', Journal of the American Medical 
Association, 262, pp1681. 
22 HIT, 1996, Reducing drug related harm in the Mersey region, HIT, Liverpool; O'Hare, P., 1992, 
'Preface: A note on the concept of harm reduction', In P O'Hare, R. Newcombe, A. Matthews, E 
Buning & E Drucker (eds), The reduction of drug related harm, Routledge, New York; Riley, D., 
1993, The policy and practice of harm reduction, CCSA, Ottawa; Riley, D., 1994, The harm reduction 
model, The Harm Reduction Network, Toronto. 
23 Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D & Trautmann, F., 2000, Drug 
consumption facilities in Europe and the establishment of supervised injecting centers in Australia, 
Drug and Alcohol Review, 19, p337. 
24 Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D & Trautmann, F., 2000, Drug 
consumption facilities in Europe and the establishment of supervised injecting centers in Australia, 
Drug and Alcohol Review, 19, p337. 
25 ibid. 
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SICs are located in primary care facilities where staff adopt a holistic approach, 
offering access to health and welfare programs and other services, with the SIC located 
in a discrete room. 26 
NSPs, SICs and MMT are three examples of harm reduction services currently 
operating in Australia. Each of these services has met, and continues to meet, 
opposition from groups claiming that such programs promote and encourage drug 
use. Indeed such harm reduction programs regularly face opposition from some 
sections of the conservative right and supporters of morality based drug policy. 
What follows is an outline of the type of opposition that harm reduction supporters 
regularly encounter. This is further background information to concepts used 
throughout the thesis. 
Dissenting Views: The Moral-Abstinence Approach 
Proponents of the 'moral-abstinence' approach to illicit drug use regard abstinence as 
the appropriate primary goal of drug policy. Historically such an approach was 
underwritten by the notion of the user as a `sinner'. 27 Substance dependencies were 
seen as the result of an inherent moral weakness and lack of willpower whereby the 
intention to get intoxicated and the failure to resist temptation was regarded as 
sinful.28 Another theory that can be used to advocate for abstinence-oriented drug 
policy is articulated in the disease theory of addiction, whereby particular people are 
26 ibid, p339. 
27 Kellehear, A., & Cvetkovslci, S., 1998, 'Grand theories of Drug Use', in M., Hamilton, A., 
Kellehear & G., Rumbold (eds) Drug Use in Australia: a harm minimisation approach, Oxford 
University Press, Melbourne, p51. 
28 Henry-Edwards, S., & Pols, R, 1991, Responses to Drug Problems in Australia, AGPS, NCADA 
Monograph, 16; Brower, S., Stetson, B., & Beatty, P., 1989, 'Cognitive and Behavioural Features of 
Adolescent Coping in High-Risk Drinking Situations', Addictive Behaviours, 14, pp43-52. 
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regarded as genetically prone to addiction. It is thought that people with this 
predisposition have less control when it comes to substances and as there is not a 
cure, this 'disease' of addiction is a lifetime ailment. 29 According to the disease 
model, the central problem is the alleged inherent nature of the pharmacology of 
drugs. In this sense some drugs are regarded as inherently harmful and as such, use 
leads to the inevitable physical, moral and social decline of humans. 3° People with 
substance dependencies are labelled as 'sick' 31  Ergo, it logically follows, (according 
to the perspective of the moral-abstinence advocate), that abstinence from drugs is 
best way to avoid inevitable problems associated with drug use. 
The manifestation of this approach is the policy of prohibition of some drugs. Such a 
policy seeks to reduce the chance that individuals will be tempted by, and thereby 
experience problems due to, drugs through a reduction in their supply into the 
community. Additionally, prohibition is also aimed at creating disincentives (in the 
form of legal penalties) for people to either use or manufacture/traffic illicit drugs. 
The priority of moral abstinence approaches is a reduction in the prevalence of illicit 
drug use. 32 
29  Erickson, C., 1992, 'A Pharmacologist's Opinion — Alcoholism: the Disease Debate Needs to Stop', 
Alcohol and Alcoholism, vol. 27, No. 4, pp325-8; Peele, S., & Brodsky, A., 1991, The Truth About 
Addiction and Recovery, Simon and Schuster, New York; Brower, K., Blow, F., & Beresford, T., 
1989, 'Treatment Implications if Chemical Dependency Models: An Integrative Approach', Journal 
of Substance Abuse Treatment, No. 6., pp147 -57. 
30 Kellehear, A., & Cvetkovslci, S., 1998, 'Grand Theories of Drug Use', in M., Hamilton, A., 
Kellehear G., & Rumbold (Eds) Drug Use in Australia: a harm minimisation approach, Oxford 
University Press, Melbourne, p52. 
31 The label of the sick person is part of the medical approach to drug use. This can also be used to 
justify harm reduction programs as well as moral abstinence programs. 
32 	• Riley, D., O'Hare, P., 2000, 'Harm Reduction: History, Definition and Practice', in Inciardi & 
Harrison (eds) Harm Reduction: National and International Perspectives, Sage, California, p2. 
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The Dialogue Between Coalitions 
This thesis does not focus on criticisms of prohibition policy by harm reduction 
advocates, however, such comments are at times relevant to the discussion and 
feature sporadically throughout this manuscript. The notion of what constitutes drug 
related harm is often a source of disagreement between coalitions. For example, is 
the principal source of harm from drugs themselves or from prohibition instruments 
that pervert elements of the illicit drug markets (for example: the effects of 
prohibition on price and purity of some drugs)? 
According to supporters of harm reduction, drug law enforcement can actually 
increase the instance of drug related harms. Indeed, it is claimed that such attempts 
to reduce the supply of drugs can be counterproductive and have the potential to 
create harms worse than the effects of drugs themselves. 33 Some harm reductionists 
further argue that prohibition has perverted the nature of the drug market (with 
regard to price and purity of drugs) and the social context in which drug use occurs, 
thus making the activity highly dangerous and ultimately creating physical harms for 
the drug user. 
...the success of supply restriction, often judged by the 
extent to which street drug prices are kept high and purity 
kept low, increases the likelihood of drug injection as the 
preferred mode of administration. High prices and low 
purity of street drugs are likely to discourage drug users 
from substituting non-injecting routes of administration, 
33  Erickson, P., 1992, 'Political Pharmacology: Thinking about drugs', Daedalus, Summer, pp239- 
267; Nadlemann, E., 1993, 'Progressive legalizers, progressive prohibitionists and the reduction of 
drug related harm', in N Heather et. al. (eds) Psychoactive drugs and harm reduction: from faith to 
science, Whurr, London, pp34-35; O'Hare, P., 1992, 'Preface: A note on the concept of harm 
reduction', in P O'Hare, R., Newcombe, A., Matthews, E., Buning & E Drucker (eds), The reduction 
of drug related harm, Routledge, New York; Riley,D., & Oscapella, E., 1997, Canada's new drug law: 
Some implications for HIV/AIDS prevention in Canada, International Journal of Drug Policy, 7:3, 
pp180-182. 
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which are not known to be associated with the risk of HIV 
transmission.34 
Ergo, prohibition policies may be responsible for creating the type of problematic 
drug users increasingly evident since 1980s. Social harms generated by prohibition 
include the demonisation of injecting drug users that results in their marginalisation 
and ostracism from the mainstream (both in terms of familial and societal groups). 
Such a dynamic means that efforts to engage such populations in treatment or 
education are hampered by the reluctance to disclose their injecting drug use status. 
Moreover, the illegality (and demonisation) of the activity of injecting drug use 
means that often the preparation and injection practices are made even more unsafe 
due to rushed preparation and administration of the drugs in public areas. Thus, 
according to some harm reduction advocates, the illicit nature of the activity is 
regarded as contributing to the sharing of injecting equipment and other unhealthy 
practices that subsequently results in the spread of BBVs and poor health of injecting 
drug users. 35 
Moreover, harm reduction advocates note the high cost of law enforcement and the 
seemingly ineffectiveness of it to restrict the supply of illicit drugs: 
Despite seventy years of increasing restrictions, and in the 
case of heroin seizures almost forty years of absolute 
prohibition, by all measures the consumption of illegal 
drugs in Australia has continued to grow. Despite — or 
perhaps because of — these policies, the costs of 
enforcement borne by the taxpayer and other costs borne by 
residents at large have continued to gxow. 36 
34 Wodak, A., 1992, 'HIV Infection and injecting drug use in Australia: responding to a crisis', The 
Journal of Drug Issues, 22:3, p555. 
35 • • lbld. 
36 Marks, R., 1992, 'The costs of Australian drug policy', The Journal of Drug Issues, 22 (3) p535. 
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Moreover, prohibition also creates incentives for people to engage in the production 
of illicit drugs due to the high financial return from the activity. High prices and 
low purity mean enormous profits for those willing to take the risk. Sophisticated 
and international criminal networks that have formed around the lucrative industry of 
illicit drugs are a result of incentives created by prohibition instruments. While such 
harms that result from prohibition are unintended results of the policy, most of the 
time, this dynamic is forgotten, sidelined or considered an unfortunate side effect of a 
necessary policy. Such a distinction between those harms that are attributed to the 
nature of the drug itself and those that are manufactured by the context in which drug 
use occurs is critical to determining the nature of the drug problem. Often discrete 
elements of the drug problem (for example: fluctuating drug purity which is a chief 
contributor to overdose) is attributed to the pharmacology of a drug without any 
recognition that such a problem might have either been created or at least 
exacerbated by the approach to drug use undertaken by governments. 
An example of a lobby group that supports the moral-abstinence approach to drugs is 
the Drug Advisory Council of Australia (DACA). 37 The group outlines policy 
positions on a number of drug policies and programs and also suggests directions for 
future drug policy. In contrast to harm reduction, groups such as DACA regard the 
notion of a drug free society as an appropriate (and one assumes attainable) goal for 
drug policy, and support diversion of current injecting drug users into mandatory 
treatment. The following statements were listed on the DACA website as key policy 
principles: 
37 Drug Advisory Council of Australia, accessed on 12/3/06 
http://www.daca.org.au/injecting/HIV.htm  
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• A drug free Australia 
• The elimination of the harm from illicit drug use 
• The illegality of illicit drugs 
• The scientific evidence that marijuana is a harmful and 
dangerous drug and must remain illicit 
• The suppression of the supply of illicit drugs 
• A national campaign to say no to illicit drugs 
• Diversion of illicit drug users into detoxification and 
rehabilitation by court order and supervision 38 
For DACA, policy approaches such as mandatory treatment, anti-drug education and 
prohibition of illicit drugs were two key instruments to reduce the prevalence of 
illicit drug use. Like many supporters of the moral-abstinence approach, DACA 
expressed concern about the effect of harm reduction programs such as NSPs and 
SICs and suggested that such programs increased both rates of drug use and the 
incidence of BBVs in society: 
The high number of injecting drug users with Hepatitis C is 
evidence of the failure of NSPs to reduce sharing of 
equipment. 39 
Maintaining injecting drug use by providing injecting 
rooms and free syringes assists in spreading blood borne 
diseases.° 
The latter quote is a common criticism of harm reduction programs whereby they are 
seen to entrench the behaviour (injecting drug use) in existing users and in turn, 
increase the spread of BBVs. From this perspective, NSPs and SICs are seen as 
being responsible for the prevalence of BBVs and represent a public health threat. 
Another argument against harm reduction programs espoused by DACA was 
regarding the perceived social impact on the communities in which they are located: 
38 Drug Advisory Council of Australia, About DACA, accessed on 12/3/06 
http://www.daca.org.au/injecting/HIV.htm  
39 Drug Advisory Council of Australia, accessed on 12/3/06 
http://www.daca.org.au/injecting/HIV.htm  
40 —mg Advisory Council of Australia, Injecting drugs leads to HIV and Hepatitis C, accessed on 
12/3/06 http://www.daca.org.au/injecting/HIV.htm  
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Like the US and Canada Australia's syringe distribution 
programs and injecting rooms are not policed leaving drug 
pushers free to trade. 41 
This is known in the literature as the so-called `honeypot effect' whereby programs 
for drug users are perceived as attracting drug vendors and associated crime to the 
area in which the service is located. Again in this argument, such programs are seen 
to exacerbate an existing problem. While this is only one example of a lobby group 
that espouses the moral abstinence rhetoric, such a group has been active in 
Australian politics, most recently providing input into the influential Road to 
Recovery report released in 2003. 42 
We support the comments that harm reduction programs 
maintain illicit drug users in their use. Drug programs must 
be aimed at getting illicit drug users completely off drugs. 
Drug dependent persons should be sent for detoxification 
and rehabilitation through the justice system as an 
alternative to incarceration. 43 
In sum, harm reduction and moral abstinence supporters have entirely different 
viewpoints on fundamental questions in relation to the role of drug use in society. At 
their core, both groups regard the other's approach as responsible for, and likely to 
exacerbate, existing drug related harms in the future. While this section provided a 
brief excursion into the nature of the dialogue between coalitions, the impasse is at a 
much deeper, epistemological level which is discussed in greater depth in chapters 
three to six. Next is a brief examination of the development of Australia's approach 
to drug use prior to 1980 in order to provide further background information leading 
up to the period of analysis from 1980 to 2000. 
41  Drug Advisory Council of Australia, Harm Minimisation Slammed, accessed on 12/3/06 
http://www.daca.org.au/injecting/HIV.htm 
42Standing Committee on Family and Community Affairs, 2003, Road to recovery: report on the 
inquiry into substance abuse in Australian communities, Commonwealth of Australia, Canberra. 
43 Drug Advisory Council of Australia, Abstinence Drug Rehabilitation Works, accessed on 12/3/06 
http://www.daca.org.au/injecting/HIV.htm 
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Illicit Drug Policy Before 1980 
Drug use has been a constant phenomenon throughout human evolution. What has 
altered over time are the types of drugs available and societal attitudes and responses 
toward use. The prevalence of alcohol (in the form of beer and wine) is thought to 
date back at least 8000 years. 44 Similarly, opium originated in Mesopotamia 
approximately 7000 years ago and then quickly spread throughout Asia and the 
Mediterranean.45 Cannabis seeds and by-products also have a long history, dating 
back to the: 
• . .earliest strata of human habitation, and the thousands of 
names by which it is known in hundreds of languages 
testify to its long history across the planet.. . 46 
Likewise, references to hallucinogenic mushrooms are sourced in ancient Hindu 
texts, whilst archaeological evidence dates peyote use to at least 7500BC. While 
drug use has existed throughout the ages, conversely, prohibition of use is a 
relatively new phenomenon. 
In Australia, the policy approach of prohibiting drugs began in the 1800s. In 1857, 
the governments of New South Wales and Victoria imposed a duty upon the 
importation of opium that was intended to be smoked or chewed. Neither medicinal 
use nor opium intoxication itself was the subject of the duty, indeed, consumption of 
opium by individuals other than Chinese immigrants was not even considered. 
Concealed by medical use, Anglo-Saxon Australians distinguished Chinese opium 
44 Lang, E., 1998, 'Drugs in Society', in Hamilton, M., Kellehear, A., & Rumbold, G., (eds), Drug 
Use in Australia: A Harm Minimisation Approach, Oxford University Press, Melbourne, pl. 
45 ibid. 
46 ibid. 
26 
use (whereby the substance was smoked) from their own (where the substance was 
usually imbibed in the form of a drink). 47 South Australia (which then administered 
the Northern Territory) passed an opium prohibition act in 1895.48 Debates in the 
South Australian parliament revealed a lack of consensus about the harms associated 
with opium. Indeed, a member for Gladstone commented on the positive effects of 
opium suggesting that it enabled Chinese porters to perform great feats of strength 
and dismissed any link between opium and crime. 49 Another proposed that it was 
immoral to use opium yet questioned whether it merited the institution of a new 
crime. 50 One Legislative Council member argued that opium use was a matter of 
personal choice, however, conceded that supplying opium to others was 
unacceptable. 51 Much of the drive underwriting the laws developed to prohibit 
opium was to demonise Chinese immigrants, who were considered a threat to 
European values: 
Disease, defilement, depravity, misery and crime - these 
are the indispensable adjuncts which make the Chinese 
camps and quarters loathsome to the sense and faculties of 
civilised nations...Wherever the pig-tailed pagan herds on 
Australian soil, they introduce and practise vices the most 
detestable and damnable — vices that attack everything 
sacred in the system of European civilisation. 52 
47 Manderson, D., 1993, From Mr Sin to Mr. Big: A History of Australian Drug Laws, Oxford 
University Press, Melbourne, p22. 
48 Lonie, J., 1979, A Social History of Drug Control in Australia, Royal Commission into the Non-
Medical Use of Drugs, Research Paper 8, South Australia, p7. 
49  South Australian Parliamentary Debates, 1895, 19 December, p3024. 
50 ibid 
51 ibid. 
52 Manderson, D., 1993, From Mr Sin to Mr. Big: A History of Australian Drug Laws, Oxford 
University Press, Melbourne, p19-20. 
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After years of debate, the importation of opium into Australia was prohibited in 
1905. Lang53 argued that increased smuggling and illegal use was soon detected, 
with some of the non-Chinese population grasping the opportunity for quick profits. 
International controls on opium developed further over the next thirty years resulting 
in the (Hague) Opium Convention of 1912 and the International Convention on Illicit 
Traffic in Dangerous Drugs. The 1912 convention, initiated by the United States 
Government, committed Australian Governments and other signatories to 
introducing laws that prohibit the use of opium for non-medicinal purposes. This 
policy stance was further consolidated and extended when the United States began to 
play a greater role in global organisations such as the United Nations in the early 
twentieth century. 54 
Following the ratification of the 1912 Opium Convention, the Australian 
Government subsequently extended import controls to other substances as well as 
opium. 55 The Australian Government signed the 1925 Geneva Convention (the 
International Convention Adopted by the Second Opium Conference) that committed 
the signatories to ensure that there were laws that limited the sale, use, importation 
and export of opiates, cocaine, and Indian hemp exclusively to scientific and medical 
purposes. Following the 1925 Geneva convention, the Australian Government 
signed a series of other international agreements in relation to drugs. Notably the 
Convention for Limiting the Manufacture of and Regulating the Distribution of 
Narcotic Drugs 1931 which established an international compliance regime, the 
" Lang, E., 1998, 'Drugs in Society', in Hamilton, M., Kellehear, A., & Rumbold, G., (eds), Drug 
Use in Australia: A Harm Minimisation Approach, Oxford University Press, Melbourne, p7. 
54 For a comprehensive treatise on the expansion of prohibition regimes and the role of the United 
States of America see Nadleman, E., 1993, Cops Across Borders: The Internationalization of US. 
Criminal Law Enforcement, The Pennsylvania State University Press, Pennsylvania. 
55 Manderson, D., 1993, From Mr Sin to Mr Big: a History of Australian Drug Laws, Oxford 
University Press, Sydney, pp513-14. 
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Paris Protocol 1948 which granted the World Health Organisation the power to 
categorise new substances as 'dangerous drugs' for the purpose of the 1931 
Convention, and the Single Convention on Narcotic Drugs 1961 that further 
extended and reinforced control over drug trades across international borders and 
within domestic arenas. 56 Other Conventions, such as the Convention on 
Psychotropic Substances 1971, further consolidated international controls to include 
other synthetic drugs in the expanding array of prohibited substances. 
The 1961 signing of the Single Convention on Narcotic Drugs in New York 
symbolised the international consensus and commitment to prohibition as a chief 
policy instrument to address drug use. This Convention established the International 
Narcotics Control Board, the main roles of which involved the administration of the 
estimates system (that limits a country's annual production of controlled substances 
according to that needed for medical purposes). The scope of the Single Convention 
was immense in comparison to previous legislation, establishing more detained 
controls on international and domestic drug use than any prior convention. 57 
The signing of the Convention and subsequent ratification in 1967, bound Australia 
more tightly to a system of control that had been steadily entrenched over several 
years. 
The Single Convention symbolised the orthodoxy that 
prevailed in the international community, the power that 
community exerted over Australian policy, and the strength 
of the United States within it. 58 
56 Brereton, D, 2000, 'The History and Politics of Prohibition', in Stokes, G., Chalk, P., & Gillen, K., 
(eds.), Drugs and Democracy, Melbourne University Press, Carlton South, p90. 
57 Manderson, D., 1993, From Mr Sin to Mr Big: a History of Australian Drug Laws, Oxford 
University Press, Sydney, p138 
58 ibid. 
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Prior to the late 1960s, drugs were not a salient issue in Australian society. The 
decision to ban cannabis and heroin (1925 and 1953 respectively) for non-medical 
purposes happened at a time when heroin and cannabis use were unrecorded and 
seemingly minimal. Alongside this expansion of prohibition regimes in many states 
around the world in the twentieth century, another concept, namely the 'medical 
model of addiction', was being promoted by medical professionals, social workers 
and other health intervention workers that had personal experience with drug 
dependent persons. 59 The drug dependent person, in this model, was regarded as not 
necessarily responsible for her/his own drug dependency, rather, they were at the 
whim of substance addiction. The behaviour of drug traffickers, however, was still 
seen as related to individual choice and thus, they were still regarded as responsible 
for their actions. Legislation, aimed at traffickers, assumed that law enforcement 
(and in particular stiffer penalties, broader search powers, and complicated 
provisions for the forfeiture of assets) was seen as the solution to restricting the 
supply of illicit drugs and thus ameliorating the 'problem' of the rising prevalence of 
drug use.6° Conversely, legislation regarding those persons that use illicit drugs had 
been amended to reflect the medical model of addiction with penalties lessened 
and/or use of other extralegal alternatives gaining favour. Desmond Manderson 
summed up the different attitudes expressed in legislation towards drug users and 
manufacturer/sellers: 
After the first opium laws had been enacted, drug use has 
been seen as a sin because it challenged the sanctity of the 
law. In later years, as the medical model of addiction 
gained favour, addicts came to be characterised as persons 
whose obsession robbed them of the power of intention. 
Their illegality was not their fault. For them, according to 
Woodward, 'the inability to choose or act wisely, or to 
modify behaviour, is limited or eliminated'. But traffickers 
ibid, p181. 
6° ibid. 
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were still seen as sinful; their illegal behaviour was a 
choice and they were responsible for their actions. Thus 
[there was]...enactment of two separate pieces of 
legislation in order 'to reflect the distinction between 
criminal exploitation of drug abuse and the social plight of 
the individual drug user'. The proposed Drugs of 
Dependence Act punished minor offences including 
possession and use. It accepted that users were sick and in 
need of help; penalties were relatively slight, and the 
emphasis was placed on treatment and community services. 
The Proposed Drug Trafficking Act was designed to 
facilitate the detection and punishment of trafficking. It 
assumed that the drug problem was a question of law 
enforcement requiring stiff penalties, broad search powers, 
and complicated provisions for the forfeiture of assets. 
Illness and vice were treated in isolation as if the problems 
they addressed were unrelated. 61 
As Manderson eluded, notions of illness and vice applied in this manner reflected a 
one dimensional view of the illicit drug issue through an avoidance of the instance of 
the recreational (one that consumes at irregular and sporadic intervals and is not 
dependent) drug user and the possibility of small scale commercial transactions 
between friendship groups and other nuances of illicit drug markets. Such a one 
dimensional conception of the illicit drug market and players within it lead to a 
mixture of policy instruments premised on these core notions whereby drug users are 
endowed with the label of 'sick' and traffickers and vendors are labelled as 
'predatory' and 'evil'. Illness and vice are core underlying principles of Australian 
illicit drug policy leading into 1980, indeed, it is these core notions that advocates of 
harm reduction have had to either incorporate in order to conform to prevailing 
orthodoxy or attempt to dismantle in an effort to provide a more detailed and 
accurate view of the nuances of drug markets. The choice between these responses 
has the capacity to have profound impacts upon the nature of the harm reduction 
policy, as is discussed in the following chapters. 
61 ibid, p181. 
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In sum, previous to 1980, the main policy instrument was the regime of regulatory 
instruments directed at preventing and/or reducing use. Moreover, the medical 
model of addiction was also a common theory applied to drug treatment and also 
affected drug laws. Both of these tools were underwritten by the perception that drug 
use was an inherently dangerous activity, and, consequently Government regulatory 
instruments served to prevent and or restrict access to them. In this sense, 
Government policy followed a simplistic line that a decrease in the prevalence of 
illicit drug use meant a decrease in drug-related harm. By the end of the 1970s and 
start of the 1980s however there was a new approach being developed that espoused 
a different view towards illicit drug use. This harm reduction approach, as noted 
earlier, was not premised on the notion of drug use as an immoral act or necessarily 
something that would lead to sickness in users. As mentioned earlier, that authors of 
such an approach would critique prohibition and abstinence-oriented treatment, as 
well as advocate for services to make illicit use less risky, heralded the start of an 
antagonistic relationship between various stakeholders in the illicit drug policy 
subsystem. Indeed, it is the rise of harm reduction in public policy and its 
relationship with traditional moral approaches towards drugs between 1980 and 2000 
that is the subject of this thesis. 
Structure of the Thesis 
To recap, this thesis is focussed upon examining both the subject of illicit drug policy 
with emphasis on the experience of harm reduction advocates and their success in 
translating key ideas into policy, and also at evaluating a public policy theory, 
namely the advocacy coalition framework. Illicit drug public policy between 1980 
and 2000 in Australia will be analysed as well as key texts, research and primary 
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commentaries on events that took place. The thesis is comprised of seven chapters, 
the outline of each follows. 
Chapter two begins with a description of key aspects of the ACF, as articulated by 
Sabatier in conjunction with Jenkins-Smith. The ACF is a subsystem approach to the 
study of public policy with a particular focus on examining policy change. Key 
concepts such as the notion of advocacy coalitions, the role of policy brokers and 
hypotheses concerning contributing factors, and conditions conducive to, policy 
change as articulated in the ACF are described and subsequently applied to the study 
of illicit drug policy. A definition of the illicit drug policy subsystem model is also 
offered. The chapter ends with a set of research questions that are used to both 
evaluate the ACF and its applicability to illicit drug policy, and also to understand 
the evolution of drug policy between 1980 and 2000. These research questions are 
examined in the subsequent chapters of the thesis. 
Chapter three charts the origins and development of harm reduction as an approach 
to drug use in Australia between 1980 and 1990. Moreover key events in illicit drug 
policy in this time are described. During this period, Australian illicit drug policy 
underwent significant change: first, with the advent of a National Drug Strategy that 
facilitated greater collaboration between law enforcement and health sectors 
regarding key aspects of policy; and second, the emerging issue of HIV/AIDS in 
Australia produced substantial impact on drug policy. These issues are discussed 
through an analysis of policies and other relevant texts produced during this period. 
In this decade, a coalition for harm reduction began to crystallise, achieving some 
success in realising policy objectives by the close of this period. Sabatier's 
hypotheses on major policy change in the ACF model are evaluated as well as core 
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notions of advocacy coalitions, guidance instruments and policy brokers as a means 
of understanding the events that occurred between 1980 and 1990. 
Following on from chapter three, chapter four charts developments in harm reduction 
theory and practice in following decade (1990 to 2000). In this period, a cross-
pollination of ideas between health and law enforcement sectors was evident with 
subsequent changes apparent in law enforcement practice. In contrast, the dialogue 
between supporters of harm reduction and moral-abstinence oriented policy were less 
than collegial. By the close of the century, the Federal Government had changed 
from being led by the Australian Labour Party (ALP) (that instigated harm reduction 
policies) to being led by the Federal Liberal party headed by a Prime Minister who 
was a highly vocal supporter of abstinence-oriented approaches in drug policy. 
Attempts to implement further harm reduction policies such as SICs and prescription 
heroin were largely rejected in this period. Similarly, the limits of the acceptability 
of the harm reduction approach were apparent through the analysis of policy 
responses to HCV. In this chapter, there is a focus on the hypotheses in the ACF on 
policy-oriented learning between health and law enforcement sectors. 
Chapter five centres on two specific debates in Australian drug policy, SICs and 
prescription heroin, that occurred between 1990 and 2000. Predominantly, this 
chapter focuses mainly on debates between supporters of harm reduction approaches 
and those that advocate for moral-abstinence oriented strategies in drug policy. 
Whereas chapters three and four examined the instance of harm reduction in illicit 
drug policy more generally, the focus in this chapter is a specific examination of two 
particular harm reduction policy initiatives. Key arguments for and against both 
policy initiatives are described as well as key events and outcomes of deliberations. 
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This chapter identifies the nature of the debates between harm reduction and moral 
abstinence advocates and in particular addresses epistemological differences that 
contribute to the fundamental deadlock in illicit drug policy debate. 
Chapter six provides a synthesis of the results from chapters three to five and 
responds to research questions posed in chapter two. Trends, themes and dynamics 
in illicit drug policy across the 20 year period of analysis from 1980 to 2000 are 
identified and analysed in the context of the ACF. The general aims of this research 
such as evaluating the utility of ACF as applied to social systems such as drug 
policy, understanding the nature of drug policy making in Australia and also 
assessing the way in which supporters of harm reduction strategise to turn beliefs 
into policy are addressed and answered. The chapter closes with a discussion 
regarding potential additions and/or directions for further development of the ACF, 
especially in relation to its application to 'social' problems. The conclusion chapter 
provides a reflection of the dilemma of how harm reduction 'fits' within the 
dominant framework and the compromises that have been made by harm reduction 
advocates in the name of policy expediency. 
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Chapter 2: Advocacy Coalitions and Australian Illicit Drug Policy 
Introduction 
This chapter outlines the approach used in this thesis to provide a framework to 
analyse Australian illicit drug policy, namely the advocacy coalition framework 
(ACF) as developed by Paul Sabatier in collaboration with Hank Jenkins-Smith. 
Such a framework places 'subsystems' as a primary unit of analysis and focuses on 
the role of ideology as an independent variable in affecting policy change. The 
analysis of illicit drug policy is expected to represent a challenge to the framework as 
the majority of applications of the ACF have been in the context of environmental 
policy or similar subsystems in which discussion revolves around phenomena in the 
'natural' world and whereby the scientific method is considered the credible method. 
In contrast, debates in relation to the illicit drug policy subsystem feature discussion 
about social phenomena and hence scientific facts compete with morality-based 
arguments. 
Despite often having being used predominantly in entirely different policy spheres, 
the ACF has been successfully used in analysis of illicit drug policy previously by 
• one author, Daniel Kubler, who examined policy change in Swiss drug pollcy. 62  The 
ACF has been chosen for analysis in this thesis because of its focus on ideology as a 
key factor in policy making and change, which is particularly relevant to illicit drug 
policy due to the convergence of different types (for example: scientific and morality 
based) of knowledge in policy debates. Further, the ACF also provides a 
62  Kubler, D., 2001, 'Understanding policy change with the Advocacy Coalition Framework', Journal 
of European Public Policy, 8:4, pp623-641. 
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comprehensive map of a political system allowing analysis of socio-cultural values, 
constitutional structures and other parameters of any political system as well as 
focusing on external events and their role in policy change. Ultimately the ACF 
provides a robust model to examine policy change in subsystems providing many 
testable hypotheses. The research questions developed at the end of this chapter will 
serve two functions: first, results will allow an evaluation of the ACF when applied 
to analyse illicit drug policy and generate directions for future development of the 
framework. Second, it is expected the framework will generate useful insights into 
the way in which harm reduction policy has been implemented and also on the 
techniques employed by the harm reduction coalition when advocating for 
'politically difficult' policy. 
The following section outlines the key concepts of the ACF and relates these to the 
illicit drug policy subsystem. Following this, a framework to analyse illicit drug 
policy from 1980 to 2000 is constructed in Table 1 to apply to the analyses in 
chapters three, four and five of this thesis. 
The Advocacy Coalition Framework 
The advocacy coalition framework (ACF) was developed initially by Paul Sabatier in 
the early 1980s, and refined in subsequent years by Sabatier in collaboration with 
Hank Jenkins-Smith. The ACF has been the subject of numerous books and articles 
(Sabatier 1987 63 , Sabatier 1989 64, Sabatier & Jenkins-Smith 1993 65, Sabatier & 
63 Sabatier, P., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Diffusion, Utilisation, 8:4, June, pp649 -692. 
64 Sabatier, P., A., 1989, 'An advocacy coalition framework of policy change and the role of policy-
oriented learning therein', Policy Sciences, 21, 129-168. 
65 Sabatier, P., & Jenkins Smith, 1993, 'The Advocacy Coalition Framework: An Assessment', Policy 
Change and Learning: An Advocacy Coalition Approach, Westview Press, San Francisco. 
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Jenkins-Smith 199466 and Sabatier 199867) and also by other authors that have 
utilised the framework in a number of different policy contexts and/or offered 
theoretical revisions 68 . The reader is referred to these for a detailed description of 
the model. 
The main function of the ACF is to provide a framework to explain policy change. 
Sabatier stated that the ACF is based on five assumptions about policy, 69 formulated 
from literature on policy implementation and the role of technical information in 
public policy. The first premise Sabatier articulated is the importance of recognising 
the role of technical information in the process of defining the policy 'problem' by 
both delineating the scope and facets of a particular policy issue and then in 
prescribing the associated causes and impacts of probable solutions. Such technical 
information creates a mutual language that not only defines membership of particular 
coalitions but also is highly instrumental in the process of defining the nature of the 
problem and consequently, the brokerage of solutions. The type and nature of 
technical information, or persuasive language, used by coalitions to advocate a 
particular position will be examined and evaluated throughout this thesis. The 
second premise underpinning the ACF concerns the appropriate length of time to 
study the process of policy change. Sabatier suggested that understanding the 
process of policy change requires a focus on a decade or longer so as to facilitate a 
reasonable assessment of policy impacts. The current analysis of illicit drug policy 
concentrates on a 20 year period starting at 1980, with the first signs of the 
emergence of the harm reduction advocacy coalition in illicit drug policy, and 
Sabatier, P., A., & Jenkins-Smith, H., 1994, 'Evaluating the Advocacy Coalition Framework', 
Journal of Public Policy, 14:2, pp175-203. 
67 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, pp1350-1763. 
68 There have been approximately 33 applications of the ACF. For a comprehensive list of authors 
that have utilised the ACF see Sabatier, P.,A., 1998, 'The advocacy coalition framework: revisions 
and relevance for Europe', Journal of European Public Policy, 5:1, March, p100-101. 
69 ibid, pp98-130. 
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finishing the analysis around the year 2000, albeit with a postscript or two on some 
issues that occurred post-2000 where relevant. 
The third premise of the ACF as stated by Sabatier, is that the policy domain or 
subsystem is a useful unit of analysis in order to understand the overall policy 
process. Such an approach has origins in the notion of the 'sub-government' in 
which societal and state actors were grouped into "...routinised patterns of 
interaction"" around a given issue. Sabatier n suggested that the boundaries of a 
policy subsystem in Heclo's 'iron triangles' 72 should be expanded from including 
administrative agencies, legislative committees and interest groups at a single level 
of government to include other actors at various levels of government as well as 
researchers, policy analysts and journalists. Sabatier posited that such actors were 
identified as being active in the development and implementation of policy and thus 
worthy of inclusion in a subsystem model. 
According to Sabatier, a policy domain or subsystem consists of actors from public 
and private organisations who regularly seek to influence the policy direction of their 
domain." In this thesis the 'illicit drug subsystem' is examined. In order to narrow 
the scope of analysis, the area of study will focus on a study of policy regarding the 
practice of intravenous drug use. Therefore the relevant drugs associated with that 
practice are as heroin and other injectable opiates (including methadone), and, 
70  Howlett, M., & Ramesh, M., 1995, 'Agenda Setting — Policy Determinants and Policy Windows', 
Policy Cycles and Policy Subsystems, Oxford University Press, Ontario, p125. 
71  Sabatier, P., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Diffusion, Utilisation., 8:4, June, p652. 
72  The theory of iron triangles, formulated in the 1960s, described 'three sided' relationships between 
interest groups, executive government and the bureaucracy that were theorised to captured the policy 
making process. In this sense, notions of democracy were subverted and self interests of the three 
groups prevail over that of the public when formulating policy. Howlett, M., & Ramesh, M., 1995, 
'Agenda Setting — Policy Determinants and Policy Windows', Policy Cycles and Policy Subsystems, 
Oxford University Press, Ontario, p125. 
73 Sabatier, P., & Jenkins-Smith, H., 1994, 'Evaluating the Advocacy Coalition Framework', Journal 
of Public Policy, 14:2, p178. 
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amphetamines. Clearly a number of drugs (legally or illicitly obtained) can be 
injected such as benzodiazepines, however the predominant types of drugs usually 
injected and thus at the centre of policy problems, tend to be opiate or amphetamine 
based. Thus, cannabis policy is not subject to analysis in this thesis except where 
relevant and complementary to the discussion in relation to drugs used intravenously. 
Thus, in this thesis the 'illicit drug subsystem' is defined accordingly: 
The illicit drug subsystem is a policy subsystem that consists of actors (individuals 
and organisations) clustered around the issue of intravenous drug use in government 
policy. These actors are both proactive and reactive in illicit drug policy, united by 
vested interests, whether material, academic or personal. Actors in this subsystem 
are predominantly drawn from health, law enforcement and research fields as well 
as affected communities, the media, community -including non government-
organisations and groups and religious bodies. 
The fourth premise of the ACF as articulated by Sabatier states that these policy 
subsystems will include actors from several levels of government within a country 
and also actors from international organisations and other countries. The analysis in 
this thesis will predominantly focus on policy actors from within Australia, however, 
many sources and organisations external to Australia will also be included in order to 
complete the analysis of the ACF and policy making in the illicit drug policy 
subsystem. The final premise underpinning the ACF is that public policies and 
related programs provide a means through which beliefs, value priorities, perceptions 
of causal relationships and the efficacy of various policy instruments can be 
identified. More importantly Sabatier and Jenkins-Smith theorised that the relative 
influence of various actors over time and the role of technical information in policy 
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learning and change can also be assessed through such textual analysis. 74 This thesis 
will examine national and state public policies, Parliamentary committee reports, 
proceedings from Hansard and key meetings/conferences/summits, key actors' 
commentary from such proceedings, reports from health and law enforcement 
institutes, National reports and surveys, journal articles and websites from advocacy 
groups. Such primary and secondary sources will serve three functions: first, such 
material can be used to gauge the influence of coalition actors on policy over time. 
In this sense, the language in key government policies and documents as well as 
operational outputs in illicit drug policy will serve to reflect the dominance or 
otherwise of coalition belief systems in public policy. Clearly, state and federal 
policy documents and operational outputs/programs will be main barometer through 
which the testing of the relative influence of coalitions will be conducted. The 
second function of analysis of textual sources described above will be to examine the 
type, and role, of technical information in advocacy efforts. Analyses will determine 
the role and type of the information in defining the problem area, and consequently, 
the prescribing of solutions. The final function of the analysis of texts will engender 
an examination and critique of the general nature, and types of, strategies employed 
by advocacy coalitions. 
These premises should be seen as constituting the bedrock of the ACF and will 
inform this analysis of Australian illicit drug policy. Below is an account of the ACF 
and the further development of the approach taken in this thesis to examine illicit 
drug policy between 1980 and 2000 in Australia. A visual representation of the ACF 
can be seen in Figure 1. In the ACF the policy subsystem is the arena in which 
debate, advocacy and policy making occurs. This process, however, is subject to and 
74 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p99. 
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affected by external parameters depicted on the right as 'relatively stable parameters' 
and external system events'. 
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The Policy Subsystem 
Advocacy Coalitions 
According to Sabatier and Jenkins-Smith, in any policy subsystem policy 
stakeholders are aggregated into a number of 'advocacy coalitions' that are 
composed of a variety of different actors from various levels of governmental and 
private organisations. Advocacy coalitions are conceptualised as including not only 
government officials and interest group leaders but also such individuals as 
legislators, researchers, the media and other community groups. Further, actors from 
peak organisations or umbrella groups that represent an entire sector, professional 
associations and also single issue organisations may also be included in a coalition. 
Moreover, other individuals that constitute the 'attentive public' (academics and 
journalists, foreign observers and other governments 75) also have the capacity to play 
a role in an advocacy coalition with the intent of influencing policy. Sabatierm 
acknowledged the existence of actors that are not aligned to a particular coalition, but 
suggests that these are of little importance over the analytical time frame used in the 
ACF because they either leave or are eventually subsumed into one of the coalitions. 
Sabatier hypothesised that the constituencies of advocacy coalitions are relatively 
fixed over time. 
On major controversies within a policy subsystem when 
policy core beliefs are in dispute, the lineup of allies and 
opponents tends to be stable over periods of a decade or 
77 
SO. 
75 Pal, L., 1992, Public Policy Analysis: an introduction, Nelson, Ontario, p109. 
76 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p103. 
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In this analysis of Australian illicit drug policy, two broad advocacy coalitions are 
identified (as discussed in chapter one) namely the 'harm reduction' and the 'moral-
abstinence' coalitions. As this thesis is primarily focused on the advocacy efforts of 
the former coalition, an analysis of the constituency and stability of the harm 
reduction coalition over two decades will take place in order to test the above 
hypothesis regarding consistent memberships of coalitions in the ACF. 
In the ACF, such members of advocacy coalitions are grouped together through their 
assumed common beliefs and values about their policy issue of interest. Sabatier 
conceptualised these belief systems as hierarchically organised into three levels: 
'deep core', 'policy core' and 'secondary aspects' of belief systems. 78 Deep core 
beliefs exist at the most fundamental level of belief systems and include basic 
ontological and normative ideas that are applicable across almost all policy domains. 
For example, deep core beliefs may include: the preference for government or market 
as an ordering device for social life or whether one considers themselves to be 
aligned with 'left' or 'right' political groups. At the intermediate level of belief 
systems are policy core beliefs that articulate basic normative convictions and causal 
perceptions. These include fundamental value priorities regarding a policy arena. 
For example in the illicit drug policy subsystem policy core beliefs might include: 
the belief that drug use is a medical issue and thus should be predominantly 
addressed within the framework of health services; perception of the nature of the 
illicit drug 'problem' and its associated causes; and a preference for policy 
instruments with the aim of realising deep core values. Sabatier suggested that 
policy core beliefs function as the 'fundamental glue' of a coalition as they represent 
basic normative and practical commitments specific to the policy domain. Further 
78 ibid, p103. 
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Sabatier suggests that coalitions are more able to reach consensus on policy core 
issues than secondary aspects. 
Actors within an advocacy coalition will show substantial 
consensus on issues pertaining to the policy core, although 
less so on secondary aspects. 79 
Secondary aspects of a coalition's belief system consist of a set of specific 
convictions (not subsystem wide) outlining, for example, the various importance of 
causal factors in particular cases, policy preferences for suitable regulations or the 
dissolution of existing regulations. For example, secondary aspects of a belief 
system might include the extent to which prescription heroin is regarded as having 
greater therapeutic value than MMT. Overall, in the ACF it is theorised that deep 
core beliefs are the most resistant to change, policy core beliefs are less rigidly held 
whilst secondary aspects are the most open to change in light of new facts, 
experience or changing strategic considerations. While not surveying policy actors 
directly, beliefs and ideas will be examined through the various texts outlined above. 
Specifically, an analysis of the convergence and discord between coalition members' 
policy core and secondary aspects of belief systems expressed in policy debates will 
also be undertaken where relevant and possible. 
The notion of advocacy coalitions to conceptually group together different types of 
actors in terms of the development of Australian illicit drug policy will also be 
examined in chapters three, four and five. More specifically, the longevity and 
stability of members within a coalition will be identified. The presumption that 
coalition actors share normative and causal beliefs about a particular policy issue, 
79 ibid, p106. 
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and, engage in sustained, co-ordinated activity over time, will also be examined in 
order to ascertain the degree to which this occurs. 
Guidance Instruments 
Another key concept in the ACF is that of 'guidance instruments'. This concept 
refers to changes that occur, within or external to, the subsystem that provide 
opportunities for coalitions to realise policy objectives. 80 For example, this might 
include changes to rules, governments, budgets or information that can be exploited 
by coalition actors to realise policy objectives. At any given time, coalition members 
may choose to integrate such changes into advocacy strategies with the function of 
translating their policy core beliefs into official policy. Sabatier and Jenkins-Smith 
identified different types of guidance instruments that included the following: 
(1) seeking to influence legislatures to alter the budgets and 
legal authority of administrative agencies through 
testimony and campaign contributions; (2) trying to change 
the incumbents of various positions, whether they be 
agency appointees, agency civil servants, or elected 
legislators and chief executives; (3) trying to affect public 
opinion ... via the mass media; (4) attempting to alter target 
group behaviour via demonstrations or boycotts... and (5) 
trying to gradually alter the perceptions of a variety of 
actors through research and information exchange. 81 
This thesis will examine the types of guidance instruments used by members of 
coalitions in illicit drug policy and then compare and contrast such strategies with 
those listed above. Moreover, the strategies employed by harm reduction coalition 
actors will also be reported and examined with the function of evaluating their 
effectiveness in realising policy objectives. 
80 ibid, p104. 
81  Sabatier, P., & Jenkins Smith, 1993, 'The Advocacy Coalition Framework: An Assessment', Policy 
Change and Learning: An Advocacy Coalition Approach, Westview Press, San Francisco, p142. 
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The Policy-Making Cycle 
Within the subsystem, the practice of policy making in the ACF is theorised to occur 
in the following terms: conflicting strategies (advocated by each coalition) are 
submitted to 'policy brokers', a group of actors that represent the Government and 
are responsible for reaching compromise and limiting conflict, whose: 
...principal concern is to find some reasonable 
compromise that will reduce intense conflict. The end 
result is one or more governmental programs, which in 
turn produce policy outputs at the operational leve1.82 
In the ACF, such policy outputs (implementation of Government programs/policies) 
generate a variety of impacts on 'targeted problem parameters' as well as other 
consequences (intended and unintended). Each coalition then processes information 
based on the new developments, as well as any other new information, and then may 
revise its (usually secondary) beliefs and operational strategies. This type of 
approach sees policy making as a cyclical process with outputs in some cases 
reconfiguring the inputs from coalitions. This thesis will examine the role of 'policy 
brokers' who are conceptualised in most incarnations of the ACF as essentially 
neutral players who are charged with the task of brokering compromise between 
coalitions. The role of the bureaucracy (or their representatives acting as brokers) in 
the illicit drug policy subsystem will be analysed. 
82 Sabatier, P.,A., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p104. 
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Sabatier suggested that affecting this cyclical process of policy making within a 
subsystem are two sets of exogenous variables that impact upon the resources and 
constraints of subsystem actors. These external variables are described below. 
Exogenous Variables 
In Figure 1, the two boxes to the left of the policy subsystem represent two sets of 
exogenous variables, entitled 'relatively stable system parameters' and 'dynamic 
system events', that impact upon any policy subsystem. As their respective labels 
suggest, the former group of variables are relatively established phenomena and thus, 
Sabatier posits, are seldom the subject of coalition strategising. In contrast, dynamic 
system events can oscillate over the course of a few years or a decade. 83 Changes in 
this second group of variables, in particular, affect coalitions in two ways: first, such 
change has the capacity to alter the constraints and opportunities of subsystem actors, 
and secondly such flux also means that coalition members must anticipate change 
and respond to the change while remaining consistent with their basic beliefs and 
interests. Accordingly, in the ACF, this second set of variables is theorised as 
representing one of the key factors affecting policy change. Sabatier ruminated: 
The process must be frustrating at times, as actors who 
have worked for years to gain an advantage over their 
competitors within a subsystem suddenly find their plans 
knocked awry by (external) events — such as the Arab oil 
boycott — over which they have little control." 
83 Sabatier, P., A., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Diffusion, Utilisation., 8:4, June, p657. 
84 Sabatier, P., A., 1989, 'An advocacy coalition framework of policy change and the role of policy-
oriented learning therein', Policy Sciences, 21, p136. 
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What follows is a discussion of both sets of exogenous variables and the further 
development of a framework to analyse Australian illicit drug policy. 
Relatively Stable Parameters 
In the ACF, 'relatively stable parameters' were described as highly resistant to 
change and encompassed such phenomena as: the constitutional structure, socio-
cultural norms, basic attributes of the problem area and the resources of a political 
system. Two of those phenomena, namely, socio-cultural norms and basic attributes 
of the problem area, are particularly salient in illicit drug policy debates and thus 
merit further examination. 
Chapter one provided an outline of the historical development of illicit drug policy in 
Australia. Socio-cultural norms regarding illicit drug use in Australian society 
echoed those in other western liberal democratic states such as the United Kingdom 
and United States of America (USA), in which alcohol and tobacco are the legal 
drugs of choice. Further, racist foundations 85 of such policy meant that certain drugs 
and types of drug use were granted legal status (alcohol, tobacco and drinking 
morphine were associated with anglo-saxons) whereas other drugs (smoking opium 
associated with Chinese immigrants) were granted illicit status. Two other factors 
were evident from analysis of the origins of Australian illicit drug policy: first, 
decisions regarding the legal status of various drugs (for example: heroin and 
cannabis) were not based upon extensive research/evidence as to their inherent 
capacity to manufacture drug related harms and second, these decisions were made in 
85 See chapter one for more information. One recurring theme of drug wars is "...the notion of a 
public menace whereby a certain drug use associated with a particular group as in the case of opium 
and the Chinese, or crack cocaine and young, urban blacks." From Lang, E., 1998, 'Drugs in Society: 
A Social History', Hamilton, Kellehear & Rumbold (eds), Drug Use in Australia: A Harm 
Minimisation Approach, Oxford University Press, South Melbourne, p10. 
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the absence of domestic problems linked to those drugs. Thus, the very basis of 
illicit drug policy was based upon seemingly arbitrary historical and political factors 
rather than on rigorous evidence and analysis in the context of domestic harm. 
Understandably, Australia's traditional socio-cultural values in relation to illicit 
drugs are still a highly influential variable that constrains illicit drug policy and will 
be a recurring feature in the analyses throughout this thesis. 
Another stable system parameter was identified as the 'basic attributes of the 
problem area'. Typically the nature of debates regarding illicit drug policy 
engenders conflict between morality-based, traditional views on illicit drug use 
versus scientific, evidence-based approaches. Furthermore, the progressive suite of 
prohibition instruments applied to illicit drug policy in Australia during the twentieth 
century was a process driven by the USA via international treaties and conventions. 
As discussed in chapter one, such policies were based upon moral convictions (and 
in some cases racist ideas) regarding the nature of drug use in society. According to 
some proponents of the harm reduction coalition, the result is an inconsistent 
application of prohibition instruments that are neither based upon rigorous evidence 
nor a balanced application of regulations attached to substances based on their 
propensity toward drug related harm. The persistence of such moral arguments 
against the use of illicit drugs remains strong and often perverts scholarly 
information exchange in the illicit drug policy subsystem. The arguments of such 
moral entrepreneurs typically rely on "faith" or "common sense" precepts when 
constructing causal assumptions and consequently definitions of a problem area and 
are by their very nature, resistant to evidence that undermines their key assumptions. 
Moreover, such an approach to debate also has a significant bank of support in the 
media and the polity. Such social conditioning is well recognised. 
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...the influence of media coverage ensures the image of the 
problem fits the needs served by the drug war while at the 
same time helping to spread the problem, the perceptions of 
the problem, to a wider population. 86 
This also serves other political purposes 87, the discussion of which remains outside 
the scope of this thesis. This is the very nature of illicit drug policy debate and 
different to some other policy subsystems, especially those that address natural 
systems whereby evidence-based technical information is one of the dominant 
mechanisms affecting policy change. Therefore this research shall examine the role 
and nature of these arguments by moral agents that seemingly have a rich reservoir 
of legitimacy borne from historical and cultural norms underwriting such approaches. 
Specifically, these arguments will be contrasted with the language and strategies 
from the harm reduction advocacy coalition. 
In the ACF, other aspects of the problem/issue area may impact upon the degree of 
policy-oriented learning that can take place. Sabatier suggested that the type of 
information used to communicate coalition policy core beliefs might impact upon the 
type and degree of policy learning across coalitions and fields such as health and law 
enforcement. 
...a problem's susceptibility to quantitative measurement 
affects the ability to ascertain performance gaps. The 
extent of learning is likewise contingent upon the feasibility 
of developing good causal models of the factors affecting a 
problem. One would thus expect more learning on air 
pollution than on mental health." 
86 ibid, p10. 
87 The vilification of so called deviant groups means that governments can ignore other social and 
economic factors. ibid, pll. 
88 Sabatier, P., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Diffusion, Utilisation, 8:4, June, p655. 
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Thus, Sabatier differentiated between types of subsystems and their relative 
propensities toward policy oriented learning across coalitions. The illicit drug policy 
coalition is one such 'social' subsystem (similar to the example of mental health as 
noted in the quote above) whereby consensus on causal models in relation to a policy 
problem is more difficult to achieve than in other subsystems based around natural 
phenomena. This point is reiterated by Sabatier in the following hypothesis: 
Problems involving natural systems are more conducive to 
policy oriented learning across belief systems than those 
involving purely social or political systems because in the 
former many of the critical variables are not themselves 
active strategists and because controlled experimentation is 
more feasible. 89 
Other basic attributes of the problem area specifically related to the illicit drug policy 
subsystem would be prevalence of drug use and illicit drug trends, the system of drug 
laws in a federal system such as Australia, the pharmacology of drugs and 
fundamental causal relationships (for example: the propensity of opiates to induce 
overdoses) that contribute to the 'drug problem'. In sum, the illicit drug policy 
subsystem is a social system in which evidence-based, scientific approaches are more 
heavily contested on philosophical grounds than in debates regarding natural 
systems. 
It is theorised in the ACF that coalitions rarely target these 'relatively stable system 
parameters for reform', except as Sabatier suggests, in the long term. Such factors in 
the illicit drug policy subsystem will be tested for their stability and consistency over 
the twenty-year period that this study examines. 
89 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p106. 
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External System Events 
In contrast, the second set of exogenous variables theorised to impact upon a policy 
subsystem are entitled 'external system events' and, according to the authors of the 
ACF, constitute a critical prerequisite to major policy change. 90 Such events have 
implications for the policy subsystem and coalition actors. As discussed above, 
these variables can often change within a relatively short amount of time and present 
significant challenges to coalition actors. Sabatier articulated four categories of 
'external system events' and these are elaborated on in turn below. 
The first external system event expressed in the ACF was identified as 'changes in 
socio-economic conditions'. Sabatier and Jenkins-Smith theorised that changing 
social dynamics can potentially undermine or reconfigure causal assumptions of 
particular policy problems. Consequently, such changes can have the effect of re-
aligning the political support for advocacy coalitions. In this sense, the rise of new 
social movements (for example the rise of gay activism around the issue of 
HIV/AIDS) and/or perceived economic marginalisation of particular groups (for 
example, identification of the marginalisation of intravenous drug users) can 
influence the direction of policy in the long term. The second external system event 
suggested in the ACF was 'changes in public opinion'. For example, changing 
opinions regarding the perceived seriousness of the policy problem might then alter 
perceptions of the relative efficacy of government spending priorities. The third 
category of events articulated in the ACF as external to the policy subsystem was 
identified as 'changes in the governing coalition'. Changes in executive 
Government through elections, whereby political parties with different approaches to 
90 ibid,p103. 
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particular issues come to power, provides and alters opportunities for coalitions to 
realise policy objectives. The final set of external events identified in the ACF was 
'policy decisions and impacts from other subsystems'. Such changes in other arenas 
can affect the workings of the subsystem in question. For example, changes in 
social policy (such as adjustments to social security pensions or the instigation of 
new social services) can impact on the lifestyles and subsequent choices of drug 
consumers. 
Types of Policy Change 
The main function of the ACF is to provide a framework to account for, and explain, 
policy change. Within the ACF are criteria for distinguishing 'major' from 'minor' 
policy change. Sabatier suggested that the former was change in the policy core 
aspects of a governmental program whereas the latter was related to changes to 
secondary aspects of government policies and programs. In the ACF, the policy core 
is defined as relating to the "...fundamental policy positions concerning the basic 
strategies for achieving normative axioms of deep core" 91 values within the 
subsystem. With regard to the illicit drug policy subsystem examples of policy core 
aspects would be the overarching philosophy of 'harm minimisation' as a guiding 
principle of drug policy; the basic choice of policy instruments being coercion 
through drug laws and the provision of health services to drug consumers; and the 
desirability of participation of particular segments of society in policy development 
and implementation, more specifically, whether these officials should be drawn from 
public versus elite arenas and/or the relative participation of experts versus elected 
officials in policy. The scope of major policy change is necessarily subsystem wide. 
91 Sabatier, P., 1989, 'An advocacy coalition framework of policy change and the role of policy-
oriented learning therein', Policy Sciences, 21, p145. 
55 
Thus for change to qualify as major it has to have impacts across the entire 
subsystem. In contrast, change to secondary aspects of subsystem policy refers to 
instrumental decisions (for example to implement a SIC or to change penalties 
regarding possession of drugs) and information necessary to implement the policy 
core for example: operational decisions, administrative rules, budgetary allocations, 
importance of various causal linkages and the information concerning the seriousness 
of the problem (for example increased rates of heroin overdose). Changes to 
secondary aspects only have impacts on part of the subsystem. 
Throughout the ACF there is an emphasis on the role of ideas as catalysts for policy 
change within subsystems. Speaking globally about the ACF, Sabatier stated that: 
...the framework argues that policy change is best seen as 
fluctuations in the dominant belief systems within a given 
policy area/subsystem over time. 92 
Such belief systems can be regarded as independent variables in relation to policy 
making. Ideas are independent variables when they have the capacity to affect 
change through the construction of the policy problem and subsequently, prescription 
of solutions. Howlett and Ramesh note the relationship between ideas and policy 
making below. 
It has long been noted that the ideas individuals hold on an 
enduring basis have a significant effect on the decisions 
they make. Although efforts have been made by 
economists, psychologists and others to reduce these sets of 
ideas to a rational calculation of self interest, it is apparent 
that traditions, beliefs and attitudes about the world and 
society also affect how individuals interpret their interests. 
These sets of ideas or ideologies, therefore, can be 
construed to have a significant impact on public policies, 
92 Sabatier, P., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Diffusion, Utilisation, 8:4, June, p650. 
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for through these ideational prisms individuals conceive of 
social or other problems that inspire the demands of 
government action. In this view, the 'problems' which 
governments resolve are not considered to have an 
'objective' base in the economy or material structure of 
society, so much as they are constructed in the realm of 
public and private discourse 93 
In social policy arenas then, the role of such belief systems is even more important 
especially as such intellectual property has the innate capacity to define the "contours 
of the social world."94 The nature of illicit drug policy as a social policy whereby 
moral debates regarding the inherent virtue or iniquity of certain behaviours means 
that certain ideas and beliefs manifested in policy become (in the eyes of some) 
immune to scientific scrutiny. Indeed, the ACF sees policy change as resulting from 
interaction between stakeholders in the subsystem and real world events (relatively 
stable system parameters and external system events) as described earlier. 
Minor Policy Change 
Minor policy change in the ACF is conceptualised as the result of policy oriented 
learning within or between coalitions. Policy oriented learning occurs when 
coalitions interact in a number of ways (committees, meetings, professional forums 
and the like). The process of constructive interaction, as theorised in the ACF, is one 
whereby information relating to the particular policy arena is exchanged, and 
produces the development of a better understanding of the factors affecting a specific 
policy area over time. Sabatier suggested this information is used to analyse policy, 
93 Howlett, M., & Ramesh, M., 1995, 'Agenda Setting — Policy Determinants and Policy Windows', 
Policy Cycles and Policy Subsystems, Oxford University Press, Ontario, p109. 
94 Eldman , M., 1988, Constructing the Political Spectacle, University of Chicago Press, Chicago, p12- 
13. 
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and moreover serves political purposes, namely to "...buttress and support..."95 a 
particular policy position. Consequently, the process described above has the 
capacity to serve an ongoing advocacy function, whereby regular meetings between 
coalitions means that mutual education takes place regarding the ideas, research and 
associated causal assumptions that underpin their respective policy positions. The 
end result of this process is not necessarily consensus: 
That does not mean that policy conflict has ceased. As 
long as actors with the requisite political resources find the 
costs of present policies unacceptable, then agreement on 
some aspects of the problem and on the probable 
consequences of some policy alternatives will not lead to a 
policy consensus. Instead the analytical debate among 
different coalitions will continue to refine actors' 
understanding of the seriousness of the problem, the 
importance of various causal relationships, and the 
consequences of various alternatives. 96 
The consequence of such interchange between coalitions can be minor policy change 
to secondary aspects of policy or programs. Sabatier hypothesised that successful 
policy oriented learning was contingent on two factors. 
Policy oriented learning across belief systems is most likely 
when there is an intermediate level of informed conflict 
between the two coalitions. This requires that: 
(a) Each has the technical resources to engage in such a 
debate; and that 
(b) The conflict be between secondary aspects of one belief 
system and core elements of another, or alternatively 
between important secondary aspects of the two belief 
systems. 97 
Sabatier, P., & Jenkins-Smith, H., 1994, 'Evaluating the Advocacy Coalition Framework', Journal 
of Public Policy, 14:2, p191. 
Sabatier, P., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Diffusion, Utilisation., 8:4, June, p681. 
97 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p106. 
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Sabatier developed further criteria that could affect the probability of policy oriented 
learning both occurring and resulting in policy change. Sabatier hypothesised that 
the nature of the forums in which coalitions exchange ideas and information was 
important. 
Policy oriented learning across belief systems is most likely 
when there is a forum which is: 
(a) Prestigious enough to force professionals from 
different coalitions to participate; and 
(b) Dominated by professional norms. 
Therefore, the forum has to have some kind of legitimacy in the views of coalition 
members that participate, and further, the kind of behavioural parameters that 
mediate such groups/committees/meetings must also satisfy, as much as possible, the 
expectations of key coalition participants. In sum then, policy oriented learning was 
theorised within the ACF, occurring as a result of ongoing dialogue, conducted in 
mutually satisfactory conditions, between opposing coalitions. This in turn has the 
capacity to lead to change in accepted information regarding the seriousness of the 
problem and decisions of public agencies. Moreover, as noted earlier, the nature of 
the policy arena and type of information is also another factor in the degree of 
success of policy oriented learning. As noted above, Sabatier hypothesised that in 
natural systems, policy debates are more conducive to cross coalition learning in 
contrast to social policy arenas. The likelihood of a "...dialogue of the deaf' 98 
occurring whereby coalition members actively filter out information due to it 
conflicting with their fundamental presuppositions on the policy issue is more likely 
in arenas where moral debates are underwritten by historical and traditional factors: 
98 Sabatier, P., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Dffusion, Utilisation., 8:4, June, p678. 
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Members of an advocacy coalition are always seeking to 
improve their understanding of variable states and causal 
relationships which are consistent with their policy core. 
Likewise they find it easy to convince each other that 
attacks on their core programs are based on invalid 
understandings of the world. When two cores conflict, 
however, the tendency is for each coalition to talk past each 
other and thus for a "dialogue of the deaf' to persist until 
external conditions dramatically alter the power balance 
within the subsystem. 99 
The assumption that social systems are vulnerable to blockages in the process of 
policy oriented learning will be tested when applied to the illicit drug policy 
subsystem. With regard to policy oriented learning, this thesis will also analyse the 
following: 
(i) the nature of policy oriented learning in social subsystems; 
(ii) the role of technical information; 
(iii) the incidence of policy oriented learning (whether secondary or policy 
core); and, 
(iv) the types of forums in which such learning takes place within the illicit 
drug policy sector. 
Sabatier added that policy oriented learning is one mechanism that can contribute to 
changes in such secondary aspects of policy, however such learning is not enough to 
affect major changes in the policy core of Government programs. 19° 
Major Policy Change 
Major policy change in the ACF is theorised as being contingent on external 'shocks' 
to the subsystem that engender opportunities for advocacy coalition members. Such 
99 ibid. 
100 Sabatier, P., & Jenkins-Smith, H., 1994, 'Evaluating the Advocacy Coalition Framework', Journal 
of Public Policy, 14:2, p191. 
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opportunities, however, must be strategically exploited by coalitions hoping to 
realise their policy objectives. In the ACF, it was further theorised that there were 
several different processes in which the reconfiguring of the political power of 
coalitions within a subsystem occurs. The way in which these processes are 
theorised to occur within the ACF is discussed below. 
In order for major policy change to occur, changes to exogenous factors of a 
subsystem, described above as 'external system events', must transpire: 
While policy analysis and learning can strongly affect 
secondary aspects of such belief systems, fundamental 
changes in subsystem policy are usually the result of 
alterations in non-cognitive, systemic parameters. m 
Sabatier hypothesised that such changes to non-cognitive events did not constitute 
the sole means that precipitated major policy change: 
Significant perturbations external to the subsystem (e.g. 
changes in socio economic conditions, public opinion, 
system wide governing coalitions, or policy outputs from 
other subsystems) are a necessary, but not sufficient, cause 
of change in the policy core attributes of a governmental 
program. 102 
Therefore this thesis will examine the above hypothesis by first identifying such 
external dynamic variables and secondly noting whether such phenomena are present 
in cases of major policy change to policy core of programs in relation to Australian 
illicit drug policy. 
1°1 Sabatier, P., 1988, 'Knowledge, Policy-Oriented Learning and Policy Change: an advocacy 
coalition framework', Knowledge, Creation, Diffusion, Utilisation., 8:4, June, p650. 
102 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p106. 
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The ACF also theorises that such changes in external system events create a 'window 
of opportunity' in which coalitions must then capitalise: 
The basic argument is that such perturbations provide an 
opportunity for major policy change but such change will 
not occur unless that opportunity is skilfully exploited by 
proponents of change i.e. the heretofore minority 
coalitions. 1°3 
In the ACF, skilful exploitation of opportunity occurs through the use of 'guidance 
instruments' as described earlier. Indeed as well as identifying the conditions around 
policy change occurs in the Australian illicit drug policy subsystem, the way in 
which coalitions capitalised on these changes is also examined in this thesis. 
Another of the conditions required for major policy change is a replacement of the 
dominant coalition with another. Sabatier hypothesised: 
The policy core attributes of a governmental program in a 
specific jurisdiction will not be significantly revised as long 
as the subsystem advocacy coalition that instituted the 
program remains in power within that jurisdiction — except 
when the change is imposed by a hierarchically superior 
jurisdiction. 104 
One of the criteria for analysis of the utility of the ACF for conceptualising illicit 
drug policy in the current thesis will be determining whether, in the event of policy 
core changes, the dominant coalition/s in the subsystem were succeeded by other 
coalitions. This thesis will examine the way in which coalitions integrated such 
external events into strategies to realise policy objectives. Sabatier described the 
reconfiguring of coalitions within a subsystem in several ways. First, the description 
of the replacement of one coalition by another: 
103 ibid, p118-9. 
1°4 ibid, p106. 
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Sometimes a tremendous surge of public concern with a 
problem leads to a process of competitive policy escalation 
by elected officials (or political parties) and thus the 
replacement of one coalition by another virtually 
overnight. 1°5 
The second way concerns political manoeuvrings and compromise by one coalition 
to gain enough political capital to broker the desired results. 
Far more frequent, we suspect, is a scenario in which the 
minority coalition increases in importance and attempts to 
take advantage of a window of opportunity opened by an 
external perturbation, but does not have the votes in the 
legislature to push through a substantial change in the 
policy core of governmental policy on its merits. Thus the 
minority coalition is likely to resort to any tactic that will 
garner additional votes, including 'pork barrel' benefits, 
trying to manipulate the dimensions of the issue to appeal 
to different constituencies, bribes, attaching the bill as a 
waiver to other legislation, etc. In short, obtaining major 
policy change usually requires that an advocacy coalition 
augment its resources by developing 'coalitions of 
convenience' with a variety of other groups. 1°6 
The third process described a situation whereby one large coalition is formed from 
members from all coalitions. This type of arrangement sees political power being 
divided between coalitions. 
In situations in which all major coalitions view a 
continuation of the current situation as unacceptable, they 
may be willing to enter negotiations in the hope of finding 
compromise that is viewed by everyone as superior to that 
status quo. ... We suspect that the conditions for such a 
successful consensus process — i.e. one that results in 
legally binding agreements viewed by everyone as an 
improvement — are similar to those for a successful 
professional forum 
(a) 	a stalemate wherein all coalitions view a 
continuation of the status quo as unacceptable 
105 ibid, p119. 
106 ibid. 
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(b) the negotiations are conducted in private and last a 
relatively long time, e.g. more than six months 
(c) there is a facilitator (policy broker) respected by all 
parties and viewed as relatively neutral. 
The end result is not a dominant coalition and several 
minority coalitions but what might be regarded as 'power 
sharing' among coalitions (analogous to a 'grand coalition' 
in parliamentary systems or the tradition of consensus 
negotiations in such countries as Switzerland or the 
Netherlands). 1°7 
Sabatier further noted that such arrangements are likely to be unstable. 1°8 This 
research will seek to identify the outcome of major policy change ascertaining the 
relative power of coalitions in the illicit drug policy subsystem and whether 
coalitions reconfigured according to processes outlined above by Sabatier. 
An Advocacy Coalition Framework For Analysing Illicit Drug Policy 
1980 to 2000 
Table 1 represents the model of analysis that will be applied in this thesis. The 
model lists key hypotheses and concepts within the ACF and also a list of research 
questions, formulated in order to facilitate a critique of the ACF when applied to 
social systems and also to act as a tool to understand policy making in the illicit drug 
subsystem in Australia. Moreover this model should also generate insight into the 
relative efficacy of coalition strategising around the issue of illicit drugs. 
107 ibid, p119-120. 
108 ibid, p120. 
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Table 1: An Advocacy Coalition Framework for Analysis of the Illicit Drug Policy Subsystem 1980 — 2000 
ACF Hypothesis or Key Concept Further information Research Questions 
I. Advocacy coalitions: 
ACF Hypothesis: On major controversies within a policy 
subsystem when policy core beliefs are in dispute, the lineup 
of allies and opponents tends to be stable over periods of a 
decade or thereabouts. 
Coalitions tested for constituency and stability 
1.1 What type of actors constitute the 'harm reduction' and 
'moral-abstinence' coalitions? 
1.2 Was there any change in the type of actors over a 20 
year period in illicit drug debates? 
1.3 (If applicable) What was the nature of the change 
(gradual or sudden) 
2. Advocacy coalition belief systems 
ACF Hypothesis: Actors within an advocacy coalition will 
show substantial consensus on issues pertaining to the 
policy core, although less so on secondary aspects. 
Consensus on policy core 
2.1 Did the harm reduction coalition display consensus on 
policy core beliefs? 
3. Guidance Instruments 
ACF concept: This concept describes the way in which 
coalitions capitalise on changes that occur, within or 
external to, the subsystem that provide opportunities for 
coalitions to realise policy objectives. For example this 
might include changes to rules, governments, budgets or 
information that can be exploited by coalition actors to 
realise policy objectives, 
Sabatier's taxonomy of guidance instruments: 
• seeking to influence legislatures to alter the 
budgets and legal authority of administrative 
agencies through testimony and campaign 
contributions; 
• trying to change the incumbents of various 
positions, whether they be agency appointees, 
agency civil servants, or elected legislators and 
chief executives; 
• trying to affect public opinion via the mass media; 
• attempting to alter target group behaviour via 
demonstrations or boycotts 
• trying to gradually alter the perceptions of a 
variety of actors through research and information 
exchange 
The utility of guidance instruments 
3.1 How did the harm reduction coalition capitalise on 
changes that occurred external to or within the subsystem? 
3.2 Did these conform to Sabatier's taxonomy of guidance 
i nstruments? 
ACF Hypothesis or Key Concept Further information Research Questions 
4. Role of policy brokers 
ACF concept: Conflicting strategies (advocated by each 
coalition) are submitted to 'policy brokers', a group of 
actors that represent the Government and are responsible for 
reaching compromise and limiting conflict, whose principal 
concern is to find some reasonable compromise that will 
reduce intense conflict. The end result is one or more 
governmental programs, which in turn produce policy 
outputs at the operational level. 
Neutrality 
Policy brokers in the ACF have an implied neutrality to their 
role. A 1987 article suggested that policy brokers could be 
both coalition members and policy makers but this has not 
been emphasised in more recent writing on the ACF. 
Policy brokers as neutral policy makers 
4.1 Do policy brokers have membership of any coalition? 
4.2 To what extent do policy brokers 'make' policy? Do 
policy brokers receive conflicting strategies? Do policy 
brokers reach compromise between coalitions? 
5. Relatively stable system parameters 
ACF concept: such system parameters are stable over 
several decades and that coalitions rarely target these 
parameters for reform except in the long term. Such factors 
will also be tested for their stability and consistency over the 
twenty-year period examined in this thesis. 
Four categories of relatively stable system parameters 
• Basic attributes of the problem area 
• Basic distribution of natural resources 
• Fundamental socio-cultural values 
• Basic constitutional rules 
Stability and consistency of relatively stable system 
parameters 
5.1 Were such phenomena as categorised in the ACF stable 
from 1980 to 2000? 
5.2 Did coalitions target these parameters for reform? 
6. Policy-oriented learning — quantitative data 
ACF hypothesis: Problems for which accepted quantitative 
data exist are more conducive to policy oriented learning 
across belief systems than those in which data and theory 
are generally qualitative, quite subjective or altogether 
lacking. 
As coalitions resist changing their policy beliefs or 
important secondary aspects, only solid empirical evidence 
i 	. s likely to lead them to do so. It is hypoesised in the ACF th 
that such evidence is most likely to be developed and 
accepted in fields where quantitative data and consensual 
theories are available, a situation more common in the 
natural sciences than the social sciences. A problem's 
susceptibility to quantitative measurement affects the ability 
to ascertain performance gaps. The extent of learning is 
likewise contingent upon the feasibility of developing good 
causal models of the factors affecting a problem. One 
would thus expect more learning on air pollution than on 
mental health. 
Technical information 
6.1 What was the role of quantitative data/information in 
policy oriented learning? 
6.2 Was such data accepted by both coalitions? 
3 If not, what were the barriers to its acceptance? 
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ACF Hypothesis or Key Concept Further information Research Questions 
7. Policy oriented learning 
ACF hypothesis: Policy oriented learning across belief 
systems is most likely when there is an intermediate level of 
informed conflict between the two coalitions. This requires 
that: 
(a) Each has the technical resources to engage in such a 
debate; and that 
(b) The conflict be between secondary aspects of one belief 
system and core elements of another, or alternatively 
between important secondary aspects of the two belief 
systems. 
Conflict between coalitions in professional forums 
7.1 In cases where policy oriented learning occurred, did 
the conflict concern secondary aspects of both coalitions or 
between the secondary aspect of one coalition and the policy 
core of the other? 
8. Policy oriented learning — nature of professional forums 
Policy oriented learning across belief systems is most likely 
when there is a forum which is: 
(a) Prestigious enough to force professionals from different 
coalitions to participate; and 
(b) Dominated by professional norms. 
Nature of professional forums 
8.1 What were the types of forums that facilitated policy 
oriented learning? 
9. Major policy change — condition 1 
Significant perturbations external to the subsystem (e.g. 
changes in socio economic conditions, public opinion, 
system wide governing coalitions, or policy outputs from 
other subsystems) are a necessary, but not sufficient, cause 
of change in the policy core attributes of a governmental 
program 
The basic argument is that such perturbations provide an 
opportunity for major policy change but such change will 
not occur unless that opportunity is skilfully exploited by 
proponents of change i.e. the heretofore minority coalitions 
Changes to external events and major policy change 
9.1 In cases of changes to policy core, was there an external 
shock to the subsystem? 
9.2 How did coalitions integrate such external events into 
strategies to realise policy objectives? 
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ACF Hypothesis or Key Concept Further information Research Questions 
10. Major policy change — condition 2 
The policy core attributes of a governmental program in a 
specific jurisdiction will not be significantly revised as long 
as the subsystem advocacy coalition that instituted the 
program remains in power within that jurisdiction — except 
when the change is imposed by a hierarchically superior 
jurisdiction 
Process of major policy change 
Three processes described by Sabatier 
f Replacement o one coalition y another •  	 i i 	b 
• Form coalitions of convenience 
• Form grand coalition 
Changes in the respective political power of coalitions in 
cases if major policy change 
10.1 In cases of changes to policy core, did the subsystem 
coalition that instituted the program remain in power? 
10.2 If yes, then was the change imposed by a 
hierarchically superior jurisdiction? 
10.3 What was the outcome of major policy change 
regarding the relative power of coalitions within the illicit 
drug policy subsystem? 
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These research questions will be answered where appropriate throughout the next 
four chapters. Chapter Six directly answers the research questions and synthesises 
findings from chapters three to five. The following chapter traces the genesis and 
development of the harm reduction advocacy coalition in the period 1980 to 1990. 
Chapter 3: The Emergence of a Coalition for Harm Reduction 
Introduction 
"Look mate, there are no votes in buggers, druggies and prozzies! ""9 
State Ministerial colleague to Neal Blewett 
This chapter examines the emergence of the harm reduction approach in the 
Australian illicit drug policy subsystem between 1980 and 1990. At the beginning of 
1980, the main tools used in illicit drug policy were prohibition to limit the supply of 
drugs and abstinence-oriented treatment with the exception of MMT that had been in 
operation for many decades. By the close of the decade, harm reduction tools were 
firmly entrenched in policy with many Australian state governments having: 
implemented NSPs (that not only disseminated free sterile injecting equipment but 
also included education about safer injecting practices), expanded the number of 
MMT places available and also funded and invited illicit drug users to not only 
provide services but also supply input into Government policy. This chapter seeks to 
understand and explain how such controversial policies that provide services for 
people who continue to use illicit drugs (without any requirement for those users to 
become abstinent) initially became enshrined in Australian public policy. 
This chapter describes: the genesis and crystallisation of a coalition of actors that 
supported the theory and practice of the harm reduction approach, key events that 
occurred in this decade in illicit drug policy, and, the way in which a group of actors 
advocated for harm reduction policy. Throughout the chapter is the identification of 
harm reduction ideas that appeared in Royal Commissions, key articles, national and 
109 Blewett, N., 2003, Aids in Australia: Reflections on Australia's policy response to the AIDS 
Epidemic, Australian Health Policy Institute, University of Sydney, p8. 
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state policies and evaluations before the approach was widely used in drug policy. 
Of principal importance to this chapter are those particular concepts of the ACF used 
to explain 'major' policy change. External shock/s to the subsystem and a shift in 
power between coalitions within the subsystem are two key conditions identified by 
the authors of the ACF as necessary prerequisites to policy change. Moreover, the 
composition of an 'advocacy coalition' for harm reduction and the idea of policy 
beliefs acting to unify actors is also identified. Other key concepts listed in Table 1. 
are also analysed and evaluated against the events between 1980 and 1990. 
The Origins of Harm Reduction 
First, do no harm. 
- Hippocrates 
Harm reduction principles and ideas as described in chapter one have a long tradition 
in medicine. The notion of reducing harm, while acknowledging that the behaviour 
that caused the harm may continue, is a fundamental principle applied to the 
treatment of many conditions. For example: patients with heart problems are not 
prohibited from having particular foods, instead they are encouraged to moderate 
dietary intake and adopt an exercise regimen. Harm reduction principles are also 
applied in public health settings. For example, the policy response to road fatalities 
has resulted in the provision of, and legal requirement to wear, seat belts and further, 
drivers are subjected to random breath testing as well as restrictions on speed. All of 
these examples are used to manage the risk associated with driving. The central 
premise with regard to these examples is that some human behaviour is both ongoing_ 
and dangerous, and, rather than prohibit such behaviour, the preferred practical 
response is to reduce harm associated with it as much as possible. Therefore, the 
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ideas and philosophy of harm reduction are well established in a number of arenas 
whereby management of a dangerous activity is seen to be more effective than 
prohibition of it. 
With regard to illicit drug policy, there were few harm reduction principles employed 
before the 1980s. Indeed, MMT and prescription heroin (in the United Kingdom) 
were solitary examples that existed sporadically within the dominant regime of 
prohibition. M1vIT 11° (and prescription of heroin) are designed to reduce the 
disruptions to a person's life when dependent on substances. Such programs work 
to reduce the association of the dependent person with criminal networks and the 
expense of a daily dependency, 111 facilitate the rebuilding of familial networks and 
re-entry into the workforce in some cases from illicit drug use. Thus such programs 
are underwritten with an understanding that dependencies can manufacture harms 
that extend beyond the scope of the pharmacological effects of the drugs themselves. 
Indeed, such harms often need to be addressed prior to, or concurrently with, the 
medical management of dependencies. 
With regard to NSPs in Australia, there are accounts of pharmacies supplying 
syringes to drug consumers in the 1970s previous to any government run program. 
To an extent, these constituted the first recorded means of dissemination of needle 
and syringes in Australia, albeit occurring sporadically and at unknown frequencies. 
110 Methadone treatment began in 1969 in Australia. Campbell, A., 2001, The Australian Illicit Drug 
Guide, Black Inc., Melbourne, p155. In the United Kingdom, the prescription of other drugs than 
methadone dates back to the 1920s, with a small few receiving injectable heroin. Riley, D., & O'Hare, 
P., 2000, 'Harm Reduction: History, Definition, and Practice', Harm Reduction: National and 
International Perspectives, Sage, London, p13. 
111 Consumers of methadone maintenance programs in Australia still have a minor cost associated 
with the prescription of methadone however this cost is minimal in comparison to the price of street 
drugs. 
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The Committee has had complaints that many pharmacists 
too freely make available hypodermic needles for the use of 
addicts. . . Experience of members of the Committee 
suggests that drug addicts are very resourceful in 
fashioning implements that can be used for hypodermic 
injections even when needles and syringes are not 
available. For example, the Drug Squad at Police 
Headquarters has in its possession many items which had 
been used as substitutes by drug users. 112 
Such an initiative, constituted an early measure by coalface workers (in this case 
pharmacists) to reduce drug related harm. The consequences of reusing injecting 
equipment many times, let alone using homemade implements, are potentially very 
negative due to the risk of bacterial infection and vein damage. Those at the coalface 
(pharmacy and medical staff), however, knew the risks of using a single syringe for 
multiple injections and acted accordingly to supply syringes, albeit in an ad hoc 
fashion. 
In sum, principles inherent in harm reduction have existed long before the term was 
indoctrinated into government policy in the 1980s. Harm reduction as a concept 
applied to the management of illicit drugs gained support and momentum in the 
1980s, buoyed partly by the perception that drug use was increasing in line with 
availability. 
The Identification of the 'Drug Problem' 
By the early 1960s there was growing, but still relatively little, reported recreational 
illicit drug use in Australia. By the end of the decade however, the issue of illicit 
112 New South Wales Joint Parliamentary Committee Upon Drugs, Report into Drug Abuses, Sydney 
p95. 
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drugs was on the political agenda 113 with reports of increasing numbers of organised 
production and trafficking syndicates. 
In the late 1960s, a new dimension of the 'drug problem' 
namely organized drug trafficking, developed in Sydney 
with the arrival of US servicemen on leave from the 
Vietnam War. Local drug markets expanded to meet their 
requirements, particularly for heroin." 
The perception of increased availability 115 and use of illicit drugs along with a new 
mode of taking drugs (self administered injections) and the reports of increasing 
sophistication in the production and trafficking of drugs, meant that drug issues 
quickly gained popular attention through the media. 116 This was echoed in several 
countries around the world with many experts convening to discuss the issue at 
conferences. 117 Consequently, numerous Royal Commissions and Inquiries 
examining the issue were conducted in the 1970s. 
1970s - The Era of the Royal Commission 
In the 1970s, six major Inquiries and Royal Commissions ensued in regard to the 
perception of a growing drug problem. 118 These Commissions aimed to provide 
ID Campbell, A., 2001, The Australian Illicit Drug Guide, Black Inc, Melbourne, p439. 
114 ibid. 
115 "In particular the sheer vastness of the growth in the availability of all drugs through a multitude of 
legal and illegal sources has been the most forceful single factor to have struck the Committee during 
its inquiry. The flood of drugs into the community still taking place must be stemmed and reversed." 
The New South Wales Joint Parliamentary Committee Upon Drugs, 1978, Report into Drug Abuse 
1978, p28. 
116 "When the Committee embarked on its task in November 1976 . . . drugs were making headline 
stories almost everyday and certainly as far as many of the media were concerned they would remain 
high on the list of public excitement", The New South Wales Joint Parliamentary Committee Upon 
Drugs, 1978, Report into Drug Abuse 1978, p17. 
117 For example — the 7" International Conference on Alcohol, Drugs and Traffic Safety in Melbourne 
in 1977. 
118 The Senate Standing Committee on Drug Trafficking and Drug Abuse 1971 (Marriot report), The 
Senate Standing Committee on Social Welfare, 1976, Drug Problems in Australia: an intoxicated 
Society, (Baume Inquiry), The New South Wales Royal Commission into Drug Trafficking 1976 
(Woodward Inquiry), Australian Royal Commission of Inquiry into Drugs 1977 (Williams Inquiry), 
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answers on the nature and problems of drug use in society in the context of very little 
existing reliable data 119, and to dispel myths surrounding drug use while ultimately 
providing direction to Governments keen to be seen by the electorate as doing 
something about the 'problem'. There were several key themes identified by the 
authors of these Commissions and Inquiries in the 1970s, these are summarised 
below: 
• the recognition that licit substances such as alcohol and tobacco caused more 
harm than illicit drugs and thus constituted the core of the 'drug problem' 120 , 
• similarly, recognition that pharmaceutical self medication constitutes part of 
the 'drug problem' 121 , 
• distinctions were made between the relative levels of harm and risk of 
specific drugs (such as cannabis in comparison to heroin) 122 , 
• distinctions were also made between types of drug use (recreational to heavy 
. 123 , use) 
• organised crime and police corruption were identified as being linked with 
the production and trafficking of illicit drugs 124 , and, 
• substantial debate regarding the degree of effectiveness of criminal law in 
addressing illicit drug use 125 in this time. 
The New South Wales Joint Parliamentary Committee Upon Drugs, 1978, Report into Drug Abuse 
1978, The South Australian Royal Commission into the Non-Medical Use of Drugs 1979 (The 
Sacicville Inquiry), The Woodward Royal Commission 1980, The Senate Standing Committee on 
Social Welfare 1981 (Waters Inquiry), The Royal Commission into Drug Trafficking 1982 (Stewart 
Inquiry). 
119 Senate Standing Committee on Social Welfare, 1977, Drug Problems in Australia: an intoxicated 
society, AGPS, Canberra, p13. 
120 South Australian Government, Royal Commission into the Non-Medical Use of Drugs, 1979, p5. 
121 ibid, p43 & p82. 
122 Senate Standing Committee on Social Welfare, 1977, Drug Problems in Australia: an intoxicated 
society, AGPS, Canberra, pl. 
123 Five categories of drug use being: experimental, social/recreational, circumstantial/situational, 
intensified & compulsive. South Australian Government, 1979, Royal Commission into the Non-
Medical Use of Drugs, p20. 
124 The New South Wales Joint Parliamentary Committee Upon Drugs, 1978, Report into Drug Abuse 
1978, p40-1. 
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Such comments served to broaden the understanding of the 'drug problem' away 
from being attributed exclusively to illicit drugs and problematic drug use patterns 
towards one that incorporated the role of licit and prescribed drugs as well as the link 
between prohibition and organised crime and police corruption. 
Comments in these Royal Commissions echoed key tenets of harm reduction. 
Authors of the Senate Standing Committee on Social Welfare 1977, and the South 
Australian Royal Commission into the Non-Medical Use of Drugs stated that 
elimination of non-medical drug use entirely from society was an unrealistic goal. 126 
Such a statement essentially challenged the utopian notion of a drug free society (and 
the efficacy of law enforcement in achieving this) that is an implicit goal of 
prohibition regimes. As mentioned in Chapter One many writers advocating for 
harm reduction in drug policy have noted that efforts to enforce a drug free society 
have the capacity to generate worse harms than from the drugs alone. 127 
Second, in the Sacicville Commission it was argued that drug use is primarily a social 
and medical problem 128 and that "...a coherent, concerted and all embracing 
125 Campbell, A., 2001, The Australian Illicit Drug Guide, Black Inc, Melbourne, p441. 
126 South Australian Government, 1979, Royal Commission into the Non-Medical Use of Drugs, 
South Australia, (Sacicville Commission), p 19; Senate Standing Committee on Social Welfare, 1977, 
Drug Problems in Australia: an intoxicated society, AGPS, Canberra, p1. Moreover, some notions 
within the harm reduction paradigm suggest that a drug free society is unachievable and as such offers 
ways of managing, arguably, ongoing and 'normal' human activity. 
127 Erickson, P., 1992, 'Political Pharmacology: Thinking about drugs', Daedalus, Summer, pp239- 
267; Nadlemann, E., 1993, 'Progressive legalizers, progressive prohibitionists and the reduction of 
drug related harm', in N Heather et. al (eds), Psychoactive drugs and harm reduction: from faith to 
science, Whurr, London, pp34-35; O'Hare, P., 1992, 'Preface: A note on the concept of harm 
reduction', in P O'Hare, R., Newcombe, A., Matthews, E., Buning & E Drucker (eds), The reduction 
of drug related harm, Routledge, New York; Riley,D., & Oscapella, E., 1997, 'Canada's new drug 
law: Some implications for HIV/AIDS prevention in Canada', International Journal of Drug Policy, 
7:3, pp180-182. 
128 South Australian Government, 1979, Royal Commission into the non-Medical Use of Drugs, South 
Australia, (Sackville Commission), p23; Senate Standing Committee on Social Welfare, 1977, Drug 
Problems in Australia: an intoxicated society, AGPS, Canberra, pl. 
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policy" 129 be formulated so to reduce drug related harm. Third, the Senate Standing 
Committee on Social Welfare suggested that a 'harm audit' should be conducted on 
various policies (for example those of law enforcement) in order to determine the 
correct approach at any one given time. Indeed one author ruminated on the 
capacity of law enforcement to contribute to drug related harm: 
The mechanism for discouragement of use should not be 
more damaging to the individual than is the drug itself. 13° 
In 1972, the Canadian Government Commission of Inquiry into the Non -Medical Use 
of Drugs (the Le Dain Reports) concluded that the notion of 'harm' was a robust 
measure of the relative efficacy of interventions: 
In every case the test must be a practical one; we must 
weigh the potential for harm, individual and social, of the 
conduct in question against the harm, individual and social, 
which is caused by the application of the criminal law, and 
ask ourselves whether, on balance, the intervention is 
justified. Put another way, the use of criminal law in any 
particular case should be justified on an evaluation and 
weighing of its benefits and costs. 131 
As mentioned in Chapter One, the notion of 'harm reduction' can be conceived of as 
a yardstick to measure policies. Indeed, in 1977, the Sackville Commission 
suggested that the reduction of drug related harm be the major goal of drug policy: 
. . .that the major goal of social policy on drugs should be 
to minimise the harmful use of mood altering drugs. There 
too we discussed the relationship between use and misuse 
and we described those kinds of drug use that might be 
considered more or less likely to lead to harmful effects, 
129 ibid. 
1313 Senate Standing Committee on Social Welfare, 1977, Drug Problems in Australia: an intoxicated 
society, AGPS, Canberra, p23. 
131 Commission of Inquiry into the Non-Medical Use of Drugs, 1972, Cannabis, Information Canada, 
Ottawa, pp282-3. 
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either for the individual or society. We pointed out that ... 
experimental, recreational or circumstantial use did not 
constitute a great hazard to the public or to the health of 
most individuals, even if the drugs involved were not 
obtained through legal sources... 132 
Such comments, that echoed concepts and principles of the harm reduction approach, 
from Royal Commissions and Inquiries occurred before harm reduction emerged in 
the 1980s. 
It is important to note however, the apparent limitation of such Royal Commissions 
and Inquiries as agenda setting instruments for public policy. Such documents 
represent the views of experts yet often recommendations are ignored. Sackville 
ruminated: 
• . . in Australia and in other countries there has been a 
record, in modern times, of extensive official inquiries into 
the regulation of drug use. The reports of these inquiries 
have often been striking for the similarity of their general 
approach and sometimes for their recommendations. The 
unwillingness or inability of governments to implement 
those recommendations has been equally striking."' 
Sackville further commented on the seemingly immovable status of law enforcement 
in illicit drug policy: 
Despite thoughtful and detailed reports from those bodies, 
governments have found it difficult to depart from 
entrenched control policies, and public perception of the 
nature of the problem has been slow to change. 34 
132 South Australian Government, 1979, Royal Commission into the non-Medical Use of Drugs South 
Australia, (Sacicville commission), p61. 
133 • • p5. 
134 ibid. 
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The incapacity of governments to act upon numerous recommendations made by a 
number of commissions or inquiries points to an irrationality or 'blockage' in drug 
policy making. 
In sum, by the end of the 1970s the 'drug problem' was a significant political issue 
with many advocating change in government policy. Royal Commissioners 
attempted to redefine the 'drug problem' to one that included licit substances and 
also suggested the existence of many different patterns of drug use from recreational 
to habitual. Moreover, the same authors also suggested that the notion of the 
reduction of drug related harm should be a major goal of drug policy, or at very least 
used regularly as a policy yardstick. This period marked the beginning of a change 
in thinking about illicit drug policy in Australia and indeed in the rest of the world. 
Berridge 135 , in the United Kingdom, argued that harm reduction was not a new policy 
objective when adopted by Governments in the 1980s. Previously, there had been a 
growing belief that harm reduction was a more pragmatic aim that the ideas of 
'treatment', 'cure' and 'abstinence'. 
The concept received its best known public expression in 
the 1984 ACMD Report on Prevention which abandoned 
the traditional division into primary, secondary and tertiary 
prevention in favour of two basic criteria: (1) reducing the 
risk of an individual engaging in drug misuse; (2) reducing 
the harm associated with drug misuse. 136 
By the early-to-mid 1980s a distinct policy community was forming in the UK that 
were sympathetic to these ideas. These ideas were accompanied also by a preference 
to downplay the medical model of addiction (at both a practical and theoretical level) 
135 Berridge, V., 1993, 'Harm minimisation and public health: a historical perspective, in N., Heather, 
A., Wodak, E., Nadleman & P., O'Hare (eds), Psychoactive Drugs & Harm Reduction: from faith to 
science, Whurr, London, p56. 
136 • • p57. 
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as a disease that required specialist treatment. The 1982 Advisory Council on the 
Misuse of Drugs (ACMD) report on Treatment and Rehabilitation posited that not all 
people with drug problems are necessarily suffering from a disease of dependence 
nor is there any uniform personality trait or type of person that is more likely to be 
vulnerable to displaying problematic drug behaviour. 137 
The Genesis of a Coalition for 'Harm Reduction' in Australia 
Other developments in the international arena also helped generate local momentum 
for a different approach to illicit drug policy. In 1980, the key topic of the first 
national conference of the Australian Medical Society on Alcohol and Drugs 
(AMSAD) was the development of a "...broad, long term, health oriented national 
strategy..." 138 to address both licit and illicit drug use. The Pan Pacific Conference 
on Drugs and Alcohol held in the same year called for a regional policy on drugs that 
was informed by empirical research and reason than by "...inflamed emotion." 139 
The World Health Organisation (WHO) publication Memorandum on Nomenclature 
and Classification of Drug and Alcohol -Related Problems used the terms "harmful" 
and "hazardous use" instead of the value laden "abuse" and "misuse". 14° This shift 
in terminology reflected a broader move towards formulating a scientific and morally 
neutral approach to the study of illicit drugs so to allow the refinement of 
classification and diagnostic systems to allow scientific endeavour into the alcohol 
137 DHSS, 1982, Treatment and Rehabilitation: Report of the Advisory Council on the Misuse of 
Drugs, London, HMSO. 
138 MacKellar, M., 1980, Opening of the First National Conference of the Australian Medical Society 
on Alcohol and other Drugs Problems, First National Conference of the Australian Medical Society 
on Alcohol and other Drugs Problems-Conference Papers, p7. 
139 Drew, L., 1981, 'The need for a regional policy on drugs', Man, Drugs and Society — current 
perspectives, proceedings of the First pan Pacific Conference on Drugs and Alcohol, Canberra, 
Australia, march 1980, p9. 
140 Edwards, G., Arif, A., & Hadgson, R., 1981, 'Nomenclature and classification of drug and alcohol 
related problems: a WHO Memorandum', Bulletin of the World Health Organization, 59:2, pp225-42. 
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and other drug arena. Such changes in terminology highlighted the bio-medical 
community's influence in the international alcohol and other drug arena. The 
terminology from the WHO memorandum was adopted by the newly formed 
AMSAD, the aim of which was to increase the awareness and knowledge of alcohol 
and other drug problems in the medical profession. 
In an article 141 published in the Australian Alcohol and Drug Review, Les Drew (a 
senior bureaucrat with the Federal Health Department) noted the existence of a 
general consensus that traditional abstinence-oriented and supply reduction policies 
had not worked and indeed were beginning to lose credibility. This view was 
endorsed at the 1982 meeting of the WHO Project on the Development of Strategies 
and Guidelines for the Prevention of Drug Dependence. 142 This further indicated 
that there was momentum for change and that a 'window of opportunity' had opened 
for policy makers to suggest new approaches. Les Drew also suggested the need to 
ensure that people who continue to use illicit drugs do so as safely as possible 
through targeted programs (for example: the provision of sterile water to drug users 
so to reduce the instance of injecting tap water and thus depositing bacteria directly 
into the bloodstream causing infections). 143 
Furthermore, professional journals and associations were initiated in this time. 
Drew also reiterated the need to instigate and, in some cases, strengthen institutions 
such as the Australian Alcohol/Drug Review (now Drug and Alcohol Review), a 
professional society (Australian Medical Society on Alcohol and Drug Related 
141 Drew, L.,1984, 'Strategies for Minimising Drug Related Health Problems', Australian 
Alcohol/Drug Review, 3:1, January. 
142 World Health Organisation, 1982, 'WHO Project on the Development of Strategies and Guidelines 
for the Prevention of Drug Dependence', Report of the Advisory Group Meeting, 20-24 April 1982. 
143 Drew, L.,1984, Strategies for Minimising Drug Related Health Problems, Australian Alcohol/Drug 
Review, vol3, No. 1, January, p17. 
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problems), a national organisation (Australian Foundation of Alcoholism and Drug 
Dependence), national centres of excellence (focusing on applied research) and 
academic bases (professorships). 144 Therefore, as an individual, Les Drew was a 
key advocate of harm reduction ideas in the 1980s. 
As well as changes in terminology and the formation of professional societies, the 
contributions of key individuals such as Les Drew and Prime Minister Hawke are 
central to the development of harm reduction policy in Australia in the 1980s. The 
first national drug strategy, the National Campaign Against Drug Abuse (NCADA) 
did not mention harm reduction initiatives (except MMT), rather it used the term 
'harm minimisation'. In this context such a term had quite a distinct meaning to the 
term harm reduction. This is discussed in the following section. 
The National Campaign Against Drug Abuse (NCADA) 
The NCADA was produced by the Department of Health following a Special 
Premier's Conference held in April 1985. Preceding the conference was consultation 
between Commonwealth and State/Territory Ministers and Officers. 145 The key 
points of the NCADA were: 
• to encourage cooperation between all levels of Government in managing 
alcohol and other drug issues; 
• a focus on illicit drugs, yet recognition of the widespread health and social 
problems from use of licit drugs; 
• maintenance and enhancement of supply reduction policies; 
144 ibid. 
145 Department of Health, 1985, National Campaign Against Drug Abuse, AGPS, Canberra, p 1 . 
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• supply reduction policies that focussed on traffickers while concurrently 
offering diversion to treatment for some users; 
• enhancement of drug control mechanisms such as Australian Federal Police; 
• emphasis on demand reduction to be achieved through education, treatment 
and rehabilitation programs; 
• support for generalist alcohol and other drug workers; 
• support for specialist substance use units/committees and policy groups; and, 
• introduction of data systems, research and evaluation of existing programs 
and drug issues. 
Previous to the implementation of the NCADA, there was not a national strategy 
designed to encompass and manage drug use, instead it was largely the realm of law 
enforcement bodies that implemented policies designed to reduce the supply of drugs 
in Australia. The medical community did have a role in treatment for dependant 
persons and had long been involved in programs such as MMT. The NCADA 
however heralded the beginning of a partnership between health and law 
enforcement sectors in illicit drug policy. Indeed, the NCADA and subsequent drug 
strategies generated many opportunities, both formal and informal, whereby law 
enforcement and health personnel would interact. 
The development of the NCADA document reflected the contributions of key 
individuals such as Prime Minister Hawke and Les Drew. By the time of the 1984 
federal election campaign, drug policy was a salient issue, with the 'illicit drug 
problem' predominantly defined with reference to the link between drugs and 
organised crime. Les Drew described the initiation of the NCADA: 
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...when Bob Hawke suddenly decided to have this program 
I actually wasn't in Canberra at the time, I was directing the 
Commonwealth's Health Services in Melbourne because 
there was nothing better to do. . .you know, nothing was 
happening. . . I came home for Christmas and was in the 
garden working and the head of the Nutrition section rang 
up to say could I give her a couple of ideas because she was 
going to draw up this national drug policy — she'd been told 
to draw up the program for Bob Hawke's new policy. I 
said you're kidding — I said I'm not going back to 
Melbourne. I'll be back in my old job on Monday. So over 
the Christmas I actually drew up the national program and 
sent it round to all my mates all round the states so by the 
time the New Year came round I was able to go back and 
say look we've got consensus, this is what we want which 
was totally different to what Bob Hawke wanted. 146 
Indeed, Les Drew was a key harm reduction advocate and had published several 
articles 147 that advocated the use of harm reduction principles in drug policy. In 
hindsight, Drew could be considered as a key member of the harm reduction 
coalition who was employed in the senior ranks of the bureaucracy and highly 
instrumental in the drafting of the NCADA. 
The key component of the NCADA was the promotion of the notion of 'harm 
minimisation' as an overall aim of drug policy. In this context the meaning of harm 
minimisation encompassed a number of strategies, most of which can be subsumed 
under the categories of demand reduction (reducing the demand for drugs for actual 
and potential users through education campaigns and treatment for those existing 
146 Les Drew's recollection of the events around 1985's formulation of the national campaign against 
drug abuse, cited in Pettingell, J., "Harmspeak: The origins of 'harm reduction' in Australia", Winter 
School in the Sun, accessed from www.adfq.org/pettinge.html,  24/2/2004. 
147 Drew, L., 1981, 'The need for a regional policy on drugs', Man, Drugs and Society — current 
perspectives, proceedings of the First pan Pacific Conference on Drugs and Alcohol, Canberra, 
Australia, March 1980; Drew, L.,1984, 'Strategies for Minimising Drug Related Health Problems', 
Australian Alcohol/Drug Review, 3:1, January; Drew, L., 1986, 'Editorial: Cannabis Health issues and 
Public Policies', Australian Drug and Alcohol Review, 5, pp125-126; Drew, L., 1987, 'Beyond the 
Disease Concept of Addiction: Towards an Integration of the Moral and Scientific Perspectives, 
Australian Drug and Alcohol Review, 6, pp45-48; Drew, L., 1987, 'The Emperor has no Clothes: The 
Limits of Science in Dealing with Drug Problems, Australian Drug and Alcohol Review, 6, pp265- 
269; Drew, L & Taylor, V., 1988, Intravenous Drug Use and the AIDS Epidemic: a review, National 
Health and Medical Research Council, ACT; Drew, L., 1988, 'Editorial Minimising drug problems: 
the importance of harm reduction strategies', Australian Drug and Alcohol Review, 7, pp  139-140. 
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drug users) and supply reduction (reduction in the amount of drugs available through 
law enforcement measures). The following excerpt from the NCADA describes the 
philosophy of demand reduction whereby preventative (and essentially anti-drug) 
education was regarded as a key way to reduce drug related harm, the aim of which, 
was to: 
...reduce underlying causes of drug abuse by helping 
people make informed responsible decisions about drug use 
and promoting self-help and positive alternatives to drug 
use. Specifically it is aimed to influence attitudes so that 
drug abuse is less attractive; to increase the ability of 
individuals to resist the perceived attractiveness of drugs; to 
promote health through activities such as exercise and 
community development; to assist individuals to set 
positive life goals and to increase their self esteem; and to 
decrease socially irresponsible behaviour. 148 
Such a view sought to pre-empt the occurrence of drug-related harm through 
strategies that aim to limit the desire for drugs by individuals. Thus demand 
reduction initiatives such as these that aimed to reduce the prevalence of illicit drug 
use in society reflected the goals inherent in the moral-abstinence approach. In the 
NCADA, treatment was also subsumed under demand reduction and involved the 
expansion of MMT, increased support for grassroots health and welfare workers, and 
further funds for new services for hospitals and community agencies promised. The 
NCADA noted the aim of MMT was to: 
...reduce the risk of harm or death to the individual, to 
promote contact between treatment programs and opiate 
dependent persons, to assist these persons to adopt a normal 
lifestyle, and to reduce crime by removing the need for 
heroin dependent persons to commit crime to finance their 
purchase of drugs. 149 
148 Department of Health, 1985, National Campaign Against Drug Abuse, AGPS, Canberra, p5. 
149 Department of Health, 1985, National Campaign Against Drug Abuse, AGPS, Canberra, p6. 
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The expansion of MMT was the only initiative in the NCADA that could be 
classified as harm reduction in nature. Harm reduction was not explicitly mentioned 
in the NCADA. The NCADA did espouse the reduction of drug related harm as a 
key strategy, however, the policies and programs designed to reduce harm 
(predominantly law enforcement and anti-drug education) were nothing new and if 
anything echoed traditional approaches to drug policy that placed emphasis on 
abstinence as a key goal. However, implementation of the NCADA resulted in 
widespread change to the way in which Australian Governments and agencies, such 
as those from health and law enforcement sectors, responded to drug use. 
The Role of HIV/AIDS in the Emergence of Harm Reduction Policy 
In 1982 the first case of the human immunodeficiency virus and acquired immune 
deficiency syndrome (HIV/AIDS) was diagnosed in Australia, with the first death 
occurring in the following year. 15° By 1985, 49 cases of HIV/AIDS were reported 
and by 1987, the number had risen to 385. 151 Around this time it was identified that, 
in western countries, HIV/AIDS was primarily transmitted through unprotected anal 
intercourse between men and the sharing of contaminated injecting equipment. 152 In 
the early 1980s the virus represented a huge threat to public health in many countries 
(and still does in many countries, especially those in the third world), as well as an 
opportunity for the harm reduction advocacy coalition to achieve policy change. In 
Aids in Australia: The Primitive Years 153 Neal Blewett (Federal Health Minister 1983 
to 1990) provided a detailed account of the nature of policy making regarding the 
150 Campbell, A., 2001, The Australian Illicit Drug Guide, Black Inc., Melbourne, p444. 
151 ibid, p445. 
152 Commonwealth Department of Health and Human Services, 1996, Partnerships in Practice: 
National HIV/AIDS Strategy 1996-7 to 1998-99, AGPS, p6. 
153 Blewett, N., 2003, Aids in Australia: Reflections on Australia's policy response to the AIDS 
Epidemic, Australian Health Policy Institute, University of Sydney. 
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impact of the HIV/AIDS in Australia in the period 1980 to 1990, the key points of 
which follow. As will be shown, HIV/AIDS was a critical contributor to the 
adoption of harm reduction policies and programs later in the decade. According to 
Blewett, initial HIV/AIDS policy was based on a thin and contested information base 
with societal mechanisms inadequately prepared. The timing of the identification of 
HIV/AIDS as a policy issue in Australia was roughly aligned with the arrival of the 
Hawke Labour Government that was essentially handed a blank slate to make policy 
to respond to the issue. I54 
The combination of blood, sex (and deviant sex at that) and 
death of course, proved irresistible to the media. There 
were a sprinkling of sensational stories and lurid headlines 
— frequently sourced from the United States where of 
course the epidemic was more advanced. I55 
On eve of 1984 federal election, news of the death of four babies in Queensland as 
result of an HIV/AIDS infected blood transfusion broke. This event propelled 
HIV/AIDS into the headlines and onto the political agenda 156 and further reinforced 
the sense of urgency for production of policy. Blewett noted a general reluctance 
and noticeable absence of policy stakeholders willing to own the problem of 
HIV/AIDS. I57 Usually the medical profession are the owners of such diseases yet 
Blewett did not recall the intervention of the Australian Medical Association (AMA) 
154 ibid. p4. 
155 ibid. 
156 • • p6. 
157 ibid. 
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into the HIV/AIDS debate until 1989. 158 Similarly, state governments did not claim 
ownership. 159 
Because of the secular and religious passions that seethed 
around AIDS, the disease added an ideological dimension 
to a portfolio that was already an administrative nightmare. 
In such an ideological maelstrom ministers could easily 
drown. 160 
The illegal status of homosexuality in three Australian jurisdictions and the general 
prohibition of injecting drug use further added to State Government inertia. 
Homosexuality and injecting drug use were two main routes of HIV/AIDS 
transmission, and as such, their illegal status (only some states had decriminalised 
homosexual sex by this time) complicated efforts to address the disease. Blewett 
argued that exaggerated future estimates of expenditure required to contain 
HIV/AIDS was the main factor contributing to the "...uncharacteristic readiness to 
cede health turf to the Commonwealth". 161 Further, the already strained health 
budgets of the states made them open to fiscal involvement and leadership of the 
Federal Government. Moreover, by 1984 four of the six state Governments were 
Australian Labor Party (ALP) run and had expectations that the ALP-led Australian 
Government (formerly known as 'Commonwealth Government') would assist with 
the burden of HIV/AIDS. Blewett argued that the "...Commonwealth emerged as 
the chief owner of the disease between the summer of 1984 and the winter of 
158 "The bulk of the medical profession was little touched by AIDS and a significant minority not 
particularly well informed; indeed governments probably underestimated the need for education 
within the medical profession. As late as 1989 a survey of [general practitioners] found that 25 per 
cent did not want to treat AIDS patients; 20 per cent feared infection from giving treatment; and 33 
per cent could not provide adequate answers on how to inhibit the spread of the disease", ibid, p7. 
189 "...the bureaucratic owners of disease in our society are primarily the state administrators. While 
the states are usually pugnacious defenders of their constitutional of their constitutional allocations, 
they were uncharacteristically unpossessive about AIDS." ibid. 
160 ibid. 
161 ibid, p8. 
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1985... 5,162 and moreover, that the Queensland baby transfusion cases occurred on 
the eve of the 1984 federal election further contributed to the Australian Government 
taking the leadership role. 163 
According to Wodak, that Blewett had a strong civil libertarian background and had 
some key advisors that were personally affected by HIV/AIDS affected the course 
taken. 164 Blewett's personal opinions on HIV/AIDS policy were formed on a visit to 
the United States whereby he identified two approaches: the California cooperative 
approach and the New York public health approach. 
The [California cooperative approach] was characterised by 
a partnership between the medical profession and the 
affected communities, with as great an emphasis placed on 
education as on medical control, with the integration of the 
gay community into both public health campaigns and 
aspects of service delivery. By contrast, the New York 
model placed greater emphasis on medical control and 
dominance, and ascribed a lesser role to the affected 
communities. 165 
Blewett recounted that he preferred the former 'cooperative' style approach adopted 
by Californian governments. 166 Ballard argued that by the time HIV/AIDS had 
reached Australia there was already a mobilised community that had been engaging 
in health promotion activities to those most affected by HIV/AIDS. Well mobilised 
homosexual communities were the products of recent legislative battles over 
decriminalisation. Countries such as France had their HIV/AIDS policy responses 
inhibited due to not having such organised groups. 167 Ballard argued that both these 
162 ibid, p9. 
163 ibid. 
164 Wodak, A, 1992, 'HIV Infection and injecting drug use in Australia: responding to a crisis', The 
Journal of Drug Issues, 22:3, p556. 
165 Blewett, N., 2003, Aids in Australia: Reflections on Australia's policy response to the AIDS 
Epidemic, Australian Health Policy Institute, University of Sydney, p9. 
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factors were essential and prerequisites for the approach Australia took, and which 
were absent elsewhere. I68 Victoria, South Australia and Western Australia, led by 
ALP state governments, pursued the cooperative inclusive approach working closely 
with affected communities. 169 In contrast Queensland (under National Party Premier 
Joh Bjelke-Peterson) pursued a more conservative approach: 
Queensland baulked at everything that the Commonwealth 
encouraged. There was no cooperation with the gay 
organisations as they were composed of illegals. There was 
little state education of at-risk groups on the grounds that it 
would encourage deviant behaviour. Indeed there was 
minimal emphasis on education particularly for young 
people, and what existed was often farcical. When AIDS 
education was at last permitted in Queensland schools—in 
April 1987—the Education Minister instructed teachers that 
the program would not include any sex education. 'If a 
student asked what sexual intercourse was the teacher 
should refer the student to a medical practitioner or health 
expert'. All best efforts were made to keep condoms out of 
the hands of the masses so that when Queensland university 
students—in defiance of a ban—installed condom vending 
machines the state police ripped them out. I70 
Thus the approach taken by Queensland did not include the involvement of affected 
communities nor frank messages about sexual behaviour in contrast to the approach 
undertaken in jurisdictions such as the Australian Capital Territory: 
Funding was provided for the production of safe-sex 
materials that drew on the real life experience of gay men 
and other 'at risk' communities and spoke their language. 
While the new educational programs adopted traditional 
health promotion techniques such as pamphlets and posters, 
the materials were shaped in radical and arresting ways. 
Educational messages were delivered in images, style, 
language and meaning which communicated directly in the 
everyday language of the street, of bars, of saunas and 
backrooms. The clinical phrases of medical practitioners 
were put aside; so too was the traditional politeness of 
168 John Ballard quoted in ibid, p37-8. 
169 ibid, p9. 
179 ibid, p10. 
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public discourse. In words and images, posters, booklets, 
bumper stickers and t-shirts all dealt franldy with, for 
example, the dimensions of gay sexual experience or the 
realities of drug use. The language was direct, the meaning 
unambiguous. As one activist put it, 'an arse was an arse 
and a fuck was a fuck.' 171 
Such frankness would be echoed in the types of publications produced by self-help 
drug user groups since their instigation in the late 1980s and onwards. 172 Indeed, it 
was evident that such parameters of HIV/AIDS policy were duplicated in illicit drug 
policy due to the overlap between issues of injecting drug use and HIV/AIDS which 
would resulted in affected communities (drug users) becoming involved in policy 
making. 
A key strategy employed by harm reduction advocates was the notion of a 'second 
aids epidemic' best articulated in a paper entitled Intravenous Drug Use and the Aids 
Epidemic presented to the National Health and Medical Research Council in 1988. 
The spread of AIDS in the intravenous drug user (IVDU) 
population has been described as the second AIDS 
epidemic, the first being in the homosexual/bisexual 
population. The critical factors which determine the spread 
of AIDS in IVDU are the sharing of needles and syringes, 
and to a lesser extent sexual contact. IVDU come from all 
classes of society and many continue to function, 
uninterruptedly as (otherwise) normal community 
members. Because of this, the most likely pathway by 
which HIV infection will spread to the general community 
is by heterosexual intercourse with infected IVDU, with a 
later secondary spread between non drug users. Although 
AIDS will cause many deaths amongst IVDU within the 
next ten years, of even greater importance is the fact that 
the spread of AIDS among IVDU represents a major threat 
171 Thompson, J., 'There isn't room for ambiguity', accessed from Aids Action Council website: 
http://vvww.aidsaction.org.au/content/events/reflections/there isnt room for ambiguity.phy, accessed 
on 2/5/06. 
172 For more information on this type of education see the website of the Australian Illicit Drug Users 
League at http://www.aivl.org.au . 
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to the health and lives of the general heterosexual 
community that does not use illicit drugs. 173 
This notion of a 'second aids epidemic' in injecting drug users changed the nature of 
the illicit drug 'problem' from one that only largely affected drug-using people and 
their family and friends, to one that had the potential to affect the public health of the 
mainstream population. Indeed, this was a key development that changed the nature 
of the problem area. Such a reconfiguration of the drug problem meant that 
Governments had to change the way their agencies responded to the phenomena of 
injecting drug use. As well as this change to the problem area was a sense of 
urgency to enact policy to limit transmission pathways from injecting drug users to 
the general population. Blewett reinforced the importance of the notion of a 'second 
AIDS epidemic' as a compelling argument that generated policy change. 
In the period 1987-88 virtually every developed nation 
shifted its public emphasis from the high risk groups to the 
community more generally. And the reason for this shift 
was the accumulating and disturbing evidence of 
heterosexual transmission in sub-Saharan Africa, 
highlighted internationally by the Second International 
AIDS Conference in Paris in mid-1986. 174 
The threat of mainstream infection was enough to induce rapid policy change in a 
number of countries around this time. McCallum recalled that this fear of HIV/AIDS 
affecting the general community was combined with the notion that the optimal way 
to shape the behaviour of marginalised communities was through their own 
organisations, lead to increased investment into community organisations. 175 
173 Drew, L., & Taylor, V., 1988, Intravenous Drug Use and the Aids Epidemic, Paper presented to the 
National Health and Medical Research Council, p 1 . 
174 Blewett, N., 2003, Aids in Australia: Reflections on Australia's policy response to the AIDS 
Epidemic, Australian Health Policy Institute, University of Sydney, p18. 
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If there was single imperative driving government policy it 
was the determination to resolve this dilemma between 
community and individual by winning the confidence and 
the cooperation of the affected individuals for policies that 
would ensure community monitoring and assessment of the 
disease. I76 
This meant that grassroots workers and affected community members 
(predominantly gay men and injecting drug users) could have input into policy in the 
development and implementation stages. This astute positioning of affected 
community members in policy roundtables generated further legitimacy for harm 
reduction strategies as such programs were endorsed by these groups as pragmatic 
and appropriate policy approaches to address HIV/AIDS transmission. Moreover, a 
focus on gathering sensitive qualitative data (on highly personal sexual and drug 
using practices) meant that the cooperation of affected communities was seen to be 
critical to the processes involved in the production of policy evaluation and disease 
trends. Gathering of such information was regarded as best achieved through 
involvement of these communities in the policy process. The expansion of self-help 
user groups meant that some drug users could also participate in policy making. Lou 
McCallum, a gay community advocate who was present at the time of this 
partnership between medical and community interests, recalls the positive role of 
peer involvement in policy: 
We could quickly translate complex policy issues into clear 
information for our communities (not just gay but 
intravenous drug user, sex worker and people living with 
HIV groups) and could communicate their views quickly 
back to government. 177 
Another factor that influenced the direction taken by Blewett was a wish to avoid the 
partisan political debates as had taken place in the USA regarding the more 
176 • • p16. 
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controversial dimensions presented by the policy problem of HIV/AIDS. Blewett 
wished to avoid the anger that Reagan had attracted over his inactivity towards the 
disease and so subsequently courted key Liberal members to partake in an all party 
parliamentary liaison committee on HIV/AIDS, instigated in 1985. 178 Further, that 
the committee was dominated by opposition members including Senator Brian 
Harradine (a well known conservative moralist) meant that moral concerns about the 
direction of Government policy were dealt with in this committee rather than in the 
public arena. The committee was regularly updated by national and international 
HIV/AIDS experts and acted as a sounding board for policies and concerns. 179 
Blewett argues that the consequence of this approach was elite and partisan 
consensus on policy. 180 Although there were some minor rhetorical flourishes 
against the direction of HIV/AIDS policy within this committee, consensus at the 
elite level meant that these flourishes were contained and without influence. Ballard 
concludes by noting that Blewett created the conditions under which innovation 
could occur, and also he drew legitimation for his approach from community and 
state initiatives. 181 
These changes to both drug and HIV/AIDS policy in the mid 1980s did not 
automatically lead to swift implementation of harm reduction programs such as 
NSPs, however. In 1986, the first NSF in Australia began as an unsanctioned 
program, initiated by grassroots workers and situated in Sydney which at the time 
was the heartland of the gay community and which also had many injecting drug 
users: 
178 ibid, p9. 
179 ibid, p19. 
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The opening of a pilot needle syringe scheme in November 
1986 by a group of Sydney alcohol and drug workers, 
frustrated by the slow pace of developments at that time, 
marked a turning point. Advisory committees had agonised 
for some time about taking this seemingly momentous first 
step and how to best monitor and evaluate the effectiveness 
of such programmes. Although this pilot programme 
breached recently proclaimed legislation, no police action 
was taken following decisions taken at a senior level. In 
December 1986 the New South Wales Department of 
Health, having only recently opposed a recommendation to 
increase the availability of sterile needles and syringes, 
announced the introduction of a needle and syringe 
distribution scheme through °retail pharmacies. Within a 
few years, all major jurisdictions in Australia had started 
distribution or exchange of sterile needles and syringes. 182 
Thus the opening of the first NSP in Australia was by workers at Sydney's St 
Vincent's Hospital who were at the frontline of the HIV/AIDS crisis and refused to 
wait until the Government had finalised arrangements to open the program. 
The link between HIV/AIDS and injecting drug use, encapsulated in the idea of a 
'second aids epidemic', was instrumental in securing a number of developments in 
the period 1985-1990. Wodak 183 recalls the explosion of harm reduction policy-
making to curb HIV/AIDS in Australia in the mid to late 1980s that included: 
• a reorientation of the role of alcohol and other drug workers from a focus on 
obtaining abstinence towards a general focus on prevention of HIV/AIDS 
infection. This included harm reduction education about virus transmission 
routes and safe sex practices; 
• harm reduction policy options such as NSPs eventually being adopted due to 
the perceived link between injecting drug use and HIV transmission; 
182 Wodak, A, 1992, Inv infection and drug use in Australia', The Journal of Drug Issues, 22:3, 
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• funding of self-help user organisations that provided peer education, 
implemented prevention strategies and advocated for HIV/AIDS infected 
drug users; and, 
• the introduction of HIV prevention measures in sex work environments. 
The link between HIV/AIDS and harm reduction policy in Australian drug policy 
became enshrined in this time with NSPs and self-help groups 184 regarded as 
effective mechanisms to affect behaviour change in injecting drug users. Moreover, 
following the NCADA, MMT was expanded 185 to allow for admission of HIV/AIDS 
infected drug users. Entrance criteria were relaxed so to allow instant inclusion of 
those injecting drug users with HIV/AIDS. 186 Wodak noted: 
Although only a few [injecting drug users] were admitted 
initially on the grounds of HIV infection alone the change 
in policy was indicative of a new and pragmatic mood... by 
1990 over eight thousand [injecting drug users] were in 
methadone maintenance treatment programmes in the six 
most populous of the eight jurisdictions in Australia... [t]he 
capacity of the methadone programmes throughout the 
country was expanded more than sixfold in eight years... 187 
Ultimately it took the threat of widespread disease in the general community before 
governments would eventually enshrine harm reduction into illicit drug policy. Such 
a policy approach was deemed "enlightened pragmatism" 188 and was previously 
184 Self help user groups had evolved in different ways in Victoria, New South Wales and Queensland 
in the late 1980s. In some cases, some groups had existed before the threat of HIV/AIDS. The 
Victorian Intravenous AIDS Group (VIVAIDS) formed in 1987, New South Wales Users and AIDS 
Organisation (NUAA) formed in 1987 and Queensland Intravenous AIDS Association (QuIVAA) 
formed in 1988. For more information on the evolution of such groups see Crofts, N, 1993, 'A 
History of Peer-Based Drug-User Groups in Australia, Journal of Drug Issues, 25, pp599-616. 
185 ibid, p550. 
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unseen in drug policy (bar MMT). In this sense, the prevention of HIV/AIDS 
infection was seen as the greater priority than the eradication of drug use. 
National HIV/AIDS Strategy 1989 
Australia produced its first National HIV/AIDS strategy in 1989. This was the first 
national strategy that explicitly supported harm reduction programs. 
Transmission of HIV is preventable, and behaviour change 
through education is the principal means of preventing the 
spread of the virus. Prevention programs, such as the 
distribution and disposal of sterile needles, have been 
introduced to complement education campaigns...The 
major aim of HIV prevention programs for [intravenous] 
drug users is to eliminate transmission of the virus. 
Because of the immediate threat of HIV transmission 
within this group, preventative programs have been 
introduced which include needle distribution and disposal 
and information about needle cleaning, safer sex practices 
and perinatal transmission. 1 89 
Harm reduction policies were regarded as critical to restricting the spread of 
HIV/AIDS among injecting drug users. Moreover, the policy also reinforced the key 
role of self-help and peer education programs in stemming HIV transmission through 
encouragement of safer injecting drug use practices. 19° This document also placed 
harm reduction strategies in the context of the NCADA: 
Promoting abstinence from drug use is the Government's 
primary aim in initiatives such as the National Campaign 
Against Drug Abuse. This is a goal which may only be 
achieved in the long term and must be complemented by 
other strategies to reduce transmission of HIV amongst 
[intravenous] drug users. 191 
189 Commonwealth of Australia, 1989, National HIV/AIDS Strategy, AGPS, Canberra, p10. 
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It was clear that harm reduction's place within illicit drug policy was as a mechanism 
to prevent the spread of HIV/AIDS rather than a strategy to address drug use per se. 
Safer education was also aimed at those who continued to use about the dangers of 
sharing equipment and unsafe sexual practices. 192 This document also advocated for 
instigation of NSPs in every state and territory and in both urban and rural settings. 193 
Moreover, the incorporation of the harm reduction ethos into drug treatment services 
was also advocated by the 1989 HIV/AIDS policy. 
As well as existing drug treatment programs, models will 
be developed, including the expansion of oral methadone 
programs, which promote harm reduction rather than 
abstinence as the cornerstone of treatment. 194 
In sum, HIV/AIDS and its link to injecting drug use continued to be the strategy used 
by the harm reduction coalition in the period following the release of the NCADA to 
1990. Indeed, the period 1985 to 1990 was a highly successful period for advocates 
of harm reduction. 
The 1989 NCADA Evaluation 
In 1989 an evaluation of the NCADA was published. 195 This document sought to 
provide future direction for drug policy in Australia and was endorsed by the 
Ministerial Council on Drug Strategy (MCDS), the peak advisory body to 
Government. A task force on evaluation of the NCADA was chosen by the MCDS 
and consisted of representatives from state and territory health authorities, one from 
192 ibid, p30. 
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Federal Government, one member from a large scale community based organisation 
and one with specialist research interests in the field. 196 
There were two common themes throughout the document that reflected further 
incorporation of harm reduction concepts into illicit drug policy. First, there were 
eight mentions of the link between the transmission of HIV and injecting drug use 
(the 1985 NCADA did not mention harm reduction nor HIV/AIDS), highlighting 
how integrated the issue of HIV/AIDS had become in the drug policy subsystem. 
Moreover, the containment of HIV/AIDS transmission through intravenous drug use 
was considered a "...high and immediate priority. ,,197  through such measures as 
enhanced treatment options, training of drug workers on HIV/AIDS and safer 
injection practices, and most notably, the advocacy of increased availability of sterile 
injecting equipment. I98 
Perhaps the single most important change of recent years in 
the context of drug policy is the emergence of AIDS as a 
major public health issue in Australia and overseas, and the 
role of unsafe injecting practice in the spread of the AIDS 
virus. 199 
In addition to alcohol and tobacco consumption, 
intravenous drug use must be given high priority during the 
next three years. Evidence on the transmission of the AIDS 
virus through shared needles and syringes shows that 
intravenous drug users face serious health risk, and in turn 
pose a risk to non-using population via perinatal and sexual 
transmission. A strong and immediate response aimed at 
minimising the harmful effects of intravenous use of drugs 
is required. 20° 
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As stated above, the document advocated immediate action to stop the potential 
spread of HIV into the mainstream population. It further reinforced the notion of a 
'second aids epidemic' in injecting drug users and the way that this group could act 
as a bridge to transmit HIV/AIDS to the mainstream heterosexual population. The 
document implied the necessity of immediate action to curb transmission pathways, 
and noted if HIV/AIDS was not quickly addressed, transmission rates would grow 
exponentially in the future. 201 Moreover, the document explicitly stated that the 
nature of the drug debate had changed as the prevention of problems and drug related 
harm had become a legitimate strategy used in concert with those policies that 
advocated abstinence.202 Thus, HIV was a major impetus and justification of harm 
reduction practice through its perceived link with injecting drug use and the potential 
for transmission to the mainstream. 
The second factor in the document that suggested that harm reduction programs had 
gained legitimacy in public policy was a redefinition of harm minimisation or 'drug 
related harm' more specifically. In the NCADA, drug related harm was seen to be 
achieved through reduction in supply of drugs into the community and also through 
demand reduction initiatives such as anti-drug education as well as MMT and other 
treatment. In the evaluation report, the minimisation of drug related harm included 
" ...preventive education and preventive health measures, early intervention 
strategies, the treatment and rehabilitation of drug dependent people and the problem 
prevention approach to drug issues."203 Public education measures aimed to delay 
the uptake of drug use by young people and also to promote safe levels and methods 
of use in relation to all drugs. Early intervention approaches sought to assist those at 
risk of problematic drug use to modifi, their intake before the entrenchment of use 
201 ibid, p32. 
202 ibid, p36. 
203 ibid, p37. 
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occurs. Such approaches reflected the incorporation of harm reduction ideas in 
which users of both licit and illicit drugs are educated about how to reduce harm 
rather than encouraged to stop using substances. The third and most notable element 
of minimisation of harm was the 'problem prevention' approach: 
This approach acknowledges that use of both legal and 
illegal drugs is entrenched in most societies, and will never 
be completely eradicated. Reduction of drug use will 
always be an important component of a comprehensive 
strategy. However, the problem prevention approach 
points to a range of strategies which, while not necessarily 
doing anything to decrease drug use, do decrease the 
likelihood of harm resulting from that use... Examples in 
the illegal drug arena would include teaching safer injection 
practices, encouraging intravenous drug users to adopt safer 
sexual practices and changing the legal status of relevant 
drugs.2°4 
By 1989, the impact of the HIV/AIDS virus on drug policy was evident through the 
change in discourse from a focus on demand and supply reduction to one that also 
included numerous references to the link between HIV/AIDS and injecting drug use 
and a reorientation of the definition of harm minimisation as one that also included 
strategies for people that continued to use drugs. Indeed, in the period between 1980 
and 1990, harm reduction ideas became more palatable to Governments due to the 
threat of HIV/AIDS and the careful stewardship of Blewett of the HIV/AIDS issue. 
Explaining Illicit Drug Policy Change Through the Advocacy 
Coalition Framework 
This final section employs the ACF to explain change in illicit drug policy in 
Australia in the period 1980-1990. The instigation of Australia's first national drug 
204 ibid, p38. 
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strategy signified a major change in policy as a partnership between health and law 
enforcement sectors was enshrined in policy under the notion of 'harm 
minimisation'. As mentioned earlier the NCADA meant increased interaction 
between the two sectors in the management of illicit drug policy. Also, the 
instigation of NSPs and education that included frank safer injecting messages, self-
help drug user groups across Australia and the expansion of MMT places were all 
changes to Government policy. Drawing on Table 1, this section will now address 
key points of the ACF and assess their utility in explaining change. 
ACF Concepts 1 & 2: Advocacy coalitions and policy core beliefs 
Sabatier's description of advocacy coalitions is a useful construct to describe actors 
in a subsystem who share a set of common and reasonably well-defined policy 
objectives. In the period 1980 to 1990, a coalition of actors from medical 
backgrounds, alcohol and other drugs workers, grassroots community workers, the 
gay community, drug users and key members of the bureaucracy and executive 
government supported and advocated for policies and programs such as NSPs and 
safer injecting drug use education, self-help drug user groups and expansion of 
MMT. Coalition members were united in their belief in the general ethos of harm 
reduction policies and programs: being a focus on ameliorating adverse health, social 
and economic consequences associated with use of illicit drugs. Another policy core 
notion identified was the link between the issue of HIV/AIDS and injecting drug use 
(in particular the 'second AIDS epidemic') and the possibility of a secondary 
epidemic of HIV/AIDS in the mainstream population. Indeed, there was an 
identifiable cluster of actors around these ideas that aimed to have their beliefs 
manifested in policy. The harm reduction coalition's 'policy core' ideas represented 
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a distinctive departure from traditional approaches that focused on promoting 
abstinence through supply reduction and anti-drug education. As per Table 1 the 
second hypothesis of the ACF was supported, namely that there was a group of 
actors that displayed consensus on issues pertaining to the policy core. 
In the ACF, it is proposed that all coalition members would agree on the policies 
stated above and the general ethos regarding the worth of policies and programs that 
reduce the harm for those that continue to use. However, given the diverse nature of 
coalition members perhaps not all would agree on deep core beliefs such as: 
Harm Reduction accepts that some use of mind altering 
substances is inevitable, and that some level of drug use is 
normal in a society. 205 
It is argued that some in the coalition may indeed see the value of NSPs inextricably 
linked to the reduction of HIV transmission alone, rather than as a response to drug 
use per se. It is a matter of conjecture as to how coalition members might have 
conceptualised harm reduction in the absence of HIV/AIDS. It is entirely possible 
and quite probable that members of the harm reduction coalition would have 
different views on such broader questions as: the inevitability of drug use in society; 
the capacity of law enforcement to curb the activity and the morality of interventions 
such as safer sex or safer drug using information. 
ACF Concept 3: Guidance instruments 
The concept of 'guidance instruments' was another useful construct in this analysis. 
Guidance instruments referred to the ways in which coalitions used changes in rules, 
205 	• Riley, D., & O'Hare, P., 'Harm Reduction: History, Defmition and Practice', Harm Reduction: 
National and International Perspectives, Sage, California, p6. 
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budgets, or information as mechanisms to realise policy objectives. 206 The chief 
guidance instrument employed by the harm reduction coalition was using the notion of 
a 'second AIDS epidemic' to reinforce the need for harm reduction policies and 
programs. With regard to Sabatier's taxonomy of guidance instruments the use of the 
'second aids epidemic' qualified as using research and information exchange to alter 
the perceptions of the problem. By broadening the likely impact of a disease from 
marginalised communities to affecting the mainstream population meant added 
concern and urgency to policy responses. As mentioned earlier, this occurred 
concurrently in many states around the world. The work of Stone provides further 
insight into this technique: 
There are several strategies by which groups define issues 
so as to make a sectional interest appear general... to 
transform what appear to be narrow interests into broader 
ones...immediate short term interests are portrayed as long-
run interests. 207 
In other words, the problem was redefined to one that now required harm reduction 
programs to be instituted so to protect the mainstream population. In this sense 
injecting drug use was now portrayed as an issue that affected many more people 
than previously thought. This strategic representation of harm reduction, as 
possessing benefits for the wider community, mobilised support for such programs. 
It can also be argued that Blewett's initiation of parliamentary committees consisting 
of partisan membership and input from health experts around the issue of HIV/AIDS 
was a type of 'guidance strategy'. The use of these structures facilitated conflict 
resolution and problem solving in arenas that were away from the media and the 
206 Jenkins-Smith, H & Sabatier, P, 1994, 'Evaluating the Advocacy Coalition Framework', Journal of 
Public Policy, 14:2, p104 
207 Stone, D., 1988. 'Interests', Policy, Paradox and Political Reason, Scott, Foresman and Company, 
USA, p183. 
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public more generally. Ultimately, this resulted in an impression of elite partisan 
consensus on the issue. This was particularly important due to the inherently 
controversial nature of HIV/AIDS and associated harm reduction measures. 
Ultimately, the minor rhetorical flourishes of Australian conservative politicians 
were without influence partly due to the presence of these committees that resolved 
issues before they reached the public arena. Another way that the coalition used the 
notion of a 'second aids epidemic' to affect policy was related to the approach 
Australia took with HIV/AIDS, whereby affected communities were engaged and 
involved in policy development and implementation so to reduce transmission of 
HIV/AIDS. 
Both these guidance instruments contributed to the adoption of harm reduction 
programs following the NCADA. Both these instruments can be classified as "trying 
to gradually alter the perception of a variety of actors through research and 
information exchange" 208 in the current schema of guidance instruments (see Table 
1). However it is suggested that Blewett's parliamentary committee process was an 
intensive, face-to-face version of information exchange that also acted as a forum in 
which questions could be answered directly and problems solved collaboratively. 
Such a process is distinct from other more indirect forms of information exchange 
such as parliamentary debate, media releases or research published in scholarly 
journals. The language in the NCADA evaluation report published in 1989 reflected 
the change to drug policy between 1985 to 1989 and reiterated the link between 
HIV/AIDS and injecting drug use. Furthermore, the authors of the report also 
sought to broaden the definition of harm minimisation (beyond supply and demand 
reduction) to include harm reduction policies and programs. 
208 Sabatier, P., & Jenkins Smith, H., 1993, 'The Advocacy Coalition Framework: An Assessment', 
Policy Change and Learning: An Advocacy Coalition Approach, Westview Press, San Francisco, 
p142. 
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ACF Concept 4: Policy brokers in strategic positions 
In the ACF it is theorised that there is a group of actors that represent the 
Government called 'policy brokers' who are responsible for receiving conflicting 
strategies, limiting conflict and reaching compromise between coalitions when 
making public policy. 209 From this analysis it is clear that bureaucrats such as Les 
Drew and Neal Blewett personally supported harm reduction programs and thus 
played a significant role in achieving change to illicit drug policy. It seems 
reasonable to suggest that these two individuals could easily be classified as 
members of the harm reduction coalition. The positions of both Les Drew in the 
bureaucracy and Neal Blewett in the political executive were crucial to the outcomes 
in drug policy in the late 1980s. While the ACF did allow for agency officials to be 
members of coalitions, and indeed possessing the capacity to hold policy beliefs and 
engage in a non trivial degree of coordinated activity over time, it also posited that: 
Conflicting strategies from various coalitions are normally 
mediated by a third group of actors, here termed 'policy 
brokers', whose principal concern is to find some 
reasonable compromise that will reduce intense conflict. 210 
Les Drew took a key role in the drafting of the NCADA and indeed had written 
several articles around that time advocating harm reduction strategies. Similarly, 
Neal Blewett as Federal Health Minister was a key member of the harm reduction 
coalition and likewise advocated harm reduction type approaches as outlined earlier. 
209 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p104. 
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It would be unwise to classify both as either coalition members or policy brokers 
exclusively, as both occupied dual roles. 
ACF Concept 9: Conditions of 'major' policy change? 
As described in Chapter Two, under the ACF, major policy change is seen as the 
result of either an exogenous shock to the subsystem, replacement of one dominant 
coalition by another, the result of a hierarchically superior unit of government 
changing policy of a subordinate level and/or a situation whereby all major 
coalitions agree that perpetuation of the current situation is unacceptable. 211 In the 
latter a compromise may be sought that is viewed by all coalitions as superior than 
the status quo. 
It was clear that the change to harm minimisation as an overarching goal of illicit 
drug policy in 1985 qualified as 'major'. The scope of this change was sector wide 
with the concept applying to all aspects of drug policy, however the policy mix was 
still dominated by supply reduction initiatives as it was previous to the instigation of 
the NCADA. This shift to using the term 'harm minimisation' did not signify that 
the underlying philosophy of Australia's illicit drug policy had moved away from 
prohibition. Rather, the concept of 'harm minimisation' was seen to include supply 
and demand reduction policies. Thus in this context, the concept of harm 
minimisation was entirely distinct from that of harm reduction which refers to 
specific services that reduce harm for those that continue to use. Arguably the 
greatest change from the instigation of the NCADA came from the amalgam of 
health and law enforcement sectors in several national drug policy committees and 
211 ibid, p119. 
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groups. Under the NCADA (and subsequent strategies) both sectors would share 
roles and be represented in such peak groups. HIV/AIDS had left an indelible mark 
on drug policy, evident by the late 1980s in the HIV/AIDS National Strategy and, 
moreover, the NCADA evaluation document emphasised this link later in the decade. 
As such the change to harm minimisation was a 'major' change in drug policy but 
did not signify a shift to the inclusion of harm reduction ideas (MMT the exception) 
in illicit drug policy. 
'Major' policy change is theorised to be precipitated by some kind of 'external 
shock' to the policy subsystem. Changes to socio economic conditions, public 
opinion, system wide governing coalitions or policy outputs from other subsystems 
are theorised in the ACF as being a necessary but not sufficient cause of major 
change (see Table 1).212 Several factors related to those categories contributed to 
major policy change characterised in the NCADA: a general consensus (from Royal 
Commission authors, the medical community and reflected in the media more 
generally) that continuation of the status quo was unacceptable, elections of several 
ALP state and federal governments and the advent of managerialist practices in 
Australian bureaucracy. 
Firstly in late 1970s, elite (in the numerous Royal Commissions and Inquiries that 
were established in this period) and mainstream concern that the traditional model of 
drug policy had proved inadequate, coupled with a perception of rising rates of 
problematic drug use and organised crime, meant that there was a growing consensus 
that a new approach to drug policy was required. This provided an opportunity for 
all stakeholders to advance options to policy brokers. 
212 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe' 
Journal of European Public Policy, 5:1, March, p106. 
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Secondly, and perhaps the most significant of all external shocks to the drug policy 
subsystem, was the election of the Federal Hawke Labour Government in 1984. This 
was articulated in the ACF as a 'change in systemic governing coalitions'. This 
change was further enhanced by the election of state ALP governments that 
facilitated coordination and cooperation between levels of governments. As drug 
policy is largely the concern of state governments, the Federal Government worked 
closely with, and gained agreement from, equivalent ministers from other 
jurisdictions both in the developmental and implementation stage. Les Drew stated 
that he was able to approach Prime Minister Hawke with the draft of the NCADA 
that already had agreement of many of his state counterparts. As stated earlier, Neal 
Blewett recounted how states with ALP Governments implemented HIV/AIDS 
policies characterised by cooperation with affected communities. In contrast, the 
Queensland State Government pursued a different process characterised by a top-
down approach that resulted in further stigmatisation of the gay community and 
injecting drug users. That the Governments of New South Wales, Victoria, Western 
Australian and South Australia pursued the cooperative model in response to 
HIV/AIDS meant that ideas associated with harm reduction were able to flourish 
through closer participation of affected communities in the policy process. 
Moreover, Neal Blewett was highly instrumental in the content and nature of 
HIV/AIDS policy that, as the chapter has argued earlier, was a key contributing 
factor to the implementation of harm reduction policy later in the decade. In sum, 
Blewett would not have been charged with this role if the ALP were not elected in 
1984 and moreover, nor might the cooperative style of policy making have existed 
across multiple jurisdictions. The overlap between the issues of HIV/AIDS and 
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problematic injecting drug use lead to the parameters of the former being duplicated 
in the policy directed toward the latter. 
A third external shock to the subsystem was the advent of `managerialism' in the 
Australian bureaucracy in the late 1980s. 213 Managerialism or 'new public 
management' (NPM) was a new approach to governance adopted by Australia and 
many other states including the United Kingdom214 and the United States215 with the 
view of reforming the practice of the public sector in the 1980s and 1990s. Key 
goals in this process were greater efficiency, effectiveness and economy in the 
production and delivery of publicly provided goods and services as well as greater 
accountability on public officials to deliver prescribed outcomes. 
Hood216 identified NPM as comprising of seven main points including: discretionary 
and active control of organisations by managers (getting the managers manage'); 
implementation of performance measurement standards and tools; a greater emphasis 
on output controls whereby resources are directed to areas according to performance; 
disaggregation of large departments into corporatised units around specific product 
areas, funded separately and "dealing with each other on an arm's-length basis" 217 ; 
introducing the concept of competition in the public sector through the employment 
of contracts and public tendering processes; using private sector styles of 
management practice through such principles as flexibility in hiring and rewards; and 
finally engendering greater discipline and parsimony in resource use. Other 
213 Hughes, 0., 1994, Public Management and Administration, Macmillan, Great Britain, p4. 
214 Horton, S., 1999, 'The Civil Service' in S Horton & D Farnham (eds), Public Management in 
Britain, Macmillan, Basingstoke, p145. 
215 Osborne, D & Gaebler, T, 1992, Reinventing Government: How the entrepreneurial Spirit is 
Transforming the Public Sector, Addison-Wesley, Reading,. 
216 Hood, C., 1991, 'A public management for all seasons?', Public Administration, 69, 1, pp3-19. 
217 thid, 
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formulations of NPM have been offered, 218 the key points being similar to the above 
formulated by Hood. 
In the ACF, the advent of NPM qualified as a 'policy decision' or impact from 
another subsystem. It is argued that propositions inherent in NPM (specifically the 
performance measurement focus, focus on outcomes and tendering of public 
services) were compatible with the principles of harm reduction. In contrast to 
supply reduction, a key principle of harm reduction policy involved the employment 
of a pragmatic process of identification, measurement and assessment of the relative 
importance of drug related problems, their associated harms and benefits/costs of 
intervention so as to focus policy priorities. This then facilitated the production of 
criteria or targets that could be used for evaluation purposes. The emphasis on 
demonstration of outputs provided evidence of the level of demand for such services. 
That harm reduction services were also proven to be highly cost effective in terms of 
savings on the public health budget, created a rationale for attracting further 
resources. As harm reduction policies are particularly cost effective, 219  this focus on 
evidence-based policy which was evident in the NCADA evaluation document 22° as 
well as the focus on outcomes only served to strengthen the legitimacy of harm 
reduction programs then and into the future. 
218 For example: Holmes, M & Shand, D., 1995, 'Management Reform: Some Practitioner 
Perspectives on the Past Ten Years, 'Governance, 8:5, p555; Pollit, C, 2001, 'Clarifying convergence: 
Striking similarities and durable differences in public management reform', Public Management 
Review, 56:2, p473-4; Osborne, D & Gaebler, T, 1992, Reinventing Government: How the 
entrepreneurial Spirit is Transforming the Public Sector, Addison-Wesley, Reading; and Hughes, 0., 
1994, Public Management and Administration, Macmillan, Great Britain. 
219 Commonwealth Department of Health and Ageing, 2002, Return on investment in needle and 
syringe programs in Australia, Department of Health and Ageing, Canberra, Available at: 
httn://www.health.gov.au/pubhlth/publicat/hac.htm (accessed Jun 2004). 
220 Commonwealth of Australia, 1989, The National Campaign Against Drug Abuse 1985-88: 
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Additionally, this new approach emphasised accountability of officials and programs 
through outcome evaluation processes and such an agenda arguably might have 
allowed program managers greater ability to drive policy than before the instigation 
of NPM practices. Finally, tendering of illicit drug services to non government 
organisations and medical/research agencies also meant a greater employment of 
harm reduction goals in most instances as such groups constituted part of the core 
membership of the harm reduction coalition. 
ACF Concept 10: How did major policy change occur? 
Sabatier hypothesised that changes to policy core of a government program will not 
be significantly revised while the subsystem advocacy coalition that instigated the 
program remains in power, except in cases where change is imposed from a 
hierarchically superior jurisdiction. In the cases of the instigation of the NCADA 
and also of harm reduction programs such as NSPs, self-help drug user groups and 
the involvement of affected communities in policy, the latter explanation of 
hierarchical imposition of policy was accurate as all these changes were instigated by 
the Federal Government, albeit, in conjunction with largely cooperative State 
Government authorities. 
The Federal Government took the lead in regard to HIV policy. As discussed in this 
chapter, the states were reluctant to own the issue area of HIV/AIDS, so the Federal 
Government was endowed with a 'blank slate' accompanied by relative cooperation 
of four ALP state Governments. Wodak argued that the federal structure of 
Government in Australia has facilitated change. 
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When relatively enlightened states introduced controversial 
policies such as needle and syringe exchange, more 
conservative states were drawn along, albeit at a slower 
pace. The number and range of responsible authorities, so 
often a barrier to progress in Australia, may actually have 
contributed to the process of change by providing a 
multitude of opportunities.221 
The sense of urgency created by HIV and associated arguments of a 'second AIDS 
epidemic' meant that most states ceded willingly to the path prescribed by Blewett 
and the Australian Government. Additionally, fiscal concerns also meant that the 
states were willing to allow federal leadership on the issue. 
How to classify HIV/AIDS in the ACF? 
A substantial contributor to both major and minor policy change was the advent of 
HIV/AIDS which altered the nature of the drug problem. This was best articulated 
by the notion of a 'second AIDS epidemic' whereby transmission and spread of 
HIV/AIDS from illicit drug users into the mainstream population was a real fear. 
Although the disease can be classified as an external system event, it does not easily 
fit into the categories outlined by Sabatier. The categories noted by Sabatier include 
changes to socio-economic conditions, public opinion, system-wide governing 
coalitions or policy outputs from other subsystems (see Table 1 and/or Chapter 2 
more generally for more information). 
Within the ACF, the advent of HIV/AIDS would be best classified as a change in the 
'basic attributes of the problem area'. The emergence of HIV/AIDS as a public 
health issue had a profound impact upon the nature of the policy problem and 
generated linkages between the illicit drug policy subsystem with other sectors such 
221 wodak A, 1992, "HIV Infection and injecting drug use in Australia: responding to a crisis, The 
Journal of Drug Issues, 22:3, p557. 
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as the Gay community. In the ACF, the category of 'basic attributes of the problem 
area' is classified under 'relatively stable parameters' (see Figure 1). Such 
parameters of a subsystem are theorised to be very difficult to change through 
coalition strategising and there is little theorising in the ACF about how they do 
affect coalition behaviour if change does occur in these variables. Indeed, changes in 
these stable parameters are not the subject or mentioned in any of the twelve ACF 
hypotheses. 222 It is argued that change in the basic attributes of the problem area can 
indeed produce more profound opportunities for coalition to realise policy objectives 
than that in dynamic system events. 
Conclusion 
Change in Australian drug policy was a combination of external (to the subsystem) 
factors such as the election of the Hawke Labour Government, the strategic location 
of key harm reduction coalition individuals within that Government and the 
bureaucracy, and of course the advent of HIV/AIDS. That harm reduction is proven 
to be a cost effective and pragmatic policy was not a key factor in its adoption by 
Governments due to its inherent controversial nature. The Advocacy Coalition 
Framework was a useful policy tool employed to analyse change in the illicit drug 
policy subsystem from 1980-1990. The framework could explain and describe the 
majority of factors that contributed to major and minor policy change. It was 
particularly useful to describe and define a coalition of players that believed in harm 
reduction ideas, policy and practice as an appropriate and effective tool to address 
the consequences of problematic drug use (such as HIV/AIDS transmission). Both 
ACF hypotheses concerning policy change were supported. 
222 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe' 
Journal of European Public Policy, 5:1, p106. 
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[T]he policy core attributes of a governmental program are 
unlikely to be significantly revised as long as the 
subsystem advocacy coalition which instituted the program 
remains in power.223 
The policy core attributes of a governmental action 
program are unlikely to be changed in the absence of 
significant perturbations external to the subsystem, i.e. 
changes in socio economic conditions, system wide 
governing coalitions or policy outputs from other 
systems. 224 
The major change to drug policy was a result of external system shocks and also the 
result of imposition of policy from a hierarchically superior jurisdiction. The latter 
though, was an interesting case as it was imposed without much resistance due to 
uncertainty felt by the states regarding information and funding in relation to 
HIV/AIDS. Ownership, and subsequently leadership, of this 'problem' was given 
automatically to the Federal Government. Thus, the policy was not imposed on 
reluctant state governments, instead, most of them responded to the agenda of the 
Federal Health Department, in similar ways (with Queensland as the main 
exception). 
Drug policy did undergo a 'major' change in 1985, yet the law enforcement sector 
still dominated the illicit drug policy subsystem. Demand reduction and treatment 
components of the NCADA were a reflection of the strength of health and 
community interests, yet neither debunked law enforcement as the chief policy of the 
NCADA. The harm reduction coalition did enjoy success in this period with some 
policies and programs implemented by the end of the decade due to the confluence of 
many factors described above. It is clear that without HIV/AIDS, injecting drug 
223 Jenkins-Smith, H., & Sabatier, P., 1994, 'Evaluating the Advocacy Coalition Framework', Journal 
of Public Policy, 14:2, p184. 
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users would not have been regarded as worthy of policy attention as they were, due 
to the perceived transmission bridge of HIV/AIDS to the mainstream community. 
The following chapter examines the continuing efforts of the harm reduction 
coalition into the following decade from 1990 to 2000. The advent of another virus, 
namely Hepatitis C, the change to a Liberal Government at the Federal level in 1996, 
and the intense policy debates in relation to SICs and prescription heroin presented 
many challenges to, and opportunities for, harm reduction coalition members to 
realise policy objectives. 
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Chapter 4: 	Harm Reduction Policy Stagnation and Police 
Innovation in Australia between 1990 and 2000 
Introduction 
In the period 1980 to 1990, illicit drug policy in Australia underwent major policy 
change with the adoption of 'harm minimisation' as an overarching philosophy and 
also with the introduction of harm reduction initiatives such as NSPs and self-help 
drug user groups. The following decade, from 1990 to 2000, is the subject of this 
chapter. In this period, supporters of harm reduction ideas, buoyed by the success in 
the previous decade, continued to advocate for further implementation of such 
policies and programs. The identification of a new BBV, hepatitis C (HCV), and the 
rise of problematic heroin use in public areas were key issues in this period and also 
provided further justification for the expansion of harm reduction programs in 
Australian illicit drug policy. Furthermore, research into the activity of policing as 
well as operational changes to police practice with regard to illicit drug-related harms 
was also conducted in this period. 
This chapter summarises key events in the Australian illicit drug policy subsystem 
taken from State and Federal Government reports, policies and evaluations as well as 
key articles and commentaries. First, key policy documents produced by the Federal 
Government bureaucracy, including two National Drug Strategies (1993 and 1997), 
two evaluations of national drug policy strategies (1992 and 1997), and national 
policies on HIV/AIDS and methadone will be examined in order to understand the 
wider context of harm reduction policy and the underlying justification for such 
services. Second, an examination of the policy response to HCV in comparison with 
that of HIV/AIDS will be used to illustrate harm reduction policy responses in 
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situations where a threat to public health is limited largely to drug-using populations. 
Third, the instance of cross-coalition learning between the harm reduction and law 
enforcement coalitions will be described. Fourth, an analysis of the proposed trial of 
prescription heroin and SICs will show instances of (largely) failed advocacy 
attempts. Fifth, the oscillating nature of what the term harm reduction means and the 
services it encompasses will be discussed. Finally the chapter will conclude with a 
section applying the ACF to the events that occurred in this period, and will evaluate 
the usefulness of the model in explaining illicit drug policy-making in this period. 
Harm Reduction in the 1990s 
This section examines several key national policy documents that were produced in 
the decade 1990 to 2000 such as: 
• No Quick Fix — the 1992 evaluation of the 1985 NCADA, 
• National Drug Strategic Plan 1993-97 — the second national drug strategy, 
released by the Federal ALP Government, 
• Mapping the Future — Evaluation of the 1993 National Drug Strategic Plan, 
• National HIV/AIDS Strategy 1996-7 to 1998-99, 
• National Policy on Methadone Treatment — released in 1997, and, 
• National Drug Strategic Framework 1998-99 to 2002-03 — the third national 
drug strategy, released by the Federal Liberal Government 
Such documents represented the views of various stakeholders ranging from health 
and law enforcement professionals working in the alcohol and other drug field, as well 
as Government and community opinion. These were examined for two reasons: firstly 
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to gauge the support for harm reduction ideas manifested in policies and programs; 
and secondly, to understand the context in which harm reduction programs were 
supported. 
Two national drug strategies were produced by Federal Governments in this decade. 
The National Drug Strategic Plan 1993-97 was produced by the Federal ALP 
Government and was the second national drug strategy (the first being the NCADA 
produced in 1985). The National Drug Strategic Framework 1998-99 to 2002-03 
was the third national drug strategy for Australia. This document was produced by a 
Federal Liberal Government following a change of federal governments from ALP to 
Liberal in 1996. Indeed, the National Drug Strategic Framework 1998-99 to 2002-03 
was the first national strategy produced by a Federal Liberal Government in Australia 
as the previous two (produced in 1985 and 1993) had been produced by the ALP 
Federal Government. National drug strategies provide a framework to coordinate the 
activities of state and territory Governments of Australia and also the health and law 
enforcement sectors across Australia. Coordination between states and sectors is 
facilitated through several structures such as the Ministerial Council on Drug Strategy 
(MCDS), the Intergovernmental Committee on Drugs (IGCD), the Australian National 
Council on Drugs (ANCD) and various national expert advisory committees. 225 State 
Governments have the primary responsibility to enact their own illicit drug policies 
within this broader framework, however funding is provided from the federal level for 
some illicit drug programs consistent with national drug strategy priorities. Ergo, 
such national documents act to represent the views of governments, health and law 
enforcement sectors and other stakeholders across Australia with regard to the broad 
illicit drug policy settings. 
225 Commonwealth of Australia, 1998, National Drug Strategic Framework 1998-9 to 2002-3, 
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As recounted in the previous chapter, in 1985, the NCADA was released. This 
document outlined Australia's 'harm minimisation' approach to (both licit and illicit) 
drug policy. The NCADA described the approach as including both supply and 
demand reduction initiatives. Indeed, it was not until the latter part of the decade 
when the importance of harm reduction policies were emphasised. This increased 
emphasis on harm reduction policies was largely due to the policy problem presented 
by HIV/AIDS. This pressing issue was encapsulated by the phrase 'second aids 
epidemic', describing the way in which injecting drug use was a major route of 
HIV/AIDS transmission both between injecting drug users through sharing of 
injecting equipment, and also between injecting drug users and the mainstream 
community via transmission through heterosexual sex. Indeed, as outlined in 
Chapter Three, in the late 1980s and early 1990s, there was an expansion in harm 
reduction policy as a response to HIV/AIDS, with jurisdictions enacting NSPs 226 and 
self-help user groups. 227 Therefore, in the period between the release of the 1985 
NCADA and the 1993 National Drug Strategic Plan there had been a raft of policy 
activity directed towards the issue of HIV/AIDS, with harm reduction approaches to 
illicit drug use (and more specifically injecting drug use) being recognised as key 
strategies to contain the virus. 
The 1993 National Drug Strategic Plan (NDS) defined the harm minimisation 
approach as one that: 
226 "Sterile injecting equipment has been readily available in all major cities and large towns in 
Australia since 1988-1989." Wodak, A., 1995, 'Needle Exchange and Bleach Distribution 
Programmes. The Australian Experience', International Journal of Drug Policy, 6:1. 
222  Queensland, Australian Capital Territory, South Australia, Northern Territory, Western Australia, 
New South Wales and Victoria implemented user groups between 1988 and 1992. Tasmania has had 
user groups on a sporadic basis. Crofts, N., 1995, 'A History of Peer-Based Drug-User Groups in 
Australia, The Journal of Drug Issues, 23:3, pp599-616. 
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...aims to reduce the adverse health, social and economic 
consequences of alcohol and other drugs by minimising or 
limiting the harms and hazards of drug use for both the 
community and the individual without necessarily 
eliminating use.228 
Such a definition of harm minimisation resonated with the notion of 'harm reduction' 
as defined in chapter one. As mentioned, the overarching principle in the harm 
reduction philosophy is to provide services for existing and continuing drug users, in 
contrast to policies whereby abstinence is a key goal. Staff in services such as NSPs 
do not attempt to compel current drug users to reduce or eliminate their use (unless 
requested for assistance to do so and such a request is initiated by the drug consumer). 
The following quote from the 1993 National Strategic Plan was indicative of the mark 
left on Australian illicit drug policy by the advent of HIV/AIDS in the mid to late 
1980s. 
Harm minimisation demands realistic strategies focused on 
preventing and reducing harm to individual drug users, 
their families, their workplaces and the wider community. 
It accepts that interventions that reduce the risks of harm 
connected with drug use, without necessarily eliminating 
use, can also have important benefits for both the individual 
user and the wider community. 229 
Indeed the notion of a 'second aids epidemic' 23° continued to be a driving force in 
illicit drug policy due to concerns that injecting drug user populations could act as a 
bridge to transmission of HIV/AIDS to the mainstream population through 
unprotected heterosexual intercourse. 
228 Commonwealth of Australia, 1993, National Drug Strategic Plan 1993-97, Canberra, AGPS, p4 
229 ibid. 
230 Drew, L., & Taylor, V., 1988, Intravenous Drug Use and the Aids Epidemic, Paper presented to the 
National Health and Medical Research Council, p 1 . 
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Similar to the NCADA, the general approach of the 1993 Drug Strategic Plan was to 
combine law enforcement and health sectors under one framework to address illicit 
drug use. However, the 1993 Drug Strategic Plan went further to also include harm 
reduction programs such as NSPs that had been enacted in the preceding few years. 
Indeed the framework articulated as a national priority to... 
Maintain an environment in which policing activities such 
as minimising the visible consequences of drug activity, 
and health activities such as methadone and needle 
exchange programs, are complementary.231 
The potential for counter-production in policy through enacting strategies that aim to 
reduce the supply of illicit drugs while also providing services for those that use 
illicit drugs is substantial. Much research232 has been conducted on the way in which 
law enforcement interventions can exacerbate or increase the severity and frequency 
of drug related harms that programs such as NSPs then have to address. The notion 
of harm reduction and supply reduction measures acting as uneasy bedfellows is 
outside the scope of this thesis yet is an important variable to consider when thinking 
about the origins of drug related harms. Indeed, this is explored further throughout 
this chapter in reference to Hepatitis C and changes to police practices that occurred 
in this decade from 1990 to 2000. Ultimately, while the 1993 National Drug 
Strategic Plan articulated the need for harm reduction services such as NSPs, it also 
reinforced the dominant and pre-existing paradigm of law enforcement as the chief 
instrument in illicit drug policy.233 
231 Commonwealth of Australia, 1993, National Drug Strategic Plan 1993 -97, Canberra, AGPS, p4. 
232 Sutton, A & James, S., 1996, Evaluation of Australian Drug Anti -Trafficking Law Enforcement, 
National Police Research Unit, Adelaide; Green, P & Purnell, I., 1996, Measuring the success of law 
enforcement agencies in Australia in targeting major drug offenders relative to minor drug offenders, 
National Police Research Unit, Adelaide; Weatherbum, D., & Lind, B., 1995, Drug Law Enforcement 
Policy and Its Impact on the Heroin Market, New South Wales Bureau of Crime Statistics and 
Research, Sydney. 
233 Wodak estimated that in 1992, 84% of Federal and State Expenditure towards addressing illicit 
drugs went to supply reduction initiatives, 6% to treatment, and 10% to prevention and research. 
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The National Drug Strategic Framework 1998-99 to 2002-03 was the third national 
strategy released by federal governments since the NCADA in 1985 and the 1993 
National Drug Strategic Plan, and the first released by a Federal Liberal Government. 
The definition of harm minimisation in the 1993 National Drug Strategic Plan was 
replaced by the following: 
Harm minimisation refers to policies and programs 
designed to reduce drug related harm. Harm minimisation 
aims to improve the health, social and economic outcomes 
for both the community and the individual and 
encompasses a wide range of approaches... 234 
The term 'harm reduction' was mentioned several times throughout the document 
and programs such as NSPs were justified on the basis of their capacity to ameliorate 
public health problems presented by BBVs such as HIV/AIDS and HCV. The 
National Drug Strategic Framework 1998-99 to 2002-03 offered this justification of 
harm reduction programs: 
Governments do not condone illegal risk behaviours such 
as injecting drug use, but they do acknowledge that these 
behaviours occur. They have a responsibility to develop 
and implement public health and law enforcement 
measures designed to reduce the harm that such behaviours 
can cause, both to individuals and the community. In these 
circumstances harm reduction strategies specifically target 
the individual using drugs and promote initiatives that 
benefit the wider community. For example, drink driving 
was identified as a serious drug related harm and changes 
to legislation and law enforcement practices were 
introduced. These harm reduction strategies aimed to 
reduce harm associated with drink driving. Similarly, 
while the practice of injecting drug use continues, the 
Wodak, A., 2000, 'Developing More Effective Responses', in Drugs and Democracy: in search of 
new directions, G., Stokes, P., Chalk & K., Gillen (eds), Melbourne University Press, Carlton South, 
p184. 
234 Minsterial Council on Drug Strategy, 1998, National Drug Strategic framework 1998-99 to 2002 — 
03, Commonwealth of Australia, Canberra, pl. 
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provision of sterile injecting equipment through needle and 
syringe exchange programs is an important harm reduction 
strategy for preventing the spread of blood borne viruses 
such as HIV and hepatitis C. 235 
Indeed, by 1998 NSPs were well established in Australia as key mechanisms to 
reduce transmission of BBVs into the wider community. Such a public health 
rationale of NSPs was an ongoing justification for such programs. Moreover, the 
document also emphasised the importance of the involvement of affected 
communities in the development of drug policy, through providing advice to peak 
policy groups such as the MCDS. 236 In sum, the document did not herald any 
clawback to existing harm reduction programs (including NSPs, self-help user 
groups and MMT) however, it did not signify an expansion of harm reduction 
services (such as prescription heroin or SICs) either. 
In the period between 1990 and 2000, evaluations of the 1985 NCADA (No Quick 
Fix237) and the 1993 National Drug Strategic Plan (Mapping the Future 238) were 
conducted. The function of the evaluations was to review the direction of national 
drug policy in accordance with new trends in illicit drug statistics and research and 
also to examine the overall structure and performance of drug policies. Both 
evaluations endorsed harm reduction initiatives such as self-help drug user groups, 
MMT and NSPs, and linked their importance to HIV/AIDS containment. 239 The 
authors of the 1992 evaluation (No Quick Fix) summed up the shift in policy that 
occurred in the late 1980s: 
235 • • p16. 
236 ibid, p22. 
237 Ministerial Council on Drug Strategy, 1992, No Quick Fix, Commonwealth of Australia, p86. 
238 Single, E & Rohl, T., 1997, The National Drug Strategy: mapping the future, AGPS, Canberra. 
239 ibid, p44, and Ministerial Council on Drug Strategy, 1992, No Quick Fix, Commonwealth of 
Australia, p45-6. 
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Services to [injecting drug users] have been characterised 
by a move away from abstinence oriented treatment toward 
holistic approaches within more general contexts. This 
shift has been fostered by the advent of AIDS and the 
recognition of the relationship between HIV infection, 
unprotected sexual activity and needle sharing, and the 
acceptance of the harm minimisation approach by the 
majority of service workers throughout Australia. 240 
The authors of the 1997 evaluation endorsed self-help drug user groups as important 
participants in the policy process. 
Support for user groups is commended and should be 
enhanced. Users are in an excellent position to help 
monitor the emergence of new drugs or patterns of use at 
the street level. Based on their personal experience, they 
can anticipate the likely impacts of new policies and 
programs. The presence of drug users in policy forums 
helps bring into consideration the likely impacts, intended 
or unintended, on users themselves. The rights of users are 
more likely to receive appropriate consideration. When 
user groups are present, the prevailing concept of an illicit 
drug user is less likely to be that of a person unable to 
control his or her actions and prone to criminal behaviour, 
and more likely to be that of an otherwise normal person 
who uses drugs and experiences a variety of consequent 
problems.. .Programs funded under the NDS would profit 
by increased consultation with user groups. 241 
As mentioned in chapter three, self-help drug user groups are an important 
mechanism used in harm reduction policy in the Australian context. Such groups 
echoed those formed in gay communities that acted as a bridge between 
medical/research communities, policy makers and the affected communities. Self-
help drug user groups translated research findings and public health messages into 
the language of their communities with the aim of encouraging behavioural change 
(such as using sterile syringes for every injection) in individuals and improving 
public health more generally. 
24° Ministerial Council on Drug Strategy, 1992, No Quick Fix, Commonwealth of Australia, p45-6. 
241 Single, E & Rohl, T., 1997, The National Drug Strategy: mapping the future, AGPS, Canberra, 
p55. 
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The strongest affirmation of harm reduction ideas in policy documents in this period 
was seen in the National HIV/AIDS Strategy released in 1996. This document 
reaffirmed a commitment toward the central principles of the previous HIV/AIDS 
strategies: partnerships with affected communities, employment of pragmatic 
strategies and non-partisan political support of HIV/AIDS policy. Further, the 
strategy championed the incorporation of affected communities at many levels of 
decision-making and policy formulation: 
Australia's success to date in dealing with HIV/AIDS [can 
be attributed to]: non partisan political support; the 
partnership between the affected communities, 
governments at all levels, and medical, scientific and health 
care professionals' and the active involvement of those 
communities most affected by HIV in all elements of the 
response, particularly individuals who are HIV positive. 242 
Australia's approach to HIV/AIDS, as described in the previous chapter, combined 
medical and scientific opinion tempered with "enlightened pragmatism". 243 The 
symbiosis between HIV/AIDS and illicit drug policy meant that harm reduction 
approaches were deemed as important strategies to address policy conundrums of 
both HIV/AIDS and problematic illicit drug use. Indeed, the 1996 National 
HIV/AIDS Strategy reaffirmed this ongoing overlap with drug policies and, more 
particularly, injecting drug use. 244 
Many of the behaviours that bear the risk of HIV infection 
are personal and private, and in some cases illegal. As a 
result, public health control measures.., are not effective.... 
Sustained and responsible behaviour change is not possible 
242 Commonwealth of Australia, 1996, Partnerships in Practice: National HIV/AIDS Strategy 1996-7 
to 1998-99, AGPS, Canberra, Foreword. 
243 ibid, pl. 
244 ibid, p3 
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if those who are most at risk are marginalised or fearful of 
discrimination.245 
From the perspective of the authors of HIV/AIDS policy, harm reduction approaches 
that employed peers/affected communities in education roles were still seen as the 
principal mechanisms to induce individual behaviour change 
The 1997 National Policy on Methadone Treatment supported the rushed entry of 
injecting drug users with HIV/AIDS into Methadone Maintenance programs. 246 The 
objectives and rationale that underpinned methadone treatment revolved around the 
notion of reducing drug related harm for individuals and the community. HCV was 
also raised as a public health concern in this document and harm reduction services 
such as education about safer injecting practices were regarded as the main 
mechanism of prevention of drug related harm (such as BBV prevention) in this 
document. 247 Thus, such harm reduction policies and programs were seen as 
complementary strategies to the national methadone policy in order to address BBVs. 
Throughout the period 1990 — 2000, the worth of harm reduction policies and 
programs was emphasised by the national policies and documents listed above. The 
authors of all these documents suggested that harm reduction policies had been 
critical to the past success of containing viruses (such as HIV/AIDS) within the 
community, and moreover, that these policies were critical to future containment 
efforts. Moreover, all these documents emphasised the necessity for harm reduction 
programs such as NSPs, methadone maintenance treatment and self-help drug user 
groups as primary mechanisms to curb their respective policy problems. While the 
245 ibid, p6-7. 
246 Commonwealth of Australia, 1997, National Policy on Methadone Treatment, Canberra, pll. 
247 ibid, p20. 
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ideas of harm reduction were clearly articulated within these documents, clear 
definitions of the approach were not as forthcoming. 
In the next section, the Australian policy response to the blood-borne virus HCV is 
examined. This virus produced another policy problem in which harm reduction 
ideas form a key solution for the containment of the spread of the virus. The 
following section examines the National Hepatitis C Strategy 1999-2000 to 2003- 
2000 and other commentaries around this issue. Australian policy responses to HCV 
during the period 1990-2000 are discussed, and contrasted with policy responses to 
HIV/AIDS . 
Hepatitis C: The 'Poor Cousin' of HIV 
The hepatitis C virus (HCV) was identified in 1988. HCV is predominantly 
transmitted through blood to blood contact248 and in many western countries is 
prevalent in people with a history of injecting drug use. Transmission is believed to 
occur predominantly through the sharing of injecting equipment including not only 
syringes and also mixing containers, tourniquets and other items used in the injection 
process.249 HCV infection is a public health concern because of its serious 
complications, such as cirrhosis of the liver and hepatocellular carcinoma, as well as 
its high prevalence, long latent period and high probability of long-term carriage and 
infectiousness. 250 In order to understand the place of harm reduction within HCV 
248 MacDonald M., Crofts N., Kaldor J., 1996, 'Transmission of hepatitis C virus: rates, routes and 
cofactors' Epidemiology Review, 18, pp137-148. 
249 Crofts N., Jolley D., Kaldor J., 1997, 'Epidemiology of hepatitis C virus infection among injecting 
drug users in Australia', Journal of Epidemiology and Community Health, 51, pp692-697. 
250 MacDonald, M., Wodak, A., Dolan, K., van Beek, I., Cunningham, P., & Kaldor, J., 2000, 
'Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe 
programs in Australia, 1995-1997', MJA, 172, pp57-61. 
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national policy during the period of analysis, this section examines the following 
documents: 
• Hepatitis C. a review of Australia's response —Department of Health and 
Ageing, 
• 'Injecting nation: achieving control of hepatitis C in Australia' —article 
written by key harm reduction advocate Dr. Alex Wodak, St Vincents 
Hospital in NSW 
• National Hepatitis C Strategy 1999-2000 to 2003-2004, and, 
• The Road Not Taken: review of the National Hepatitis C Strategy. 
Grassroots organisations that formed to address the issue of HCV started in the early 
1990s as affected communities and health professionals formed organisations, while 
staff from NSPs lobbied for HCV resources. Health care workers, particularly 
gastroenterologists called for a national response to HCV, partly motivated through a 
perceived occupational risk of contracting the disease, thus playing a role in the 
agenda setting process. 251 In 1993, the Federal Government established a joint task 
force to address HCV. Members were taken from the National Health and Medical 
Research Council and the Australian Health Ministers Advisory Council, and this 
group initiated the first National HCV action plans. 252 These documents informed 
approaches to the diagnosis, treatment and management of HCV-infected people and, 
to a lesser extent, prevention of further spread. In 1999, the Federal Government 
released the first national strategy for HCV. The National Hepatitis C Strategy 
251 Department of Health and Aged Care, 1999, Hepatitis C: a review of Australia's response, 
Commonwealth of Australia, Canberra, p99. 
252  National Health and Medical Research Council and Australian Health Ministers' Advisory 
Council, 1994, Hepatitis C: epidemiology, natural history, control and treatment, AGPS, Canberra 
and National Health and Medical Research Council, 1997, A strategy for the detection and 
management of hepatitis C in Australia, AGPS, Canberra,1997. 
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1999-2000 to 2003-2004253 regarded harm reduction approaches as key strategies in 
the reduction of drug related harm, one component of which was the reduction in 
rates of transmission of HCV: 
There is compelling evidence that harm reduction 
interventions such as peer support education and needle and 
syringe programs continue to be highly effective in 
reducing risk behaviour and the transmission of blood 
borne viruses such as HIV among people who inject 
drugs.2" 
NSPs act to contain HCV through the provision of sterile injecting equipment and 
also through the provision of information about the virus (especially routes of 
transmission) to injecting drug users. Such education and equipment provision 
attempt to increase knowledge and provide the means by which injecting drug users 
can avoid transmission of the virus. According to some commentators, however, 
such initiatives that seek to generate behaviour change among injecting drug users 
are not sufficient to contain the spread of HCV in the injecting drug user population. 
Indeed, efforts to enact such behavioural change in injecting drug users are impeded 
by the context of the illegality of the behaviour: 
The incidence and prevalence of hepatitis C in Australia are 
far higher than those of HIV infection. An estimated 130 
000 Australians have been infected with hepatitis C virus 
(HCV) over the last 20 years, with about 6000 new chronic 
infections a year through injecting drug use alone. In 
contrast, an estimated 15450 people have been infected 
with HIV by all routes of transmission, with about 500 new 
infections a year between 1994 and 1996. Although a 
smaller proportion of individuals infected with HCV 
experience serious morbidity and mortality, and only after a 
longer delay (10%-20% are estimated - conservatively - to 
develop cirrhosis within 20 years and 5% of these develop 
hepatocellular carcinoma within five years), the far larger 
253 Commonwealth Department of Health and Ageing, 2000, National Hepatitis C Strategy 1999-2000 
to 2003-2004, Commonwealth of Australia, Canberra. 
254 ibid, p14. 
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pool of infected people and longer duration of illness 
suggest that the total health and economic burden of 
hepatitis C in Australia is considerable and may well 
surpass HIV before too long. 255 
A 2002 review of the National Hepatitis C Strategy 1999-2004 entitled The Road Not 
Taken alerted Governments to the threat posed by HCV stating that it was the most 
common notifiable disease in Australia. 256 The report noted the limitations of policy 
to curb the public health impact of HCV (in contrast to that of HIV/AIDS) and 
attributed it to counterproductive drug laws and policies, a failure to understand the 
complexity of care of HCV, inadequate governance structures, inadequate research 
and lack of resources.257 According to Wodak258, a fundamental limitation of 
Australia's policy response to HCV was the similarity in approach with HIV/AIDS. 
While the transmission pathways for HCV and HIV/AIDS are similar (sharing 
syringes being a high risk activity in relation to the transmission of both viruses), the 
differing disease characteristics meant that policy needed to reflect such 
distinctiveness in order to contain HCV. 
The remarkable infectiousness of hepatitis C by blood to 
blood spread is illustrated in studies of occupational 
exposure. Following a needlestick injury with blood from 
an infected patient, 0.3% of health workers are estimated to 
have become infected with HIV compared to 3% who 
become infected with hepatitis C. 259 
255 Wodak, A, 1997, 'Hepatitis C: waiting for the grim reaper', MJA, 166, p283 accessed at 
http://www.mja.com.au/public/issues/mar17/wodak1wodak.htm1 on 28/3/2006. 
256 Levy, M., Baum, F., & Thomas, H., 2002, The Road Not Taken: review of the National Hepatitis C 
Strategy, 2002 Reviews of the National HIV/AIDS and Hepatitis C Strategies and Strategic Research, 
accessed 7/1/04, from Australian Government Department of Health and Ageing website: 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pubhlth-publicat-document-
metadata-hivhepc review.htmMILE/hivhepc_part3.pdf p83. 
257 ibid. 
258 Wodak, A., 1997, Injecting nation: achieving control of hepatitis C in Australia, Drug and Alcohol 
Review, 16. 
259 • • 	- p2 -  
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Instead of separate structures to address HCV transmission, however, the approach 
undertaken by Australian Governments mirrored that of HIV/AIDS, and HCV 
policy/programs were incorporated into existing HIV/AIDS infrastructure. While 
these approaches proved to be successful in the containment of the HIV/AIDS virus, 
they were not as effective in addressing the spread of HCV. 
In the review of the literature there were three key factors identified as reasons for 
the failure of these approaches to effectively contain the spread of HCV. First, the 
HCV-affected communities had not been as effectively engaged as those associated 
with HIV/AIDS. With HIV/AIDS, the gay community mobilised around the issue 
buoyed by recent successes in the 1980s with regard to homosexual law reform. 
While HCV is certainly not confined to injecting drug users and a number of 
transmissions were linked to blood transfusions previous to 1988, over ninety per 
cent of new HCV infections occurred among people who injected drugs. 260 Dr Alex 
Wodak mused on the political strength of injecting drug users noting that such a 
group is not traditionally well politically organised (in comparison with HIV/AIDS 
policy in which gay men successfully formed organisations around a decade before) 
due to stigma attached to identifying with, and admitting to participation in, an 
illegal activity. Moreover, few public health practitioners were willing to advocate 
for injecting drug users. 261 As such, even though HCV presented a serious threat to 
public health during the 1990s it did not attract attention as HIV/AIDS had the 
decade before: 
Unlike the situation which prevailed after a few years of 
knowledge of the existence of HIV/AIDS, there has been 
260 Commonwealth Department of Health and Ageing, 2000, National Hepatitis C Strategy 1999-2000 
to 2003-2004, Commonwealth of Australia,Canberra, p21 
261 Wodak, A., 1997, 'Injecting nation: achieving control of hepatitis C in Australia', Drug and 
Alcohol Review, 16, p278. 
132 
no National Hepatitis C Task Force, no epidemic of 
hepatitis C pamphlets and posters, no vigorous calls for 
research and no quilts, ribbons, candlelight vigils, plays, 
novels, poems or films based on this new public health 
threat. 26z 
There are more than five times as many Australians already 
infected with hepatitis C as HIV and approximately ten 
times more new cases of hepatitis C every year than 
HIV.. .While the burden of HIV is far greater per infected 
individual, the overall health and economic burden of 
hepatitis C may be at least comparable with HIV because of 
the far larger pool of hepatitis C infection... If HIV was the 
epidemic that Australia did not need to have, hepatitis C is 
the epidemic that many feared HIV might become. 263 
Second, the nature of the problem also impacted upon the policies chosen for HCV. 
HIV/AIDS containment measures were buoyed by community fear of a widespread 
epidemic into the heterosexual population. The future spread of HCV, however, 
most likely will remain largely contained within current and ex-injecting drug user 
population (because it is only transmitted through blood to blood contact and sexual 
transmission is thought to be rare) and therefore is perceived as being less of a threat 
to the mainstream community than HIV/AIDS: 
Hepatitis C is a much less dramatic illness that HIV. 
Predominantly, it threatens marginalized members of the 
community rather than the talented and creative figures 
who all too often succumb to HIV. AIDS involves an 
intriguing combination of sex, drugs, film stars, celebrities 
and sports stars. 264 
Existing governance structures have reinforced the position 
of hepatitis C as the 'poor cousin' of HIV...When hepatitis 
C began to emerge as a serious public health concern in 
Australia the HIV/AIDS infrastructure was well 
established." Hepatitis C was integrated into this 
infrastructure...Hepatitis C is yet to achieve priority within 
this infrastructure despite its greater impact in terms of the 
number of people affected and the projected cost burden 
relative to HIV/AIDS. Because of the dominance of the 
262 ibid. 
263 ibid. 
264 ibid. 
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HIV/AIDS agenda, many opportunities for early, 
coordinated action to meet the challenges of hepatitis C 
have not been realised. 265 
Third, prohibition policy is counterproductive to public health. Wodak suggested 
that to contain HCV infection, the adoption of traditional responses to reduce HIV 
transmission were insufficient. 266 Indeed, the practice of injecting was at the centre 
of the problem and Wodak asserted that a change in injecting behaviour, moving 
from intravenous to non injectable routes of administration (NIROA), was a key way 
to curb HCV rates of infection. 267 The conundrum was, however, the interplay of the 
individual and the environment: systemic factors such as the prohibition regime 
around illicit drugs maintains high prices for illicit drugs, which in turn, provides a 
disincentive to use drugs in any other way than injection, as this is the most cost-
effective mode of administration. 268 As previously stated, injection practices have 
accounted for the vast majority of new transmissions of HCV. Authors of the 
National Hepatitis C Strategy 1999-2000 to 2003-2004 also agreed that action was 
required to reduce the stigmatisation and discrimination associated with drug laws, 
especially in health care settings of those infected with HCV. 
Self administration (or 'use') of a prohibited substance 
remains an offence in New South Wales; that discourages 
people who inject drugs from attending NSPs and carrying 
sterile injecting equipment, increasing the likelihood that 
265Levy, , Baum, F., & Thomas, H., 2002, The Road Not Taken: review of the National Hepatitis C 
Strategy, 2002 Reviews of the National HIV/AIDS and Hepatitis C Strategies and Strategic Research, 
accessed 7/1/04, from Australian Government Department of Health and Ageing website: 
http://vvww. health. g  o v. au/intemet/wcms/publishing .nsf/Content/health-pubhlth-publicat-document-
metadata-hivhepc_review.htm/SFILE/hivhepc_part3.pdf,  pp84-5. 
266 wodak, 
A 1997, 'Injecting nation: achieving control of hepatitis C in Australia', Drug and 
Alcohol Review, 16, p279. 
267 ibid. 
268 Commonwealth Department of Health and Ageing, 2000, National Hepatitis C Strategy 1999-2000 
to 2003-2004, Commonwealth of Australia,Canberra, p50 and Levy, M., Baum, F., & Thomas, H., 
2002, The Road Not Taken: review of the National Hepatitis C Strategy, 2002 Reviews of the 
National HIV/AIDS and Hepatitis C Strategies and Strategic Research, accessed 7/1/04, from 
Australian Government Department of Health and Ageing website: 
http://www.health.gov.au/intemet/wcms/publishing.nsf/Content/health-publilth-publicat-document-
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they will share injecting equipment... Fundamental to the 
success of Australia's approach to HIV was the 
decriminalisation of homosexuality. Reform of drug laws 
and policies is now needed to reduce hepatitis C 
transmission.269 
The affected communities are very marginalised, 
experiencing cultural, social and economic disadvantage. 
This situation is not unique to hepatitis C: most diseases 
thrive in such circumstances. 2" 
Other factors such as policing of public injecting can lead to rushed injections which 
exacerbate unsafe techniques and therefore increase the risk of HCV transmission. 
Ultimately, harm reduction advocates argue that the criminalisation of injecting drug 
use compounds the instance of HCV transmission. 
In sum, a comparison of the relative impacts of the policy problems presented by 
HCV and HIV/AIDS on drug policy revealed the way in which the potential benefits 
of harm reduction programs were thought to be undermined by law enforcement 
responses to drug use. Containment of HCV required a more systemic view of the 
environment that engendered HCV transmission. The focus on getting drug users to 
change drug using behaviours, without addressing contextual factors of use (such as 
the effect of drug laws on injection practises), was inadequate to contain the virus. 
That HCV mainly affected injecting drug users with less risk of transmission into the 
mainstream population than HIV/AIDS meant that policy was not drafted with the 
urgency or scope that HIV/AIDS was. Around the time HIV/AIDS had become a 
major public health threat, laws prohibiting homosexual sex had been overturned that 
had the effect of the removal of stigma and allowance of more effective public health 
269 Levy, M., Baum, F., & Thomas, H., 2002, The Road Not Taken: review of the National Hepatitis C 
Strategy, 2002 Reviews of the National HIV/AIDS and Hepatitis C Strategies and Strategic Research, 
accessed 7/1/04, from Australian Government Department of Health and Ageing website: 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pubhlth-publicat-document-
metadata-hivhepc_review.htm/SFILE/hivhepc_part3.pdf  p98. 
270 ibid, p100. 
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interventions however drug laws and attitudes towards injecting drug use are deeply 
entrenched and act to limit Governments' action toward HCV. 
Changes to Law Enforcement: the Softening of Prohibition? 
Previous to the NCADA, health and law enforcement worked in relative isolation 
from each other. Since 1985 however, health and law enforcement agencies have 
had regular contact through a series of structures formally enacted under the 
NCADA and successive national drug strategies. The MCDS, the IGDS and the 
ANCD are three examples of national structures that meet regularly to discuss illicit 
drug issues and that feature membership drawn from both health and law 
enforcement sectors as well as other illicit drug stakeholders. Such increased contact 
between the sectors lead to changes to police practice, however, the ideas of harm 
reduction in policing have a clear precedent. Concepts such as random breath testing 
and police assistance in the development of such concepts as responsible service of 
alcohol are two examples of the capacity of law enforcement to affect areas 
previously thought only applicable to the domain of health.271 Moreover, the wider 
structure of successive national drug strategies has meant new perspectives on law 
enforcement practice. Indeed the authors of The National Drug Strategy: mapping 
the future stated that successive national drug strategies had engendered a 
collaborative relationship between health and law enforcement agencies that has had 
an impact on both sectors. 
With the NDS has come a research philosophy which has 
been instrumental in encouraging police at all levels to 
consider options which would not have been examined in a 
271 Single, E & Rohl, T., 1997, The National Drug Strategy: mapping the future, AGPS, Canberra, 
p67. 
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traditional law enforcement paradigm. Police are starting 
to recognise the intrinsic value of harm minimisation within 
a community policing context. Similarly, health agencies 
are starting to appreciate the police role in contributing to 
the effectiveness of harm minimisation. 272 
The earliest example of harm reduction ideas in policing was encapsulated in the 
'Merseyside Model' from the early 1980s in the UK. In this model, there were three 
factors that constituted this particular approach to illicit drug use. First, psychiatrists 
at a Merseyside drug dependency clinic prescribed injectable opiates on a take-home 
basis. 273 Second, the area implemented one of the first NSPs in the UK. 274 Both 
these initiatives were supported by the third element of the Merseyside Model - 
namely the support and cooperation of the local police who agreed not to observe 
drug services and also referred drug users who had been arrested to local drug 
services.275 
The police role in the administration of drug policy towards 
drug dependent people in Rotterdam is completely 
integrated with other agencies. The 'harm reduction' 
principle in the police context means that trafficking is 
pursued whilst the drug user is left alone as much as 
possible. This applies to both 'hard' and 'soft' users and 
low level dealers. Only if they cause 'unacceptable 
annoyance' to other citizens, especially in residential areas, 
do the police take action. 276 
In this model the police were a critical element that contributed to the overall 
success of the both drug treatment agencies and services such as NSPs. In many 
areas, where harm reduction and law enforcement activities co-exist, police were 
initially reluctant to support NSPs as they were seen to be counterproductive to their 
272 ibid, p68. 
273 Riley, D., O'Hare, P., 2000, 'Harm Reduction: History, definition and Practice', in J. Inciardi & L. 
Harrison (eds) Harm Reduction: national and international perspectives, Sage, California, p3-4. 
274 ibid. 
275 ibid. 
276 Chappell, D., Reitsma, T., O'Connell, D., & Strang, H., 1993, 'Law Enforcement as a harm 
reduction strategy in Rotterdam and Merseyside', in N. Heather, A. Wodak, E. Nadlemann & P. 
O'Hare (eds) Psychoactive drugs & Harm Reduction, Whurr, London, p120. 
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work and also as condoning drug use. Authors of the Australian Illicit Drug Report 
suggested that the adoption of harm minimisation as the key goal of illicit drug 
policy created "conceptual difficulties for law enforcement". 277 Understandably 
such difficulties stemmed from the traditionally disparate roles of both law and 
health agencies in relation to drug use. Changes to police practice, especially the 
incorporation of harm minimisation, have not been without operational challenges. 
These have included: the tension between the application of operational discretion 
and fair and consistent enforcement of the law, secondly, recognition that drug busts 
could increase crime in an area or displace crime to another area, and, a lack of 
adequate treatment facilities or places to refer offenders. 278 
Law enforcement's adoption of the harm minimisation 
approach to drug laws has, however, been problematic. 
Most senior law enforcement officers have embraced the 
approach, but many junior officers have found it difficult to 
reconcile the concept with their traditional role...some 
police still believe that in relation to illicit drugs, their role 
is to simply identify drug criminals, [with] other agencies 
being responsible for prevention, treatment and harm 
minimisation.279 
Since implementation of harm reduction services in many countries however, there is 
now a wider understanding and support for such schemes. 28° In Australia, the ways 
in which law enforcement agencies supported harm reduction initiatives included 
better integration with harm reduction programs such as NSPs and treatment 
agencies. Indeed, it is now recognised that the support of law enforcement for harm 
277 Australian Bureau of Criminal Intelligence, 1997, Australian Illicit Drug Report 1996-7, 
Commonwealth of Australia, p8. 
278 Single, E & Rohl, T., 1997, The National Drug Strategy: mapping the future, AGPS, Canberra, 
p68. 
279 Australian Bureau of Criminal Intelligence, 1997, Australian Illicit Drug Report 1996-7, 
Commonwealth of Australia, p7. 
280 Hellawell, K., 1995, 'The Role of Law Enforcement in Minimising the Harm Resulting from Illicit 
Drugs', Drug and Alcohol Review 14, pp317-22. 
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reduction programs is a critical element in the success of such programs. 28I In one 
example of the impact of police activity on harm reduction activities, in July 1994, 
police activity around an NSP in Victoria resulted in a significant reduction in the 
number of service users (particularly Vietnamese clients) and amount of returned 
syringes.282 This example of zealous law enforcement activity and the effect it can 
have on the operation of harm reduction programs occurred despite stipulations in 
policy that police were to support measures designed to reduce HIV/AIDS and HCV 
transmission.283 The liberalisation and standardisation of laws relating to the 
possession of injecting equipment that occurred as a result of the implementation of 
NSPs was also another example of how changes in law enforcement practice can 
engender responsible disposal of injecting equipment, protect public health and 
generally enhance the operation of harm reduction programs. 284 
The second example of changes to law enforcement in this period is regarding the 
introduction of cannabis cautioning programs and diversion schemes in Australia in 
this period was another change to the role of law enforcement. Reviews of cannabis 
laws were undertaken by the Australian Capital Territory (ACT) Legislative 
Assembly Select Committee on HIV, Illegal Drugs and Prostitution and the 
Queensland Criminal Justice Commission. 285 The (ACT) Drugs of Dependence 
(Amendment) Act 1992 resulted in the issuing of 'cannabis offence notices' for 
281 Griffin, M., 1995, 'Building on Common Ground', Connexions, 15:4, pp8-14 and Hellawell, K., 
1996, The Role of Law Enforcement in Minimizing the Harm resulting from Illicit Drugs', Drug and 
Alcohol Review, 14, pp317-22. 
282 Kutin, J., 1998, Taw Enforcement and Harm Minimisation', M. Hamilton, A. Kellehear & G 
Rumbold (eds) Drug use in Australia: a harm minimisation approach, Oxford University Press, 
Melbourne, p163. 
283 Victoria Police, 1997, 'Needle Exchange Program', section 5.1.6 of the Operating Procedures, 
Victoria Police Manual, Victoria Police, Melbourne quoted in ibid, p163. 
284 The illegality of carrying injecting equipment means that some users might choose to dispose of 
the equipment in public areas soon after injecting rather than carry syringes back to the NSP and risk 
an infringement. Kutin, J., 1998, 'Law Enforcement and Harm Minimisation', M. Hamilton, A. 
Kellehear & G Rumbold (eds) Drug use in Australia: a harm minimisation approach, Oxford 
University Press, Melbourne, p163. 
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possession of small amounts of cannabis that meant that users could pay within a 
period of sixty days without a conviction recorded. 286 In 1998, Tasmanian and 
Victorian Police introduced the Cannabis Cautioning Policy287 whereby offenders in 
possession of small amounts could receive a caution notice that included information 
on health and legal issues. 288 
In 1994, the Alcohol and Other Drugs Council of Australia conducted a study of the 
diversion of drug users in Australia. The term 'diversion' was defined to include a 
large and varied range of approaches and policies aiming to reduce the number of 
offenders entering the criminal justice system. The authors, Collins and Lapsey 289 
estimated the costs of law enforcement activity related to illicit drugs to be in excess 
of $450.6 million. Of this, $230.5 million was for the prison system, $64.1 million 
was for court funding, with $156 million left for state and territory police, the 
National Crime Authority, the Australian Federal Police and Customs Service. Thus, 
it was apparent that over half of the law enforcement costs dedicated to illicit drugs 
was allocated to prison and court systems. 
Diversion programs and cannabis cautioning schemes not only reduced the harm 
associated with illicit drugs for some drug users through the removal of criminal 
286 ibid. 
287 „Formal cautioning, the newest approach to minor cannabis offences in Australia, is being 
embraced by governments who see problems with the total prohibition approach but do not want to 
change the cannabis law in a way which could be construed as 'soft on drugs'. In 1998 VIC and TAS 
introduced cautioning systems for cannabis use, and WA began a trial of a limited cannabis-
cautioning scheme in two police districts. The Victorian scheme aims to provide an alternative to 
court proceedings and associated stigma, reduce the lag between offending and punishment, provide 
support, assistance and encouragement, and optimise informal communication between police and 
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penalties and convictions (that can often affect a person's chance of employment as 
well as other opportunities reliant on minimal or no criminal convictions) but also 
through the reduction in court time and police work involved in the prosecution of 
drug users with possession-type offences. The Australian Bureau of Criminal 
Intelligence (now the Australian Crime Commission) supported the notion of 
diversion for "...appropriately classified offenders. ,,290  and suggested that this 
practice would "...allow police to rationalise their role consistent with the harm 
minimisation philosophy.' ,291 In 1999, the NSW Government experimented with the 
notion of a drug court as an alternative to existing judicial processes. 292 The purpose 
of the drug court was to deal with people who were dependent on illegal drugs and 
had committed a non violent crime, with an overall aim of helping people progress 
on from their drug dependencies (albeit through being compelled to attend drug 
treatment) and move away from criminal networks. Such changes in approaches and 
penalties directed toward drug users was indicative of the overall trend towards 
lessening penalties (and drug related harms) for drug users and increasing penalties 
toward drug manufacturers, traffickers and suppliers in this period. 
Amendments to drug laws and implementation of, for example, diversion programs 
reflected a change in thinking about the nature of drug use as being a health problem 
rather than a criminal problem. Another benefit of diversion programs was a 
redirection of resources dedicated to the penalisation of drug use towards trafficking 
offences. Sutton and James 293 , Green and Purne11 294 and Weatherburn and Lind295 in 
290 Australian Bureau of Criminal Intelligence, 1997, Australian Illicit Drug Report 1996-7, 
Commonwealth of Australia p10. 
291 ibid. 
292 ibid, p126. 
293 Sutton, A & James, S., 1996, Evaluation of Australian Drug Anti-Trafficking Law Enforcement, 
National Police Research Unit, Adelaide. 
294 Green, P & Purnell, I., 1996, Measuring the success of law enforcement agencies in Australia in 
targeting major drug offenders relative to minor drug offenders, National Police Research Unit, 
Adelaide. 
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their studies of law enforcement practice all presented arguments for a distinction 
between manufacturers/traffickers and drug users in policy. To an extent economic 
imperatives (for example the reduction of court costs allocated to processing 
possession offences) provided a further rationale for this change while the health 
sector seen as best placed to address issues of drug use. 
Third, there has also been research and focus on the counter-productive and 
unintended effects of policing and, specifically, how such activities can exacerbate 
and/or generate drug-related harms. In the 1990s, research 296 into the connection 
between law enforcement and the effect on drug-related harms occurred. Previously 
the notion of unintended harm that resulted from law enforcement efforts to police 
illicit drugs had been regarded as a necessary evil. For example, while street level 
policing of illicit drug use and dealing in public areas has the overall aim of reducing 
the prevalence of drug use and associated criminal activity, it may also however, lead 
to displacement of the problem into neighbouring areas. Moreover, zealous street 
level policing of drug use in public places can also impact on the way in which drug 
consumers administer drugs (for example: rushed injection practices leading to 
increased risk on contracting BBVs) and dramatically increase harms well beyond 
those associated with the drug itself. Indeed, by the 1990s such a dynamic was 
recognised by law enforcement agencies, with a report from the Australian Bureau of 
Criminal Intelligence reporting that: 
295 Weatherbum, D., & Lind, B., 1995, Drug Law Enforcement Policy and Its Impact on the Heroin 
Market, New South Wales Bureau of Crime Statistics and Research, Sydney. 
296 Sutton, A & James, S., 1996, Evaluation of Australian Drug Anti-Trafficking Law Enforcement, 
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National Police Research Unit, Adelaide; Weatherbum, D., & Lind, B., 1995, Drug Law Enforcement 
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Drug users react in various ways to street level policing in 
order to avoid detection. They often go 'underground' to 
avoid scrutiny and in some cases they even fail to seek out 
treatment opportunities because they fear police 
involvement. Under a strict law enforcement approach 
heroin users found injecting in public places should be 
arrested. Consequently, some users inject drugs in less 
than ideal situations, often quickly, soon after purchase, 
without sterile needles, and under constant pressure of 
detection. It would appear that street level policing is 
leading to an unintended, but potentially serious, harm for 
users. In the long run this will harm society as a 
whole...Law enforcement thus must strike a balance 
between the need to deter drug use and the need to avoid 
harming consumers.297 
In Drug law enforcement policy and its impact on the heroin market, Weatherburn 
and Lind noted the way in which law enforcement can drive up heroin prices which 
then creates a need for drug users to commit crime to fund higher costs of the drug. 
It is the effect of prohibition on the price of heroin, after all, 
not the effect of the drug on heroin users, which causes 
them to commit property crime at very high rates. 298 
Weatherburn and Lind's research found that variations on the average amount of 
heroin seized exerted no impact on the price, purity or availability of heroin at street 
level, and, rate of arrest for heroin users similarly exerted no effect on the street price 
or the rate at which users seek treatment. 299 Moreover this research also examined 
whether street level policing impacted upon the rate of admission into MMT. 
Examples of such research examined not only the effect of policing interventions on 
crime outcomes but also on health outcomes. Such research into the effect of law 
enforcement on drug related harm and the interplay between policing efforts and the 
price and purity of illicit drugs is indicative of the development of a greater 
297 Australian Bureau of Criminal Intelligence, 1997, Australian Illicit Drug Report 1996-7, 
Commonwealth of Australia, p7. 
298 Weatherburn, D., & Lind, B., 1995, Drug law enforcement policy and its impact on the heroin 
market, New South Wales Bureau of Crime Statistics and Research, Sydney, piii. 
299 ibid. 
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understanding by law enforcement bodies of the impact of their activities on drug 
related harm and the ways in which such agencies can work to minimise such 
impacts. 
Ultimately, in the period between 1990 and 2000, there was a focus on improving the 
performance of police in relation to the overall goal of reducing harm. In this period, 
several groups advocated for changes to police practice. The Victorian Drug Expert 
Committee30° suggested changes to the role of police such as: greater cooperation 
and links with health agencies, especially treatment providers (for example MMT); 
initiation of drug courts; monitoring of the counterproductive impacts of law 
enforcement across jurisdictions; commitment for further training in harm 
minimisation for police officers; and relaxation of laws regarding medicinal use of 
cannabis. Indeed the majority of the recommendations for law enforcement in this 
document advocated further entrenchment of harm minimisation ideas in illicit drug 
policing. Additionally, the 1996- 7 Australian Illicit Drug Report301 suggested that 
training in harm minimisation for Police be enhanced and continued. 
In 1996, the Victorian Premier's Drug Advisory Council also suggested that the 
Police should ensure that harm minimisation strategies govern operational practice at 
all levels of the force. 302 The 1997 Single and Rohl evaluation of the 1993 National 
Drug Strategic Plan made recommendations in regard to enhancing the cooperation 
between health and law enforcement that included: rescheduling MCDS meetings so 
to allow greater law enforcement personnel attendance as well as more law 
300 Drug Policy Expert Committee, 2000, Drugs: meeting the Challenge, Stage Two Report, Victorian 
Government, accessed at http://www.health.vic.gov.au/drugservices/pubs/polcomm.htm  , on 12/12/04, 
p182 
301 Australian Bureau of Criminal Intelligence, 1997, Australian Illicit Drug Report 1996-7, 
Commonwealth of Australia, p8. 
302 State Government of Victoria, 1996, Turning the Tide: Victorian Government Response to the 
Report of the Premier's Drug Advisory Council and Implementation Strategy, State Government of 
Victoria, Melbourne. 
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enforcement involvement in secretariat functions and agenda setting. 303 Finally, in 
the period 1990-2000, elites from the law enforcement sector have advocated such 
initiatives as supervised injecting centres and prescription heroin. This is discussed 
in greater detail in the following section and in chapter five. 
Up until the NCADA in 1985, law enforcement and health agencies worked in 
relative isolation from each other to address particular illicit drug issues. In the 
period 1990 to 2000, it was evident that police practice had undergone some change 
in relation to the way law enforcement agencies addressed the issue of illicit drugs. 
Changes to police practice, implementation of cannabis cautioning and diversion 
programs and research into the role and effects of policing can be at least partly 
attributed to the increased collaboration between law enforcement and health sectors 
generated by the successive NDS' that created ongoing opportunities for increased 
collaboration and cooperation. Moreover, it is clear that policy-makers seemed 
willing to change the policy 'status quo' toward regarding personal use as a health 
issue while promoting the enhancement of the role of law enforcement in addressing 
trafficking and manufacturing. 
303 S ingle,  E & Rohl, T., 1997, The National Drug Strategy: mapping the future, AGPS, Canberra, 
p67. 
145 
Advocating Prescription Heroin and Supervised Injecting Centres 
A substantial increase in opioid overdose and associated rise in public nuisance 
associated with heroin use in cities such as Melbourne and Sydney in the 1990s 
meant that options such as supervised injecting centres (SICs) and trials of 
prescription heroin were considered by some state governments. While harm 
reduction advocacy attempts in relation to prescription heroin and SICs are the 
subject of the following chapter, a brief outline is provided here as such efforts are 
relevant in the period of analysis of this chapter. The proposed 'heroin trial' 
involved the provision of injectable heroin as a form of treatment for opioid 
dependent people which had either not sought treatment or who had failed at other 
forms of treatment, including MMT.304 SICs are premises designed to provide a safe 
environment for the injection of illicit drugs and also called 'drug consumption 
facilities', 'injecting rooms' or 'medically supervised injecting centres' (in New 
South Wales), 'supervised injecting place' (ACT) and 'off street injecting facilities' 
(Victoria). Both SICs and prescription heroin are easily classified as harm reduction 
interventions due to their focus on the reduction of drug related harm for people that 
continue to use illicit drugs. Around the time when the issue of problematic heroin 
use was identified as an issue in metropolitan cities such as Sydney and Melbourne, a 
change of federal government occurred. In March 1996, the Howard-led Liberal 
Coalition Government was elected by voters, succeeding the Keating-led ALP 
Government. The ALP Government had been instrumental in the establishment of 
harm reduction measures such as NSPs and self-help drug user groups in the 1990s. 
3°4 Hall, W., Kimber, J & Mattick, P., 2002, Breaking the deadlock over an Australian trial of 
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Heroin trial 
Advocates for a trial of prescription heroin in Australia suggested that the initiative 
would increase the proportion of people with opiate dependencies in treatment, 
reduce street heroin use, drug-related crime, and deaths due to overdose. In 1997, 
the MCDS voted in favour of a heroin tria1. 305 After only a year in Government, the 
Howard Cabinet intervened to stop the trial occurring, with the justification that the 
Australian Government would require special legislation to enable the importation of 
heroin.306 Prime Minister Howard suggested that the trial was contingent on this 
legislation and also that such an initiative "would send the wrong message" to the 
community in regard to drug use. 307 The trial was to be conducted in the ACT, 
which is under Australian Government rule. Consequently the Government refused 
to amend legislation to allow heroin to be imported for the trial or allocate funds to 
monitor the use of heroin in accordance with international treaties. 308 Dramatic rises 
in the number of deaths caused by opioid overdose in subsequent years prompted 
further calls for a heroin tria1. 309 The Australian Government, by refusing to 
countenance a trial, created a policy deadlock that prevented the evaluation of a 
program that proponents claimed was a potentially valuable policy option for both 
health and law enforcement sectors. 
Supervised Injecting Centres 
SICs have been operating in Europe since the 1970s as a public health intervention 
and as a response to public nuisance problems associated with injection of drugs in 
public places. Facilities were located mainly within other health services that were 
305 ibid. 
306 Campbell, A., 2001, The Australian Illicit Drug Guide, Black Inc, Melbourne, p450. 
307 ib id.  
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directed both at those that continued to use and those who wished to stop their use. 
In 1997, the report from the Wood Royal Commission into the NSW Police Service 
advocated for SICs, which generated widespread debate in Australia. 310 A diverse 
group participated in the debate that included: members of all tiers of Government; 
community organisations; the clergy; researchers; alcohol and other drug agencies; 
professional bodies; and advocacy groups. 311 Following the Royal Commission, a 
NSW Parliamentary Group was established in 1997 to consider trialling the 
centres.312 Recommendations in the Report on the Establishment or Trial of Safe 
Injecting Rooms from this group suggested that the trial should not take place. 
Subsequently, in 1998 frustrated workers decided to open an unofficial supervised 
injecting room called the 'Tolerance Room' located at the Wayside Chapel, Uniting 
Church in Kings Cross. The room attracted much controversy and was open for 
several weeks. 313 In 1999 the Vatican instructed the Sisters of Charity 314, to 
abandon plans to open a SIC in Sydney. 315 Such grassroots resistance in the form of 
civil disobedience was reminiscent of the instigation of NSPs in the previous decade 
whereby drug and alcohol workers at St Vincent's Hospital in Sydney started 
Australia's first NSP. A detailed discussion on the policy debates surrounding 
prescription heroin and SICs occurs in the following chapter. 
310 Campbell, A., 2001, The Australian Illicit Drug Guide, Black Inc, Melbourne, p450. 
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It is important to note in this chapter, however, that the prescription heroin trial came 
very close to being implemented and was supported by the peak illicit drug body, the 
MCDS yet was thwarted by the Howard Government. Chapter five provides a 
detailed examination of the arguments used for and against, and the advocacy 
methods, employed by both harm reduction and moral-abstinence coalitions with 
regard to prescription heroin trial and SICs undertaken by stakeholders. 
The Softening of Harm Reduction? 
Another phenomenon that occurred into the 1990s was a focus on the meanings of 
the terms 'harm minimisation' and 'harm reduction', and more specifically, what 
types of interventions/policies/programs such terms encompassed. The central issues 
in debates were whether the term 'harm reduction' could encompass abstinence-
oriented approaches and moreover, whether the term harm minimisation could 
describe initiatives such as supply reduction. As stated in the first chapter, the 
original meaning of harm minimisation/reduction (both were used originally used 
interchangeably), coined in the early 1980s, was to describe policies and programs 
designed to reduce drug related harm without requiring a reduction in drug use 
among individuals that accessed such programs. This kind of philosophy toward 
drug use accepted that people may continue to use illicit drugs, in contrast to 
abstinence-oriented approaches that aim to have a drug user become drug free. With 
the adoption of 'harm minimisation' as the key notion of Australia's drug policy in 
1985, the meaning of the term was widened (in the Australian context) to include 
supply reduction initiatives as well as abstinence-oriented approaches. Indeed, 
definitions of 'harm minimisation' in Australia's national drug strategies since 1985 
have stated that the very combination of supply, demand and harm reduction act in 
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concert to result in the reduction of drug related harm. Therefore since 1985 in the 
Australian context, the term harm minimisation has an entirely distinct meaning to 
'harm reduction'. 
In 1998, Single and Lenton316 identified 'narrow' and 'broad' definitions of harm 
reduction. Narrow definitions included those that referred only to the reduction of 
harm among people that continued to use. Thus, within this definition, interventions 
could only be called harm reduction if they were aimed at people that wished to 
continue to take drugs, therefore excluding abstinence-oriented strategies. The broad 
definition of harm reduction, however, encompassed any program or policy that was 
theorised to reduce drug-related harm. Such a definition could include abstinence-
oriented approaches such as those seen in some drug treatment interventions (for 
example, Narcotics Anonymous). In 1995, Wodak and Saunders noted "...to some 
harm reduction means the employment of any means to reduce the harm resulting 
from illicit drugs"317 thus reflecting the way in which the term had been co-opted 
since the original meaning was coined in the early 1980s. Essentially, for some the 
broad definition was too inclusive, whereby any policy or program could claim to 
reduce drug related harm. In this vein then, '12 step' (for example: narcotics 
anonymous) programs could be classified as harm reduction programs. Wodak and 
Saunders suggested that the logical extension of these broad definitions could include 
drug-free states or the indefinite incarceration of drug users to prevent them doing 
harm to themselves or others. 318 
316 Lenton, S., & Single, E., 1998, 'The definition of harm reduction', Drug and Alcohol Review,17 . 
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The National Drug Strategic Framework 1998-99 to 2002-03 (released by Federal 
Liberal Government) was the third instalment of national strategies released by 
federal governments since the NCADA in 1985 (the two latter strategies were 
released by Federal Labor Governments). The document offered this justification of 
harm reduction: 
Governments do not condone illegal risk behaviours such 
as injecting drug use, but they do acknowledge that these 
behaviours occur. They have a responsibility to develop 
and implement public health and law enforcement 
measures designed to reduce the harm that such behaviours 
can cause, both to individuals and the community. In these 
circumstances harm reduction strategies specifically target 
the individual using drugs and promote initiatives that 
benefit the wider community. For example, drink driving 
was identified as a serious drug related harm and changes 
to legislation and law enforcement practices were 
introduced. These harm reduction strategies aimed to 
reduce harm associated with drink driving. Similarly, 
while the practice of injecting drug use continues, the 
provision of sterile injecting equipment through needle and 
syringe exchange programs is an important harm reduction 
strategy for preventing the spread of blood borne viruses 
such as HIV and hepatitis C. 319 
The quote reflects the politically sensitive nature of harm reduction programs, as the 
rationale for such approaches are often accompanied by a caveat suggesting that 
governments do not really wish to implement such programs but are compelled to do 
so in the interests of public health. The 1996 National HIV/AIDS strategy echoed 
the importance of harm minimisation as a broad approach and the utility of harm 
reduction strategies within this broader framework. This document, however, saw 
the term 'harm reduction' as including both approaches aimed at those who 
319 Minsterial Council on Drug Strategy, 1998, National Drug Strategic framework 1998-99 to 2002 — 
03, Canberra, Commonwealth of Australia, p16. 
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continued to use and also abstinence-oriented approaches. 32° The following quote 
was drawn from the 1998 NDS, written before the quote above: 
Governments do not support or encourage illegal risk 
behaviours such as injecting drug use, but they do 
acknowledge that these behaviours occur. They recognise 
their responsibility to develop and implement public health 
measures designed to minimise the harm that such 
behaviours can cause, both to individuals and to the 
community. Harm minimisation seeks to balance the cost 
to the community and to individuals of illegal behaviours 
...This approach acknowledges the fact that some 
individuals will continue to participate in illegal 
behaviours. 321 
Lenton and Single critiqued the narrow definition and suggested that it may have 
excluded some interventions such as abstinence-oriented detoxification programmes, 
court diversion and cautions for first offenders that clearly have the capacity to 
reduce drug related harm. They insisted that abstinence-oriented strategies can result 
in reduction of drug related harm and thus to omit these might exclude what could be 
an effective alternative. Moreover, sometimes a contained period of abstinence can 
be negotiated with a user who wishes to work towards a long term goal of self 
regulated use. Lastly they argue that this narrow definition did not reinforce 
communication between different sections of the drug treatment sector that is 
conceptually divided between abstinence and non abstinence-oriented services and 
similarly created divisions between supply reduction versus law reform. 322 The 
authors argue that this last point is the main reason that Australian and Canadian 
drug strategies have used the broader definition of harm reduction. It was also noted 
that the narrow definition is of little use when applied to tobacco smokers that 
320 Commonwealth of Australia, 1996, Partnerships in Practice: National HIV/AIDS Strategy 1996-7 
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usually aim for cessation. Moreover, some harm reduction measures involved 
affecting the amount or frequency of drug use, for example: trying half of one's 
supply first in order to test for quality so to avoid overdose or taking a break from 
use. Further, some research has described a situation whereby peers exert pressure 
on fellow users in order to stymie excessive or inappropriate drug use. 323 
In 1998, Single and Lenton defined three criteria that characterised harm reduction: 
A policy, programme or intervention should be called harm 
reduction if, and only if: (1) the primary goal is the 
reduction of drug related harm rather than drug use per se; 
(2) where abstinence-oriented strategies are included 
strategies are also included to reduce the harm for those 
who continue to use drugs; and (3) strategies are included 
which aim to demonstrate that, on the balance of 
probabilities, it is likely to result in a net reduction in drug 
related harm.324 
Successive national drug strategies from the NCADA in 1985 to the National Drug 
Strategic Framework 1998 -99 to 2002-03 used the broader definition of harm 
minimisation that included supply reduction and demand reduction and sometimes 
mentioned harm reduction (indicated by problem prevention and/or use of the phrase 
"without necessarily eliminating use"). Single and Lenton argued that the broader 
definition of harm minimisation as encompassing many different types of approaches 
adopted in all national drug strategies has provided common ground for all drug 
policy stakeholders to collaborate, and "...to a greater or lesser extent, to reduce drug 
related harm". 325 The broader definition reflected the interaction between health and 
323 Gamble, L., & George, M., 1997, 'Really useful knowledge': the boundaries, customs and folk 
laws governing recreational drug use in a sample of young people', in Erickson, P, Riley, D., Cheung, 
Y, O'Hare, P., (eds) Harm Reduction: a new direction for drug policies and programs, Toronto, 
University of Toronto Press, pp340-62. 
324 Lenton, S., & Single, E., 1998, The definition of harm reduction, Drug and Alcohol Review, 17, 
pp213-220. 
325 ibid, p215. 
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law enforcement sectors under the framework of successive national drug strategies. 
That supply reduction was classified as a strategy that reduced drug related harm was 
dubious for some commentators as the policy mix of supply reduction and harm 
reduction could be construed as counterproductive: 
It has been claimed that attempts to legislate and enforce 
abstinence are counterproductive, and that there are harms 
due to these measures that are far worse than the effects of 
the drugs themselves. 326 
Indeed, supply reduction has the capacity to create a new suite of drug related harms 
(for example, displacement of heroin users and vendors to other areas and rushed 
preparation and injection can lead to unsafe injecting techniques and associated 
harms such as BBV transmission and poor vein health) and in some cases exacerbate 
existing harms (for example, the fluctuating purity of opiates purchased on the illicit 
market can lead to overdoses). The measurement of the extent to which law 
enforcement activity actually manufactures drug related harms that harm reduction 
programs must then respond to is beyond the scope of this research, however it must 
be mentioned here that this dynamic in illicit drug policy has the capacity to be 
somewhat ironically counterproductive. 
Ultimately, the original meaning of harm reduction encompassed a set of ideas which 
challenged dominant approaches to illicit drug use, moreover many writers that 
advocated for harm reduction critiqued existing models of drug policy such as 
prohibition. Since the implementation of harm reduction programs however, such 
326 Erickson, P, 1992, 'Political pharmacology: Thinking about drugs', Daedalus, Summer, pp239 — 
267; Nadelmann, E., 'Progressive legalizers, progressive prohibitionists and the reduction of drug-
related harm', Psychoactive drugs and harm reduction: from faith to science, N, Heather, A, Wodak, 
E, Nadelmann & P, O'Hare (eds), London, Whurr; O'Hare, P., 1992, 'Preface: A note on the concept 
of harm reduction', in P., O'Hare, R., Newcombe, A., Matthews, E., Bunning & E., Drucker (eds), 
The reduction of drug related harm, New York, Routledge; Riley, D., & Oscapella, E., 1997, 
'Canada's new drug law: Some implications for HIV/AIDS prevention in Canada', International 
Journal of Drug Policy, 7:3, p180-182. 
154 
policies and programs have had to work within the dominant framework and as such 
confront underlying tensions between traditional abstinence-based and alternative 
approaches. A reluctance to be more inclusive of abstinence oriented programs, 
exemplified in the debate regarding the definition of harm reduction, may be a result 
of a fear held by harm reduction supporters that such a move might constitute a first 
step to co-option of their policies and programs. Indeed the underlying politics of 
harm reduction (which were more evident before the approach was enshrined in 
mainstream policy) were in direct opposition to traditional abstinence-oriented 
models. 
Explaining Policy Change through the Advocacy Coalition 
Framework 
In this period there were several changes to policy such as the instigation of HCV 
organisations and changes to police practice in relation to illicit drugs. Support for 
those harm reduction services implemented in the previous decade (NSPs, self-help 
drug user groups and expansion of MMT) remained fairly stable in their period yet 
attempts to implement further harm reduction such as prescription heroin and SICs 
were stymied. The stronger relationship and greater interaction between health and 
law enforcement agencies under the framework of NCADA and successive national 
drug strategies was evident in this period and resulted in policy change. Indeed, the 
main type of policy change between 1990 and 2000 was changes to law enforcement 
practice and also the types of questions that research into policing posed. Drawing 
on Table 1, this section will examine key points of the ACF and their utility in 
explaining policy change. 
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ACF Concept 1 & 2: Advocacy Coalitions & Policy Core Beliefs 
The notion of advocacy coalitions adequately describes the variety of policy actors 
united by their belief in the utility of harm reduction ideas. Such individuals and 
organisations supported phenomena as NSPs, safer injecting education, self-help 
drug user groups, expansion of MMT as well as SICs and prescription heroin. In the 
period 1990 to 2000, the harm reduction coalition consisted of individuals and 
groups from medical and research fields, workers in the alcohol and other drugs 
sector, grassroots community workers, some members of the Gay community, 
affected communities represented in self-help drug user groups, key members of the 
bureaucracy and representatives from law enforcement fields. The inclusion of law 
enforcement among the coalition advocating for harm reduction ideas in policy was a 
relatively new phenomenon. Although certain judges and experts with a law 
enforcement background had advocated in previous decades for incorporation of 
some harm reduction ideas to government policy (most notably in the Royal 
Commissions in the 1970s), in this decade there was systemic support for harm 
reduction policies and programs from law enforcement personnel. This occurred 
most notably in debates regarding SICs which will be expanded upon in the 
following chapter. In this period harm reduction ideas were increasingly integrated 
into policing policies and practices reflecting the extent of policy oriented learning. 
Research into the counterproductive effects of policing, specifically the capacity of 
law enforcement activities to manufacture drug related harm also reflected policy 
oriented learning and the increasing importance of the concept of drug related harm 
being used as a policy barometer. Thus in this period there was a noticeable 
expansion of the harm reduction coalition to include law enforcement personnel. 
This expansion of the support base for harm reduction may be attributed to the 
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increased interaction between health and law enforcement sectors since the 
instigation of the NCADA in 1985. Indeed, the extent of policy-oriented learning 
between sectors is discussed further in this chapter. 
That coalition actors' displayed consensus on such 'policy core' ideas, such as the 
reduction of drug-related harm as a primary policy goal in health services (rather 
than abstinence), was clear from policy documents surveyed in this chapter. Central 
to advocacy efforts throughout this decade was the public health utility of harm 
reduction programs, especially in regard to the prevention of the transmission of 
BBVs both within the drug using community, and between drug users and the 
mainstream populations. The link between harm reduction programs and their 
capacity to curb HIV/AIDS transmission, (established in the previous decade) 
continued and influenced the way that harm reduction policies and programs were 
justified. HCV presented a new threat to public health in this period and galvanised 
advocacy efforts. Indeed, critical support for harm reduction programs and policies 
were also drawn from such arenas as gay and public health communities (for 
example, public health departments in the bureaucracy). The considerable overlap 
between both HIV/AIDS and HCV prevention efforts and harm reduction programs 
for illicit drugs highlighted the importance of such approaches in terms of their 
potential impacts on public health. 
ACF Concept 3: Guidance Instruments 
The identification in 1988 of a second BBV, namely HCV, that may be spread 
among injecting drug users and into the general community presented the harm 
reduction coalition with further opportunities to affect policy in the 1990s. In the 
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late 1980s and early 1990s, coalition actors mobilised and instigated peak national 
groups and state organisations to respond to this public health issue. As noted 
earlier, the link between the HCV virus and injecting drug use was well recognised 
with the majority of new transmissions linked to the phenomenon of injecting drug 
use.327 Harm reduction approaches that focused on safer injecting techniques to 
encourage behaviour change among those that injected were deemed critical to 
limiting the spread of the virus. In contrast to HIV/AIDS in the previous decade, 
however, the disease characteristics of HCV (being a slow acting virus with less 
aggressive symptoms than HIV/AIDS - at least in the short to medium term - and 
transmitted exclusively through blood to blood contact, in contrast to HIV/AIDS 
whereby saliva and other bodily fluids contain the virus) meant that the virus 
presented less of a threat to the mainstream population as HIV/AIDS and 
consequently advocacy efforts were not as successful with HCV policy mirroring 
that of HIV/AIDS. 
The upsurge in problematic heroin use during the 1990s also presented the harm 
reduction coalition with opportunities to affect policy. Feasibility studies and 
community development regarding the implementation of a trial of prescription 
heroin were conducted in the early to mid 1990s. Moreover, SICs were also offered 
as possible responses to address the visibility of problematic heroin use. Ultimately 
when the issue of problematic heroin use was raised in the 1990s, the harm reduction 
coalition were prepared to present possible solutions having conducted the necessary 
community development and research. Both prescription heroin and SICs are the 
subject of the following chapter and as such are not discussed at length here. 
327 Crofts N., Jolley D., Kaldor J., 1997, 'Epidemiology of hepatitis C virus infection among injecting 
drug users in Australia', Journal o f Epidemiology and Community Health, 51, pp692-697. 
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While both the identification of HCV as a virus transmissible through the sharing of 
injection equipment and the increase in drug related harm from heroin use occurred 
in this period, the election of the Federal Howard Government in 1996 had a major 
limiting effect on the advocacy efforts of the harm reduction coalition. Coalition 
efforts to implement a trial of prescription heroin and SICs were largely unsuccessful 
due to direct intervention from the Federal Liberal Government. The prescription 
heroin trial was abandoned in 1997 following an intervention and accompanying 
decree from Prime Minister Howard that such an approach would not be 
implemented. While one SIC was implemented in this period, it was an isolated 
victory for the harm reduction coalition. 
ACF Concept 7 & 8: Policy oriented learning and policy change 
A key part of the theorising on policy change in the ACF revolved around the notion 
of cross-coalition learning. The authors of the ACF contended that policy change 
might be the result of policy oriented learning within and between coalitions. The 
assumptions in the ACF regarding the cross pollination of ideas in professional 
environments includes hypotheses on the way in which information is disseminated 
and moderated and the nature of the forums. Sabatier developed two hypotheses 
about cross coalition learning and one schema that outlined the qualities of 
"successful forums". 
ACF Hypothesis: policy oriented learning across belief 
systems is most likely when there is an intermediate level 
of informed conflict between the two coalitions. This 
requires that: 
a) each has the technical resources to engage in such a 
debate. 
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Sabatier's hypotheses regarding cross-coalition learning and consequent policy 
change holds in this analysis of Australian drug policy developments during 1990- 
2000. Both the health and law enforcement sectors were funded through successive 
national drug strategies and had to interact with each other when debating drug 
policy as part of the national framework. Sabatier's hypothesis regarding the 
conduct and nature of such professional norms is as follows: 
ACF Hypothesis: policy oriented learning across belief systems 
is most likely when there is a forum which is: 
a) prestigious enough to force professionals from different 
coalitions to participate; and 
b) dominated by professional norms 328 
This hypothesis is also supported in this analysis with these forums (discussed 
below) conducted at a national level and constituting the apex of decision making in 
Australian drug policy. Such forums are necessarily dominated by professional 
norms. Personnel drawn from the elite level of both health and law enforcement 
sectors regularly engaged in high level committees and meetings in such forums as: 
• the Ministerial Council on Drugs (MCDS), the peak policy and decision- 
making body in relation to licit and illicit drugs in Australia. The council 
membership included representatives of Australian and state and territory 
Ministers from health and law enforcement, including the Minister 
responsible for Education. The role of the council was to determine national 
policies and programs within the Australian community. The MCDS met 
biannually since inception. 329 
328 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe, 
Journal of European Public Policy, 5:1, p106. 
329 For details about the membership of the MCDS, see the Australian Government National Drug 
Strategy website: http://www.nationaldrugstrategy.gov.au/councils/mcds.htm,  accessed 15/3/05. 
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• the Intergovernmental Committee on Drugs 33° (IGCD) (and its predecessor, 
the National Drug Strategy Committee) which provided policy advice to 
Ministers on the full range of drug-related matters and was responsible for 
implementing the National Drug Strategic Framework. This Committee 
membership was comprised of senior officers representing health and law 
enforcement in each Australian jurisdiction as well as people with expertise 
in identified priority areas, including representatives of the Australian 
Customs Service, the Ministerial Council on Aboriginal and Torres Strait 
Islander Affairs and the Department of Education, Science and Training. 331 
• the Australian National Council on Drugs (ANCD), which was established 
in March 1998 as a vehicle to exact the voice of the non-government sector 
into drug policy. The ANCD represented a cross-section of interests and 
expertise ranging through academia, medicine, education, law enforcement, 
treatment services, families who have suffered loss, those who have been 
affected by drugs, the Indigenous community and government. This forum 
met quarterly since its 1998 inception. 
Professional forums such as these were conducted regularly throughout the period of 
analysis and were pivotal in the development of illicit drug policy. 
A key factor articulated in the ACF related to the process of policy change is the 
nature of the professional forums that facilitate exchanges of ideas, and consequently 
learning, between coalitions. In order to be defined as a successful forum under the 
330 For details about the membership of the Intergovernmental Committee on Drugs, see the 
Australian Government National Drug Strategy website. This lists the current membership of the 
committee, it is clear that it is equally shared between both health and law enforcement sectors with 
relevant members from other jurisdictions such as education, aboriginal affairs and state 
representatives. http://www.nationaldrugstrategy.gov.au/councils/iged members.htm, accessed 
15/3/05. 
331 For details about the membership of the Australian National Council on Drugs, see the Australian 
Government National Drug Strategy website 
htto://www.nationaldrugstrategy.gov.au/councils/igcd.htm, accessed 15/3/05. 
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ACF, consensus must be reached among previously disagreeing members, and 
secondly the decisions of the forum must have been accepted by the major coalitions 
involved. 332 Further characteristics of successful forms are described in the ACF as 
such: 
1) Composition: forums must be composed of officials associated with each of 
the coalitions and chaired by a neutral official. 
2) Funding: Funding must come from a source not dominated by a specific 
coalition. 
3) Duration: the forum should meet at least half a dozen times "over a year or 
so". 
4) Context of a mutually unacceptable policy stalemate: a successful forum is 
one in which coalitions view a continuation of the status quo are 
unacceptable. Meaningful compromise is only attained when coalitions are 
willing to alter their perceptions in aspects, such as the seriousness of various 
causes of the problem. 
When related to the above groups, Sabatier's schema on 'successful' forums holds in 
this analysis, and these are considered in turn below: 
1) Composition: all of the committees described above had shared membership 
from heath and law enforcement sectors, and while the chair was not always a 
neutral player, this role was often shared between both sectors on a rotational 
basis. 
332 Sabatier, P., et. al. 1993, The Advocacy Coalition Framework, Policy Change and Learning, 
Westview Press, San Francisco, p148. 
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2) Funding: committees were funded from Government sources under the NDS 
and thus not dominated by either health or law enforcement. 
3) Duration: some forums met more, or less, regularly than the frequency 
described in the ACF, however due to the complex web of committees and 
official groups it is clear that both sectors have countless opportunities (in 
many types of committees and groups) to meet in this period. 
4) Context of a mutually unacceptable stalemate: both health and law 
enforcement sectors, and Government more generally, were clearly frustrated 
with the status quo of drug policy during the period of analysis and had been 
so since the late 1970s. Reform efforts conducted prior to 1990 were not 
considered to have produced satisfactory results and the issue of the 'drug 
problem' as a challenge for policy had been recurrent since the late 1970s. 
Another minor change involved research into the counterproductive effects of law 
enforcement on drug related harm. Where previously the role of law enforcement 
went largely unchallenged, research in this area in Australia started to be conducted 
in the 1990s with the results articulated by law enforcement bodies. Such changes 
signified that, to an extent, the aim of drug policy had started to change from 
protection of morality to protection of the public health. Another minor change 
within the law enforcement sector were cannabis cautioning policies and diversion 
schemes as a way of reducing legal harms to those that consumed illicit drugs. 
However, at the same time, penalties remained significant for those who 
manufactured and/or sold illicit drugs. 
These changes to law enforcement in this period are classified as 'minor changes' in 
the drug policy subsystem but classified under the ACF as 'major' in the law 
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enforcement subsystem. These minor changes can, at least, be partly attributed to the 
policy oriented learning which had taken place as a result of the increased interaction 
between the health and law enforcement sectors during the period of analysis, that 
was in turn, generated by the broad framework of the NDS. 
Coalition strategising 
The advent of HCV presented simultaneous opportunities and challenges for those 
that advocated for harm reduction programs and policies. The virus had the potential 
to cause both significant physical harm in some individuals and substantial economic 
cost to the public health budget in the long term. Harm reduction approaches were 
widely endorsed as a sound public intervention to the spread of HCV with 
organisation around the issue mimicking that of HIV/AIDS. Indeed, similar to the 
public health threat of HIV/AIDS half a decade before, the advent of HCV further 
strengthened the utility of harm reduction policies and programs as sound 
interventions to engender the containment of BBV transmission. 
Australia's response to the management of HCV, described earlier, highlighted 
contemporary challenges to harm reduction policy and practice. First, and in contrast 
to HIV/AIDS, policy responses to contain HCV were impeded by drug laws and law 
enforcement activity that inhibited behaviour change of injecting drug users. For 
example and as described earlier, increased surveillance and policing of an area 
deemed to be a drug using totspoe can result in increased drug related harm as 
injecting drug users attempt to inject quickly to avoid scrutiny, potentially leading to 
careless injecting practices and consequently HCV transmission. Indeed, harm 
reduction strategies that encourage behaviour change of injecting drug users (such as 
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safer using education that suggest the optimal way to inject so to avoid BBV 
transmission) will always be contingent upon such contextual factors such as drug 
laws and policing. In the case of HIV/AIDS, legislation in regard to homosexual sex 
was repealed in most states and territories in the 1980s, thus beginning the process of 
removing the stigma attached to such activity which enabled safe sex education. In 
contrast, laws prohibiting possession and self administration of drugs remained in 
states and territories around Australia to varying degrees in this period. In sum, the 
illegality of injecting drug use continued to limit the potential of the public health 
benefits from harm reduction approaches in reducing the transmission of BBVs, and 
drug related harm more generally. 
The second challenge to harm reduction advocates was the differing disease 
characteristics of HCV in comparison to HIV/AIDS. That the virus would largely be 
contained within the injecting drug user community (a largely diverse and 
marginalised group) and thus not present the same threat to the mainstream 
population as did HIV/AIDS meant that acceptance and support of the issue was 
difficult to broker in the political marketplace. Organisation in response to the virus 
mimicked that in response to HIV/AIDS however, given the particular characteristics 
of HCV, the annual rate of new transmissions far outnumbered that of HIV/AIDS. 
Hepatitis C is the most commonly diagnosed notifiable 
communicable infection in Australia. There have been 
more than 165 000 notifications of hepatitis C infection 
since 1990, when antibody testing became available in 
Australia. The number of notifications remained very 
stable, at 18 000-20 000 a year, between 1994 and 2000. It 
is estimated that there were approximately 210 000 people 
living with hepatitis C infection in Australia in 2001 and 
that around 16 000 new infections are occurring each year. 
The total number of notified cases represents 
approximately 60 per cent of the estimated number of 
people living with the virus. This is probably one of the 
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highest rates of diagnosis in the world. The actual rate of 
undiagnosed people may be lower, depending on the extent 
of multiple notifications. 333 
Curbing transmission rates of HCV continues to be a challenge to advocates of harm 
reduction policies and programs. The problem of how to garner support for 
programs to curb transmission rates of HCV among injecting drug users from a 
polity hostile and dismissive to the health problems of such populations remains one 
of the most salient public health issues in relation to injecting drug use in Australia 
today. As such, self-help drug user groups remain critical to these efforts as well as 
the long term goal of changing drug laws. 
Conclusion 
In this period harm reduction ideas, policies and programs were supported by key 
national policies, however toward the end of the decade it was clear that the coalition 
had experienced an 'identity crisis'. This identity crisis was in regard to the lack of a 
consensus regarding the correct definition of harm reduction, specifically questioning 
whether abstinence-oriented approaches could be classified as harm reduction 
approaches. Concurrently in this period, law enforcement had amended its approach 
toward some drug users with penalties being reduced or substituted with compulsory 
treatment programs (albeit some treatment programs being very short in duration). 
Finally an examination of the issue of HCV showed how supply reduction and harm 
reduction approaches coexist in an essentially counterproductive relationship as the 
former essentially generates a degree of drug related harm that the latter are then 
charged with the responsibility of ameliorating. 
333 Australian National Council on AIDS, Hepatitis and Related Diseases, 2003, National Hepatitis C 
Testing Policy, p3-4. 
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Another important factor in the period 1990 to 2000 was the extent of policy oriented 
learning conducted as a result of successive NDS'. As described above, research into 
the counterproductive effects of policing and resulting changes to operational 
practices of law enforcement resulted in greater awareness of the way in which law 
enforcement is a contributor of drug related harm. Thus, to an extent the harm 
reduction project has benefited from the federal arrangements generated by NDS' 
through the propagation of harm reduction ideas in other arenas such as law 
enforcement. 
The following chapter examines the attempts to implement a trial of prescription 
heroin in the ACT and several SICs in metropolitan areas in Australia in the mid to 
late 1990s. In contrast to the previous two chapters, chapter five centres on the 
arguments, both supporting and opposing, such initiatives. Indeed, the essence of 
such arguments for harm reduction programs is explored and evaluated. Both 
prescription heroin and SICs are highly controversial policy options implemented 
sporadically in the European context, in comparison to NSPs and MMT which have 
been more widely accepted and implemented in many more contexts around the 
world. 
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Chapter 5: Moral entrepreneurs and the undeserving: advocating 
prescription heroin and supervised injecting rooms in Australia in 
the 1990s 
Introduction 
For many people, the implementation of harm reduction initiatives such as 
supervised injecting centres (SICs) and prescription heroin signifies that the values of 
society have taken a step towards increasing permissiveness in relation to illicit 
drugs. That argument follows that an implicit 'message' is sent to the polity that 
illicit drug use is now condoned and by extension, encouraged, and, that this leads to 
an increase in the prevalence of injecting drug use. To date, this position is regarded 
as common sense by those who espouse it regardless of the fact that there is little to 
no evidence to support the link between such facilities or programs to an increase in 
intravenous drug use. For other sections of the community, such facilities and 
programs represent a pragmatic response to a public health and order problem. The 
capacity to ameliorate such drug related harms as BBV transmission (especially 
HCV), rates of overdose and moreover, to reduce the visibility and problems 
associated with public injecting of heroin are seen as necessary trade offs. 
Chapters three and four of this manuscript examined advocacy of harm reduction 
policy in response to drug use over a 20 year period, commenting on the emergence 
of a coalition in the 1980s and the stagnation of harm reduction policy in the 1990s. 
This chapter focuses on a particular issue within that 20 years: namely the dramatic 
rise in problems associated with heroin use in the mid-to-late 1990s in Australia. 
This rise in problems meant an opportunity for stakeholders to suggest policy 
responses. Two potential policy panaceas advocated by the harm reduction coalition 
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were prescription heroin and SICs. This chapter examines the advocacy efforts of 
the harm reduction and moral-abstinence coalition regarding these proposed 
initiatives. 
Two groups of actors were identified around this issue, the 'harm reduction' and the 
'moral abstinence' coalition. Both groups were unified by their distinct approaches 
to the policy problem presented by increased problematic heroin use. These two 
groups and their associated ideologies have consistently been at the forefront of illicit 
drug policy debates since the early 1980s. Both groups used distinct strategies to 
influence policy: the harm reduction coalition largely employed an evidence based, 
scientific approach to support their policy positions whereas the moral abstinence 
coalition appealed to 'moral truths' while also drawing legitimacy for their position 
from general socio-cultural values whereby heroin is external to the boundaries of 
societal mores, often demonised and the practice of intravenous drug use is seen as 
'evil'. 
Government policy papers (for example: the Commonwealth National Heroin 
Strategy), Parliamentary Committee reports (such as Joint Select Committee into 
Safe Injecting Rooms), proceedings from Hansard and key meetings (such as the 
NSW Drug Summit), key actors' commentary from proceedings, websites from 
advocacy groups, National surveys, newspaper reports, reports from law enforcement 
and health institutes and journal articles were used. Largely the harm reduction 
coalition was unsuccessful in attempts to affect policy change regarding these 
particular initiatives. Only one trial of a SIC was approved in NSW while both a trial 
of prescription heroin in the ACT and the attempt to implement several SICs in 
Victoria were unsuccessful. 
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Finally, the chapter will reveal that the moral abstinence coalition did not have a 
monopoly on 'moral' arguments'. The discussions regarding SICs in NSW showed 
that harm reduction coalition members attempted to use moral arguments to both 
support their advocacy efforts and also to distance themselves from the usual 
comments applied to harm reduction programs, namely that such approaches 
normalise, condone and encourage illicit drug use. 
The Heroin 'Problem' 
During the 1990s heroin use and associated problems escalated in large metropolitan 
cities in Australia. Problematic heroin use increasingly became visible in this period. 
In NSW the price of heroin reached a historic low, with purity around 60% and 
heroin being the most commonly used drug among regular injecting drug users. 334 In 
the late 1990s there were increased numbers of: people that commenced treatment 
for heroin dependence; HCV infections; arrests related to heroin and heroin related 
overdoses. 335 Indeed, all these variables had steadily escalated in the first half of the 
decade. 
During the 1990s deaths from heroin use had nearly quadrupled in a decade... 
Over the last decade there has been a steady increase in the 
number of heroin related deaths. The Australian Illicit Drug 
Report (AIDR) 1999-00 indicates that in 1991, there were 
approximately 250 overdose deaths in Australia. In 1997, 
there were 600 overdose deaths in Australia... In 1998, 737 
people died in Australia as a result of heroin related 
overdose.. .While in 1999, there were a total of 958 deaths 
334 Degenhardt, L., Conroy, E., Gilmour, S., & Hall, W., 2005, 'The effect of a reduction in heroin 
supply on fatal and non-fatal drug overdoses in New South Wales', Australia, MJA 182:1, pp20-23. 
"5 ibid. 
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attributable to opioid overdose among those aged 15 to 44 
years. 336 
Law enforcement studies also reiterated the increased supply and availability of 
heroin in Australia in the late1990s. 
The increasing availability of heroin at street level is of 
growing concern to law enforcement and health agencies in 
Australia. The increase is evident in all States and 
Territories but New South Wales continues to experience 
the highest level of availability and of trafficking in bulk 
high-grade heroin, from Sydney to other centres and 
jurisdictions. 337 
Data taken from the 2004 National Drug Strategy Household survey also indicated an 
increase in recent (within last 12 months) heroin use around 1998. 
Table 2: Recent use of heroin: proportion of the population aged 14 years and 
over338 
Males Females 
1995 1998 2001 2004 1995 1998 2001 2004 
0.5 1.0 0.3 0.2 0.2 0.5 0.2 0.1 
Source: 2004 National Drug Strategy Household Survey 
Other problems with an increase in heroin use in the 1990s also were identified. It 
was estimated339 that between 12,000-21,000 non-fatal overdoses occurred in 
Australia annually in the late 1990s. Such non-fatal opioid overdose can result in 
significant permanent morbidity such as brain damage. Furthermore, up to 60% of 
336 Commonwealth of Australia, 2001, National Heroin Overdose Strategy, Commonwealth 
Department of Health and Aged Care, p4. 
337 Australian Bureau of Criminal Intelligence, 1999, Australian Illicit Drug Report 1998-1999, 
accessed online at: 
http://www.crimecommission.gov.au/content/publications/aidr 2000/03 Heroin.pdf on 10/7/05. 
338 Commonwealth of Australia, 2001, National Heroin Overdose Strategy, Commonwealth 
Department of Health and Aged Care, p4. 
339 Warner-Smith M., Lynskey M., Darke S., Hall W., 2000, Heroin overdose: prevalence, 
correlates, 
consequences and interventions Monograph No. 46, National Drug and Alcohol Research 
Centre, University of New South Wales. 
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heroin users reported having experienced at least one overdose while up to 70% had 
witnessed an overdose.34° Health care costs associated with heroin related overdose 
also impacted upon health budgets 341 (for example spending on ambulance 
attendances), the public health system, upon family and friends and broader 
community were further compelling reasons toward gaining changes in policy. 
There was also evidence that prohibition responses to escalating heroin use further 
exacerbated drug related harms. Changes in the concealment methods applied by 
heroin providers due to increased vigilance by police further exacerbated the harms 
associated with heroin use. 
Oral and nasal storage and transfer of heroin between 
dealers and users has become commonplace. At the time of 
purchase, the dealer simply spits the cap, which is 
contained within a small balloon, into their hand and passes 
it to the customer in exchange for cash. Such transfers 
happen so quickly that they are very difficult to detect. In 
some circumstances the cap may be passed directly from 
mouth to mouth. As police have become more alert to these 
concealment and transfer methods dealers have begun 
storing caps in their noses before passing them to users, 
who may then place the caps in their own nose or mouth. 
As well as risking disease, people involved in transactions 
of this kind are at greater risk of overdose because they 
may swallow the heroin in order to avoid detection. 342 
This was a further example of the way in which prohibition policies had created 
further drug related harm for consumers of drugs. As the quote suggested, oral and 
340 Gossop M., Griffiths P., Powis B., Williamson S., Strang J., 1996 'Frequency of non-fatal 
heroin overdose: survey of heroin users in non clinical settings', British Medical Journal, pp 313:402; 
Darke S., Ross J., Zador D., Sunjic S., 2000 'Heroin-related deaths in New South Wales, Australia 
1992-1996', Drug and Alcohol Dependence 60, pp141-150; McGregor C., Darke S., Ali R, Christie 
P., 1998 'Experience of non-fatal overdose among heroin users in Adelaide, Australia' Addiction 93:5, 
pp701 -711; Loxley W., & Davidson P., 1998, Forgetting to Breathe: opioid overdose and injecting 
drug users in Perth, National Centre for Research into the Prevention of Drug Abuse, Perth; Strang J., 
Powis B., Best D., Vingoe L., Griffiths P., Taylor C., Welch, M., Gossop M., 1999, 'Preventing opiate 
overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability' 
Addiction 94:2, pp199-204. 
341 Zook C., and Moore F., 1980 'High-cost users of medical care The New England Journal of 
Medicine' 302: pp996-1002. 
342 Australian Bureau of Criminal Intelligence, 1999, Australian Illicit Drug Report 1998-1999, 
accessed online at: 
http://www.crimecommission.gov.au/content/publications/aidr 2000/03 Heroin.pdf  on 10/7/05. 
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nasal storage was preferred by some so to avoid random searches by street level 
police. This, however, had meant that there was an increased degree of risk of 
overdose if the carrier felt they had to swallow the drugs to avoid detection. Further 
risks in this scenario included bacteria from the mouth contaminating the drug 
mixture and subsequently leading to infections when administered intravenously. 
Research conducted on the consequences of concentrated police activity targeting 
heroin use and dealing in public places had unintended negative effects. 
The University of New South Wales recently completed a 
detailed three-year study of the impact of street-level law 
enforcement of heroin use and distribution. It was 
concluded that crackdowns by uniformed police resulted in 
counter-productive effects, among them public health risks, 
threats to community safety (as a result of geographical, 
social and substance displacement) and harm to the 
relationship between the police and the community—in 
turn resulting in lowered police efficiency. Increasing 
attention by law enforcement authorities has forced users to 
leave public business areas and go to private and semi-
private areas such as cars and abandoned houses. This 
dispersal of users and locations over a wider geographical 
area is spreading the problem further into the community. 
More members of the public are being exposed to discarded 
syringes, while emergency services are having greater 
difficulty getting to and dealing with overdose situations in 
isolated areas. Heroin is now available in neighbourhoods 
where it was previously hard to obtain and drug-related 
property offences have increased in those 
neighbourhoods. 343 
The quote also describes to the 'public nuisance' aspects of the problem. Syringe 
litter, crime, increased availability of heroin and rates of overdoses all created visible 
reminders of the 'problem' of heroin use. Other research has found an increased 
unwillingness of consumers to carry sterile injecting equipment due to a fear of 
detection meaning that drug consumers are less likely to have access to sterile 
343 ibid. 
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equipment and more likely to engage in high risk practices such as picking up used 
needles from the street. 344 
Such increases in rates of overdose and public nuisance issues prompted increased 
attention in the media345 in the late 1990s. These reports in the media were mainly 
focused on the extent of the increase in overdose and public nuisance problems 
associated with heroin injection. Also in the media was a discussion regarding 
suggested solutions to this issue such as the instigation of SICs and/or dedicating 
more street level police. Headlines included: 'Heroin Toll soars to record level', 
'Injecting room — saving lives or foolish compassion', 'Injecting room appeals to 
users', 'Moralising while the body count rises' among many others. 
By the mid to late 1990s problematic heroin use had become a visible issue for all 
illicit drug policy stakeholders due to the escalation of rates of overdose and 
associated public nuisance problems. Kingdon 346 argued that many changes in 
public policy result from 'policy windows' that open sporadically. These 'windows' 
are the result of the convergence of problems, policies and politics347 and rarely stay 
open for long and present opportunities for policy actors to act on policy initiatives. 
The increase in problems around heroin use in Australia in the mid 1990s created a 
window of opportunity for policy actors in the harm reduction coalition to propose 
solutions. Two such solutions were the instigation of prescription heroin and 
344 . Dixon, D. 1999, Law Enforcement, Harm Minimisation and Risk Management in a Street-level 
Market, University of New South Wales, Sydney. 
345 National Drug and Alcohol Research Centre, 1999, 'Heroin Overdoses Up Over 20%: New Figures 
Released Today', Media Release, Sydney; 'Moralising while the body count rises', The Sunday Age, 
7/3/99; 'Push for civil disobedience campaign', The Age, 29/5/99; 'Injecting rooms appeal to users', 
The Age, 14/12/98; 'Opening injecting room the right thing to do' The Sydney Morning Herald, 
10/5/99; 'Injecting room: saving lives or foolish compassion?', The Sydney Morning Herald, 7/5/99; 
'Why more police won't stop heroin dealers', The Sydney Morning Herald, 10/3/99; 'Heroin hot-spots 
pray for church as lifesaver', The Australian, 19/7/99; 'Heroin toll soars to record level', The Age, 
15/12/98; 'Shooting galleries the politics of heroin', The Sydney Morning Herald, 5/6/99. 
346 Kingdon, J., 1984, Agendas, Alternatives and Public Policies, Little, Brown and Company, Boston. 
347 "The separate streams of problems, policies and politics come together at certain critical times. 
Solutions become joined to problems, and both of them are joined to favourable political forces". 
ibid, p21. 
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supervised injecting rooms. What follows is a description of the way in which the 
harm reduction coalition advocated for these proposals. 
Prescription Heroin 
Prescription of drugs to dependent people is a key type of harm reduction strategy as 
such approaches place an emphasis on the reduction of drug related harms such as 
BBVs, crime and other consequences of drug use. Heroin on prescription is a similar 
approach to MMT that is currently available on a controlled basis to eligible opiate 
dependent people. MMT seeks to ameliorate the consequences of being addicted to 
'street' opiates and allow the consumer to get on with a 'normal' life away from 
criminal networks while reducing doses of opiates in a controlled environment. 
Obtaining funds, often through criminal or other means, in order to ward of the 
physical discomfort of withdrawal often becomes time consuming. Moreover, 
engaging in criminal networks to procure the drug is also another unavoidable side 
effect of being dependent on illicit opiates. Thus, much the same as MMT, the 
function of prescription heroin is to stabilise the lives of people dependent on drugs 
through the medically controlled provision of opiates. 
Not all entrenched heroin users respond to MMT, thus the purpose of a scientific trial 
was to examine further treatment options for this group, such as prescription heroin. 
Getting this group off street heroin and on treatment could benefit not only the drug 
users but also their families and the mainstream population though reductions in 
crime and health care costs. The prescription of heroin is seen as another treatment 
option for chronic heroin dependent people who have repeatedly failed in other 
available treatments such as MMT. Indeed, some research from Switzerland has 
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shown that prescription heroin treatment retained drug users in treatment as well as 
affecting reductions in crime and improvements in health. 348 
Britain began using prescription heroin as treatment in the 1920s. 349 This initiative 
was born from recommendations of the Rolleston Committee that consisted of a 
group of physicians experienced in the treatment of people dependent on drugs. The 
committee reported in 1924: 
When ... every effort possible in the circumstances has been 
made, and made unsuccessfully, to bring the patient to a 
condition in which he is independent of the drug, it may ... 
become justifiable in certain cases to order regularly the 
minimum dose which has been found necessary, either in 
order to avoid serious withdrawal symptoms, or to keep the 
patient in a condition in which he can lead a useful life. 350 
In 1912 'maintenance clinics' began to open in the United States, yet by 1921 these 
clinics were closed. To date, Britain is the only country to use prescription heroin for 
many years. Since 1965, however the number of prescribing doctors in the UK, and 
subsequently the number of opiate addicted people treated with heroin, had 
diminished due to limitations imposed by Government. 
In the 1980s and 1990s the idea of using prescription heroin as treatment was 
debated in several countries such as Australia, Switzerland, Germany, the 
348 Uchtenhagen A. Summary of the synthesis report. In: Uchtenhagen A, Gutzwiller F, Dobler-
Mikola A, editors, 1997, Programme for a medical prescription of narcotics: final report of the 
research representatives, Institute for Social and Preventive Medicine, University of Zurich, Zurich, 
quoted in Metrebian, N., Shanahan, W., Wells, B & Stimson, G., 1998, 'Feasibility of prescribing 
injectable heroin and methadone to opiate dependent drug users: associated health gains and harm 
reductions', MJA, 168, pp596-600. 
349 Canrwath, T., 2004, 'Heroin prescription for heroin addiction - an English view', Ada 
Neuropsychiatrica, 16:5, p275, from 'Prescription of Opiates and Controlled Stimulants' accessed on 
27/4/05, from http://www.aidslaw.ca/Maincontent/issues/druglaws/e-iduback/Paper3/prescription-
3.htm 
350 . . 
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Netherlands, Spain, and Canada. 351 In the Netherlands in 1983, experiments were 
conducted whereby the physician prescribed intravenous morphine and amphetamine 
to five patients. Following positive results published in the Dutch Monthly Journal 
of Mental Health352 the physician negotiated with local health facilities to extend the 
program. After much debate a morphine dispensation program for 37 patients was 
approved and ran for two years. 353 Around the same time the city council of 
Amsterdam announced plans for heroin prescription for 300 drug users, however this 
was rejected by the Dutch Government. 354 Swiss authorities conducted experimental 
trials of prescription heroin from 1994 to 1996 with evaluations indicating positive 
results. Follow-up consultations with patients showed that they were more likely to 
succeed in social integration into the community, stop illicit drug use, decrease 
cocaine use and decrease contact with drugs more generally. 355 Furthermore, the 
project attracted considerable popular support with 71 percent of all voters 
supporting it in a national referendum. Consequently the medical prescription of 
heroin remains an important treatment option in Switzerland. 356 
The debate surrounding prescription heroin in Australia began in 1989, with the 
medical research community spearheading the advocacy process. While the project 
attracted wide support within and external to the harm reduction community, the 
debate was polarised along familiar lines, with the ideas of harm reduction in 
opposition to those from moral-abstinence groups. 
351 The International Heroin Trials Debates: To Prescribe or not Prescribe: the State of Heroin 
Trials Around the World, Report from 10th International Conference on the reduction of drug related 
harm 21-25 March 1999, accessed from http://cfdp.ca/heroin.htm on 20/4/2005. 
352 van den Brink, W., Hendricks, V, van ree, J., 1999, 'Medical co-prescription of heroin to chronic, 
treatment resistant methadone patients in the Netherlands', Journal of Drug Issues, Summer, 
accessed: http://www.findarticles.com/p/articles/mi_qa3733/is_199907/ai_n8841987/pg_8  
3" ibid. 
354 ibid. 
355 The International Heroin Trials Debates: To Prescribe or not Prescribe: the State of Heroin Trials 
Around the World, Report from 10th International Conference on the reduction of drug related harm 
21-25 March 1999, accessed from http://cfdn.ca/heroin.htm 011 20/4/2005. 
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Advocating prescription heroin in Australia 
The idea of a prescription heroin trial was initiated in 1989 by members of the Select 
Committee on HIV, Illegal Drugs and Prostitution formed from the ACT Legislative 
Assembly. Members of this committee were derived from both political parties and 
resident groups (for example: groups such as the 'Resident Rally'). This committee 
approached key experts in the science/medical community who endorsed the idea 
and by 1991 had attracted a grant to investigate it. A four year feasibility study was 
enacted, resulting in proposals for a medical trial of prescription heroin. The 
proposed medical trial was to involve two pilot studies and a full-scale clinical 
trial. 357 The trial attracted overwhelming support from research/medical interests 
involved in drug treatment358 and was to take place in the ACT. Box 1 — 'A Brief 
history of the prescription heroin feasibility study' describes the process undertaken 
by Gabrielle Bammer (chief researcher) and her team to initiate a heroin trial in the 
ACT. 
357 Bammer, G & Douglas, R., 1996, The ACT heroin trial proposal: an overview, MJA, 164, pp690- 
692. 
358 ibid. 
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Box 1: A brief history of the prescription heroin feasibility study 
A BRIEF HISTORY OF THE FEASIBILITY STUDY - Gabriele Bammer, The National 
Centre for Epidemiology and Population Health, The Australian National 
University, Canberra. 
In 1989, the newly formed ACT Legislative Assembly established a Select Committee on HIV, 
Illegal Drugs and Prostitution. It had representatives from both major political parties and was 
presided over by Mr Michael Moore, then a member of the Residents' Rally, a minor party, and 
later an independent member. ...In March 1991, the Presiding Member approached the Director of 
the National Centre for Epidemiology and Population Health (NCEPH), Professor Bob Douglas, to 
discuss the possibility of a trial of controlled heroin availability. In April a group of Australian 
experts in drug treatment and drug policy assembled at NCEPH, endorsed the need for a study into 
the feasibility of controlled heroin availability and suggested a four-stage process. Each stage was 
to be self-contained, ending with a decision about whether or not to proceed further. The first stage 
was to consider the issue of feasibility in principle, the second to consider logistic feasibility, the 
third to pilot procedures and the fourth to be the trial itself. 
In April 1992, the then Minister for Health, Mr Wayne Berry, took the issue of the feasibility study 
to the Ministerial Council on Drug Strategy (MCDS)... In subsequent years progress reports about 
the study were noted and in 1994 a subcommittee of the National Drug Strategy Committee 
(NDSC) was established to consider the stage 2 report when it was released. NDSC is a similarly 
representative committee of senior officers (public servants and police), which supports MCDS. 
NCEPH and [Australian Institute of Crime] decided to proceed with the stage 2 feasibility research 
after strong support at a one-day national seminar 'Heroin Treatment -New Alternatives' in 
November 1991. The decision was made possible by a peer reviewed competitive grant of 
$A445000 over 5 years.... A further $A115000 was raised through other competitive peer-
reviewed grants to fund a number of specific sub-projects. 
...The process was guided by a 19-member Advisory Committee which met three times in 1992 
and annually thereafter. The Committee had Australia-wide representation from academics, 
advocates for illicit drug users, judiciary, police, policy makers and treatment service providers. In 
order to ensure that a balance of views was represented on the Advisory Committee, it was agreed 
at the outset that the Committee would not be asked to formulate or endorse the final 
recommendations. 
As discussed in more detail below, there was emphasis on an open, consultative process.. .ACT 
community surveys were conducted in 1991 and 1994; Sydney and Queanbeyan residents were 
surveyed in 1991; and a national survey was conducted in 1995. There were also informal 
discussions with individuals and particular community interest groups.. .The police were surveyed 
in 1991, were involved in a workshop about drug markets in 1992 and in a workshop specifically 
on policing issues for a trial in 1994. There were regular discussions with the ACT Drug Squad and 
the Australian Bureau of Criminal Intelligence. There were also discussions with the Australian 
Federal Police Association (the police union) and individual ACT and interstate police.. .illicit drug 
users in and out of treatment were surveyed in 1991 and 1993. A reference group of people who 
are advocates for illicit drug user interests (without necessarily being users or ex-users themselves) 
was also consulted regularly and there were many informal discussions with individuals and 
advocacy groups, locally and interstate. There was also participation in public meetings organised 
by the ACT Intravenous Drug Users League (ACTIV) and the Dependency Care Foundation... 
There were a number of discussions with staff from the ACT Health Drug and Alcohol Service and 
staff from non-government organisations, particularly Assisting Drug Dependants Inc. and the 
Alcohol and Drug Foundation of the ACT. There were also discussions with the Australian 
Medical Association, the Australian Salaried Medical Officers Federation and individual doctors, 
pharmacists and other health professionals. 
Source: Bammer, G, 1996, 'When science meets politics: the Australian heroin trial feasibility study', 
The International Journal of Drug policy, 7:1. 
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As described in Box 1, many key groups were contacted and surveyed in order to 
gauge public acceptance of the trial. Further, representatives from the drug treatment 
and law enforcement sectors were briefed regularly through MCDS meetings. The 
research team also were subject to a steering group that comprised a mixture of 
stakeholders such as academics, advocates for illicit drug users, judiciary, police, 
policy makers and treatment service providers. Ultimately, while the process was 
driven by medical interests, the research team also engaged comprehensively with 
other sectors, groups and individuals throughout the process. See Box 1 for any 
further detail on the process. 
The architects of the trial posed a central question: 
If maintenance treatment for opioid dependence is 
expanded, so that both injectable diacetylmorphine (heroin) 
and oral methadone are available, is this more effective 
than current maintenance treatment with oral methadone 
alone?359 
Thus the rationale was to determine if there would be improved outcomes if 
prescription heroin was included in the armamentarium of treatment options. Such 
outcomes included the: 
• Ability to attract dependent heroin users into treatment; 
• Ability to prevent premature drop-out from treatment; 
• Ability to improve health and well-being of people with 
opiate dependencies, including reducing drug use and 
criminal behaviour and improving social functioning; 
• Analysis of cost-effectiveness of prescription heroin. 360 
The architects of the trial had also evaluated potential risks arising from a 
prescription heroin trial such as: displacement of more dependent heroin users to the 
359 ibid. 
360 ibid. 
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ACT; an increase in 'permissive' attitudes to illicit drug use; increase in road 
accidents related to heroin use; diversion of heroin to the black market; the site of the 
trial might act as a `honeypot', attracting those who use heroin to congregate at the 
site; increase in diacetylmorphine-affected babies and further institutionalisation and 
marginalisation of a trial-dependent heroin users. 361  Ultimately, the authors of the 
study concluded that the benefits (reduction in drug related crime, BBVs and general 
drug related harm) of testing prescription heroin as a new treatment option 
outweighed potential risks. 
The proposal for a trial of heroin on prescription attracted a great deal of media 
attention in 1996 and 1997. On April 9th 1996, the then Commonwealth Minister for 
Health, Michael Wooldridge (only a month after the Liberal Party assumed 
Government at the federal level) stated that he was unsure if a trial would proceed. 362 
As debate intensified, it was evident that the coalition supporting the trial consisted 
of a wide variety of individuals and organisations predominantly from health, 
medical and research and law enforcement interests. Religious organisations were 
split on the idea of a trial. Indeed the main opposition to the trial arose from 
individuals such as the Prime Minister John Howard and others who campaigned 
against it on moral grounds. The following quotes are taken from an article entitled 
'Heroin hell their own making: construction of heroin users in the Australian press 
1992-97 363 that analysed the perception of drug users within the press debate about 
the heroin trial. 
Child abuse, sexual assault and stealing also could, with 
some justification, be seen as sicknesses, but no one would 
361 ibid. 
362 Campbell, A., 2001, The Australian Illicit Drug Guide, Black Inc, Melbourne, p450 
363 Elliot, A., Chapman, S., 2000, 'Heroin hell their own making: construction of heroin users in the 
Australian press 1992-97', Drug and Alcohol Review, 19, pp191-201. 
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seriously suggest that society supply the ingredients to 
make these activities possible (Salvation Army leader). 364 
For some heroin addicts death is better than the degrading 
lives they lead, a Sydney religious leader said yesterday. — 
There are worse things than death when it comes to heroin 
addiction. Heroin users become very degraded by things 
they have to do to support their addiction. (Salvation Army 
leader). 365 
It is often claimed that heroin addiction is a victimless 
crime. Tell that to those whose lives have been ruined by 
the addicts — the parents, husbands and wives of the 
junkies, or the decent citizens who have had their homes 
ransacked and their possessions ripped off (columnist). 366 
Such comments were used to oppose the trial. Indeed, the identification of heroin as 
an agent of destruction on familial relationships meant that efforts to prescribe the 
drug were regarded as having the potential to cause further harm in the community. 
Supporters of the trial included a wide range of organisations and individuals. In 
terms of political parties both the Democrats 367 and the ALP 368 released statements 
that suggested they would consider proposals for a trial of heroin prescription. 
Federal Greens leader Bob Brown and several Liberal Members of Parliament 
(including Brendan Nelson and Jeff Kennett) also supported the trial. Public support, 
measured in three polls conducted between 1997 and 1999, concluded that around 
45-50% of those polled supported the trial. 
364 ibid, p195. 
365 ibid, p196. 
366 ibid, p198. 
367 Family and Friends for Drug Law Reform, Supporters of a heroin trial in Australia, accessed at 
www.ffdlr.org.au/factfile/WhoSupports  on 12/12/04. 
368 ibid. 
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Table 3: Public support of prescription heroin 
Supported Against Undecided 
Neilsen-McNair 
19/8/97 
(Australia-wide) 
45% 
Canberra 	Times 
17/10/97 
50% 40% 10% 
Herald 	AC- 
Neilson 
4/3/99 
45% 48% 
Source: Data accessed from Friends and Families of Drug Law Reform website: 
www. ffdlrorg.aulfactfile/WhoSupports. 
Justice James Wood, in the Royal Commission into the New South Wales Police 
Service published in 1997 also supported a 'cautious move' towards a heroin tria1. 369 
Other supporters included: the Australian Medical Association (AMA); Royal 
Australasian College of Physicians; Royal Australian College of General 
Practitioners; Society of Hospital Pharmacists; Australasian Faculty of Public Health 
Medicine; Law Council of Australia; Law Society of NSW; Directors of Public 
Prosecutions of NSW, South Australia and the ACT; all capital city mayors; 
Australian Lions Drug Awareness Foundation; Australian Federation of AIDS 
Organisations; Former Australian Federal Police Commissioner Mr Mick Palmer; 
NSW Commissioner for Police Peter Ryan; South Australia Police Commissioner 
Mal Hyde; Former Police Commissioner for Tasmania, Jack Johnston; Former 
Victoria Police Commissioner, Neil Comrie; Head of National Crime Authority, 
Gary Cooke; Former Bishop Richard Randerson; Anglican Diocese of Canberra and 
Goulburn; Victorian Uniting Church Community Services Director Colleen Pearce; 
Reverend Gregor Henderson; National General Secretary, Uniting Church; Salvation 
Army Southern Command; Family and Friends for drug law reform; The Damien 
369 Wood, J, 1997, Royal Commission into the New South Wales Police Service, The Government of 
the State of New South Wales, Volume 2, p228. 
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Trimingham Foundation; Australian Drug Foundation and DrugAid. 37° Indeed, in 
the coalition that supported prescription heroin were many individuals from health 
and law enforcement and religious organisations that grouped together to support the 
medical/research interests to examine new options for drug treatment. 
In publicly supporting a trial of prescription heroin, the 
National Crime Authority has joined along list of 
distinguished individuals and organisations from health 
professional and law enforcement backgrounds which have 
concluded that this research is a fundamental step before 
we can make sustained progress on illicit drugs. 371 
The MCDS issued a communiqué on 31 g of July 1997 announcing the start of a trial 
in the ACT: 
If a number of preconditions can be met, the ACT 
Government will undertake a small trial of controlled 
availability of heroin involving 40 people. 372 
Federal Cabinet, however, on 19 th of August 1997, put an end to the trial through an 
application of federal powers to override the ACT government's decision. Two 
reasons were stated as rationales to oppose the trial. Firstly, that legislation to allow 
the provision of heroin for the trial would need to be amended, and secondly, a moral 
imperative to block the trial as it 'sends the wrong message'. Prime Minister John 
Howard was particularly vocal on the latter issue: 
I have had parents of children who have died through drug 
overdoses plead with me, plead with me not to weaken the 
law, not to experiment with trials, not to do anything that 
could send an adverse signal... I am a human being, I am a 
370 Family and Friends for Drug Law Reform, Supporters of a heroin trial in Australia, accessed at 
www.ffdlr.org.au/factfile/WhoSupports on 12/12/04 
371 Wodak, A., 2,001, 'Overseas heroin trials point the way ahead', Sydney Morning Herald, 10/8.01. 
Also available at : http://www.forensics.edu.au/article.php?sid=41 
372 Quoted in Wodalc, A., 1997, 'Public health and politics: the demise of the ACT heroin trial', MJA, 
167, p348. 
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father, I am the Prime Minister and I am trying to bring the 
best judgment I Ca11. 373 
Despite much interest and determination by members involved in the planning stages 
of this process, the Minister of Health overturned the decision to go ahead and did 
not support the heroin trials. Even though Victoria's peak Drug Advisory group 
expressed support for the notion of a trial in the 'Pennington report' 374, the Victorian 
Government announced that it would not support a clinical trial of heroin in Victoria 
and instead injected around $2 million into a feasibility study of alternative drug 
therapies such as slow release oral morphine, buprenorphine and naltrexone. 375 
On the subject of morality and illicit drug policy, Nick Crofts, a prominent member 
of the harm reduction coalition, ruminated: 
The issue of morality often underlies the arguments 
[against harm reduction approaches]. Moral arguments 
have their place, but are meaningful only when based on 
accurate information. The morality that rejects a place for 
opiates in this society because they are dangerous, when the 
danger demonstrably comes more from their illegality than 
from the drugs themselves, is flawed. I have often pondered 
why it is heroin that we have demonised and suspect that 
such violent reactions must be extremely attractive to those 
waging the War on Drugs. The obverse of approaches 
considered to "condone" heroin use are those which make it 
as dangerous as possible. It is a strange morality which 
argues for so many deaths to prevent the use of a substance 
that is relatively harmless under controlled conditions - a 
morality that has given us enormous epidemics of HIV 
infection among children of heroin users in the United 
States and elsewhere. This is a morality which I suspect 
most people would not support without the intense social 
conditioning of the War on Drugs. 376 
"3 John Howard quoted in 'Heroin trials not on, says Howard', The Australian, 20/8/97. 
374 Premier's Drug Advisory Council report, 1996, Drugs and our Community: Report of the 
Premier's Drug Advisory Council (Pennington Report), Melbourne, pp93-4. 
"5 Campbell, A., 2001, The Australian Illicit Drug Guide, Black Inc, Melbourne, p450 
376 Crofts, N, 1996, 'The heroin trial we had to have', MJA, 164, p695. 
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The role of morality-based arguments in drug policy leads to an impasse between 
stakeholders as evidenced in the approval and then rejection of the prescription 
heroin trial. Prime Minister John Howard's personal conviction that such an 
initiative was 'the wrong thing to do' and decision to stop the trial contrasted with 
the rational-scientific approach of Bammer and her team. The competition between 
morality based and rational-scientific approaches is an ongoing characteristic of 
illicit drug policy since the inception of harm reduction approaches (and of course 
medical approaches more generally) and points to the importance of examining the 
intersection between established cultural and social values and policy making. 
Moreover, such values also mean that some harm reduction policies can be 
discredited or misrepresented automatically (for example: harm reduction policies as 
condoning or encouraging drug use) without any requirement of evidence. As 
described in the first chapter the foundations of most of these values towards illicit 
drugs are based on historically arbitrary decisions, and according to some, fallacies. 
Thus the way in which this knowledge has been created and reinforced is a key 
systemic factor that has affected the perception and consequently the political 
palatability of harm reduction policies. 
In parallel to the prescription heroin debate was the debate regarding supervised 
injecting centres. As noted earlier, both initiatives were advocated by the harm 
reduction coalition as responses to the problem of heroin use in Australia in the 
1990s. 
Supervised Injecting Centres 
As noted earlier, heroin use and associated problems had escalated in the 1990s in 
major capital cities. One of the proposed solutions advanced by a coalition of health 
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workers, law enforcement personnel, research bodies and other key stakeholders was 
the notion of instigating medically supervised injecting centres in appropriate 
metropolitan areas. SICs are premises designed to provide a safer environment away 
from public areas for the injection of illicit drugs. Such premises have also been 
referred to as 'drug consumption facilities', 'injecting rooms' or 'medically 
supervised injecting centres' (in New South Wales), 'supervised injecting place' 
(ACT) and 'off street injecting facilities' (Victoria). For clarity, the term supervised 
injecting centre (SIC) will be used to refer to those injecting rooms that have been 
sanctioned by Governments. It is acknowledged that there are illegal injecting rooms 
operating yet these differ from legally sanctioned rooms that provide not only sterile 
equipment but also qualified professionals who provide information and referrals to 
mainstream services. Below are two definitions of SICs: 
...legally sanctioned and supervised facilities designed to 
reduce the health and public order problems associated with 
illegal injection drug use.377 
...a legally sanctioned indoor facility where injecting drug 
use would occur under the supervision of appropriately 
trained personnel, who could provide access to medical 
equipment in the event of an overdose. 378 
SICs are premises, sanctioned by Government, in which people are able to inject 
illicit drugs under supervision from health professionals with the rationale that such 
facilities both reduce the problems associated with injecting (such as overdose and 
transmission of BBVs), and, public nuisance issues associated with injecting in 
public places (such as syringe litter and public order problems). Many European 
countries, such as Switzerland, the Netherlands and Germany, have had SICs since 
377  Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D & Trautmann, F., 2000, Drug 
consumption facilities in Europe and the establishment of supervised injecting centers in Australia, 
Drug and Alcohol Review, 19, p337. 
378 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales, p5. 
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the 1990s with some as early as the 1980s. In most cases, the facilities were located 
within primary care services where qualified staff provided a holistic approach to the 
issue of injecting drug use with mainstream health and welfare services accessible in 
the centres as well as NSPs. The first Swiss SIC opened in 1986 and by 2000, there 
were seventeen operating. 3 79  In most cases, these Swiss facilities contained cafes, 
counselling rooms, and primary care clinics with discrete injecting rooms within the 
centre. Moreover, such facilities were tolerated by Swiss community. 38° The 
Netherlands established their first SIC in the 1970s and by 2000 there were sixteen 
operating. 381 
In the Netherlands, SICs have been regarded as measures to reduce public nuisance 
and harms associated with injecting in public places. 382 Most Dutch SICs are run by 
regional drug services and incorporate harm reduction measures as well as 
abstinence-oriented treatment and are integrated within other services that offer 
medical care, counselling, food and wider health services. 383 The first SIC opened in 
Germany in 1994, and in 2000 there were thirteen in operation 384. Similar to other 
European countries, these SICs were seen as a measure to address and minimise 
injecting in public areas and centres were located within professionally staffed 
services. 385 In February 2000, laws were amended in Germany allowing for their 
legal operation. 386 Indeed, such research from the European experience suggested 
that SICs had the capacity to address those problems associated with heroin use in 
379 Centres were in Basel, Bern, Olten, Schaffenhausen, Wattil, Wil, Solothurn, St Gallen, Winterthur, 
Chur and Zurich. Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D & Trautmann, F., 2000, 
Drug consumption facilities in Europe and the establishment of supervised injecting centers in 
Australia, Drug and Alcohol Review, 19, p337. 
380 ibid, p339. 
381  Centres were in Amsterdam, Apeldoorn, Arnhem, Den Bosch, Eindhoven, Heerlen, Maastricht, 
Rotterdam and Veno. ibid, p 338. 
382 ibid, p339. 
383 ibid. 
384 Hamburg, Frankfurt, Hannover and Saarbrucken, ibid, p339. 
385 ibid, p340. 
386 ibid. 
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Australia, especially overdose rates and public nuisance problems as such facilities 
had addressed those problems in the European context. 
Groups in New South Wales (NSW) and Victoria initiated the idea of SICs in the late 
1990s. An inquiry into the relative costs and benefits of establishing SICs in NSW 
began in 1997 by the Joint Select Committee into Safe Injecting Rooms. This was 
borne from a recommendation made at the Wood Royal Commission into the New 
South Wales Police Service. Commissioner James Wood concluded that the 
Commission was supportive of the establishment of SICs and stated: 
At present, publicly funded programs operate to provide 
syringes and needles to injecting drug users with the clear 
understanding they will be used to administer prohibited 
drugs. In these circumstances to shrink from the provision 
of safe, sanitary premises where users can safely inject is 
somewhat short sighted. The health and public safety 
benefits outweigh the policy considerations against 
condoning otherwise unlawful behaviour... For these 
reasons, the Commission favours the establishment of 
premises approved for this purpose and invites 
consideration of an amendment of the Drug Misuse and 
Trafficking Act to provide for the same. 387 
Thus Commissioner Wood regarded SICs as a logical extension of harm reduction 
services, such as NSPs, that had been operational in Australia since the mid 1980s. 
In 1999, the state ALP government in Victoria announced it would introduce SICs 
"in five locations on a controlled trial basis." 388 The five proposed SIC locations 
were announced in September 1999: Melbourne central business district (CBD), 
Collingwood, St. Kilda, Footscray and Dandenong/Springvale and nominated $1.5 
387 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales, pxvi. 
388 Paras, R., 2000, Medically Supervised Injecting Service: A Primary Health Care Facility, City of 
Greater Dandenong, p7. 
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million specifically for their establishment. 389 In December 1999, Victoria's state 
Labor Government released Labour's Health Policy on Tackling Drug and Alcohol 
Abuse that stated: 
Labor will take immediate action to prevent the tragic 
deaths occurring amongst our young people, particularly 
from heroin overdose. This will include a focus on drug 
safety education, mobile overdose response services, a 
medically supervised heroin trial, safe injecting facilities 
and the development of alternatives to methadone. 39° 
One group that mobilised to support the instigation of SICs in Victoria was 
Tootscray Cares'. This group was constituted by concerned residents of Footscray 
and surrounding suburbs39I and was mainly concerned with issues to do with heroin 
use and as such organised 'heroin reform rallies' and public meetings. Included in 
these meetings were public figures such as well known performers and religious 
figures that culminated in a wide mix of people that supported such a facility. Thus 
by the late 1990s Victorian and NSW state governments were confronted with 
proposals for SICs. The types of arguments used by harm reduction and moral 
abstinence coalition arguing for and against SICs respectively are detailed below. 
Not just for the 'undeserving': advocating SICs in Australia 
According to the NSW Report on the establishment or trial of safe injecting rooms, 
arguments in relation to SICs in Australia can be ordered into four categories: 
'health', 'social', 'economic' and 'legal' rationales. It is evident however, that 
another category can be added as 'moral' rationales for SICs became apparent when 
889 ibid, p8. 
89° Paras, R., 2000, Medically Supervised Injecting Service: A Primary Health Care Facility, City of 
Greater Dandenong, Attachment 1. 
3°1 Footscray cares web page: accessed at www.paradigm4.com.au/footscraycares/  on 6/12/2004. 
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studying proceedings from the 1999 NSW Drug Summit. Each type of argument is 
discussed in turn below. The harm reduction coalition that advocated for SICs drew 
upon the European experience and research into the positive outcomes of such 
facilities. Moreover, this group also repetitively framed their arguments in support 
of SICs as having benefits beyond the drug policy arena to police service, local 
residents and the public health of society more generally. The objectors to SICs 
resonated with similar arguments to those in the debate around prescription heroin. 
Largely 'moral' reasons against SICs that such facilities 'send the wrong message' 
and thus, by extension, have the function of entrenching or encouraging drug use was 
a recurring theme. Furthermore, the dichotomy of 'deserving' and 'undeserving' 
recipients of Government aid also peppered moral objections. 
'Health' arguments for SICs 
The harm reduction coalition argued the health benefits of SICs as producing: 
• Reductions in fatal and non fatal overdoses, 
• Reductions in transmission of BBVs (benefiting both injecting drug users and 
the wider community), 
• Reductions in health risk behaviours such as sharing or reusing injecting 
equipment, 
• Increased access to mainstream health providers for injecting drug users, and, 
• Improvement of occupational health and safety for health workers regarding 
needlestick injuries. 
The coalition supporting SICs suggested that the implementation of SICs had the 
potential to benefit not only injecting drug users but also health workers and the 
191 
wider community. The coalition drew upon research that indicated that SICs may be 
linked to a reduction in the number of fatal and non fatal overdoses. In particular it 
was argued that, the provision of increased access to resuscitation and dissemination 
of information on safer using practices and overdose prevention had the capacity to 
reduce the amount of overdoses. 392 The coalition reported that cities with SICs such 
as Frankfurt in Germany had experienced more reductions in fatal overdoses than the 
rest of Germany as a whole.393 
Further, it was argued that SICs could affect a reduction in the transmission of BBV 
infections such as HIV and HCV through provision of free sterile injecting 
equipment as well as information on how to use drugs without contracting such 
viruses. A study by Buerki examined HIV risk behaviour among injecting drug users 
that attended SICs in Berne, Switzerland found that over time there was a decrease in 
such behaviour. 394 Another study pointed to a stabilisation, and in some cases an 
improvement in, the general health of injecting drug users attending SICs in Basel, 
Switzerland. This included a stabilisation of HIV prevalence and abscesses. 395 
There were further arguments that SICs may provide injecting drug users with better 
access to primary medical care and drug treatment programs through on site referrals 
made by qualified staff with the consent of the service consumer. 396 Finally, the 
harm reduction coalition argued that SICs may improve the occupational health and 
safety conditions for health workers, police officers and ambulances, as such groups 
392 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales, p81. 
393 ibid. 
394 Buerki, C., 1996, 'HIV risk Behaviour Among Street IVDUs attending a shooting room in Berne, 
Switzerland, 1990 and 1995', University Psychiatric Services. 
395 Ronce, C., Coda, P., & Schopter, R., 1994, Evaluation der Gassenzimmer I, II und III in Basel, 
Institut fur Sozial und Praventivmedizin der Universitat Basel. 
396 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales, p88. 
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are often at most risk of neefflestick injury when engaged with drug consumers such 
as when conducting searches or attending an overdose. 397 The argument followed 
that the lower the number of overdoses officials had to attend in uncontrolled 
environments such as public places like streets and parks or in private homes, the less 
the risk of contracting a needlestick injury. 
'Social' arguments for SICs 
The harm reduction coalition argued that SICs had the potential to provide social 
benefits in terms of: 
• a capacity to address public nuisance problems through provision of a place 
to inject, 
• clarification of the role of police around existing illegal injecting rooms, 
• entrenching access for drug consumers to mainstream health services such as 
drug treatment services, 
• reintegrating marginalised populations into the wider community through 
greater access to activities and services provided on SIC premises, and, 
• an ability for SIC staff to interact with drug consumers and to encourage 
behaviour change such as reductions in drug driving. 
The increased incidence of injecting in public places aggravated local communities 
and was a major problem in the 1990s in large metropolitan areas in Australia. 398 
Inappropriately discarded injecting equipment, witnessing people injecting drugs and 
encountering drug-affected people were also of concern. Moreover, the use of public 
spaces such as parks and public toilets as regular injection venues meant that some in 
397 ibid, p89. 
398 ibid, p93. 
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the broader community regarded these areas as hazardous to use. The NSW Report 
on the establishment of or trial of safe injecting rooms stated that SICs had the 
capacity to reduce public injecting through provision of a place to inject and 
subsequently reduce the amount of inappropriately discarded needles in public 
places. 399 Other proponents reiterated that SICs are a logical extension of the service 
provided through NSPs: 
...[community members] would prefer it if the needle 
exchange outlet had an injecting room so that users would 
not have to inject in front of their house. 409 
Another argument links the SIC and reduction of police corruption: 
Based on evidence given at the Wood Royal Commission 
into the NSW Police Service that a corrupt relationship 
existed between some members of the police and 
distributors of narcotics and that this relationship extended 
to the protection of those operating illegal injecting 
401 MOMS- 
Police had wrestled with the idea of illegal injecting rooms as officers had to weigh 
up the possible health and social benefits associated with injecting rooms against 
their illegal status when considering whether to close them down. 402 Alex Wodak 
summarised the dilemma police faced: 
The third type of benefit after public nuisance and public 
health would be reducing the opportunities for corruption in 
the police service. This is not an area I can claim any 
expertise as a medical practitioner, but I have certainly 
been able to observe what has been happening in Kings 
Cross over the last few years. I think the community put 
the police in a dreadful position, of being forced to choose 
399 ibid, p94. 
400 Ibid, p96. 
401 ibid, p98. 
402 ibid, p99. 
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either between acting in a way that was contrary to public 
health or enforcing the laws. The police, I think, very 
bravely, chose to do the right thing by public health. They 
allowed a number of injecting rooms that were run by 
illegal operators, they allowed these to continue, and I am 
sure that this reduced the number of overdose deaths and 
reduced the number of people who got terrible infections. 
But by the same token the police were doing something that 
no one can really feel comfortable with and where there is a 
great opportunity for corruption. I think the police deserve 
better treatment from the community than that, and I think 
the police deserve to be put in a position where it is very 
clear that they are acting both to enforce the laws and to 
preserve public health. I think the best way of doing this is 
by having injecting rooms run by legal operators run 
officially out in the open. If the community is not ready to 
have legal injecting rooms I am sure that we will continue 
to have illegal injecting rooms with all the problems that 
that ensues. 403 
Another argument was that SICs, through offering assistance with access to drug 
treatment might mean that users commit less crime. Results from surveys of 
attendees at Swiss and German SICs suggested an increase in the number of their 
service consumers that had shifted to relying on welfare benefits for income possibly 
meaning that users had moved away from crime to support themselves. 4" 
Furthermore, some concerned residents had reported many users driving straight 
after using drugs: 
I live on the first floor of my building and I have witnessed 
many times people injecting in their cars who then drive 
off. You notice when you look down a car with a cigarette 
lighter lit in the car. It is perfectly obvious what they are 
doing. It is lit for quite some time while they are heating 
the heroin in the spoon ready to inject. We see this happen 
day in and day out. 
403 Alex Wodak's submission to the Committee, 9 October 1997 quoted in Joint Select Committee into 
safe injecting rooms, 1998, Report on the establishment or trial of safe injecting rooms, Parliament of 
New South Wales, p99. 
404 Buerlci, C, 1996, 'HIV risk Behaviour Among Street IVDUs attending a shooting room in Berne, 
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Attendees at an SIC would be encouraged to remain on the premises after using 
drugs and moreover be encouraged not to drive while intoxicated.405 
Lastly, SICs would enable contact with this extremely marginalised group of people. 
Currently NSPs are the main point of contact for injecting drug consumers yet most 
of the time transactions at an NSP are fleeting. Staff at SICs would have the time to 
develop rapport and thus be better able to provide injecting drug users with 
information on other drug treatment programs and services. 406 
Injecting rooms would be of benefit not only to the wider 
community but to individual drug users themselves by 
providing a means by which they could reintegrate into 
mainstream society.4° ' 
The harm reduction coalition argued that provision of activities and job schemes 
through SICs (as is the case in the Rotterdam and Frankfurt SICs) may further 
contribute to such reintegration. Evidence from the European SICs indicated that 
development of vocational activities and life skills enabled some drug users to 
control and reduce their drug use. Moreover it is widely recognised that for many, 
problematic drug use lasts a few years until the person has enough information to 
modify their behaviour or makes the decision to reduce their use to a level that is not 
problematic.408 Thus, it was argued that SICs had the capacity to keep people safer 
during this experimental time and decrease the likelihood of contracting a lifelong 
viral infection such as HIV/AIDS or HCV. Such 'social' arguments ostensibly 
broadened the theoretical impact of SICs from having benefits for the drug consumer 
to the wider community. 
405 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
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'Economic' arguments for SICs 
The harm reduction coalition argued also that SICs have the capacity to affect 
economic savings through: 
• prevention of fatal and non fatal overdoses and associated problems, 
• reduction in BBV transmission both within the drug using community and 
broader society and, and, 
• more drug consumers opting for treatment. 
Supporters of SICs in the Report on the establishment or trial of safe injecting rooms 
stated that such facilities have the capacity to reduce costs to the community through 
prevention of overdose or at least a reduction in the number of ambulance responses 
to overdose as well as treatments in hospital emergency departments, intensive care 
units, general hospital wards and the cost of rehabilitation if the person is disabled 
following the overdose. 409 Further, the harm reduction coalition argued that SICs, 
through provision of sterile equipment and also safer injecting information (generally 
staff can engage injecting drug users longer in this context than NSPs) might impact 
on transmission rates of BBVs such as HIV or HCV. Moreover, it was stated that 
medical costs of treating these infections are considerable: 
One HIV infection in terms of medical and health cares 
costs reresents about $100,000 to the Australian health 
budget.4 
We assume that there are about 88,000 or 90 000 people in 
New South Wales with hepatitis C and it is going to cost 
the health system $1.258 billion for the current pool. For 
409 	• p110. 
410 
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new infections which are taking place, it is adding $71 
million per year to the already high number. 41 I 
Results from European studies412 were drawn upon to support the claim that SICs 
reduce rates of transmission for infections and subsequently the financial burden on 
the community of supporting people living with such illnesses would also be 
lessened. 
As it was argued that SICs have the capacity to improve the health of injecting drug 
users through acting as a gateway to mainstream services, therefore such facilities 
were claimed to also have the capacity to affect savings on the health budget. 
Health costs of a drug dependant person are estimated to be 
some 80% higher than those of an average citizen in the 
same age group. If injecting rooms provided information to 
injecting drug users on issues such as primary health care, 
how to avoid needle-site infections and overdoses and how 
to access drug treatment and rehabilitation programs, 
economic and social costs to the community related to 
injecting drug use may be reduced. 4I3 
Moreover, the harm reduction coalition continued, if the information provided to 
drug consumers meant that more access drug treatment, the costs associated with 
problematic illicit drug use would be lessened (for example, reduction in BBVs and 
overdose). SICs also have the capacity to reduce the number of discarded syringes in 
public areas through provision of and public place to inject along with appropriate 
disposal facilities, consequently reducing the amount of money spent by councils on 
retrieval. 
411 ibid. 
412 In Frankfurt, the ratio of HIV positive people that had overdoses declined from 21% in 1986 to 8% 
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'Legal' arguments for SICs 
One 'legal' rationale mentioned by the harm reduction coalition to support 
implementation of SICs was that such programs would clarify the role of police role 
around existing illegal injecting rooms. As illegal injecting rooms already existed in 
Australia, it was argued that the implementation of a legal SIC would clarify the role 
of police in relation to both drug consumers and those running such 
establishments.414 Police have a difficult task when balancing public health needs 
versus upholding the law. Self administration, possession, possession of drug 
paraphernalia (other than sterile needles and syringes), aiding and abetting or 
involving another person in the administration of drugs are all offences yet police are 
expected to tolerate some practices from a harm reduction perspective. 415 
Commissioner Wood noted: 
Tension exists between law enforcement and the recognition 
that addiction to prohibited drugs is also a medical and social 
problem. Criminal sanctions do not and can not address the 
latter. The National Drugs Strategy objective is harm 
minimisation... there remains a substantial area of potential 
conflict between the traditional law enforcement methods and 
the harm minimisation mode.416 
Legalising injecting rooms and exempting certain activities in the relevant state acts 
would resolve this problem for police. 
Moral arguments for SICs 
In the 1999 NSW Drug Summit proceedings, it was clear that some of the language 
and arguments used in advocacy for SICs had a moral undercurrent. What follows 
414 ibid, p119. 
415 ibid. 
416 ibid. 
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are excerpts from the working group. Advocates of SICs suggested that the existing 
approach to the 'heroin problem' was more unacceptable than the implementation of 
SICs. 
I feel it is also necessary to say that the only thing I have 
found more confronting and repugnant in my career on a 
day to day basis is when young people whom I have been 
managing over a period — sometimes years — have died. 
One of their friends would come into Kirketon Road and 
say that they heard that a particular person died over the 
weekend. Nobody tells us this information officially: as I 
say, it comes via the grapevine. We ring the morgue to find 
out whether or not it is true, and it is not unusual for us to 
be asked to identify the body because a lot of these young 
people have been well and truly out of contact with their 
families for a long time. When their parents have been 
contacted, on more than one occasion they have asked if 
they could take the young person's medical file home 
because that is the only tangible thing that they have to 
prove that their child was ever alive. That is a lot more 
repugnant than safe injecting rooms... I urge this Summit 
forward to consider what can possibly be best described as 
a necessary evil. Safe injecting rooms are not something 
that should be in every suburb, but certainly where there is 
street injecting and a public order issue, I think this 
recommendation is well worth considering on a trial 
basis.4I7 
One of the key rationales advanced for SICs was the capacity to provide medical 
assistance to overdoses that occur on site and thus save more lives than if the 
overdoses occurred in an unsupervised setting. 
Moreover many of the advocates also felt the need to express moral objections to the 
practice of intravenous drug use. NSW Premier Carr stated at the Summit Working 
group: 
There is no one more repelled by the whole business of 
injecting heroin than I. But the proposition is one that will 
417 Dr van Beek speaking at NSW Drug Summit 1999 — 'Summit Outcomes, Consideration of 
Resolutions', Working Group, Health Maintenance and Treatment Services, Extract from report of 
proceedings of 20/05/99, accessed online at www.sydneymsic.com/PF/Pfdsummitoutcome  1 .htm 
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be given the most careful and painstaking consideration by 
the Government... I speak as someone whose repugnance 
for the whole business of injecting additive poisons into 
people's bodies is as repulsive as anything I can 
contemplate, but we will give the fairest consideration to 
this as fashioned by this conference, to see that all the 
concerns and aspects of dealing with this horrendous 
problem are dealt with as fairly and critically as possible. 418 
By taking such a moral position, Premier Carr distanced himself from the claims that 
advocates of such programs are necessarily pro-drug use by announcing that he was 
in fact anti-injecting drug use. Traditionally harm reduction advocates display a 
value neutral attitude toward drug use. Moreover, the coalition also directly 
addressed a criticism that is often levelled at harm reduction namely that the logical 
consequence of implementation of harm reduction programs such as NSPs and SICs 
is normalisation or entrenchment of injecting drug use. Another participant at the 
working group rejected notions (most famously suggested by Prime Minister John 
Howard) that such facilities 'send the wrong message' and indeed suggested to the 
contrary: 
If people are sincerely concerned about the sorts of 
messages that injecting rooms might send to young people, 
I can only say that, if anything, these rooms are so far from 
glamorous environments that I would go so far to say this it 
might be almost worth considering having young people 
attend the facilities to prevent them from taking up drug 
use. I feel very strongly that not only do these rooms not 
send the wrong message, but also that they may well send 
the right message as to where drug use ends up or where it 
can end Up.419 
Lastly, one participant noted the similarities between the philosophies of Christianity 
and harm minimisation: 
...I would like to recount to you again that after four days 
and a long conversation with Brian Watters and Ingrid van 
Beek earlier today, the three of us come from different 
parts of this debate. Our conversation was about how much 
418 NSW Premier Bob Carr speaking at NSW Drug Summit 1999 — ibid. 
419 Dr van Beek speaking at NSW Drug Summit 1999 — ibid. 
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we agreed on, whether it was 90 per cent or 95 per cent. 
There is an increment of difference and whether we call it 
Christian compassion or harm minimisation, the words are 
potent. I stress that what we have is actually a description 
of an increment of growth on mechanisms that we have all 
supported with good intent. I appreciated that dialogue. 420 
From this brief survey of the ideas and types of arguments used by the harm 
reduction coalition, several strategies are apparent. Firstly, a number of the 
arguments presented aimed to broaden the benefits of SICs beyond injecting drug 
users to having benefits to the whole of society. For example the reduction in 
transmission of BBVs, economic savings through reduction of health problems and 
lessening of the prevalence of drug use and most critically, reduction of the incidence 
of public nuisance problems were key benefits cited. This type of argument meant 
that even those people that objected to public funds being dedicated to so called 
'undeserving' populations such as drug users, that implementation of SICs would 
benefit those 'deserving' of taxpayer funding. Secondly, the claims that SICs would 
lead to economic savings was a key point. Expansion of health budgets and the 
increasing focus upon responsible economic management and mangerialist practice 
within bureaucracy and those contracted to provide services means that this type of 
argument is politically shrewd. Indeed the insistence on an evidence base for harm 
reduction services is entirely compatible with the focus on outcome evaluation that 
has been a key approach by Government departments in Australia since the shift to 
new public management techniques 421 in the 1980s and 1990s. Thirdly, the harm 
reduction coalition appealed to the sensibilities of the moral coalition through claims 
420 Mr P Woods speaking at NSW Drug Summit 1999 — ibid. 
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that SICs would lower the prevalence of drug use through increasing access to 
mainstream services for drug consumers and reintegration of this group into 
mainstream society. Finally, advocates in NSW used moral arguments to advocate 
for an SIC. There were two types of moral arguments used: objections to the current 
situation (that it was immoral to allow the escalating rate of overdose to continue) 
while concurrently expressing moral objections to the practice of injecting drug use 
in general. The latter meant that harm reduction advocates distanced themselves 
from any possibility of being portrayed as pro-drug advocates. 
Helping the undeserving leads to more of them: advocating against SICs 
The recurring criticisms of harm reduction programs more generally were also 
directed towards the implementation of SICs. Indeed, there is a recycling of 
arguments against harm reduction programs that has occurred in the period of 
analysis. The main objection to SICs was underwritten by 'moral' concerns largely 
that providing services for people that continue to use drugs will entrench or promote 
the activity. Consequently, so the argument follows, the prevalence of illicit drug 
use would either remain stable (an unacceptable outcome) or likely increase. Thus, 
harm reduction programs are regarded as essentially normalising the 'evil' and 
dangerous 'nature' of illicit drug use. Moreover, the labelling of injecting drug users 
as 'undeserving' recipients of scarce public money was also a key theme of 
arguments applied by moral agents. The following section outlines the health, 
social/moral, economic and legal arguments against the implementation of SICs in 
Australia as applied by the moral abstinence coalition. 
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'Health' arguments against SICs 
In the Report on the establishment or trial of safe injecting rooms, there was concern 
about the health and safety implications for service consumers and staff of SICs. 
Some of those that made submissions suggested that some drug consumers might 
react violently to staff as a result of using drugs such as amphetamines. 422 Others 
suggested that SICs would lead to an increase of injecting drug use (through 
normalisation of such an activity) and also might delay drug consumers from 
entering rehabilitation (through entrenching drug use). 423 These last points are key 
criticisms of harm reduction ideas and programs more generally and are related to 
'moral' arguments against SICs. These are discussed below. 
Moral and Social' arguments against SICs 
Several submissions put to the Joint Select Committee into Safe Injecting Rooms 
suggested that there were some concerns about the social impact of SICs. Firstly, 
moral concerns that that such a facility may send the 'wrong signal' to the 
community that injecting drug use is condoned is a common argument often directed 
toward harm reduction programs. This was the argument that the Howard 
Government produced in response to the trial of heroin prescription. Professor 
Pennington, Chair of the Premier's Drug Advisory Council in Victoria described 
these types of 'moral' arguments to harm reduction programs in a presentation at the 
New South Wales Parliament House in July 1996: 
I went into it knowing that it would be controversial, I 
went into it knowing that we would be dealing with a 
situation where a number of people in the community have 
422 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales, p92. 
423 ibid, p90. 
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very strongly held views, that use of illicit drugs is to them 
an immoral act, open and shut, that anything to do with 
illicit drugs is something wicked, something that is very 
closely aligned to peoples' religious views or peoples' set 
of moral values. That is one problem and many of those 
people are not willing even to have questions raised to 
analyse the situation to see whether or not arrangements, 
as they now stand, are working, whether they are 
productive or counter-productive. 424 
One example of such an argument can be seen in the following submission to the 
Joint Select Committee into safe injecting rooms: 
The use of addictive drugs is a voluntary action and if the 
person becomes addicted to heroin, morphine etc it is for 
the want of a better word 'a self inflicted wound' and the 
law abiding citizens and society owes the addict nothing... 
safe injecting rooms for drug addicts is revolting, vulgar 
and an insult to all law abiding citizens who face everyday 
problems without turning to drugs. Safe injecting rooms 
would be a reward for illegal actions and would encourage 
weak willed persons to follow the same road. 425 
The argument that implementation of SICs in Australia would lead to normalisation 
and entrenchment of drug use, was a real concern for those that advocated against 
SICs. This is also a common argument against harm reduction programs yet this 
claim does not have the support of evidence. 
The second theme or arguments applied by the moral coalition against the 
implementation of SICs reason was the effect of such a facility on the local area. It 
was suggested that the opening and presence of an SIC may lead to a congregation of 
drug users around the site (the 'honey pot' effect) that might lead to further problems 
(such as drug dealing and an increase in opportunistic street and property crime 
around the site) and labelling of an area as a drug centre. 
The public image of Cabramatta or the City of Fairfield has 
been somewhat that is far less than desirable and the public 
424 Professor Pennington quoted in Joint Select Committee into safe injecting rooms, ibid, p108-9. 
425 Submission to Joint Select Committee into safe injecting rooms, ibid, p109. 
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perception of the place, I must say, has been very very 
damaging to the local community who live there... no 
doubt we would send a very wrong signal to the local 
community that: 'Oh well, because of that particular region 
of Sydney has such a large concentration of Indo-Chinese 
or Asian communities, if we cannot have it elsewhere in 
Sydney we will just dump it in that area of Cabramatta 
because those Indo-Chinese would not know how to react, 
would not know how to object, let them have it if nobody 
else wants it-426 
We believe that the provision of a 'safe house' in Nimbin 
will serve to further identify our town as 'the drug capital 
of Australia' and as such will attract more itinerant, untidy, 
unlawful, indolent and unemployed youth of the type we 
already have an excess of. 427 
Thus, some local councillors were concerned that the public image of their localities 
may be tainted by the centres. 
'Economic' reasons against SICs 
Several submissions to the NSW Joint Select Committee into safe injecting rooms 
expressed resentment that scarce public funds were being spent on consumers of illicit 
drugs. For some, the medical problem of drug dependencies was regarded as a matter of 
an individual lacking willpower. In this line of argument dependencies were 
conceptualised as self-inflicted problems and thus those with them considered as 
'undeserving' of public funds. Others were apprehensive and fearful of injecting drug 
use. 
Why should we make their lives comfortable? Why should 
we pay for their habit? Why should we feel uncomfortable 
walking down the main street of our own town? Why are 
their problems in life any worse than ours? We have 
suffered all the grief and despair but we know if you hang 
in there and plug on you can get on top of it. Letting 
yourself slide down and hide behind a veil of unreality is 
not the answer and expecting to be picked up at society's 
expense is unrealistic and grossly unfair to those who do 
426 Submission to the Joint Select Committee into safe injecting rooms, ibid, p107. 
422 Submission to the Joint Select Committee into safe injecting rooms, ibid. 
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play on and climb out. Society is already feeding them, 
housing them, clothing them... How much further do we 
have to go? Ask them what they give back to society. 428 
Another theme to financial arguments levelled against SICs was concern regarding 
the impact SICs would have local business and property values nearby. 429 Other 
costs estimated as linked to the implementation of SICs included: due to the 
congregation of drug users means that councils and businesses would require 
upgrades to security systems due an increase in drug related crime such as 
shoplifting; tourism and custom to local businesses might be affected and insurance 
premiums might be rise. 430 Other arguments raised against SICs were that money 
would be better spent on law enforcement and/or treatment programs that encourage 
people to become abstinent. 431 This last point is related to the claim that a drug free 
country is both an achievable and desired aim. These words resonate with the key 
tenets of the moral-abstinence coalition's approach toward illicit drug policy as 
described in chapter one. 
'Legal' arguments against SICs 
A further theme of arguments raised against the SIC revolved around legal concerns 
and inconsistencies that might be encountered following the implementation of SICs. 
It was argued that to legalise some behaviour, such as self administration of drugs, in 
the context of a SIC while such an act remains illegal in all other arenas, would 
generate problems for law enforcement. Director of the Criminal Law Review 
Division stated: 
428 Gregory Soward, president of the Nimbin Agricultural Industrial Society quoted in Joint Select 
Committee into safe injecting rooms, ibid, p115. 
429 ibid, p116. 
430 ibid. 
431 ibid, p117. 
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...one cannot get away from the fact that there are going to 
be arbitrary cut off points and there are going to be 
undoubted anomalies and all of those things simply arise 
from... seeking to say that something is legal in one part of 
New South Wales and illegal in another part. 432 
A second argument levelled against SICs from a legal perspective revolved around 
potential legal liability of incidents that occur. Civil liability issues for the operators 
if a consumer dies or if a staff member is injured could be considerable. 433 
From a survey of those arguments and testimonials presented in the Report on the 
establishment or trial of safe injecting rooms, several factors are evident. Firstly, the 
nature of the 'moral' argument against SICs is based on 'faith' rather than evidence. 
In contrast to the harm reduction coalition, that drew upon research from 
implementation in the European setting, criticisms of SICs are necessarily based 
upon anecdotal incidents or concerns of what might happen. Research around harm 
reduction programs more generally that refuted these claims was ignored or treated 
with scepticism. For example, studies have shown that harm reduction programs do 
not result in an increase in illicit drug use and moreover studies from the European 
experience have pointed to positive outcomes for both drug consumers and the public 
more generally.434 The moral-abstinence coalition's submission did not include 
evidence based analysis, nor did it draw upon research more generally, rather there 
was faith that their arguments were correct. This is due to the convergence or 
reflection of the values of the moral-abstinence coalition with those traditional values 
432 ibid, p123. 
433 ibid. 
434 Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D & Trautmann, F., 2000, Drug 
consumption facilities in Europe and the establishment of supervised injecting centers in Australia, 
Drug and Alcohol Review, 19; Buerlci, C, 1996, HIV risk Behaviour Among Street IVDUs attending a 
shooting room in Berne, Switzerland, 1990 and 1995, University Psychiatric Services. 
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of states such as Australia. Put simply, evidence was not needed, as this point of 
view was regarded as "common sense". 
Secondly, the moral-abstinence coalition implied that such harm reduction programs 
are not deserving of public money, arguing that money should not be spent on 
immoral programs that have the effect of entrenching and encouraging drug use. 
Moreover that injecting drug users have themselves to blame for their own 
dependencies/drug related harms means that these people are labelled as 
'undeserving' of public money. The moral abstinence coalition in submissions to the 
Joint Select Committee into Safe Injecting Rooms did not provide strategies on how 
to ameliorate the public health dimensions of drug use such as the impact of BBVs 
and economic costs associated with illicit drug use. 
Debates and Outcomes: a trial of a medically supervised injecting centre in 
Kings Cross 
Both Victorian and New South Wales Parliaments debated bills to instigate SICs. In 
June 2000 in Victoria, retailers such as Myer and David Jones echoed moral 
abstinence coalition members in calling for greater law enforcement to address drug 
problems in the CBD and advocated for the area to become 'a drug free zone'. 435 
Both Melbourne City Council and the City of Greater Dandenong Council voted 
against SICs in their area in June 2000. 436 In September 2000 the Victorian 
Parliament voted against the Drugs, Poisons and Controlled Substances (Injecting 
435 Gunaratnam, P., 2005, Drug policy in Australia: The supervised injecting facilities debate, Asia 
Pacific School of Economics and Government, ANU, accessed online: www.apseg.anu.edu.au , 
7/9/2005. 
436 ibid. 
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Facilities Trial) Bill 2000.437 Those opposing the bill cited financial and legal 
problems with the trial and also expressed scepticism of the science that underpinned 
the evidence that pointed to the benefits of SICs in the European context. 
The Joint Select Committee into Safe Injecting Rooms voted against the 
establishment of a trial of SICs in NSW. 438 Subsequent to this decision a group of 
clergymen, former MPs, doctors, drug users and parents of drug users established an 
unsanctioned SIC in early 1999 at the Wayside Chapel in Kings Cross, Sydney. 
Such a facility was intended by its founders to act as a "...symbol of civil 
disobedience". 439 The facility was closed by police soon after it had opened and the 
issue was on the agenda for the 1999 NSW Drug Summit. 
SICs were debated at the 1999 Drug Summit in NSW. A long time advocate of 
harm reduction programs and policies, and participant at the Summit, Dr Alex 
Wodak, described the Summit as "...marking a watershed" 44° for illicit drug policy 
and recalled that these talks were remarkable in comparison to other such events. 
Another major outcome of the Summit was the astonishing 
discovery that drug users are, after all, also human beings. 
The need for a more compassionate approach to drug users 
was widely endorsed, although only grudgingly for 
some.441 
437 Drugs Poisons and Controlled Substances (Injecting Facilities Trial) Bill, Victorian Hansard, 
7/9/2000. 
438 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales, p188. 
439 Wodak, A., Symonds, A., & Richman, R., (2003), 'The role of civil disobedience in drug policy 
reform: how an illegal safe injection room led to a sanctioned medically supervised injecting centre', 
Journal of Drug Issues, 33:3, p609. 
440 Wodak, A, 1999, 'That was the Summit that was', posted on www.onlineopinion.com.au , accessed 
on 16/11/05. 
441 ibid. 
210 
The way in which the issue of SICs was debated at the NSW Drug Summit was also 
a politically shrewd measure. SICs were linked to treatment442 rather than programs 
such as NSPs which are primarily focussed on disseminating equipment to drug 
consumers. Similar to SICs, one of the core functions of NSPs however is in 
providing a link or gateway to treatment services for marginalised consumers. This 
categorisation of SICs as treatment or health maintenance programs was evident as 
the discussion about the facilities at the NSW Drug Summit was conducted at 
sessions entitled 'Health Maintenance and Treatment Services' ."3 
Further, as discussed earlier those advocating for harm reduction provided 'moral 
reasons' (specifically that the existing situation and number of deaths was 
unacceptable and an abhorrence of the practice of injecting) to support the 
implementation of SICs. Expression of a moral repugnance for injecting drug use is 
not a tactic commonly employed by advocates of harm reduction programs. 
Wodak also noted the different approaches of harm reduction and moral-abstinence 
advocates: 
It is hard not to comment on the very different performance 
of the Government and the Opposition. There was also a 
striking difference in the performance of supporters of 
evidence based change compared to those advocating 
retention of a morality based approach. The Premier... 
began well by opening the Summit with a plea for open 
minds. Although the leader of the Opposition responded 
well, the Leader of the National Party proudly announced 
that members of his party were not going to change their 
opinions just because of evidence presented at the Summit. 
The Goverment came across as disciplined and strategic. 
The Opposition case was often argued by an irascible and 
442 NSW Drug Summit 1999 — Summit Outcomes, Consideration of Resolutions, Working Group No. 
#, Health Maintenance and Treatment Services, Extract from report of proceedings of 20/05/99, 
accessed online at www.sydneymsic.com/PF/Pfdsummitoutcomel.htm on 23/4/05. 
443 ibid. 
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poorly informed National Party backbencher who would be 
a liability to any side of a debate.' 
Wodak observed that battles around establishment of the Wayside Chapel tolerance 
room previous to the Drug Summit lead to members of the gay community providing 
assistance to advocates of SICs. 
When leaders of the gay community saw public health 
advocates fighting all too familiar battles over 
discrimination and HIV control, they generously provided 
to users and their supporters consummate strategic skills, 
discipline and a sense of focus. If this new coalition is 
sustained, the future of advocacy involving drug use and 
public health in Australia will be changed forever. 445 
For scholars of illicit drug policy, the amalgam of the issues of injecting drug use and 
HIV/AIDS was a familiar one, as the issue of HIV/AIDS had precipitated and was 
instrumental in the implementation of harm reduction programs ten years previously. 
Wodak also noted that the process employed by the Summit was also instrumental. 
The combination of all involved parties — parliamentarians, 
drug users, families of drug users, lawyers, police, 
clinicians, researchers and government officials — talking to 
each other directly rather than through the media was time 
consuming and costly. But in the long run this process will 
be seen as an efficient and effective way of achieving 
progress with some of our difficult to resolve social policy 
issues.446 
The working group at the Summit voted in favour of instigating a trial of an SIC in 
Kings Cross. Following the Summit, in July 1999, Premier Bob Carr announced that 
an 18 month trial would be implemented in Kings Cross, Sydney and run by the 
Catholic religious order the 'Sisters of Charity' (an order focussed on health and 
education across Australia). The Drug Summit Legislative Response Bill was 
444 Wodak, A, 1999, 'That was the Summit that was', posted on www.onlineopinion.com.au, accessed 
on 16/11/05. 
445 ibid. 
446 Wodak, A, 1999, 'That was the Summit that was', posted on www.onlineopinion.com.au, accessed 
on 16/11/05. 
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presented to the NSW Parliament in September 1999. Leader of the Opposition, 
Kerry Chikarovslci echoed Prime Minister John Howard's comments about the failed 
heroin trial, and stated: 
It will convey the wrong message to young people and the 
wrong message to the community. Indeed, it will not 
convey to the rest of the world that we are serious about 
tackling drugs in NSW. 447 
Regardless, the Drug Summit Bill was passed in September 1999 and the NSW 
Government defied the Prime Minister and the International Narcotics Control Board 
stating that such a facility did not contravene International law. 448 Further problems 
surfaced during the implementation of the trial. In July 2000, the Vatican intervened 
and ordered the Sisters of Charity to withdraw from the trial. Cardinal Ratzinger 
(now Pope Benedict), head of the Vatican's Congregation for the Doctrine of the 
Faith, in a letter tabled in NSW Parliament stated: 
...these facilities encourage the abuse of and illegal 
trafficking in drugs, undermine respect for the law, degrade 
social mores, and often represent the first step toward 
decriminalisation of drugs. 449 
As a result of this, the catholic 'Sisters of Charity' organisation withdrew from the 
trial and the Uniting Church was funded to provide a SIC in Kings Cross. The Kings 
Cross Chamber of Commerce also had reservations about the impact the facility 
would have on local businesses and challenged the legality of the operating license to 
the Uniting Church. Despite this, the trial started on 2001 in Kings Cross, Sydney 
and was extended in 2002. 45° 
447 Kerry Chilcarovski quoted in NSW Hansard, 11/11/1999. 
448 Gunaratnam, P., 2005, Drug policy in Australia: The supervised injecting facilities debate, Asia 
Pacific School of Economics and Government, ANU, accessed online: www.apseg.anu.edu.au , 
7/9/2005 
449 Gunaratnam, P., 2005, Drug policy in Australia: The supervised injecting facilities debate, Asia 
Pacific School of Economics and Government, ANU, accessed online: www.apseg.anu.edu.au , 
7/9/2005. 
450 ibid. 
213 
Heroin Prescription and Supervised Injecting Rooms: Is the ACF 
adequate to explain policy success and failure? 
This chapter examined the way in which the harm reduction coalition advocated for 
prescription heroin in the ACT and SICs in Victoria and New South Wales in the 
1990s. As described above, only the trial of the Medically Supervised Injecting 
Room in Kings Cross, Sydney was successful. Below is a discussion regarding 
particular aspects of the ACF as charted in Table 1 accompanied by an evaluation of 
their utility in the analysis of events and debates regarding prescription heroin and 
SICs in Australia. 
ACF Concept 1: Advocacy Coalitions 
The notion of advocacy coalitions is a useful mechanism to aggregate a multitude of 
actors around a particular stance to a policy issue. In debates around SICs and 
prescription heroin there were two major identifiable advocacy coalitions — the harm 
reduction coalition and the moral abstinence coalition. Both coalitions, as 
mentioned in chapters three and four, have been active in illicit drug policy debates 
from 1980 to 2000. Moreover both groups recycled their respective arguments for 
debates around prescription heroin and SICs as outlined in this chapter. 
As described in this chapter, those that advocated for harm reduction programs 
consisted of law enforcement officials, medical research personnel, alcohol and other 
drug workers, affected communities, politicians and community workers. The 
'intellectual glue' binding the harm reduction coalition was a belief in the 
instrumental value of prescription heroin and SICs to achieve public health outcomes 
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that would benefit society as a whole not just the communities directly affected. For 
example, the outcomes argued to arise from the implementation of each program 
included a reduction in the prevalence and transmission of BBVs and the 
amelioration of public order problems associated with public injection of heroin. 
One of the interesting departures for the harm reduction coalition however in the 
debate around SICs was the 'moral' component. Notes from the proceedings of the 
1999 NSW Drug Summit showed a relatively new strategy for harm reduction 
advocates: claiming intellectual ground familiar to advocates of moral-abstinence 
approach. That SICs had the capacity to reduce the number of fatal overdoses meant 
that such facilities were considered as ethical and the 'right thing to do'. Indeed such 
claims were made by many religious groups and drug workers as noted above who, 
indeed, found it morally repugnant to continue the status quo. The expression of 
moral repugnance toward the practice of intravenous drug use, while not a usual 
approach of harm reduction advocates that traditionally remain value neutral to such 
activities, was a politically shrewd measure that effectively pre-empted the usual 
accusations directed towards opponents of harm reduction advocates as being pro-
drug and subsequently, pro-drug use. Consequently, facilities such as SICs were 
then labelled as a 'necessary evil' rather than as being 'good' for society. The final 
component of the 'moral' approach was in appointing carriage of the program to the 
Sisters of Charity (and later the Uniting Church) rather than, for example, a self-help 
drug user organisation. This further reinforced the moral nature of such a facility 
through its placement in the carriage of moral agents. There are drawbacks to 
emphasising the morality of SICs in this manner however and this will be discussed 
in the next chapter. 
215 
As described above, the moral abstinence coalition consisted of members of 
Parliament (mainly Liberal and National parties and minor parties located on the 
Christian right), Christian interests (for example, from the Vatican and Fred Nile), 
Prime Minister John Howard and some past drug consumers and their families and 
friends. Further, the United Nations Narcotic Control Board also opposed instigation 
of both prescription heroin and SICs. The moral abstinence coalition's 'intellectual 
glue' was a position that that such programs condone, promote and encourage illicit 
drug use though normalisation of the activity. The claim that such programs 'send 
the wrong message to the community' was a key point used by many members. This 
argument further suggested that SICs were the first step towards decriminalisation 
and then legalisation of illicit drugs. 
Thus the ACF was accurate in its depiction of a subsystem in which actors are 
grouped into two or more advocacy coalitions around particular beliefs and thus 
share policy core ideas and solutions. Both coalitions displayed consensus on policy 
core ideas that prescribed whether or not prescription heroin trials and SICs should 
be implemented. Sabatier was correct in the assumption that coalition members 
might differ in opinion on deep core or secondary aspects of the policy problem. 
Evidence from the proceedings of the NSW Drug Summit — whereby NSW Premier 
Carr expressed repugnance towards injecting drug use (harm reduction ideas 
typically express a value neutral position towards the practice of injecting) might 
differ from other harm reduction advocates such as drug user groups (for example: 
the Australian Illicit Drug Users League) that may advocate the activity of illicit drug 
use as a fundamental human right. Indeed, a survey of the key actors of the harm 
reduction coalition could measure the degree of consensus on beliefs such as the 
nature and role of drug use in society. 
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ACF Concept 3: Guidance Instruments 
The upsurge in problematic heroin use in the mid 1990s created a window of 
opportunity for coalitions to generate policy responses. Chapter two outlined 
Sabatier's taxonomy of the ways in which coalitions can use such changes to affect 
policy change. The main ways that the harm reduction coalition responded to the 
rise in problematic heroin use was through presentation of research and information 
exchange at appropriate forums such as the NSW Drug Summit and also through 
intergovernmental groups such as the MCDS and ICDS. As detailed above the harm 
reduction coalition had a vast array of research that supported their programs and 
indeed broadened their function from helping drug consumers to producing positive 
public health outcomes. Information exchange also involved ongoing extensive 
consultation with local communities (as well as opinion polls to measure community 
attitudes to prescription heroin) and other stakeholders. The prescription heroin 
process that began in 1989 employed extensive consultation with a range of groups 
as listed in Box 1. 
The consultation process was so effective and thorough that most of the supporters of 
a trial of prescription heroin held elite prestigious positions and included 
organisations and actors from law enforcement, medical research bodies, Bishops 
and religious organisations more generally. The extensive consultation process 
meant that stakeholders were briefed and educated about prescription heroin with 
questions and concerns able to be regularly answered by the proponents of the trial. 
In this sense the proponents of the trial could work with local communities and 
stakeholders to negotiate mutually appropriate terms for the trial. Moreover due to 
the ongoing nature of consultation through such formal channels, officials from other 
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sectors such as law enforcement could be regularly updated and have input into the 
process. Such a process leads to increased ownership of a program by those that 
participate in its design. 
With regard to Sabatier's list of guidance instruments, most of the harm reduction's 
responses were classified under number five: "trying to gradually alter the 
perceptions of a variety of actors through research and information exchange". A 
specific type of information exchange occurred with regard to prescription heroin: 
namely the use of community development processes. While such approaches can be 
broadly classified as information exchange, community development is a particular 
type of information exchange with a specific agenda. It is suggested that such a 
device be included in Sabatier's taxonomy of guidance instruments. 
ACF Concept 6: Policy oriented learning and types of data 
It was hypothesised in the ACF that policy oriented learning is more likely to occur 
in systems conducive to the gathering and analysis of quantitative data. The illicit 
drug policy subsystem necessarily concerns issues of a social and moral nature 
whereby such types of data are more likely to succumb to politics than equivalent 
data in natural systems. In debates and advocacy regarding prescription heroin and 
SICs, the harm reduction coalition used scientific evidence and social research (such 
as opinion polling or program evaluation) to support advocacy. This was a key 
strategy for the harm reduction coalition and not inconsistent given the membership 
of personnel from medical and general research communities. Such evidence was 
systematically ignored or treated with scepticism by moral entrepreneurs, the 
approaches of which, were quite different. Their position consisted of strong 
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convictions that drug use was an immoral act (bolstered by the prevailing Christian 
values of Australian society) and by extension such harm reduction programs by 
their very nature encourage/promote and ultimately normalise such an immoral act. 
As such, the moral-abstinence coalition relied on moral convictions and testimonials 
from politicians and concerned citizens about their observations about the evils and 
destructive consequences of heroin use. Occasionally such an approach was 
peppered with the expert views regarding the legality of such initiatives. 
Ultimately, the role of quantitative/technical data in affecting policy change in the 
illicit drug policy subsystem is as an important and compelling device for policy 
makers. To a large extent the moral-abstinence coalition are bolstered by historical 
and political factors that have supported prohibition regimes. Sabatier's hypothesis 
holds in this analysis: that in social systems, quantitative data in policy change is not 
as persuasive as it may be in natural systems. 
ACF Concept 8: Policy oriented learning and professional forums 
Proponents of the prescription heroin trial used professional forums such as the 
MCDS and regular briefings of such bodies as ACT Drug Squad, Australian Bureau 
of Criminal Intelligence, Australian Federal Police Association, ACT Intravenous 
Drug Users League (ACTIV), Australian Medical Association as well as contact with 
individuals from police, health and alcohol and other drugs professions. Such 
interchanges with professional bodies and individuals meant that the project elicited 
support from a variety of sources as noted earlier in this chapter. With regard to 
implementation of SICs, the issue was discussed in the context of the Joint Select 
Committee into Safe Injecting Rooms and the NSW Drug Summit All of the forums 
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listed above were prestigious enough to enable coalitions to participate and all were 
dominated by professional norms. 
Explaining policy failure 
This section will examine the extent to which the ACF can account for policy failure 
referring specifically to an analysis of why the prescription heroin trial was 
abandoned in the ACT. Sabatier's work provides explanations of policy change and 
essentially attributed it to two factors. Firstly policy change was seen to occur 
through 'policy oriented learning' within policy subsystems: this is where the 
hegemonic coalition refines and adapts its belief systems through interaction with 
other coalition/s in the subsystem. Secondly, 'non cognitive external events' (such 
as the advent of HIV/AIDS virus in the 1980s) was the other likely precursor to 
policy change as such phenomena had the capacity to affect resources and 
knowledge regarding a policy problem. For a more detailed examination of this 
approach please see chapter two. 
The ACF is helpful to account for some aspects of why the ACT was unsuccessful in 
a bid to secure a trial of prescription heroin. The ACF is useful to explain how 
policy change can be thwarted by a hierarchically superior jurisdiction such as the 
Howard Federal Government intervention into the stopping prescription heroin from 
taking place in the ACT. The capacity of the Howard government to stop the trial 
after it was passed by the ACT Parliament is accounted for in the following ACF 
hypothesis: 
The policy core attributes of a governmental program in a 
specific jurisdiction will not be significantly revised as long 
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as the subsystem advocacy coalition that instituted the 
program remains in power within that jurisdiction — except 
when the change is imposed by a hierarchically superior 
jurisdiction. 451 
Even though that hypothesis refers to policy change rather than policy failure, the 
ACF still can account for the intervention of the Federal Government into the 
prescription heroin trial. The Federal Government had the authority to override 
legislation enacted in territory parliaments such as that of the ACT and in this case 
chose to do so. 
ACF Concept 4: Policy Brokers in strategic policy posts 
When key players that believe vehemently in the ideas expressed by advocacy 
coalitions occupy certain influential and important roles in a political system, policy 
outcomes are affected. Similar to Neal Blewett, then Federal Health Minister, being 
a key actor in the emergence of the harm reduction coalition in the 1980s, Prime 
Minister John Howard was a key player in the moral-abstinence coalition. In the 
case of the proposed prescription heroin trial, Prime Minister Howard used his 
statutory powers to override territory legislation. Moreover comments such as the 
following indicate his personal commitment against prescription heroin: 
While ever this Government is in office and while ever I 
am Prime Minister of this country...there will be no heroin 
tria1.452 
Granted as the Prime Minister is necessarily part of a political party (in this case the - 
Federal Liberal Party), such a position is not a sole decision making entity, however, 
451 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe, 
Journal of European Public Policy, 5:1, March, p106. 
452 Sydney Morning Herald, Editorial, 10/8/2001. 
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his personal interest in illicit drug policy (as illustrated by the carriage of the MCDS 
in his personal Ministerial portfolio and his appointment of Major Brian Waters of 
the Salvation Army as Chairperson of that committee) demonstrated a particular 
interest in this field of policy. It is argued that this interest along with his role as 
Prime Minister meant that his allegiance with the moral-abstinence coalition was a 
key factor in influencing policy in this period. Moreover, the trial of prescription 
heroin had been approved and was ready for implementation until a last minute 
intervention by the Prime Minister as described above. Thus the ACF would benefit 
from the inclusion in the ACF theory of the relative degree of influence of policy 
players within coalitions or at least the recognition that this is a factor that can 
influence the nature of policy change. 
Role of policy brokers 
The ACF states that a group of actors known as 'policy brokers' mediate conflict 
between coalitions with the function of reaching compromise between coalition 
positions. 
Conflicting strategies from various coalitions are normally 
mediated by a third group of actors, here termed 'policy 
brokers' whose principal concern is to find some 
reasonable compromise that will reduce intense conflict. 
The end result is one or more governmental programs, 
which in turn produce policy outputs at the operational 
leve1.4" 
In the case of prescription heroin, medical interests led the developmental process in 
which operational policy parameters around prescription heroin were developed. 
Granted the process was highly consultative and involved many groups as described 
453 Sabatier, P., 'The advocacy coalition framework: revisions and relevance for Europe, Journal of 
European Public Policy, 5:1, March, p104. 
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in Box 1, however, it was clear that policy in this case was led by coalition members 
rather than 'policy brokers' as described by Sabatier. Similarly, in the case of the 
Medically Supervised Injecting Centre in Kings Cross, the process was led by harm 
reduction coalition members. Due to the nature of the debate, compromise was 
minimal. The proceedings from the Drug Summit did show that instead of 
implementing several SICs, a trial of one facility was settled upon. 454 A number of 
other minor compromises in terms of location was brokered yet this was done at the 
'Health Maintenance and Treatment Services' Working Group at the 1999 NSW 
Drug Summit rather than by a set of actors divorced from either coalition. 
Conclusion 
Using an exploration of policy debates in response to the issue of increased 
problematic heroin use, the explanatory power of the ACF was examined and 
supported, however, particular limitations of the ACF were exposed. An 
examination of roles of key coalition actors and their capacity to influence policy 
would expand the capability of the ACF to explain policy change, major or minor. 
Further the inclusion of community development processes as particular types of 
guidance instruments to affect policy change would also strengthen the ACF. 
Moreover, this chapter also provided further information on the nature and strategies 
employed by advocates of harm reduction policy and programs. 
The following chapter will has two aims, first, findings from chapters three to five 
will be synthesised and used to evaluate the ACF and specifically respond to discrete 
454  NSW Drug Summit 1999 — Summit Outcomes, Consideration of Resolutions, Working Group No. 
#, Health Maintenance and Treatment Services, Extract from report of proceedings of 20/05/99, 
accessed online at www.sydneymsic.com/PF/Pfdsummitoutcomel.htm accessed 23/4/05. 
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research questions formulated in Table 1. Second the ACF will be used to 
understand the nature of illicit drug policy making in Australia in the period 1980 to 
2000. 
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Chapter 6: 20 years of Epistemological Struggle over Illicit Drugs: 
Can the ACF Explain Illicit Drug Policy Change? 
Introduction 
...several people have wondered whether the ACF applies 
to policy domains — such as abortion, gun control, human 
rights, gay rights, school prayer and gender politics — in 
which technical issues are completely dominated by 
normative and identity concerns. Our own perception is 
that it should work very well. These subsystems seem to 
be characterized by well defined coalitions driven by belief 
driven conflict, which resort to a wide variety of guidance 
instruments at multiple levels of govemment. 455 
An important question underpinning this thesis is an evaluation of the extent to 
which the ACF can be employed to examine a social policy arena. A fundamental 
characteristic of the illicit drug policy subsystem is that the basic ideas and 
assumptions (such as the role of the state in managing illicit drug use and the nature 
and role of drug use in society) held by various stakeholders about the direction of 
illicit drug policy are highly variable. A further complication is a lack of consensus 
on the appropriate way to evaluate such questions. In the analysis of natural systems, 
rational/scientific approaches dominate the way such issues are considered. In 
contrast, analysis of illicit drug policy gives rise to a pattern of systemic rhetorical 
skirmishes whereby various interests question the validity of the way policy ideas 
and beliefs are intellectually manufactured. 
This final chapter synthesises findings from the previous three chapters. Trends and 
key patterns are identified across the 20 year period of analysis drawing on several 
455 Sabatier, P., & Jenkins Smith, H., 1993, 'The Advocacy Coalition Framework An Assessment', 
Policy Change and Learning: An Advocacy Coalition Approach, Westview Press, San Francisco, p 
152. 
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research questions (see Table 1.). In some cases these were addressed and answered 
in previous chapters, however in this chapter a synthesis of all the findings is 
presented and questions posed in chapter two are directly addressed. This chapter 
has three overarching research aims: first, to evaluate the theoretical power of the 
ACF when applied to the illicit drug policy subsystem; second, to use the ACF to 
explain the nature of policy making in the illicit drug policy subsystem and third, to 
provide information on the performance of the harm reduction coalition in realising 
policy objectives. 
Differences and tensions became evident in preceding chapters with regard to the 
way the ACF had been developed according to its applications to natural systems. 
While the ACF was a highly capable tool to explain changes to illicit drug policy 
between 1980 and 2000, some difficulties were encountered. The lack of consensus, 
mentioned above, between coalitions resulted in a fundamental deadlock regarding 
the appropriate way to think about drug policy. Regardless of whether information 
was quantitative and technical in nature, the discord occurred at a deeper level 
whereby the relative validity of moral and scientific approaches was questioned. 
Advocacy Coalitions 
Research Question 1.1: What type of actors constituted the harm reduction and 
moral abstinence coalitions? 
In Australia, the predominant type of actor that advocated for harm reduction policies 
was from the medical and research communities where problematic drug use was 
seen from a health or sociomedical perspective. Such actors have been highly 
instrumental in their continuing advocacy efforts with such individuals as Dr Alex 
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Wodak providing ongoing commentary in relation to drug trends and associated 
policy/public health challenges. Moreover, personnel such as Dr. Wodak have also 
contributed to operational advances in harm reduction practice, for example being 
part of a team at St Vincent's Hospital that instigated the first unsanctioned NSF in 
Sydney in the mid 1980s. Similarly, Dr Gabrielle Bammer drawn from the National 
Centre for Epidemiology in Canberra was a key advocate in the case for prescription 
heroin. Moreover, the chief advocator for SICs in NSW was Dr Ingrid van Beek, 
who had previously worked in the field of cardiac surgery. Undoubtedly, there were 
many more individuals from medical/research fields that took a leading role in harm 
reduction advocacy in this period, these were three key players identified in the 
period of analysis. 
Harm reduction advocates were also drawn from the government arena. Key 
members of the bureaucracy and executive government were identified in chapter 
three in the period 1980 to 1990 as being key advocates of harm reduction policies 
and programs. Senior bureaucrat Les Drew and then Federal Minister for Health 
Neal Blewett were also highly instrumental in achieving policy outcomes. Over the 
period of analysis, the support base for harm reduction expanded. Support for 
prescription heroin programs in the 1990s was from a variety of fields including 
medical, research, legal, Police, community groups, some Church groups, peak 
bodies such as the Australian Drug Foundation, HIV/AIDS Organisations and 
affected communities. "Grassroots" workers such as those from the alcohol and 
other drugs field had also campaigned for such policies based on their experiences 
from working with injecting drug users. 
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What is termed the 'moral-abstinence' coalition was examined in chapter five with 
regard to debates around SICs and prescription heroin. Such actors were 
predominantly drawn from so called conservative religious groups such as the 
Catholic Church (including the Vatican) and Fred Nile's Christian Democratic Party 
and supported by the United Nations Narcotics Control Board and Prime Minister 
(from 1996 onwards) John Howard. Further advocates of this approach tended to be 
drawn from concerned parents and friends of drug users and members of society that 
provided testimonials to peak groups of inquiries into drug policy over the 20 year 
period. 
Research Question 1.2: Was there any change in the type of actors over a 20 
year period in illicit drug debates? 
As mentioned in chapter three, harm reduction ideas had been used in medical 
practice for many years. Furthermore, key notions of harm reduction approaches 
such as a focus on 'drug related harm' and operational practices such as 
dissemination of syringes to drug users existed a decade before the term was 
recognised as a cohesive approach in its own right. The six Inquiries and Royal 
Commissions that were established in the 1970s supported (in hindsight) key aspects 
of what became known as the harm reduction approach to illicit drug use. Between 
1980 and 1990 there were three broad changes to the membership of the harm 
reduction coalition. 
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Coalition Genesis (early 1980s) 
As recounted in chapter three, in the early 1980s, individuals and groups of actors 
were beginning to speak of 'harm reduction/minimisation' while questioning the 
efficacy of traditional prohibitionist approaches. Debate was lead by medical groups 
(Australian Medical Society on Alcohol and Other Drugs, Australian Foundation on 
Alcoholism and Drug Dependence) and echoed by the bureaucracy (for example, by 
senior federal bureaucrat Les Drew and also when NSW State Health Department 
adopted 'harm minimisation' as chief policy goal for illicit drugs) and international 
organisations (such as WHO). Further changes to terminology to facilitate data 
collection and analysis in regard to illicit drug problems reflected the influence of the 
bio-medical community both in Australia and internationally. For example, value-
laden terms (abuse and misuse) were replaced with neutral terms (harmful and 
hazardous) so to avoid moral judgements on levels of drug use. Indeed, such 
reorientation to focus on the measurement and evaluation of the consequences of 
drug use enabled a level of objectivity endemic to the scientific endeavour. 
Crisis time (mid-1980s) 
Debate in the mid-1980s was lead by public health advocates concerned about the 
potential impact of HIV/AIDS. The advent of HIV/AIDS broadened the support for 
the harm reduction coalition from medical/health fields to include members of the 
gay community through the connection between injecting drug use and HIV/AIDS 
transmission. Further, the virus also meant changes to illicit drug policy whereby 
harm reduction services such as the expansion of MMT and instigation of self-help 
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drug user groups and NSPs were enacted. Consequently the harm reduction coalition 
was expanded to include those involved with such services. In this period the 
Federal Minister for Health, Neal Blewett was a key advocate for harm reduction 
policy and programs as was then Prime Minister Bob Hawke. 
Post-HIV/AIDS (late 1980s —2000) 
In this period debate was lead by medical/research interests evidenced in the 
discourse surrounding the policy problems presented by HCV and the increase in 
problematic heroin use in the mid 1990s. The third change to the membership of the 
harm reduction coalition occurred in the 1990s and was linked to the structure of 
successive NDS'. The systemic collaboration between health and law enforcement 
sectors since the 1985 NCADA was accompanied by increased support of the latter 
for the former. This was particularly evident in debates in relation to SICs and 
prescription heroin in the mid to late 1990s. Further support for the ideas of harm 
reduction was evidenced in changes to policing in the 1990s. The election of the 
Federal Howard Government in 1996 galvanised the harm reduction coalition as it 
signalled the end of support from the Federal ALP Government. While the Howard 
Government continued programs such as NSPs and self-help drug user groups, the 
Prime Minister intervened to reject such initiatives as SICs and prescription heroin. 
In this sense, Prime Minister Howard was a key member of a group of individuals 
and organisations described earlier as advocating for programs and policies that have 
an abstinence-oriented approach. 
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Research Question 1.3: What was the nature of the change? Gradual or 
sudden? 
The membership of the harm reduction coalition was generally stable over the 20 
year period with two exceptions. The principal policy actors were derived from the 
medical/research communities with some grassroots/community groups also 
providing ongoing support for harm reduction organisations. In the case of the latter 
this was logical due to their involvement in the development and implementation of 
harm reduction services and close proximity to affected communities. In terms of 
changes to the constitution of the coalition, the advent of HIV/AIDS as a major 
public health issue did have a sudden and profound impact in two ways. First, the 
perceived crisis of HIV/AIDS resulted in a sudden expansion of harm reduction ideas 
and associated personnel working in those programs in illicit drug services. Second, 
HIV/AIDS also generated the initiation of, and ongoing collaboration between, 
homosexual and medical/research interests and other illicit drug policy stakeholders 
in advocating for public policy to reduce transmission rates for HIV/ADJS. Such an 
expansion of support in the mid 1980s was the result of major policy change. 
The other change to the coalition described above was the increased support of harm 
reduction programs by law enforcement personnel, however and in contrast to above, 
such a change was gradual and reflected the broad structure imposed on the sector by 
successive NDS'. Thus the following ACF hypothesis was generally supported by 
the findings of this thesis: 
On major controversies within a policy subsystem when 
policy core beliefs are in dispute, the lineup of allies and 
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opponents tends to be stable over periods of a decade or 
thereabouts. 456 
The membership of the harm reduction coalition was generally stable over the 20 
year period between 1980 and 2000. The two changes described above were the 
result of changes in the subsystem: the sudden and profound change in the mid 1980s 
was in response to the advent of HIV/AIDS that had impacted the illicit drug policy 
subsystem; in the latter case the change was a result of policy oriented learning 
between health and law enforcement sectors. It may be interesting in future 
examinations of the ACF to encourage study of the effect of such external system 
events not only on policy change but also on coalition membership. Indeed, an 
inspection of the interplay between changes in exogenous factors and instances of 
policy oriented learning can redefine the policy problem and in the process 
reconfigure coalitions might further provide interesting commentary on the policy 
process. 
Policy Beliefs 
Research Question 2.1: Did the harm reduction coalition display consensus on 
policy core over 20 years? 
The hypothesis in the ACF that advocacy coalition actors will show substantial 
consensus on issues pertaining to the policy core was supported in the analysis with 
advocates for harm reduction generally choosing to focus on 
programs/policies/theory in which the focus on ameliorating the consequences of 
problematic drug use (such as overdose, BBV transmission, public order problems, 
456 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p103 
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general health risks) was regarded as a greater priority than reduction in levels of 
drug use. In contrast to the moral-abstinence coalition that framed the illicit drug 
problem as a moral issue, the harm reduction coalition considered issues related to 
problematic drug use from medical/scientific/public health perspectives. While 
increases in drug use were of a concern to the harm reduction coalition, advocacy 
efforts were steered towards health interventions rather than criminal sanctions. 
While there was some minor discussion on whether the term 'harm reduction' could 
include abstinence-oriented approaches, the overall focus of the term was on 
reducing drug related harm without requiring a reduction in use. 
It is argued that HIV/AIDS played a major role in uniting the harm reduction 
coalition both in practice, through the flurry of policy development and 
implementation around the virus, and also in theoretical linkages between 
HIV/AIDS, injecting drug use and public health problems. In the absence of a crisis 
such as HIV/AIDS the extent of support for harm reduction programs is surmised to 
be considerably less. 
The following ACF hypothesis was supported in this analysis: 
Actors within an advocacy coalition will show substantial 
consensus on issues pertaining. to the policy core, although 
less so on secondary aspects. 4)7 
Advocacy efforts at the NSW Drug Summit in 1999 were a good example of where 
there was a divergence, however, in advocacy approaches. Traditionally, advocates 
of harm reduction have a value-neutral outlook towards drug use, however when 
advocating for SICs in 1999 the then Premier Bob Carr, made personal statements 
457 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p106. 
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expressing moral repugnance at the practice of intravenous drug use. Such 
statements acted as a disclaimer that the Premier was not pro-drug use, as such 
allegations are often aimed at those that support harm reduction. It is suspected 
however that other members of the harm reduction coalition would not share the 
same view. Regardless, it was clearly a politically expedient move that acted as a 
disclaimer on behalf of himself and the NSW Labor Party. As noted in chapter one, 
some writers on harm reduction argue that drug use is inevitable in human societies 
across time and culture and therefore efforts to prohibit such an activity are close to 
futile. It is surmised that the extent of consensus on such a view from all harm 
reduction coalition actors might also diverge somewhat. Such a divergence was 
accounted for in the ACF as such an outlook regarding the role of drug use in 
societies is classified as part of deep core beliefs. 
Guidance Instruments 
Research Question 3.1: How did the harm reduction coalition capitalise on 
changes that occurred external or within the subsystem? 
Between 1980 and 2000 several changes transpired that had implications for policy 
makers, these are listed as follows: 
• Periodic interest in a perceived increase in prevalence of all illicit drug use 
and associated drug related harm (both to individual drug user and wider, 
community). Identified first in late 1960s and continuing into the 1970s with 
the issue the subject of several Royal Commissions, 
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• Identification of two BBVs, HIV/AIDS and HCV, as potential threats to 
public health, and, 
• Increased problematic heroin use and associated rise in rates of overdose and 
general public nuisance issues in the mid 1990s. 
While there were other minor incidents that occurred (for example the death of four 
babies as a result of HIV infected blood transfusions in 1984), this analysis focused 
on the wider changes over the 20 year period of analysis. 
In the early 1980s a coalition for harm reduction was beginning to crystallise within 
the medical community as a result of growing disillusionment with traditional 
approaches to respond to the issue of increasing drug use. The early stages of 
coalition building involved agenda setting processes whereby professional 
organisations called for empirically based policies and a shift away from value-
driven policy. It was argued that existing terminology in policy did not enable 
scientific endeavour into the issue. Further, criticism of traditional abstinence-
oriented strategies and the capacity of such approaches to respond to growing levels 
of drug use was also raised by individuals and organisations both within Australia 
and internationally. Such commentary was primarily in the form of research and 
information exchange through conferences and scholarly journals. 
The way in which the harm reduction coalition mobilised to capitalise on the impact 
of the virus included energising a research program and trying to alter the 
professional and public perceptions of the injecting drug use problem. As noted in 
chapter three the notion of a 'second aids epidemic' was a persuasive concept for 
policy makers interested in protecting public health. Moreover, that state 
235 
governments were unequipped to respond to the HIV/AIDS crisis, coupled with the 
deaths of four babies from HIV infected blood transfusions, also left a vacuum 
requiring the Federal Government to act promptly. This meant that the coalition for 
harm reduction through then Health Minister Neal Blewett could opportunistically 
provide policy options to combat the public health threat posed by the virus. 
Moreover, the process was managed astutely by Blewett through the convening of 
committee structures that discussed controversial subject matter away from the 
public arena. Lastly, the involvement of affected communities was another 
mechanism used to ensure that harm reduction initiatives such as safer drug using 
education and NSPs were appropriately targeted. 
Another mechanism employed by the harm reduction coalition, frustrated by 
Government inactivity in relation to the provision of sterile injecting equipment to 
illicit drug users, was through resorting to civil disobedience and instigating an 
unsanctioned NSP at St Vincent's Hospital, NSW in 1986. In this case police action 
was not taken and the following year such programs were approved. There was a 
second instance of civil disobedience in 1999 when a group set up an unsanctioned 
SIC in Kings Cross, NSW. While the facility was closed soon after opening, the 
issue was debated at the 1999 NSW Drug Summit. To an extent, such civil 
disobedience, lead by doctors and clergymen, served an agenda setting purpose. 
The advent of HCV as a public health issue also provided opportunities to influence 
policy. Advocates of harm reduction programs mobilised around the issue through 
participation in committees advocating for harm reduction measures to curb 
transmission rates and research and information exchange about the nature of the 
virus. Identification of the virus as a threat to public health was not accompanied by 
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similar levels of urgency as was with HIV/AIDS and moreover it was regarded that 
HIV/AIDS structures were already in place to respond to such problems. 
The increase in problematic heroin use in the 1990s also generated opportunities for 
the harm reduction coalition. Systemic presentation of research and information 
through a variety of formal and informal channels meant that the coalition was armed 
with a cache of research and policy solutions. Indeed the extensive community 
development activities undertaken by the architects of the prescription heroin trial 
also contributed to the way in which a controversial initiative had been accepted by 
local communities prior to the intervention of the Howard Government. 
Furthermore, that the proponents of the prescription heroin trial had undertaken 
community development activities systematically, as were the scientific and 
evaluative components of the trial, also meant that the local community in which the 
project would be conducted and illicit drug and Government sectors more widely 
were not only accepting of the initiative but also were cognisant of the nature of such 
a policy. Such a process raised both the feeling ownership of such groups of the trial 
and also the capacity to discern myths and misinformation about the aim and scope 
of the trial. In sum, the community development activities undertaken meant that 
when problematic heroin use was identified as an issue in the mid 1990s the harm 
reduction coalition was 'policy ready'. 
Research Question 3.2: Did these conform to Sabatier's taxonomy of guidance 
instruments? 
The following guidance instruments were identified in the ACF: 
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(1) trying to change the incumbents of various positions, 
whether they be agency appointees, agency civil servants, 
or elected legislators and chief executives 
(2) seeking to influence legislatures to alter the budgets 
and legal authority of administrative agencies through 
testimony and campaign contributions; 
(3) trying to affect public opinion ... via the mass media; 
attempting to alter target group behaviour via 
demonstrations of boycotts 
(4) trying to gradually alter the perceptions of a variety of 
actors through research and information exchange. 458 
Below is a summary of the strategies identified in this thesis that contributed to the 
way in which in which coalition advocates responded to changes within or external 
to the illicit drug policy subsystem: 
Ongoing research and information gathering and opportunistic policy ambush 
The harm reduction coalition had, since the early 1980s, conducted and evaluated 
research into several aspects of illicit drug policy. The vacuum in HIV/AIDS policy 
and an associated urgency to respond to the problem, saw medical/research interests 
capitalising on this gap through the provision of targeted research and potential 
responses to address the perceived threat to public health posed by HIV/AIDS and 
HCV. In the case of increased problematic heroin use in the 1990s, the coalition 
sorted through their extensive research cache and presented policy options of SICs 
and prescription heroin trials. With regard to the latter, community development 
activities preceded this opportunistic research exchange. It is argued that such 
approaches were critical precursors to the acceptance of such controversial policy 
initiatives and moreover constituted a particular type of research and information 
exchange. 
458 Sabatier, P., & Jenkins Smith, 1993, 'The Advocacy Coalition Framework: An Assessment', 
Policy Change and Learning: An Advocacy Coalition Approach, Westview Press, San Francisco, 
p142. 
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Circumventing controversy through strategic channels 
Debates about illicit drug use can often deteriorate into ideological polarities 
whereby rational discussion underwritten by empirical study is overshadowed by 
morally driven symbolism. The image of the 'junkie' or an insulin syringe discarded 
in a school ground can overpower research into harm reduction programs that are 
often regarded as encouraging drug use despite some evidence suggesting otherwise. 
In the case of employing harm reduction programs to combat HIV/AIDS 
transmission, the instigation of bipartisan committee structures by Blewett enabled 
such sensitive topics to be debated and problems solved away from the spotlight of 
the media. Similarly, in the case of the lead-up to prescription heroin trials, 
extensive community development activities were undertaken whereby local 
communities were given a formal channel to express discontent and/or to have 
questions answered. Both initiatives lead to increased support of the proposed 
initiatives without interference from the media or other groups that attempt to 
sidetrack or in some cases misrepresent debate. 
Civil disobedience as a mechanism for policy change 
When a stalemate occurs and the unsuccessful policy actors possess the requisite 
personal conviction that the decision made by sovereign authorities is in fact the 
wrong one, then disobedience of process and rules can ensue. This can have several 
effects: in the case of disillusioned workers opening the first NSP in Australia in 
1986, the facility was allowed to continue and within a year more were opened in 
NSW. Several years later each state and territory had implemented NSPs; in the case 
239 
of the opening of an unsanctioned SIC, such a process had an agenda setting 
function. In both of these examples the principal personnel involved in the civil 
disobedience processes were from respected backgrounds, being medical and 
religious organisations, as such this may have strengthened the way others perceived 
their actions. 
While the list of guidance instruments in the ACF included the first point above 
(research and information exchange), it might benefit from including the notion of a 
'policy ambush' and the way in which some coalitions systemically gather 
information and take advantage of subsequent opportunities. Second, community 
development approaches also should be included in types of guidance strategies. 
Such processes, whereby the proponents of a program systematically engage with 
stakeholders and in some cases approach other groups not necessarily instantly 
associated with the initiative, are often used in many different settings. The process 
of getting diplomatic experts in a particular policy area to engage with the uninitiated 
on a controversial subject matter on a regular and ongoing basis whereby issues and 
questions can be raised and answered directly is a constructive tool. Such an 
approach is similar to the one undertaken by Blewett in the 1980s whereby 
committee structures circumvented controversy through providing other channels to 
respond to questions and debate the subject matter. Furthermore, in the case of 
social systems in which quantitative data is not as readily accepted as in natural 
systems, coalitions that are underwritten by such information must be more careful to 
employ strategies (such as above by Blewett and community development activities 
undertaken by proponents of prescription heroin trial) to ensure such data does not 
become overshadowed by more controversial aspects of the initiatives. It is proposed 
that the above list is considered for inclusion in the ACF schedule of guidance 
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instruments is amended to include the above categories where relevant when 
examining advocacy of potentially controversial issues. 
Policy Brokers 
Research Question 4.1: Do policy brokers have membership of any coalition? 
Very little is written about policy brokers in the ACF. The most extensive 
description follows, taken from one of the earlier articles written in 1987: 
...there will almost certainly be a category of actors — here 
termed "policy brokers" — whose dominant concern is with 
keeping the level of political conflict within acceptable 
limits and with reaching some "reasonable" solution to the 
problem. This is a traditional function of some elected 
officials (particularly chief executives) and, in some 
European countries such as Britain and France, of high civil 
servants... The courts, "blue ribbon commissions" and 
other actors may also play the role of policy broker. The 
distinction between advocate and broker is however a 
continuum. Many brokers will have some policy bent, 
while advocates may show serious concern with system 
maintenance. The framework merely insists that this is an 
empirical question that may or may not be correlated with 
institutional affiliation. While high civil servants may be 
brokers, they are often policy advocates — particularly when 
their agency has a clearly defined mission. 459 
Further  with:leo on policy brokers in the ACF however do not emphasise the notion 
of a continuum whereby policy makers are endowed with the capacity to be both 
advocates and intermediaries between coalitions to varying degrees. 
459 Sabatier, P., 1987, 'Knowledge, Policy Oriented Learning, and Policy Change', Knowledge, 
Creation, Diffusion, Utilization, 8:4, June, pp649 — 692. 
4'513 Sabatier, P., 1989, 'An advocacy coalition framework of policy change and the role of policy-
oriented learning therein', Policy Sciences, 21, 129-168; Sabatier, P., & Jenkins-Smith, H., 1993, 
Policy Change and Learning: an Advocacy Coalition Approach, Westview Press, Colorado; Sabatier, 
P., & Jenkins-Smith, H., 1994, 'Evaluating the Advocacy Coalition Framework', Journal of Public 
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Three policy actors were identified in preceding analyses as occupying duel roles of 
policy brokers/makers and coalition members. Out of the three, senior bureaucrat 
Les Drew is most easily classified as a 'policy broker' as he was a member of the 
bureaucracy and directly charged with the drafting of policy (specifically the 
NCADA in 1985). The other two policy actors identified were then Federal Health 
Minister Neal Blewett and Prime Minister John Howard. Blewett recounted at length 
his personal involvement in making HIV/AIDS policy 461 , particularly the way in 
which study trips conducted around the time of the crisis influenced the details of 
policy and the use of parliamentary committees to avoid overt partisan conflict 
regarding sensitive and controversial issues to do with HIV/AIDS and injecting drug 
use. As identified, both Drew and Blewett strongly supported, and were responsible 
for the implementation of, harm reduction policies in Australia. Prime Minister 
Howard's personal interest in illicit drug policy was evidenced in a number of ways: 
through intervention into stopping the prescription heroin trial from proceeding, his 
personal appointment of Salvation Army Major Brian Wafters as head of the peak 
body, the MCDS, and also locating the MCDS in his personal portfolio as well as 
numerous statements with regard to his personal opinion on the direction of illicit 
drug policy all suggest some direct involvement in the shape and nature of policy. 
Indeed, Prime Minister Howard was a strong and vocal supporter of the moral-
abstinence coalition since winning Government in 1996. 
With these examples in mind it is suggested that the conceptualisation of a 
continuum that encompasses the roles of coalition advocate and policy broker at 
Policy, 14:2, pp175-203; Sabatier, P., 1998, 'The advocacy coalition framework: revisions and 
relevance for Europe', Journal of European Public Policy, 5:1, March, pp1350-1763. 
461 Blewett, N., 2003, Aids in Australia: Reflections on Australia's policy response to the AIDS 
Epidemic, Australian Health Policy Institute, University of Sydney. 
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either end be expanded and re-emphasised in further writings of the ACF. The extent 
to which such actors are coalition advocates or policy brokers is a key variable that 
has the potential to contribute to whether a policy is adopted. 
The government actors playing a critical role in the process 
are the executive, bureaucracy and legislature. In most 
cases the bureaucracy plays the main role, though high 
profile issue or the talents and determination of individual 
ministers are likely to encourage a greater role for the 
executive. 462 
Thus exploration of the degree of influence of key coalition members that are policy 
brokers requires further consideration. To have a coalition representative in a 
strategic role (such as a Federal Minister or a Prime Minister) within the subsystem 
is a substantial variable when it comes to examining policy change. With this in 
mind it is suggested that a second continuum be added that gauges the degree of 
influence of such a position. 
Figure 2: Policy broker axis of role and influence 
Highly influential 
Coalition advocate 
  
Policy broker 
  
For example if such a tool was used in this thesis and the roles and relative degree of 
influence of senior bureaucrat Lew Drew (LB), Federal Health Minister Neal Blewett 
(NB) and Prime Minister John Howard (JH) were plotted on these axis the following 
would result: 
462 Howlett, M & Ramesh, M.,1995, Studying Public Policy: policy cycles and policy subsystems, 
Oxford University Press, Ontario, p199. 
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Figure 3: Policy broker axis of role and influence 
Highly influential 
Coalition advocate 
  
Policy broker 
  
  
In sum, such a tool could be considered for inclusion into the ACF and provide 
further explanatory power into the relative power of individual members and the 
consequent implications for policy success. 
The work by Kingdon,463 specifically the concept of 'policy entrepreneurs', is highly 
relevant and could compliment the ACF in this area. Kingdon conceptualises policy 
entrepreneurs as stakeholders who develop proposals and solutions to problems and 
who act opportunistically when such problems arise in the public debate. Such 
opportunities are coined 'policy windows'. A critical function of the entrepreneur is 
to change beliefs and attitudes about particular issues through investing time and 
resources to advance a position or policy when such an opportunity presents. Such a 
conceptualisation of policy actors in the context of illicit drug policy in Australia in 
this period aptly describes individuals such as Les Drew and Neal Blewett, among 
many others in this period, for example, Dr Alex Wodak. 
Further, Kingdon's work could be helpful to describe the opportunity structure inside 
the Government and the way this allows for coalition formation and for new ideas to 
enter the institutional world. Harm reduction policy entrepreneurs regularly 
encounter opposition with the more politically expedient moral abstinence ideas that 
are commonly espoused by most members of the political executive unless and until 
463 ICingdon, J,. 1984, Agendas, Alternatives and Public Policies, Little Brown, Boston. 
244 
(as the ACF correctly predicts) an external shock triggers a policy window and thus 
engenders policy entrepreneurs into action. An amalgamation of Kingdon's and 
Sabatier's models could well strengthen the explanatory power of both. The ACF 
provides the systemic contextual factors as well as the triggers for policy change with 
Kingdon's work, where relevant to the subject under investigation, providing further 
detail on how those ideas are translated into policy through the agency of key 
individuals. 
• Research Question 4.2: To what extent do policy brokers 'make' policy? Do 
policy brokers receive conflicting strategies? Do policy brokers reach 
compromise between coalitions? 
This analysis explores the policy making cycle as described in the ACF and the role 
of policy brokers as described as follows: 
Conflicting strategies (advocated by each coalition) are 
submitted to 'policy brokers', a group of actors that 
represent the Government and are responsible for reaching 
compromise and limiting conflict, whose principal concern 
is to find some reasonable compromise that will reduce 
intense conflict The end result is one or more 
governmental programs, which in turn produce policy 
outputs at the operational leve1. 464 
The wording of this process does not reflect the extent to which policy makers can 
occupy both roles of advocates and brokers and the impact that this has on the 
process of policy-making. Moreover, different types of policy forums are also not 
adequately reflected in the above summation. For example, the process of 
deliberating the operational parameters of a proposed SIC was undertaken at the 
464 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p104. 
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NSW Drug Summit. Working groups were convened to discuss and vote for a 
number of recommendations and conditions related to implementation of such a 
facility. In such a forum representatives from both the moral-abstinence (for 
example Reverend Fred Nile, Leader of the State Opposition Kerry Chikarovski) and 
harm reduction (for example Premier Bob Carr, Clover Moore) coalitions debated 
various aspects of the topics that were subsequently subjected to a vote from the 
group. The results of the vote formed the basis for policy on the SIC in Kings Cross. 
In this sense 'compromise' was reached through this participative process which is 
quite different from the process described in the ACF. 
External Variables 
Research Question 5.1: Were such phenomena, as categorised in the ACF, 
stable from 1980 to 2000? 
As described in chapter two, the ACF contains two sets of exogenous variables. It is 
hypothesised that 'stable system parameters' are rarely targeted by coalition 
members for reform because, as the name suggests, such factors are less likely, or 
more difficult to, change. Such a notion was generally supported in this analysis 
with two exceptions identified. Both changes occurred in the category entitled 'basic 
attributes of the problem area' in the ACF and are outlined below. 
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Emergence of a new language 
In this period the harm reduction coalition, buoyed by medical/research interests, 
presented an alternative way to examine illicit drug policy, namely using empirical 
research to underwrite and evaluate policy and practice. Such an approach, 
reinforced and spearheaded by medical and academic personnel, was characterised 
by a scholarly approach to examination of the illicit drug problem. Examples of the 
types of research conducted by harm reduction advocates are evident throughout this 
thesis. Previous to this approach, there was little in the way of systemic investigation 
into the efficacy of services or phenomena that generated drug related harms. 
Furthermore, such research was also conducted in arenas other than health. Law 
enforcement agencies also examined the link between police practice and illicit drug 
harms465 providing further information on the interaction between law enforcement 
and health sectors and the former's capacity to manufacture (albeit unintended) drug 
related harm. The general shift in the bureaucracy towards incorporating 
performance reporting to underscore public programs and policies also presented an 
opportunity for harm reduction advocates to further strengthen the legitimacy of their 
programs through demonstration of cost effectiveness and positive outcome based 
evaluations of programs. Indeed, the Return on Investment in Needle and Syringe 
Programs in Australia report stated that NSPs were highly cost effective in terms of 
465 For example: Weatherbum, D., & Lind, B., 1997, 'The impact of law enforcement activity on a 
heroin market', Addiction, 92:5, pp557-569; Hellawell, K., 1995, 'The Role of Law Enforcement in 
Minimizing the Harm Resulting from Illicit Drugs', Drug and Alcohol Review, 14, pp317-22; Aitken, 
C., Moore, D., Higgs, P., Kelsall, J., & Kerger, M., 2002, 'The impact of a police crackdown on a 
street drug scene: evidence from the street', International Journal of Drug Policy, 13, pp193-202; 
Chilvers, M., & Weatherbum, D., 2003, 'The impact of heroin dependence on long terms robbery 
trends', Crime and Justice Bulletin, 79. 
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the prevention of HIV and HCV infections and also improvements in the general 
health of drug users.466 
It is posed here that the research focus of the harm reduction project presents an 
indirect yet ongoing challenge (in the long term) to the moral-abstinence coalition. 
That a core tenet of the practice of harm reduction is that policies and programs must 
be underwritten by empirical research that focuses on a rational calculation of costs 
and benefits467 poses a challenge to the moral-abstinence coalition to replicate this 
approach in order to justify its policy positions. This is particularly pertinent in an 
age where policy outcomes and cost effectiveness is increasingly scrunitised. In this 
period, discourse that emphasised the morality or immorality of drug use was often 
not underscored by research. Further, advocates of the moral-abstinence approach 
sometimes expressed scepticism toward research that supported harm reduction. It 
is argued that the continual application of research (propagated by such groups such 
as National Drug Research Institute and National Drug and Alcohol Research 
Centre) would serve to provide further support to harm reduction programs and 
policies through provision of an evidence base. 
Despite the emergence of a new language to discuss illicit drug issues, morality 
driven arguments continued to feature throughout the period of analysis. Indeed, 
since the election of the Federal Howard Government in 1996 such arguments 
seemed more prolific in the period 1995-2000 than in the previous 15 years. This is 
possibly explained by the degree to which Prime Minister Howard personally 
subscribed to such thinking and his direct intervention in policy. 
466 Commonwealth Department of Health and Ageing, 2002, Return on investment in needle and 
syringe programs in Australia, Department of Health and Ageing, Canberra, available at: 
http://www.health.gov.au/pubhlth/publicat/hac.htm  (accessed Jun 2003). 
467 Riley, D., & O'Hare, P., 2000, 'Harm reduction: History, Definition and Practice', in J., Inciardi et 
al. (eds) Harm Reduction: National and International Perspectives, Sage, California, p7. 
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Emergence of a new disease and reconfiguration of the 'problem' 
As well as a new language with which to debate policy, the illicit drug problem also 
increasingly became seen as a 'health' issue. During the 1980s, the role of health in 
responding to illicit drug use was expanded, encapsulated by the first national drug 
strategy in 1985. This expansion coincided with the appearance of HIV/AIDS and 
its link with injecting drug use. Previous to HIV/AIDS the harms resulting from 
illicit drug use included: harm to individuals, conceptualised as experiencing some 
kind of 'sickness' (predominantly that associated with overdose and dependencies); 
the direct impact of such sickness on friendship, familial and community groups; and 
last, economic consequences (costs of rehabilitation and drug related crime). 
HIV/AIDS, however, added another dimension to the nature of the problem 
(captured in the phrase 'second aids epidemic') whereby injecting drug use could 
potentially result in major illnesses of people who did not inject. As stated this 
dramatically changed the nature of the problem. In contrast, the advent of HCV did 
not dramatically alter the nature of the problem as the virus was/is relatively 
contained within the injecting drug user population and also does not always result in 
chronic illness or death. 468 
Ever-changing drug trends between 1980 and 2000 
While increases in illicit drug use can be exaggerated and sensationalised in the 
media, there were some changes in the prevalence of drug use and availability of 
illicit drugs. 
468 It is recognised that the disease has the potential to pose a substantial threat to government health 
budgets in the long term however. 
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The prevalence of injecting drug use has increased 
significantly in Australia in recent years. Using the 
nationally representative 1998 National Drug Strategy 
Household Survey we estimate the size of the lifetime 
prevalence injecting drug use population at 302710 people, 
compared to 67474 in 1988. Those who have injected drugs 
in the previous year are estimated at 108750 people in 
1998. Amphetamines have displaced heroin as the most 
popular drug to inject among the general population. 469 
While falling just outside the period of analysis the shortage in heroin availability in 
early 2000s meant an increase in the popularity of amphetamine use. 
A number of studies have consistently suggested that 
between 2000 and 2001, there was a sizeable decrease in 
both prevalence and frequency of heroin injection among 
injecting drug users. These changes were accompanied by 
increased prevalence and frequency of stimulant 
inj ection.47° 
The illegality of some drugs means that their supply is not easily controlled. While 
some drugs such as marijuana can be grown with relatively little infrastructure or 
effort, supply of the other drugs such as .amphetamines rely on the availability of 
precursor chemicals471 whereas heroin supply is contingent on relatively 
sophisticated concealment methods 472 (and a degree of luck) in order to import it. 
Therefore, while there has been a steady supply of different illicit drugs throughout 
1980 to 2000, to a degree the prevalence of some drugs has fluctuated during this 
469 McAllister, I., & Maldcai, T., 2001, 'The prevalence and characteristics of injecting drug users in 
Australia', Drug and Alcohol Review, 20:1, p29. 
470 Topp, L., Day, C., & Dehenhardt, L., 2003, 'Changes in patterns of drug injection concurrent with 
a sustained reduction in the availability of heroin in Australia', Drug and Alcohol Dependence, June, 
5:70 (3), p275. 
471 	.precursors will be imported illicitly, or licit precursor chemicals will be diverted to syndicates 
manufacturing amphetamine in Australia." From Mahoney, P., 2000, 'Illicit Drugs in Australia: an 
overview', in G., Stokes, P., Chalk & K., Gillen (eds), Drugs and Democracy, Melbourne University 
Press, Carlton South, p66. 
472 For example heroin was smuggled in via plastic chairs: Australian Federal Police, 2005, 'Plastic 
Chairs attempt to hide massive heroin import', Media Release, 13/5/2005 available at: 
http://www.afp.gov.au/data/assets/pdf file/1908/mr050513operationdomini.pdf and Australian 
Federal Police & Australian Customs Service, 'Heroin found concealed in hard sided suitcase', Media 
Release, 26/4/2006, available at 
http://www.afp.gov.au/media_releases/nationa1/2006/heroinfound_concealed_in_hard-sided_suitcase  
both accessed on 25/5/2006. 
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time. This means that one of the basic characteristics of the problem area is this 
ever-changing prevalence of use due to fluctuations in availability. This is an 
interesting feature when analysing policy change in relation to the illicit drug policy 
subsystem through the lens of the ACF. Of the two sets of variables classed in the 
ACF as external to a subsystem, this systemic feature of the illicit drug policy 
subsystem fits best in one of the stable categories entitled 'basic attributes of the 
problem area'. That ongoing change is a constant in the illicit drug policy subsystem 
presents a conundrum for the ACF. As the majority of applications of the ACF have 
been directed toward analysis involving natural systems (for example investigations 
of energy policy, nuclear waste and weapons, water policy, environmental policy, 
forest policy, public lands, auto pollution control, water pollution, professional fora, 
climate change, oceans waste, roads policy473) is reflected in the ACF as basic 
attributes of such systems change over a slower time scale. In contrast, the open and 
unregulated nature of illicit drugs markets results in changing drug use patterns based 
on availability of source materials and consumer demand over a relatively quicker 
time period. According to the ACF, the other set of dynamic exogenous factors 
entitled 'external system events' (this category includes: changes to socio economic 
conditions, public opinion; systemic governing coalitions and policy decisions and 
impacts from other systems) constituted the major means to affect policy change. It 
is argued here that changes such as HIV/AIDS and drug trends were highly 
significant factors and should be classified under this set of dynamic external 
variables. 
473 Sabatier, P., 1998, 'The advocacy coalition framework: revisions and relevance for Europe, 
Journal of European Public Policy, 5:1, March, p100-101. 
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Research Question 5.2: Did coalitions target these parameters for reform? 
It is illogical that coalitions could target such parameters as the emergence of a new 
disease and also changes to illicit drug trends between 1980 and 1990 as such events 
are beyond the control of regulatory agencies. It is clear, however, that the harm 
reduction coalition was quick to react to such changes. The public health challenge 
presented by HIV/AIDS was an opportunity for coalition actors to advocate for 
policy that responded to the threat of widespread transmission of the virus. The 
upsurge in problematic heroin use in the mid 1990s resulted in increased calls for 
policy responses from the community. The exception, however, in this time period, 
was the increase in medically driven and program evaluation research regarding drug 
policy and programs. In a sense, such research challenged traditional approaches to 
illicit drug policy that were not typically evidence-based and generally enacted 
without requiring proof of their efficacy. That the harm reduction coalition took 
such an approach was a product of their membership including scientists actively 
involved in research. The extent to which such personnel deliberately set out to 
derail other approaches to illicit drug policy at the start of the period is unknown, 
however by the close of the 1990s, it was evident that harm reduction coalition actors 
were consistently armed with a cache of research with the aim of both justifying their 
policy and also critiquing other policy approaches. 
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Policy Oriented Learning 
Research Question 6.1: What was the role of quantitative data/information in 
policy oriented learning 
From 1980 to 2000 there was an increase in research into illicit drug pharmacology 
and harms. Through the NCADA, funding was provided for research institutes in the 
late 1980s that continued through to 2000 and beyond. The National Drug and 
Alcohol Research Centre (NDARC) at the University of New South Wales, 
established in 1987, examines key research areas such as evaluation of treatment 
modalities and epidemiological research. Such research aims to increase knowledge 
about the nature and extent of drug related harms generally and the range and 
effectiveness of treatment available to substance users in Australia. Moreover, 
epidemiological research conducted in each state and territory monitors the price, 
purity and patterns of use of the main illicit drugs used in Australia, acting as an 
"...early warning system for emerging trends in illicit drug market." 474 The National 
Drug Research Institute (NDRI) at Curtin University in Western Australia, 
established in 1986, also has a research focus on examining issues related to drug 
related harm. Priority areas for research included: the monitoring of drug 
consumption, stopping BBV transmission among injecting drug users (for example 
through informing the development of initiatives that aim to prevent HCV), 
evaluation of educational, legislative and regulatory strategies, evaluation of school 
drug and education programs, increasing understanding of community based drug 
prevention and investigating the ways in which educational, legislative and 
regulatory strategies impact on the social contexts of alcohol and other drug use to 
474 From National Drug Alcohol Research Centre website: 
http://notes.med.unsw.edu.au/NDARCWeb.nsf/page/IDRSa  accessed 11/3/06 
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produce or reduce harm. Other research groups such as Turning Point 475 (operating 
since 1994) and the Centre for Harm Reduction 476 (operating since 1986) also have 
produced research relevant for personnel working in harm reduction programs. 
Many of the research projects and papers from the above institutes were cited in this 
thesis. Moreover and as noted throughout the thesis, Dr Alex Wodak 477 also 
contributed a substantial amount to the harm reduction project. Similarly, Dr Nick 
Crofts478 has conducted research on BBVs and the connection with injecting drug use 
is another high profile contributor to harm reduction research. It is acknowledged 
that many other individuals and organisations (especially self-help drug user 
organisations) have also contributed to the production of research in relation to harm 
reduction theories and practice. Indeed research into the effectiveness of harm 
reduction policies and programs from other countries 479 was also effective when 
advocating for equivalent policies in the domestic context. In the case of advocating 
for SICs in NSW, an evaluation of the European experience was critical to forming a 
case to debunk myths such as the assertion that harm reduction initiatives lead to an 
475 from Turning Point website: http://www.tumingpointorg.au/index.html  accessed 11/3/06 
476 from Centre of Harm Reduction website: http://www.chr.asn.au/home accessed 11/3/06 
477 Examples of Dr Wodak's work follow: Wodalc, A., 1997, 'Injecting nation: achieving control of 
hepatitis C in Australia', Drug and Alcohol Review, 16; Wodak, A, & Owens, R., 1996, 'Drug 
Prohibition a Call for Change', Frontlines, University of New South Wales Press, Sydney; Wodalc, 
A., & Saunders, B., 1995, 'Special issue on harm reduction', Drug and Alcohol Review, 14; Wodak, 
A., 1999, 'What is this thing called harm reduction?', International Journal of Drug Policy, 10, 
pp169-171; Wodak, A., 2000, 'Developing more Effective Responses', in Drugs and Democracy, G 
Stokes, P., Chalk & K., Gillen (ects), Melbourne University Press, Canton South; Wodak, A., Fisher, 
R., & Crofts, N., 1993, 'An evolving public health crisis: HIV infection among injecting drug users in 
developing countries', in Psychoactive Drugs and Harm Reduction: from faith to science, N., Heather, 
A., Wodalc, E., Nadlemann & P., O'Hare (eds), Whurr, London; Wodak, A., & Moore, T., 
Modernising Australia's Drug Policy, UNSW Press, Sydney; Wodak, A., 1997, 'Public health and 
politics: the demise of the ACT heroin trial', MJA, 167. 
478 Examples of Dr Croft's work follow: Crofts, N., & Aitken, A., 1997, 'Incidence of bloodbome 
virus infection and risk behaviours in a cohort of injecting drug users in Victoria 1990-1995', eMJA, 
accessed at http://www.mja.com.au/public/issues/jul7/crofts/crofts.html on 20/2/06; Crofts N., Louie 
R., Rosenthal D., & Jolley D., 1996, 'The first hit: circumstances surrounding initiation into 
injecting', Addiction, 91, pp1187-1196; Crofts, N., & Aitken, C., & Kaldor, J., 1999, 'The force of 
numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not', MJA, 
170, pp220-221. 
479 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales; Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., 
McDonald, D & Trautmann, F., 2000, 'Drug consumption facilities in Europe and the establishment 
of supervised injecting centers in Australia', Drug and Alcohol Review, 19. 
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increase in drug use. Such research institutes, funded by Federal Governments since 
the NCADA, contributed to the research base used by harm reduction advocates used 
to both justify and advocate for policies and programs. 
Research Question 6.2: Was such data accepted by both coalitions? 
Research Question 6.3: If not what were the barriers to its acceptance? 
When referring to policy oriented learning in this thesis, it is clear that there are two 
possible avenues in which this can occur. The first opportunity is for learning to take 
place was between harm reduction and moral-abstinence coalitions, whereas the 
second opportunity was between health (with regard to learning on harm reduction 
more specifically) and law enforcement groups. It was expected that the latter will 
be more conducive to cross pollination as there was ongoing and systemic contact 
between the two groups as outlined in chapter four. 
With regard to the relationship between health/medical/harm reduction and law 
enforcement sectors, in the early days of the establishment of harm reduction 
programs (especially NSPs) there was some resistance. Some police were not 
supportive of harm reduction interventions as NSPs as such programs were regarded 
as both undermining police work and also condoning drug use. 48° By the late 1990s, 
as noted in chapter four, many law enforcement personnel were outwardly supportive 
of harm reduction programs and policies and were conducting research into the way 
in which police practice can generate harms. This was a significant change and 
related to the systemic and scholarly collaboration between the two sectors. 
48° From Kutin, J., 1998, 'Law Enforcement and Harm Minimisation', in Drug Use in Australia: A 
Harm Minimisation Approach, M., Hamilton (et al., Oxford University Press, Melbourne, p162. 
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In contrast, the relationship between the harm reduction and moral-abstinence 
coalitions was not as collegial. Throughout the period, there was little change in the 
types of criticism of harm reduction programs from members of the moral-abstinence 
coalition. Indeed, members were suspicious of the worth and in some cases directly 
opposed to the harm reduction approach to illicit drug use. Moreover the coalition 
remained unmoved by the ongoing production of credible, peer reviewed, scholarly 
research. In this period the moral-abstinence coalition relied more on testimonials 
drawn from observations of concerned citizens/parents in conjunction with "moral 
truths" in debates (specifically in those regarding prescription heroin and SICs) than 
on evidence using the scientific method. Further such groups also treated with 
scepticism the evidence produced by the harm reduction coalition. 
Of interest was the way in which the moral-abstinence coalition was not compelled 
to justify their positions as much as the harm reduction coalition. This is an 
interesting phenomenon in illicit drug policy debates and not unique to the Australian 
setting. That such approaches are adopted in many states and championed by such 
international bodies as the United Nations Narcotics Control Board with little 
evidence required of their effectiveness points to the global stranglehold on illicit 
drug policy by the international moral-abstinence coalition's approach in relation to 
illicit drugs. The nature of moral approaches as those based on religious or deep 
convictions that particular activities are inherently right or wrong is a common theme 
in many social issues. Issues to do with sexuality (for example, abortion, 
contraception and homosexuality), gender (for example, policies directed at women 
in work) and illicit drugs all seem to have coalitions of policy actors that champion 
the moral basis to policy making. Such beliefs when translated into policy are based 
on religious or other deep convictions about the way social phenomena should be 
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governed. With regard to drug use, dependencies are seen as an indication of moral 
weaknesses and/or lack of willpower and often the fault of the drug itself which is 
regarded as always associated with physical, moral and social decline. 481 Such an 
approach often seems impervious to scholarly information exchange due to the 
following factors: 
• Moral-abstinence advocates require different types of proof or verification of 
their policy beliefs such as morality or religious beliefs, 
• Such approaches are the antithesis of the rational scientific method, 
• A rejection of the rational scientific method as a mechanism to examine 
moral issues, and, 
• Suspicion that the harm reduction coalition has a secondary agenda of 
promoting or encouraging drug use, and an associated general disregard for 
society. 
Such qualities result in a deadlock. As was seen in the 1990s, some members of the 
harm reduction coalition were uncomfortable with the inclusion of abstinence-
oriented approaches in the term harm reduction. 482 By 2000, the harm reduction 
coalition had accepted that a range of approaches was necessary to give service 
consumers greater choice in drug treatment. 483 In terms of curbing HIV/AIDS and 
HCV, however, the harm reduction coalition were adamant programs such as NSPs 
were critical to reducing the impact of the virus on public health and indeed those 
countries that did not implement such programs experienced worse outcomes. 484 
481 Kellehear, A., & Cvetkovsld, S., 1998, 'Grand theories of Drug Use', in ibid, p49-50. 
482 Lenton, S., & Single, E., 1998, 'The definition of harm reduction', Drug and Alcohol Review, 17. 
483 ibid. 
484 "Australia has a 5% HIV infection rate among injection drug users as compared to 14% in the 
United States. Furthermore, it has been argued that this difference is due to the limited number of 
needle exchange programs in the United States, from Wodak, A., & Lurie, P., 1997, 'A tale of two 
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Generally speaking members of the moral-abstinence coalition remained unmoved 
by the end of the 20 year period of study. In contrast, the law enforcement sector had 
changed in some ways both in research and practice. Such change was evident from: 
attitudes of personnel expressed in various reports whereby they expressed support 
for programs such as SICs485 and prescription heroin486 , operational changes such as 
harm minimisation policing487  and research into police practice and drug related 
harins.488 
Research Question 7.1: In cases where policy oriented learning occurred, did 
the conflict concern secondary aspects of both coalitions or between the 
secondary aspect of one coalition and the policy core of the other? 
Policy oriented learning between the health and law enforcement sectors was 
facilitated through national drug strategies since 1985. As outlined in chapter four, 
both sectors shared membership of various national committees and were regularly 
exposed to each other's perspectives on illicit drug issues. Such committees were 
collegial and prestigious and reinforced the policy core aspects of both belief 
systems. Harm reduction approaches were understood to be important public health 
strategies whereas law enforcement was regarded as having a role to play in the 
policing of manufacturers and traffickers. That law enforcement strategies could 
produce drug related harms was a salient point that was investigated further. 
Moreover, diversion programs and the lowering of some penalties for some drug 
countries: Attempts to control HIV among injecting drug users in Australia and the United States', 
Journal of Drug Issues, 27, pp117-134. 
485 Joint Select Committee into safe injecting rooms, 1998, Report on the establishment or trial of safe 
injecting rooms, Parliament of New South Wales, pxvi. 
486 
Wood, 
 v. a	1997, Royal Commission into the NSW Police Service, vol 2, NSW Police Integrity 
Commission, Sydney, p228. 
487 Drug Policy Expert Committee, Drugs: meeting the Challenge, Victorian Government, accessed at 
www.dhs.vic.gov.au/publications/index.htm,  on 12/12/04, pl 82. 
488 Australian Bureau of Criminal Intelligence, 1997, Australian Illicit Drug Report 1996-7, 
Commonwealth of Australia. 
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users was also another concession by the law enforcement sector. Both of these are 
considered to be secondary aspects of belief systems. Thus this assertion in the ACF 
holds in this analysis. 
As noted above policy oriented learning between the harm reduction and moral-
abstinence coalitions was minimal to non-existent. This is surmised to be due to the 
difference in approaches taken by both coalitions whereby one focuses on scientific 
reasoning and the other on moral or religious beliefs to inform illicit drug policy. 
The differing philosophies that underwrite both types of evidence are in opposition 
and result in a deadlock of debate. 
Research Question 8.1: What were the type of forums that facilitated policy 
oriented learning? 
As mentioned in chapter four, policy oriented learning between harm reduction and 
law enforcement personnel was facilitated by their shared membership on several 
national committees such as the MCDS, IGCD and ANCD. All three forums also 
conformed to the typology of successful forums in the ACF as discussed in chapter 
four. The characteristics of these forums were as follows: shared membership and 
alternating leadership of both health and law enforcement on the forums; all forums 
were funded by the Federal Government rather than have funding originating from 
either coalition; and all the forums were convened regularly, in most cases several 
times a year. Moreover the forums were underwritten by professional norms and 
highly prestigious in the sector. 
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Thus the work on policy oriented learning in the ACF was supported in this thesis 
with remarkably different outcomes from learning between harm reduction and law 
enforcement groups in contrast to harm reduction and moral-abstinence coalitions. 
In the case of the latter, members of the harm reduction and moral abstinence group 
interacted via the media and other arenas such as the NSW Drug Summit. Some 
moral abstinence advocates did participate in the peak national forums such as 
MCDS, IGCD and ANCD, however such forums were underwritten by professional 
norms and as such this meant that policy core ideas such as the role of harm 
reduction within the overall framework of the national drug strategy was not overtly 
challenged in these arenas. Indeed, the more fundamental challenge to harm 
reduction was enacted outside such forums. 
Policy Change 
In the period 1980 to 2000 several changes occurred in illicit drug policy as noted in 
previous chapters. There was one instance of major policy change heralded with the 
introduction of a national drug strategy (NCADA) in 1985. This major change 
spawned several minor changes that occurred in following years. Several types of 
policy change occurred in this period, these are categorised below: 
1. 'Major' 
Policy change that impacts across a subsystem and necessarily effects the 
foundations of an issue area is typified as 'major' in the ACF. In this sense the 
instigation of the NCADA that reorganised the way in which agencies responded to 
illicit drug use is considered a 'major' change. A key part of the NCADA was an 
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increase in the role of health agencies and an accompanying change to 'harm 
minimisation' (in this sense, the term encompasses the three strategies of supply, 
demand and harm reduction approaches) as the principle overarching concept. 
Details of this were discussed at length in chapter three. Of particular interest in this 
chapter is the long-term effect of such major policy change. Indeed it is suggested 
here that the instigation of the NCADA, a national document that essentially married 
health and law enforcement sectors resulted in systemic suite of secondary policy 
changes. 
/ 
2. 'Secondary' 
Policy change that impacts on parts of the subsystem such as localised decisions, 
rules and budgetary allocations related to the illicit drug problem (for example the 
problem of heroin overdose) is classified as secondary in the ACF. In the period 
1980 to 2000, several secondary policy changes were identified in preceding 
chapters. The main changes relevant to this analysis are as follows: the 
implementation of NSPs and safer using education in all states and territories by 
1993, the expansion of MMT for injecting drug users with HIV/AIDS, the 
implementation of programs to divert some injecting drug users charged with 
possession offences away from court and to treatment programs, and, opening of one 
SIC in Kings Cross, NSW. The first two examples were initiatives designed to curb 
the number of transmissions of HIV/AIDS in injecting drug users. Diversion of 
injecting drug users away for court and to treatment programs and the 
implementation of a SIC, reflected the way that agencies had increasingly regarded 
drug use as a health issue. It is suggested that this increased perception was 
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facilitated by successive national drug strategies and consequent policy oriented 
learning between health and law enforcement sectors. 
3. 'Gradual and systemic' 
A third type of policy change was identified in this analysis. While both previous 
categorisations of policy change have focused on the scope of policy change, 
whether resulting in system wide or localised impacts, a third type is identified as 
occurring in the 20 year period of analysis. Gradual and systemic policy change is 
distinct from that termed 'major' and 'secondary' as such change often takes a longer 
period of time (usually best examined in hindsight) to germinate results. Moreover, 
this type of modification to part of a subsystem can signify a wider shift in the 
philosophical disposition of an issue area. It is also proposed that in the case of illicit 
drug policy, such gradual and systemic change was the result of major policy change 
conducted in 1985 noted above. Below are examples of such gradual and systemic 
policy change identified in the preceding chapters: 
Involvement of injecting drug users in the development of policy 
Between the late 1980s and 2000, affected communities engaged with policy makers 
to varying degrees in developmental and consultative capacities. The inclusion of 
injecting drug users in the development of some drug policy was largely linked to the 
nature of HIV/AIDS policy and its overlap with illicit drug policy. Chief HIV/AIDS 
policy architect, then Federal Minister for Health, Neal Blewett championed this 
approach. The notion of involving affected communities had two effects. First, it 
contributed to the instigation of self-help drug user groups in most states and 
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territories that served the purpose of providing policy advice and analysis on the 
impact of policy on drug related harm of injecting drug users. Such self-help drug 
user groups contributed to policy throughout the period since their establishment. 
Such organisations were best placed to convert complex policy issues into 
appropriate information so to reach marginalised injecting drug users and moreover 
to feedback information to governments. Second, such groups were able to further 
the harm reduction project through participating in service delivery. Research 489 
suggests that peer run NSPs and education are particularly effective tools to limit the 
spread of BBVs into the community. Such contributions from affected communities 
served to promote and strengthen harm reduction ideas and their role in illicit drug 
policy. 
Harm minimisation policing 
In the 1990s, the results of successive national drug strategy frameworks became 
evident as the law enforcement sector incorporated key ideas of harm reduction into 
its theory and practice. As described in chapter four, the notion of 'harm 
minimisation policing' meant greater understanding and cooperation between health 
and law enforcement agencies with an overall aim of affecting a reduction in drug 
related harm and also a level of introspection regarding the links between police 
practice and drug related harm. In this example of gradual and systemic policy 
change, ideas from one coalition or sector had infiltrated another. The way in which 
such cross pollination occurred is discussed above and encapsulated in the notion of 
489 31 "Further decreases in needle-sharing will require increased support for accepted programs 
(increased funding and reach of needle exchange programs, pharmacy sales, peer education)..." from 
Crofts, N., Aitken, C., & Kaldor, J., 1999, 'The force of numbers: why hepatitis C is spreading among 
Australian injecting drug users while HIV is not', MJA, 170, pp220-221; Davis, A., Davey, J., Hunter, 
A., Williams, M., Richards, N., & Symonds, T., 2002, The role of amphetamine injection in hepatitis 
C and drug use risk behaviours, Queensland Health, Brisbane. 
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policy oriented learning. That law enforcement agencies adopted such ideas in 
operational practice signified a level of acceptance toward the deployment of harm 
reduction ideas in particular contexts. Lastly such developments also suggested that 
critiques by harm reduction advocates (written at least a decade previous) that 
identified ways in which law enforcement practice manufactured drug related harm 
were taken into consideration. While this was not a direct victory for harm reduction 
advocates, indirectly it was an important development and also a starting point with 
regard to challenging the hegemony of law enforcement approaches in illicit drug 
policy. 
The establishment of a national framework to respond to problems associated by 
illicit drugs in 1985 resulted in both secondary, and, gradual and systemic policy 
change. The choices made at the time of the advent of HIV/AIDS affected the way 
illicit drug policy was made over a decade later. While the broader definition of 
harm minimisation, as noted in chapter four, was contested by some harm reduction 
advocates, such a description also engendered a more inclusive environment where 
both agencies were regarded as working toward a common aim. 
Research Question 9.1: In cases of changes to the policy core, was there an 
external shock to the subsystem? 
Research Question 9.2: How did coalitions integrate such external events into 
strategies to realise policy objectives? 
HIV/AIDS constituted the major shock to the illicit drug policy subsystem in this 
period and the effect on changes to the policy core has been documented at length 
already in this thesis. Moreover the guidance strategies used by coalition members 
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have also been discussed earlier. Of particular interest is why the identification of 
another BBV (namely HCV) was not accompanied by a similar level of interest and 
policy making. Some possible reasons for this may include the following: 
• Long term threats are less compelling to policy makers than those with 
immediate to medium-term ramifications, 
• Linkages with other communities (such as the gay community) strengthen the 
rationale underwriting policies, 
• The illegal status of injecting drug use and associated social stigma of the 
activity limits the efficacy of harm reduction policy. 
The existence of HIV/AIDS and BBVs more generally continued to reinforce the 
currency of policies directed toward current injecting drug users. Since 1985, a key 
part of advocating for such initiatives as MMT, NSPs, prescription heroin and SICs 
was the proposed reductions in BBV transmissions that could ensue from such 
programs. Of secondary concern were the benefits directly afforded to injecting drug 
users such as better physical, economic and social outcomes associated with such 
programs. Indeed, from evidence presented in preceding chapters there exists a 
general indifference, and in some cases open hostility, toward injecting drug users. 
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Major Policy Change — Condition 2 
Research Question 10.1: In cases of changes to policy core, did the subsystem 
coalition that instituted the program remain in power? 
Research Question 10.2: If yes, then was the change imposed by a 
hierarchically superior jurisdiction? 
Research Question 10.3: What was the outcome of major policy change 
regarding the relative power of coalitions within the illicit drug policy 
subsystem? 
In the ACF, it was suggested that some kind of power shift had to occur between 
coalitions as a consequence of change to the policy core of subsystems. One 
qualification to this was that policy core changes could occur without changes to the 
status of coalitions in a subsystem if the changes were imposed from a 
"...hierarchically superior jurisdiction." 4" This second qnalification sums up the 
way in which the change to harm minimisation in 1985 did not result in diminished 
authority of the law enforcement sector. The Federal ALP Government instructed 
bureaucrats to draft a policy that essentially ramped up the role of the health sector in 
policy while concurrently expanding funding for law enforcement. Throughout the 
period law enforcement strategies continually received more funding that that 
directed toward health. 
In financial terms, Federal and State Government 
expenditure in response to illicit drugs in 1992 was 
estimated at $U5393 million ($A620 million)...Of this not 
inconsiderable sum, 84 percent was allocated to law 
enforcement, 6 percent to treatment and 10 percent to 
prevention and research. Although these figures are 
somewhat imprecise, they represent the best indication 
490 Sabatier, P., A., 1998, 'The advocacy coalition framework: revisions and relevance for Europe', 
Journal of European Public Policy, 5:1, March, p106. 
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available of the uneven proportions of government 
expenditure allocated to supply reduction and demand 
reduction. Federal and State expenditure on methadone 
programs has been estimated at $A30 million per year. In 
1991, Australian expenditure on needle syringe programs 
was estimated at $A10 million. 491 
Indeed the prevailing attitude toward illicit drug policy in Australia and many other 
western states around the world is that it is an activity that should be discouraged due 
to the opinion that it presents unacceptable levels of risk. In this sense the changes in 
1985 to illicit drug policy with the instigation of the framework of the NCADA did 
not debunk the existing paradigm of law enforcement as the chief instrument with 
which to ameliorate the illicit drug 'problem', and the associated power of the law 
enforcement agencies within the subsystem. 
Conclusion 
This final section summarises and discusses potential additions and/or directions for 
future research concerning further theoretical development of the ACF identified in 
this research. The following points require further attention in the ACF: 
• An external shock, such as HIV/AIDS, has the capacity to generate both 
secondary and gradual policy change, fortify coalitions and change the 
makeup of coalitions, 
• The extent to which policy brokers can also act as coalition advocates is an 
important contributing factor to policy change, 
491 Wodak, A., 2000, 'Developing more Effective Responses', in Drugs and Democracy, G Stokes, P., 
Chalk & K., Gillen (eds), Melbourne University Press, Carlton South, p184. 
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• The policy-making cycle in the ACF needs to be reworked to include such 
phenomena as policy-making forums whereby deliberative processes 
contribute to the nature of policy, 
• Categories of guidance instruments need to be expanded to include 
community development and other forums that facilitate face-to-face 
meetings with experts and laypeople. Additionally acts of civil disobedience 
can also serve an agenda setting function, and, 
• Basic attributes of the (illicit drug) problem area were more changeable than 
allowed for in the ACF. 
Furthermore, while the ACF seems to cope reasonably well in applications to social 
problems like drug use, there are some limitations in the framework when examining 
social phenomena. Such limitations are also discussed below. 
In this analysis it became clear that the main external shock (HIV/AIDS) to the 
subsystem in the period of analysis was responsible for not only major policy change 
but also a suite of secondary policy changes. The multitude of secondary changes 
that occurred as a result of HIV/AIDS, were implemented both at the time of 
identification of the virus but also a decade later. HIV/AIDS prompted an explosion 
of policy activity to curb the spread of the virus into the mainstream population in the 
late 1980s and, moreover, the structures set up for HIV/AIDS in this time resulted in 
changes to drug policy a decade later. For examples, please see the section on 
'gradual and systemic' policy change identified earlier in this chapter. Furthermore, 
HIV/AIDS acted to fortify the harm reduction coalition from being a group that 
advocated for a new way to address problems associated with illicit drugs to a group 
that offered solutions to ameliorate the potentially disastrous impact of HIV/AIDS on 
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public health. Moreover, HIV/AIDS had a profound effect on the makeup of a 
coalition as identified earlier in this chapter. In sum, some external shocks have the 
capacity to have more of a profound impact upon a policy subsystem and as such 
warrants further development in the ACF. 
Further development of the conception of the policy making cycle, and the role of the 
policy broker within it, in the ACF is also required. The cycle of policy making as 
described in the ACF does not reflect types of policy forums (such as the 1999 NSW 
Drug Summit) whereby 'compromise' was reached through deliberative face-to-face 
processes with stakeholders. Moreover, this research has shown, in three cases, 
whereby policy makers from the bureaucracy or executive government have also 
been passionate advocates of a particular policy stance. Indeed, the personal 
convictions of senior health bureaucrat Les Drew, then Federal Health Minister Neal 
Blewett and Prime Minister John Howard clearly impacted upon the direction of 
policy. This research has suggested that an axis of role and influence be used to 
map the nature of the policy broker in order to qualify and quantify the extent of 
influence and allegiance to a particular coalition. Moreover, the ACF could be 
strengthened by consideration of Kingdon's concept of 'policy entrepreneurs' in 
order to explain in more detail the ways in which particular influential individuals 
impact on policy change. 
The idea that coalitions use 'research and information exchange' as 'guidance 
instruments' or strategies to convert beliefs into policy was supported in this 
analysis, however, it is suggested that sub-types of 'research and information 
exchange' be expanded upon. Community development strategies undertaken by the 
proponents of the ACT heroin trial and also the bipartisan parliamentary committees 
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enacted under Blewett were two examples of mechanisms whereby information 
about policy positions was disseminated in a particular way. Such forums provided 
an opportunity for the dissemination of politically sensitive or controversial 
information in face-to-face encounters between experts and stakeholders (often 
populated by many a layperson). Such an approach allowed questions to be 
answered and dissemination of correct information directly to stakeholders and was a 
clever way to curb misinformation or misrepresentation of policy positions that often 
occurs when controversial information and/or policy is disseminated through other 
channels such as the media. The use of strategies to circumvent controversy and 
misrepresentation of policy positions was a shrewd tactic used by members of the 
harm reduction coalition. Misrepresentation and other tactics used to discredit harm 
reduction ideas, policies and programs was an ongoing obstacle to harm reduction 
advocates looking to convert ideas into policy. Indeed such mechanisms that 
circumvent controversy and misinformation, it is posited, are more important to 
policy success in social systems than in natural systems. Information on 
controversial topics such as abortion, sexuality and drugs may be best disseminated 
in such forums. Moreover, morality-based undercurrents to such debates means that 
scientific information does not hold the same degree of legitimacy as in natural 
systems and as such the requirement to keep messages simple and accurate is a 
critical, yet difficult to achieve imperative especially when the topic to be 
disseminated challenges preconceived notions about human nature and social 
behaviour. Moreover, research and information gathering and exchange also, if 
conducted systematically, means that some coalitions are in a permanent state of 
being 'policy ready' should a window of opportunity present. This was the case in 
the 1990s with the harm reduction coalition quick to respond to policy problems with 
detailed solutions. 
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Another category or type of guidance instrument was identified in the research, 
namely the use of civil disobedience tactics as having an agenda setting function. As 
noted, this occurred twice in the period of analysis and resulted in the 
implementation of the program (for examples NSPs and SICs) a short time after. 
One caveat to this however, was that the civil disobedience actions in the two 
examples noted in this thesis were led by medical practitioners and a church group, 
ergo such groups enjoy a degree of legitimacy and/or prestige to their occupations 
and thus it is suggested that this lent credence to their actions. 
An unresolved issue generated by this research concerns the nature of stable system 
parameters in social systems. As noted earlier, changes to the 'basic attributes of the 
subject area' occurred more regularly than accounted for in the ACF. Changes such 
as the identification of HIV/AIDS and HCV (that changed the harm profile of 
injecting drug use) and the emergence of a new language in which to discuss policy 
were two examples of fundamental changes to system parameters that occurred in the 
period. Moreover the ever-changing nature of the availability and purity of illicit 
drugs meant that that change was a constant and fundamental factor of the illicit drug 
policy subsystem. Thus, the basic attributes of the problem area were more 
changeable than accounted for in the ACF. As noted earlier the ACF was formulated 
to initially examine natural systems in which change is hypothesised to occur on a 
slower time scale than in social systems. Moreover, phenomena in social systems are 
highly subjective and many critical variables are themselves active strategists. The 
illicit status of drugs also contributes to make the activity highly changeable and 
reliant on a number of volatile factors along the production cycle and commercial 
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transactions. In this sense, the changeable nature of some of the fundamental 
parameters in illicit drug policy presents a challenge to the ACF. 
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Conclusion 
This thesis had three broad aims: to explain the nature of policy change in the illicit 
drug policy subsystem; to provide direction for future development of the ACF; and 
to analyse the politics of harm reduction within the Australian setting. First, with 
regard to the nature of policy change, the persistent prevalence of illicit drug-related 
harm (for example: rates of overdose, problematic dependencies and drug related 
crime) mirrors the sustained deadlock in policy debate — a deadlock which, in turn, 
narrows the array of palatable policy responses. This thesis has explained the nature 
of this standoff between the two major coalitions within the illicit drug policy 
subsystem, as resulting from a difference in methods in which information is 
validated. Indeed, when advocates have vastly different ways of understanding and 
evaluating social problems (in this case the example was scientific/evidence-based 
approach versus morality-based appraisals), the result is a standoff between 
coalitions resulting in a 'dialogue of the deaf', with coalitions talking past each other. 
Scientific, evidence based accounts of social problems are treated with suspicion by 
moral-abstinence coalition (who suspect a wider agenda of normalisation of drug 
use), and similarly, the emphasis on moral beliefs in debates does not impress the 
harm reduction coalition (who suggest that such an approach is based on inaccurate 
assumptions). Consequently this inhibits debate as coalitions struggle with each 
other's basic assumptions about the way to evaluate the problem and thus find it 
difficult to entertain proposed policy solutions. Thus, both groups look to like-
minded individuals located in the policy making arena (which includes both 
executive government and the bureaucracy) in order to further their policy 
objectives. In contrast, the relationship between health and law enforcement 
agencies more generally is more collegial and consequently conducive to 
engendering secondary policy change. As noted, both sectors regularly engage in 
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prestigious, high-level forums and accept each other's relative positions - and as a 
result can co-exist within the illicit drug policy subsystem. Such a relationship 
means that problems regarding controversial subject matter can be discussed with 
relative dispassionate complexity thus facilitating policy oriented learning. Sabatier 
would rightly argue that this discussion would occur only at the 'secondary' level of 
policy beliefs, as the 'policy core' level of beliefs (that encompass, for example, 
beliefs about the roles of each agency in illicit drug policy) are agreed upon before 
the discussion occurs. 
Ultimately this thesis has identified a 'dialogue of the deaf' between some members 
of the harm reduction and moral-abstinence coalitions that runs parallel to the more 
constructive relationship between health and law enforcement agencies. The phrase 
'dialogue of the dear characterises the precise nature of the irrationality of illicit 
drug policy and, with the aid of the ACF, this thesis provided some explanation as to 
the reasons for the stalling of harm reduction policy in the 1990s. Indeed, such a 
stagnation in policy also explains the seeming apparent inability of the state to 
address problems connected to drug use and why they continue to occur. The search 
for a common language and epistemological tools by which illicit drug policy can be 
evaluated remains elusive and continues to stifle further implementation of harm 
reduction ideas in illicit drug policy and rational debate on this issue of injecting 
drug use more generally. 
With regard to the second aim of the thesis, the research questions posed in chapter 
two, that provided a framework to test the applicability of the ACF to policy change 
in illicit drug policy subsystem, were answered in chapter six. This thesis has clearly 
shown that the ACF can be applied to understand policy change in relation to illicit 
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drug policy, however there were some aspects of the ACF identified in this thesis 
that could be amended and/or addressed in the future in order to better respond to 
such scenarios. Indeed, further applications of the ACF to explain change in policy 
subsystems in which the activity studied is illicit and therefore unable to be 
controlled by Governments, would be useful in order to examine how the ACF can 
explain systems in which a fundamental and constant variable is change itself. 
Studies of social/moral policy questions (for example, abortion and sex work policy) 
in which a policy deadlock is more likely to occur due to epistemological differences 
between the main coalitions would complement and build upon the work conducted 
in this thesis, especially the implications for policy oriented learning. 
The third aim of this thesis, a discussion of the politics of harm reduction in 
Australia, has shown that the approach intersects with philosophies and debates that 
describe human nature and the role of drug use in society more generally. This 
thesis has shown that there is a ceiling that inhibits the further implementation of 
harm reduction approaches and that the oft-levelled accusation that such programs 
lead to an increase in illicit drug use is a key issue to be resolved. Harm reduction 
programs should invest in further research to debunk and/or respond to this 
argument492  , as it is an unresolved question that thwarts the implementation of, and 
discredits the notion of harm reduction policies in the wider community. 
It is clear that throughout the period of analysis in most writing on illicit drugs 
(whether such writing was derived from harm reduction or moral-abstinence 
coalitions, from Government, research institutes and other materials used in this 
thesis) that there was a ubiquitous image of the 'typical drug user'. This image relied 
492 While there have been some sporadic analyses however more systemic appraisals might be 
required. 
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on a simplification of the central image of a 'typical' user, their type of use, and the 
consequences of this use for mainstream society. The images associated with this 
popular construction of the illicit drug use problem are pervasive, for example: 
people overdosing in public areas; emancipated people at the mercy of dependencies; 
untidy appearances of drug users; labels such as 'welfare-seeking', 'work avoiding' 
and 'lazy'; and people subject to the 'disease' of drug use. This representation of the 
typical illicit drug user as ostensibly a 'hopeless junkie' that experiences problematic 
consequences as well as a chaotic lifestyle associated with their illicit drug use 
implies a homogeneity of the issue. From the perspective of the harm reduction 
coalition, while many advances had been made in illicit drug policy in Australia 
between 1980 and 2000 (for example: the lessening of penalties towards illicit drug 
users; implementation of NSPs; self-help drug user groups; and the recognition that 
licit drugs cause more harm than illicit drugs), by the end of this period the notion of 
the 'hopeless junkie' (and all the imagery associated with it) was still pervasive. 
Moreover, such stereotypes were used and/or perpetuated (whether consciously or 
inadvertently) as key constructs in the stages of problem definition and formulation 
of solutions by nearly all stakeholders — be they part of the harm reduction or moral-
abstinence advocacy coalitions - to varying degrees in the illicit drug policy 
subsystem. 
Such constructs as the 'hopeless junkie' notion are based on an assumption that illicit 
drugs are inherently harmful, and consequently that use of illicit drugs will result in 
negative outcomes (in terms of health, social, economic, moral and legal dimensions 
of harm) for most (if not all) people that use them. While it is understandable to 
direct social policies towards those with an identified need, the entire issue of illicit 
drug use in society seems to be represented by just one of its parts, and consequently 
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this focus has the function of defining all illicit drug users in relation to this 
'hopeless junkie' construct. The largest proportion of illicit drug consumers — the 
vast number of drug users that enjoy medium to high socio economic status, maintain 
relationships and otherwise experience minimal or no harms from recreational illicit 
drug use - were often forgotten in the (many types of) literature reviewed in this 
thesis when discussing illicit drugs and drug related harms. This ubiquitous usage of 
the 'hopeless junkie' as the image of the 'typical' drug user has the function of 
discounting and marginalising other possible variables such as socio-economic 
status, employment status, educational backgrounds and prohibition policy as factors 
that contribute to the experience of adverse consequences associated with illicit drug 
use. This homogeneity in the portrayal of drug consumers in the policy problem 
serves a clear political purpose, namely to reinforce core notions associated with the 
'war on drugs' rhetoric. This is a relic of the anti-drug social conditioning project 
that occurred alongside the implementation of prohibition regimes in the twentieth 
century (discussed briefly in chapter one). Assumptions underpinning this 'hopeless 
junkie' construct are key elements of the moral abstinence coalition's approach. It 
follows that if all drugs are inherently destructive in terms of physical, social, 
economic and moral harms, then abstinence from such drugs is the best approach in 
order to avoid such harms from occurring in both the context of the individual user 
and wider society. 
In its attempts to gain political support for its approaches to illicit drug policies, the 
harm reduction coalition often, perhaps inadvertently, reinforced the notion of the 
'hopeless junkie'. One example of this was in relation to the debates justifying the 
instigation of a SIC in NSW. Harm reduction advocates (in this case Dr. Ingrid van 
Beek) drew upon the notion of the disenfranchised, chaotic, problematic drug user 
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and appealed to moral arguments to help such people when advocating for the 
facility. Moreover, as recounted in chapter five, Premier Bob Can qualified his 
support for the facility with a statement on the immorality and personal abhorrence 
of the activity of injecting drug use. Indeed in advocacy attempts by the harm 
reduction coalition regarding SICs, the facility was generally advanced as a 
necessary evil rather than as a program to address public health problems of injecting 
drug users. Another example of the tacit reinforcement of the notion of the 'hopeless 
junkie' was with regard to the emphasis of harm reduction programs as either 
treatment gateways (in the case of NSPs) or treatment programs (in the case of SICs). 
Emphasis of the treatment gateway function of NSPs assumes that the majority of 
service consumers are in need of treatment. 
However, such a pragmatic approach to advocacy has worked well for the harm 
reduction coalition. While many a subset of harm reduction coalition members do 
attempt to deconstruct the 'hopeless junkie' notion to varying degrees, often, 
perpetuation of such an image is the entry price to mainstream debate. Membership 
of the harm reduction coalition is at its largest when the policy battlefield is closest to 
the mainstream. Echoing and reinforcing mainstream values, and emphasising the 
utility of harm reduction subjugated within that dominant framework was, and 
continues to be, a highly pragmatic strategy in order to realise policy objectives in 
the short term. This over-emphasis on the treatment function of NSPs reflects the 
way in which harm reduction advocates have to function within the dominant 
approach and avoid offending the sensibilities of mainstream society. Nevertheless, 
the strategy of ignoring or downplaying the existence of drug users that are high 
functioning with minimal harm connected to their drug use reinforces the hopeless 
junkie stereotype and the idea that all illicit drug use has negative consequences. 
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The example of HCV demonstrated that when a policy issue is confined to being 
ostensibly about improving the health of drug users (in contrast to HIV/AIDS 
whereby the threat to the mainstream health was more obvious and thus compelling) 
the size and potency of the harm reduction coalition shrinks. Indeed, in the case of 
HCV, the harm reduction coalition seems unable to get any traction with regard to 
policy change directed towards reductions in transmission within the drug using 
community. For transmission rates of HCV to be reduced, supply reduction 
initiatives must be reformed on a number of fronts as discussed in chapter four (in 
order to remove the stigmatisation and counter-productive environment that 
contributes to the ongoing transmission of HCV). This is a trade-off that most 
politicians are not prepared to make. The trade-off is essentially to decriminalise 
illicit drug use in order to reduce the health problems of those that choose to 
undertake the activity. Ultimately such a change to drug laws may also increase the 
number of users while concurrently reducing the harm associated with the activity. 
Such a situation is described by Wodak: 
Nevertheless, the view that society is better off with a tiny 
minority badly damaged by the high costs of drug use 
rather than a larger population only slightly injured is 
difficult to displace. This is the nub of the argument 
between supporters of supply reduction and advocates of 
harm reduction. A hypothetical world where policy 
relaxation might, by making drug use less hazardous, 
double the number of drug users but more than halve the 
number of casualties, would be applauded by harm 
reduction supporters and condemned by supply reduction 
supporters.493 
Authors of the ACF quite rightly theorised that phenomena such as drug laws are 
recognised as very hard to change by coalitions and therefore are rarely the subject of 
493 Wodak, A., 1997, 'Injecting nation: achieving control of hepatitis C in Australia', Drug and 
Alcohol Review, 16, p281. 
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coalition strategising. There is a drug law reform group 494 that shares some 
membership with, but is visibly separate to the harm reduction coalition. It is 
anticipated that the harm reduction coalition would reconfigure and most probably 
shrink in size if it was to pursue a longer-term agenda that agitated mainstream 
values. Sabatier and Jenkins-Smith were correct when they hypothesised that the 
fundamental glue of coalitions is at the level of policy core rather than deep core 
beliefs. It is hypothesised in this thesis that there would be a disparity between the 
deep core beliefs of harm reduction coalition members derived from church groups, 
self-help drug user groups and the medical community regarding the role of drug use 
in society. Indeed, this disparity would be apparent both between and within the 
groups. If harm reduction coalition members attempted to, on a large scale, 
dismantle the image of the 'hopeless junkie', in the short term they would be open to 
accusations of having a pro-drug stance. Consequently, allegations that the harm 
reduction approach is linked to a broader agenda of normalising (and by extension 
encouraging the uptake of) illicit drug use would ensue. Obviously this accusation 
would sully future advocacy attempts. 
There are many benefits that may ensue from the reconstruction of the notion of the 
illicit drug user away from the 'hopeless junkie' construct and toward a more 
complex representation of the issue by the harm reduction advocacy coalition. By 
reconstructing the popular image of illicit drug takers as those that occupy all levels 
of socio-economic status and experience different degrees of harm from their use 
might broaden the relevance of harm reduction programs such as NSPs to a wider 
audience of existing drug users (some might not currently wish to access such 
programs due to a fear of breach of confidentiality or associating with problematic 
494 Australian Drug Law Reform Foundation website: http://home.vicnet.net.au/-adlr)'ouraims.html  
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drug users) and in turn engender more adventurous and more effective harm 
reduction practice. Consequently, harm reduction programs might not be seen as a 
'necessary evil' by Governments, subordinate to prohibition and contingent on the 
existence of BBVs such as HIV/AIDS and HCV to survive. Finally, such a direction 
might also serve to de-stigmatise drug use and drug users - in the process improving 
health outcomes as the activity of drug use is not something that consumers need to 
necessarily conceal to the extent that occurs currently. Such concealment of the 
practice arguably compounds the instance of drug-related harm as stated in earlier 
chapters. Meanwhile, other groups in society, such as the drug law reform group 
could pursue a more radical agenda independent of the harm reduction coalition, for 
example suggesting that: 
...drugs should be appreciated as a cultural asset, similar to 
religion and art. In the "high" an inner field of experience 
is opened up that would remain closed forever without 
mind-altering substances. Temporary but drastic changes 
in the mind are produced that one could never experience 
without drugs, just like there is no substitute for a loving 
relation or a parachute jump. The induced feeling can be 
wild and ecstatic, or soft and empathic. The experience can 
be spiritual, oppressive or alienating or on the contrary 
endlessly serene. The user can "go through the roof', 
observe a colour never before observed or feel a cosmic 
'nothing' on his own skin but everyone who has ever used 
LSD or ecstasy knows that the experience is unique, and 
that they who claim that they can reach the same effect just 
as well "in another way", simply do not know what they are 
talking about. Now the fact is that a great many citizens of 
all countries of the world feel deeply attracted to this type 
of experience. 495 
As noted earlier any challenge to the fundamentals underwriting the dominant 
thinking on illicit drugs is a momentous task, and to an extent, might confirm the 
suspicions of those who distrust the harm reduction ethos and/or alienate existing 
495 van Ree, E., 1999, 'Drugs as a human right', International Journal of Drug Policy, 10, p93. 
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supporters of harm reduction, such as some church groups. Nevertheless this tension 
within the harm reduction coalition in relation to deep core beliefs may be raised as 
an issue in the longer term depending on the direction of future illicit drug policies. 
In sum, it is apparent from this study of the evolution of harm reduction policy in 
Australia between 1980 and 2000 that there is a tension between aspects of the 
original political agenda implicit within the harm reduction ethos (as described in 
chapter one) and the manner in which harm reduction ideas have evolved as a result 
of being implemented by governments and manifested in mainstream illicit drug 
policy. As noted, the tension concerns whether to exist within (and consequently not 
agitate to a great extent) the dominant paradigm of illicit drug policy and wider 
cultural norms regarding the 'hopeless junkie', or, whether to attempt to pursue a 
more political agenda that challenges status quo ideas about the illicit drug 
'problem'. To an extent, the trade-off of occupying a role in mainstream policy 
means that policy advocates must be careful not be perceived as too radical in their 
policy proposals (in this sense they are occupying a policy strait-jacket), however 
much could be gained in the long term if advocates would aim to further discredit the 
'hopeless junkie' construct, and at the very least, continue to identify the phenomena 
of problematic drug use as often linked to (and in some cases generated by) 
prohibition regimes and other variables such as economic status that exacerbate drug-
related harms. 
It is predicted that, in the future, moral-abstinence advocates will be compelled to 
produce more evidence than they currently provide to support advocacy efforts, 
whether focused on new solutions or on criticisms of harm reduction. It is not 
suggested, however, that this will be a major change or occur in the short term. 
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Indeed, the current Australian Government lead by Prime Minister John Howard 
seems entirely resolute to not implement or at very least to vehemently discourage 
any further types of harm reduction programs that are perceived to be more radical 
than those that currently exist (specifically more SICs or prescription heroin) while 
in office. In 2001, the position of the Federal Liberal Government was reaffirmed on 
the issue of a prospective heroin trial by the then Minister of Justice and Customs, 
Senator Ellison: 
The Government believes that the most effective way to 
tackle the illicit drug problem is to reduce the supply of 
illicit drugs in the community. It is in this environment that 
education about the dangers of illicit drugs for young 
Australians and health and diversionary programmes are 
most effective. 496 
In the same press statement Senator Ellison distinguished the Federal ALP's stance 
from that of the Howard Governments'. 
Mr Beazley again confirmed today that the Labor Party 
would support any State that brought forward a trial for 
heroin injecting rooms, a clear confirmation of their soft on 
crime approach to illicit drugs.497 
It would be naive and somewhat presumptuous to suggest that in the future, the 
election of a Federal ALP Government in Australia would automatically signify a 
supportive environment for harm reduction policies and programs to flourish. 
However, even a change to the leadership of the Federal Liberal Party, would no 
doubt, generate hope for the coalition that has been regularly thwarted by Prime 
Minister Howard who has personally buoyed the political power of supporters of 
moral-abstinence approaches. While such a change in Government might not 
496 	. . Minister of Justice and Customs, 8/10/2001 'Government rejects heroin trial', Media Release, 
From: 
http://www.ag.gov.au/agd/WWW/justiceministerHome.nsf/Page/Media Releases 2001 3rd Quarter  
8 August 2001 - Government Rejects Heroin Trial 
4" ibid. 
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engender changes to the policy core of illicit drug policy, secondary changes might 
be more forthcoming. 
Injecting drug use continues to be regarded as an extremely immoral and dangerous 
activity. Any efforts that attempt to reduce the stigmatisation associated with this 
activity frightens the majority of the population. That injecting drug use does not 
always cause harm to the consumer or other people, in combination with the 
evidence suggesting that the majority of harm associated with injecting drugs is 
created by government policies, the level of concern about this activity is arguably 
disproportionate, and at very least, misdirected. The ACF has proven to be valuable 
in identifying reasons why Australian illicit drug policy has been in a rut since the 
1980s and the persistence of drug related harms. While some level of harm is no 
doubt unavoidable due to the pharmacology of illicit drugs, a secondary layer of 
harm is directly maintained by the dominant policy framework within which harm 
reduction operates. In the longer term, harm reduction advocacy will continue to be 
hamstrung by both its opponents and its own members. The latter is due to the 
discord in deep core values between members of the harm reduction coalition in 
regard to the role, and the inherent danger or otherwise, of drug use to society. The 
diverse membership of the coalition is at least united by pragmatism and a belief in 
evidence-based approaches, however the elasticity of the support base is often 
tenuous. 
In sum this research has proved useful in understanding advocacy of 'politically 
difficult' policy. To advocate the spending of public funds on what is often regarded 
284 
as undeserving group of people is a brave contention, unless it is framed in the 
interests of the general public. It can only be hoped in the future that the issue of 
drug use is examined more critically in the interests of future casualties that occur 
alongside the deadlock in illicit drug policy debate. 
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